FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Steppuhn, H
   Laussmann, D
   Baumert, J
   Kroll, L
   Lampert, T
   Plass, D
   Scheidt-Nave, C
   Heidemann, C
AF Steppuhn, Henriette
   Laussmann, Detlef
   Baumert, Jens
   Kroll, Lars
   Lampert, Thomas
   Plass, Dietrich
   Scheidt-Nave, Christa
   Heidemann, Christin
TI Individual and area-level determinants associated with C-reactive
   protein as a marker of cardiometabolic risk among adults: Results from
   the German National Health Interview and Examination Survey 2008-2011
SO PLOS ONE
LA English
DT Article
ID MATTER AIR-POLLUTION; INFLAMMATORY MARKERS; SOCIOECONOMIC-STATUS;
   CARDIOVASCULAR-DISEASE; PARTICULATE MATTER; WAIST CIRCUMFERENCE;
   VASCULAR-DISEASE; BLOOD MARKERS; LIFE-COURSE; HS-CRP
AB Background
   High-sensitivity C-reactive protein (hsCRP) is a sensitive biomarker of systemic inflammation and is related to the development and progression of cardiometabolic diseases. Beyond individual-level determinants, characteristics of the residential physical and social environment are increasingly recognized as contextual determinants of systemic inflammation and cardiometabolic risks. Based on a large nationwide sample of adults in Germany, we analyzed the cross-sectional association of hsCRP with residential environment characteristics. We specifically asked whether these associations are observed independent of determinants at the individual level.
   Methods
   Data on serum hsCRP levels and individual sociodemographic, behavioral, and anthropometric characteristics were available from the German Health Interview and Examination Survey for Adults (2008-2011). Area-level variables included, firstly, the predefined German Index of Socioeconomic Deprivation (GISD) derived from the INKAR (indicators and maps on spatial and urban development in Germany and Europe) database and, secondly, population- weighted annual average concentration of particulate matter (PM10) in ambient air provided by the German Environment Agency. Associations with log-transformed hsCRP levels were analyzed using random-intercept multi-level linear regression models including 6,768 participants aged 18-79 years nested in 162 municipalities.
   Results
   No statistically significant association of PM10 exposure with hsCRP was observed. However, adults residing in municipalities with high compared to those with low social deprivation showed significantly elevated hsCRP levels (change in geometric mean 13.5%, 95% CI 3.2%-24.7%) after adjusting for age and sex. The observed relationship was independent of individual-level educational status. Further adjustment for smoking, sports activity, and abdominal obesity appeared to markedly reduce the association between area-level social deprivation and hsCRP, whereas all individual-level variables contributed significantly to the model.
   Conclusions
   Area-level social deprivation is associated with higher systemic inflammation and the potentially mediating role of modifiable risk factors needs further elucidation. Identifying and assessing the source-specific harmful components of ambient air pollution in populationbased studies remains challenging.
C1 [Steppuhn, Henriette; Laussmann, Detlef; Baumert, Jens; Kroll, Lars; Lampert, Thomas; Scheidt-Nave, Christa; Heidemann, Christin] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany.
   [Steppuhn, Henriette; Laussmann, Detlef; Scheidt-Nave, Christa; Heidemann, Christin] German Ctr Diabet Res DZD, Munich, Germany.
   [Plass, Dietrich] German Environm Agcy, Dept Environm Hyg, Berlin, Germany.
RP Steppuhn, H (reprint author), Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany.; Steppuhn, H (reprint author), German Ctr Diabet Res DZD, Munich, Germany.
EM steppuhnh@rki.de
FU Federal Ministry of Health Germany [IIA5-2513-FSB-73]; German Federal
   Ministry of Education and Research [01GI1121B]; German Center for
   Diabetes Research (DZD) - German Federal Ministry of Education and
   Research [HMGU2016Z2]
FX The DEGS study was funded by the Federal Ministry of Health Germany
   (IIA5-2513-FSB-73; http://www.bmg.bund.de/en.html) and the German
   Federal Ministry of Education and Research (01GI1121B;
   https://www.bmbf.de/en/index.html).This study was supported by a
   research grant from the German Center for Diabetes Research (DZD,
   https://www.dzd-ev.de) funded by the German Federal Ministry of
   Education and Research (HMGU2016Z2). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ahmadi-Abhari S, 2013, EUR J EPIDEMIOL, V28, P541, DOI 10.1007/s10654-013-9819-6
   BBSR, 2016, INKAR 2016 ERL RAUMB
   Brahimaj A, 2017, EUR J EPIDEMIOL, V32, P217, DOI 10.1007/s10654-017-0236-0
   BRAUNS H, 1999, ZUMA NACHRICHTEN, V44, P7
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Brooks GC, 2010, AM J CARDIOL, V106, P56, DOI 10.1016/j.amjcard.2010.02.017
   Broyles ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045419
   Choi WW, 2016, SSM-POPUL HLTH, V2, P889, DOI 10.1016/j.ssmph.2016.11.001
   Creatore MI, 2016, JAMA-J AM MED ASSOC, V315, P2211, DOI 10.1001/jama.2016.5898
   Dallmeier D, 2014, BEST PRACT RES CL EN, V28, P281, DOI 10.1016/j.beem.2014.01.003
   Davillas A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02888-6
   Delignette-Muller ML, 2015, J STAT SOFTW, V64, P1
   Ellulu MS, 2017, ARCH MED SCI, V13, P851, DOI 10.5114/aoms.2016.58928
   Fedewa MV, 2017, BRIT J SPORT MED, V51, P670, DOI 10.1136/bjsports-2016-095999
   Ford ES, 2002, EPIDEMIOLOGY, V13, P561, DOI 10.1097/01.EDE.0000023965.92535.C0
   Fraga S, 2015, PREV MED, V71, P12, DOI 10.1016/j.ypmed.2014.11.031
   Haftenberger M, 2016, OBESITY FACTS, V9, P332, DOI 10.1159/000446964
   Hampel R, 2015, ENVIRON INT, V82, P76, DOI 10.1016/j.envint.2015.05.008
   Heidemann C, 2014, DIABETIC MED, V31, P1269, DOI 10.1111/dme.12480
   Hennig F, 2014, ENVIRON HEALTH PERSP, V122, P703, DOI 10.1289/ehp.1307081
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46, DOI DOI 10.1080/1047322X.1990.10389587
   Inst Med, 2010, EVALUATION OF BIOMARKERS AND SURROGATE ENDPOINTS IN CHRONIC DISEASE, P1
   Jannasch F, 2017, J NUTR, V147, P1174, DOI 10.3945/jn.116.242552
   Johnson TV, 2013, MOL DIAGN THER, V17, P147, DOI 10.1007/s40291-013-0026-7
   KALLWEIT D, 2013, UMW MENSCH INFORM, V4, P18
   Kamtsiuris P, 2013, BUNDESGESUNDHEITSBLA, V56, P620, DOI 10.1007/s00103-012-1650-9
   Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477
   Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7
   Kianoush S, 2017, J AM HEART ASS, V6
   Koenig W, 2008, CLIN CHEM, V54, P335, DOI 10.1373/clinchem.2007.100271
   KROLL LE, 2017, J HLTH MONITOR, V2, P98, DOI DOI 10.17886/RKI-GBE-2017-048
   Kroll LE, 2017, GERMAN INDEX SOCIOEC
   Krug S, 2013, BUNDESGESUNDHEITSBLA, V56, P765, DOI 10.1007/s00103-012-1661-6
   Kurth BM, 2009, BUNDESGESUNDHEITSBLA, V52, P557, DOI 10.1007/s00103-009-0843-3
   Lanki T, 2015, ENVIRON HEALTH PERSP, V123, P785, DOI 10.1289/ehp.1408224
   LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158
   Lehtonen R, 2004, PRACTICAL METHOD DES
   Levitzky YS, 2008, ATHEROSCLEROSIS, V201, P217, DOI 10.1016/j.atherosclerosis.2007.12.058
   Li Yanli, 2012, Reviews on Environmental Health, V27, P133, DOI 10.1515/reveh-2012-0012
   Loucks EB, 2010, SOC SCI MED, V71, P187, DOI 10.1016/j.socscimed.2010.03.012
   Ludwig J, 2011, NEW ENGL J MED, V365, P1509, DOI 10.1056/NEJMsa1103216
   Macintyre S, 2002, SOC SCI MED, V55, P125, DOI 10.1016/S0277-9536(01)00214-3
   Maier W, 2013, DIABETIC MED, V30, pE78, DOI 10.1111/dme.12062
   Maier W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089661
   McDade TW, 2006, PSYCHOSOM MED, V68, P376, DOI 10.1097/01.psy.0000221371.43607.64
   McEvoy JW, 2015, ARTERIOSCL THROM VAS, V35, P1002, DOI 10.1161/ATVBAHA.114.304960
   Mensink GBM, 2013, BUNDESGESUNDHEITSBLA, V56, P786, DOI 10.1007/s00103-012-1656-3
   Muller G, 2015, DIABETIC MED, V32, P1017, DOI 10.1111/dme.12652
   Muller G, 2013, AM J EPIDEMIOL, V178, P221, DOI 10.1093/aje/kws466
   Nasef NA, 2017, ARCH TOXICOL, V91, P1131, DOI 10.1007/s00204-016-1914-5
   National Cholesterol Education Program (NCEP), 2002, CIRCULATION, P3143, DOI DOI 10.2215/CJN.04131206
   National Institutes of Health, 2000, NIH PUBLICATION
   Nazmi A, 2010, HEALTH PLACE, V16, P1104, DOI 10.1016/j.healthplace.2010.07.001
   Neale EP, 2016, NUTR RES, V36, P391, DOI 10.1016/j.nutres.2016.02.009
   Noble M, 2006, ENVIRON PLANN A, V38, P169, DOI 10.1068/a37168
   OPENSHAW S, 1984, ENVIRON PLANN A, V16, P17, DOI 10.1068/a160017
   Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45
   Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921
   Petersen KL, 2008, PSYCHOSOM MED, V70, P646, DOI 10.1097/PSY.0b013e31817b8ee4
   Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI [10.1093/eurheartj/ehw106, 10.1016/j.rec.2016.09.009]
   Pollitt RA, 2008, J EPIDEMIOL COMMUN H, V62, P484, DOI 10.1136/jech.2006.054106
   Pollitt RA, 2007, EUR J EPIDEMIOL, V22, P55, DOI 10.1007/s10654-006-9082-1
   Ricordi C, 2015, J AM COLL NUTR, V34, P10, DOI 10.1080/07315724.2015.1080101
   Ridker PM, 2018, LANCET, V391, P319, DOI 10.1016/S0140-6736(17)32814-3
   Ridker PM, 2016, CIRC RES, V118, P145, DOI 10.1161/CIRCRESAHA.115.306656
   Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x
   Sallis JF, 2016, LANCET, V387, P2207, DOI 10.1016/S0140-6736(15)01284-2
   SCHEIDTNAVE C, 2012, BMC PUBLIC HEALTH, V12
   Schuurman N, 2007, J URBAN HEALTH, V84, P591, DOI 10.1007/s11524-007-9193-3
   Sears B, 2012, EUR REV MED PHARMACO, V16, P1137
   Shih WJ, 1987, J STAT COMPUT SIM, V28, P81
   Shivappa N, 2014, PUBLIC HEALTH NUTR, V17, P1825, DOI 10.1017/S1368980013002565
   Tang Y, 2017, CLIN EXP PHARM PHYSL
   Tawakol A, 2017, LANCET, V389, P834, DOI 10.1016/S0140-6736(16)31714-7
   Viehmann A, 2015, OCCUP ENVIRON MED, V72, P656, DOI 10.1136/oemed-2014-102800
   Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702
   Williams ED, 2012, DIABETES CARE, V35, P1455, DOI 10.2337/dc11-1410
   Wolf K, 2016, DIABETES, V65, P3314, DOI 10.2337/db15-1567
   World Health Organisation, 2006, WHO AIR QUALITY GUID
NR 79
TC 0
Z9 0
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 8
PY 2019
VL 14
IS 2
AR e0211774
DI 10.1371/journal.pone.0211774
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HK7PK
UT WOS:000458181200026
PM 30735532
OA Other Gold
DA 2019-05-24
ER

PT J
AU Qu, YM
   Pan, Y
   Niu, HK
   He, YH
   Li, MQ
   Li, L
   Liu, JW
   Li, B
AF Qu, Yangming
   Pan, Yang
   Niu, Huikun
   He, Yinghua
   Li, Meiqi
   Li, Lu
   Liu, Jianwei
   Li, Bo
TI Short-term effects of fine particulate matter on non-accidental and
   circulatory diseases mortality: A time series study among the elder in
   Changchun
SO PLOS ONE
LA English
DT Article
ID EXPOSURE MEASUREMENT ERROR; HEART-RATE-VARIABILITY; AIR-POLLUTION;
   HEALTH; PM2.5; PARTICLES; CITIES; EPIDEMIOLOGY; ASSOCIATION; MODIFIERS
AB Background and objectives
   Fine particulate matter (PM2.5, particulate matter with an aerodynamic diameter less than or equal to 2.5 mu m) has multiple adverse effects on human health, especially on the respiratory and circulatory system. The purpose of this study was to evaluate the short-term effect of PM2.5 on the mortality risk of non-accidental and circulatory diseases, and to explore the potential effect modification by sex, education and death location.
   Methods
   We collected daily mortality counts of Changchun (China) residents, daily meteorology and air pollution data, from January 1, 2014, to January 1, 2017. We focused on the elderly (>= 65 years old) population who died from non-accidental causes and circulatory diseases, and stratified them by sex, education, and death location. A generalized additive Poisson regression model (GAM) was used to analyse the impact of air pollutants on mortality. We fit single pollutant models to examine PM2.5 effects with different lag structures of single-day (distributed lag:lag0-lag3) and multi-day (moving average lag:lag01-lag03). To test the sensitivity of the model, a multi-pollutant model was established when the PM2.5 effect was strongest.
   Results
   In the single pollutant models, an increment of PM2.5 by 10 mu g/m(3) at lag0-3 was associated with a 0.385% (95% CI: 0.069% to 0.702%) increase in daily non-accidental mortality and a 0.442% (95% CI: 0.038% to 0.848%) increase in daily circulatory disease mortality. NO2 (lag1) and O-3 (lag0, lag1, lag2, lag01, lag02, lag03) were associated with daily non-accidental death and NO2 (lag1, lag3, lag03) and O-3 (lag0, lag1, lag01, lag02, lag03) were associated with daily circulatory disease mortality. In the co-pollutant models, the risk estimates for PM2.5 changed slightly. The excess mortality risk of non-accidental and circulatory diseases was higher for women, people with low education, and died outside hospital.
   Conclusions
   We found that short-term exposure to PM2.5 increased the mortality risk of non-accidental and circulatory diseases among the elderly in Changchun. Women, people with low education and died outside hospital are more susceptible to PM2.5. NO2 and O-3 were also associated with an increase in mortality from non-accidental and circulatory diseases and the O-3 is a high effect.
C1 [Qu, Yangming; Niu, Huikun; Li, Meiqi; Li, Lu; Li, Bo] Jilin Univ, Sch Publ Hlth, Minist Educ, Key Lab Zoonosis Res, Changchun, Jilin, Peoples R China.
   [Pan, Yang; He, Yinghua; Liu, Jianwei] Jilin Prov Ctr Dis Control & Prevent, Changchun, Jilin, Peoples R China.
RP Li, B (reprint author), Jilin Univ, Sch Publ Hlth, Minist Educ, Key Lab Zoonosis Res, Changchun, Jilin, Peoples R China.
EM li_bo@jlu.edu.cn
FU China's central government; Key scientific research project of Jilin
   Provincial Health and Family Planning Commission [2015Z03]
FX China's central government subsidizes projects to monitor the impact of
   local air pollution on people's health; Key scientific research project
   of Jilin Provincial Health and Family Planning Commission in 2015
   (2015Z03).
CR Apte JS, 2015, ENVIRON SCI TECHNOL, V49, P8057, DOI 10.1021/acs.est.5b01236
   Atkinson RW, 2015, J EXPO SCI ENV EPID, V25, P208, DOI 10.1038/jes.2014.63
   Baxter LK, 2013, J EXPO SCI ENV EPID, V23, P457, DOI 10.1038/jes.2012.114
   Brauer M, 2016, ENVIRON SCI TECHNOL, V50, P79, DOI 10.1021/acs.est.5b03709
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Chen RJ, 2011, SCI TOTAL ENVIRON, V409, P4923, DOI 10.1016/j.scitotenv.2011.08.029
   Chen RC, 2017, AM J RESP CRIT CARE, V196, P700, DOI [10.1164/rccm.201612-2427OC, 10.1164/rccm.201609-1862OC, 10.1164/rccm.201609-1862oc]
   Clougherty JE, 2010, ENVIRON HEALTH PERSP, V118, P167, DOI 10.1289/ehp.0900994
   Cox LA, 2013, REGUL TOXICOL PHARM, V66, P336, DOI 10.1016/j.yrtph.2013.05.006
   Devlin RB, 2003, EUR RESPIR J, V21, p76S, DOI 10.1183/09031936.03.00402403
   Electric heating versus oil heating in the service territory of Long Island Lighting Company, 1973, ELECT HEATING VERSUS
   Fiordelisi A, 2017, HEART FAIL REV, V22, P337, DOI 10.1007/s10741-017-9606-7
   Franklin M, 2007, J EXPO SCI ENV EPID, V17, P279, DOI 10.1038/sj.jes.7500530
   Gong H, 2004, INHAL TOXICOL, V16, P335, DOI 10.1080/08958370490439470
   Hong YC, 2002, ENVIRON HEALTH PERSP, V110, P187, DOI 10.1289/ehp.02110187
   Janssen NAH, 2013, SCI TOTAL ENVIRON, V463, P20, DOI 10.1016/j.scitotenv.2013.05.062
   Jindal SK, 2007, INDIAN J MED RES, V126, P409
   Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1183, DOI 10.1289/ehp.10851
   Kim CS, 1998, J APPL PHYSIOL, V84, P1834
   Kim KH, 2015, ENVIRON INT, V74, P136, DOI 10.1016/j.envint.2014.10.005
   Kloog I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088578
   Kloog I, 2013, EPIDEMIOLOGY, V24, P555, DOI 10.1097/EDE.0b013e318294beaa
   Krewski Daniel, 2009, Res Rep Health Eff Inst, P5
   Lepeule J, 2012, ENVIRON HEALTH PERSP, V120, P965, DOI 10.1289/ehp.1104660
   Li P, 2015, ENVIRON SCI POLLUT R, V22, P358, DOI 10.1007/s11356-014-3301-1
   Li T, 2018, ENVIRON INT, V111, P52, DOI 10.1016/j.envint.2017.10.023
   Liang HQ, 2018, SCI TOTAL ENVIRON, V615, P558, DOI 10.1016/j.scitotenv.2017.09.266
   Niu JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083782
   Pellizzari ED, 1999, J EXPO ANAL ENV EPID, V9, P49, DOI 10.1038/sj.jea.7500025
   Petronella SA, 2003, NURS CLIN N AM, V38, P725, DOI 10.1016/S0029-6465(03)00099-9
   Ren M, 2017, CONCENTRATION RESPON, V2017, DOI 10.1155/2017/5806185
   Romieu I, 2005, AM J RESP CRIT CARE, V172, P1534, DOI 10.1164/rccm.200503-372OC
   Rotko T, 2001, J EXPO ANAL ENV EPID, V11, P216, DOI 10.1038/sj.jea.7500162
   Samoli E, 2013, ENVIRON HEALTH PERSP, V121, P932, DOI 10.1289/ehp.1206124
   Schwartz J, 2007, J EXPO SCI ENV EPID, V17, pS2, DOI 10.1038/sj.jes.7500619
   SEXTON K, 1993, TOXICOL IND HEALTH, V9, P843, DOI 10.1177/074823379300900509
   Song YS, 2016, J CLEAN PROD, V112, P1312, DOI 10.1016/j.jclepro.2015.05.006
   Sorensen M, 2003, ENVIRON HEALTH PERSP, V111, P161, DOI 10.1289/ehp.5646
   Wang Y, 2017, EPIDEMIOLOGY, V28, P207, DOI 10.1097/EDE.0000000000000614
   Wilkinson RG, 1997, LANCET, V350, P516, DOI 10.1016/S0140-6736(05)63105-4
   Yang CX, 2012, INT ARCH OCC ENV HEA, V85, P579, DOI 10.1007/s00420-011-0707-7
   Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382
   Zeka A, 2006, AM J EPIDEMIOL, V163, P849, DOI 10.1093/aje/kwj116
   Zuo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023116
NR 44
TC 0
Z9 0
U1 9
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 31
PY 2018
VL 13
IS 12
AR e0209793
DI 10.1371/journal.pone.0209793
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HG0IO
UT WOS:000454627200086
PM 30596713
OA DOAJ Gold
DA 2019-05-24
ER

PT J
AU Karki, P
   Meliton, A
   Shah, A
   Tian, YF
   Ohmura, T
   Sarich, N
   Birukova, AA
   Birukov, KG
AF Karki, Pratap
   Meliton, Angelo
   Shah, Alok
   Tian, Yufeng
   Ohmura, Tomomi
   Sarich, Nicolene
   Birukova, Anna A.
   Birukov, Konstantin G.
TI Role of truncated oxidized phospholipids in acute endothelial barrier
   dysfunction caused by particulate matter
SO PLOS ONE
LA English
DT Article
ID ACUTE LUNG INJURY; AIR-POLLUTION; VE-CADHERIN; TYROSINE PHOSPHORYLATION;
   CARDIOVASCULAR-DISEASE; VASCULAR-PERMEABILITY; DNA METHYLATION;
   EXPOSURE; INFLAMMATION; P120-CATENIN
AB Particulate matter (PM) air pollution is a global environmental health problem contributing to more severe lung inflammation and injury. However, the molecular and cellular mechanisms of PM-induced exacerbation of lung barrier dysfunction and injury are not well understood. In the current study, we tested a hypothesis that PM exacerbates vascular barrier dysfunction via ROS-induced generation of truncated oxidized phospholipids (Tr-OxPLs). Treatment of human pulmonary endothelial cells with PM caused endothelial cell barrier disruption in a dose-dependent fashion. Biochemical analysis showed destabilization of cell junctions by PM via tyrosine phosphorylation and internalization of VE-cadherin. These events were accompanied by PM-induced generation of Tr-OxPLs, detected by mass spectrometry analysis. Furthermore, purified Tr-OxPLs: POVPC, PGPC and lyso-PC alone, caused a rapid increase in endothelial permeability and augmented pulmonary endothelial barrier dysfunction induced by submaximal doses of PM. In support of a role of TR-OxPLs-dependent mechanism in mediation of PM effects, ectopic expression of intracellular type 2 platelet-activating factor acetylhydrolase (PAFAH2), which specifically hydrolyzes Tr-OxPLs, significantly attenuated PM-induced endothelial hyperpermeability. In summary, this study uncovered a novel mechanism of PM-induced sustained dysfunction of pulmonary endothelial cell barrier which is driven by PM-induced generation of truncated products of phospholipid oxidation causing destabilization of cell junctions.
C1 [Karki, Pratap; Birukova, Anna A.] Univ Maryland, Dept Med, Baltimore, MD 21201 USA.
   [Meliton, Angelo; Shah, Alok; Tian, Yufeng; Ohmura, Tomomi; Sarich, Nicolene; Birukova, Anna A.; Birukov, Konstantin G.] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.
   [Birukov, Konstantin G.] Univ Maryland, Dept Anesthesiol, Baltimore, MD 21201 USA.
RP Birukov, KG (reprint author), Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Birukov, KG (reprint author), Univ Maryland, Dept Anesthesiol, Baltimore, MD 21201 USA.
EM kbirukov@som.umaryland.edu
OI Shah, Alok/0000-0003-2916-9267
FU National Heart, Lung, and Blood Institute [HL076259, HL087823, HL107920,
   HL130431]; National Institute of General Medical Sciences [GM122940,
   GM114171]
FX This research was supported by the National Heart, Lung, and Blood
   Institute, HL076259 (KGB), HL087823 (KGB), HL107920 (AAB), HL130431
   (AAB), National Institute of General Medical Sciences, GM122940 (KGB)
   and GM114171 (AAB).
CR Alcaide P, 2008, BLOOD, V112, P2770, DOI 10.1182/blood-2008-03-147181
   Anderson JO, 2012, J MED TOXICOL, V8, P166, DOI 10.1007/s13181-011-0203-1
   Angelini DJ, 2006, AM J PHYSIOL-LUNG C, V291, pL1232, DOI 10.1152/ajplung.00109.2006
   Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC
   Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06
   Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com
   Birukova AA, 2007, AM J PHYSIOL-LUNG C, V292, pL924, DOI 10.1152/ajplung.00395.2006
   Birukova AA, 2007, J CELL PHYSIOL, V211, P608, DOI 10.1002/jcp.20966
   Birukova AA, 2013, TRANSL RES, V161, P495, DOI 10.1016/j.trsl.2012.12.008
   Birukova AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030957
   Birukova AA, 2011, J CELL PHYSIOL, V226, P2052, DOI 10.1002/jcp.22543
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Bochkov VN, 2010, ANTIOXID REDOX SIGN, V12, P1009, DOI 10.1089/ars.2009.2597
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8
   Budinger GRS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018525
   Cantone L, 2017, ENVIRON RES, V152, P478, DOI 10.1016/j.envres.2016.11.002
   Carpenter CT, 1998, CHEST, V114, P1653, DOI 10.1378/chest.114.6.1653
   Chiarella SE, 2014, J CLIN INVEST, V124, P2935, DOI 10.1172/JCI75157
   Cui YQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16339
   Dai JW, 2016, FEBS OPEN BIO, V6, P720, DOI 10.1002/2211-5463.12077
   Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897
   Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127
   Downs SH, 2007, NEW ENGL J MED, V357, P2338, DOI 10.1056/NEJMoa073625
   Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159
   Esser S, 1998, J CELL SCI, V111, P1853
   Farina F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056636
   Fiordelisi A, 2017, HEART FAIL REV, V22, P337, DOI 10.1007/s10741-017-9606-7
   Gauderman WJ, 2004, NEW ENGL J MED, V351, P1057, DOI 10.1056/NEJMoa040610
   Karki P, 2018, TISSUE BARRIERS, V6, DOI 10.1080/21688370.2017.1385573
   Ke YB, 2017, CIRC RES, V121, P244, DOI 10.1161/CIRCRESAHA.116.310308
   Kelly FJ, 2015, ANN NY ACAD SCI, V1340, P84, DOI 10.1111/nyas.12720
   Lawal AO, 2016, TOXICOL IN VITRO, V32, P92, DOI 10.1016/j.tiv.2015.12.015
   Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371
   Madrigano J, 2011, ENVIRON HEALTH PERSP, V119, P977, DOI 10.1289/ehp.1002773
   McIntyre TM, 2012, BBA-BIOMEMBRANES, V1818, P2456, DOI 10.1016/j.bbamem.2012.03.004
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Montuschi P, 2000, AM J RESP CRIT CARE, V162, P1175, DOI 10.1164/ajrccm.162.3.2001063
   Murley JS, 2001, FREE RADICAL BIO MED, V30, P1426, DOI 10.1016/S0891-5849(01)00554-8
   Mutlu GM, 2006, AM J RESP CELL MOL, V34, P670, DOI 10.1165/rcmb.2005-0329OC
   Newby DE, 2015, EUR HEART J, V36, P83, DOI 10.1093/eurheartj/ehu458
   Nonas S, 2006, AM J RESP CRIT CARE, V173, P1130, DOI 10.1164/rccm.200511-1737OC
   Nonas S, 2008, CRIT CARE, V12, DOI 10.1186/cc6805
   Opal SM, 2015, J INTERN MED, V277, P277, DOI 10.1111/joim.12331
   Oskolkova O, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19197-1
   Paulin L, 2016, F1000RES, V5, DOI [10.12688/f1000research.7108.1, DOI 10.12688/F1000RESEARCH.7108]
   Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200
   Quinlan GJ, 1996, CRIT CARE MED, V24, P241, DOI 10.1097/00003246-199602000-00010
   Shasby DM, 2002, AM J PHYSIOL-LUNG C, V282, pL1330, DOI 10.1152/ajplung.00329.2001
   Soberanes S, 2009, J BIOL CHEM, V284, P2176, DOI 10.1074/jbc.M808844200
   Starosta V, 2012, AM J RESP CELL MOL, V46, P331, DOI 10.1165/rcmb.2011-0153OC
   Tamagawa E, 2008, AM J PHYSIOL-LUNG C, V295, pL79, DOI 10.1152/ajplung.00048.2007
   Tarantini L, 2009, ENVIRON HEALTH PERSP, V117, P217, DOI 10.1289/ehp.11898
   Tian XY, 2014, J BIOL CHEM, V289, P5168, DOI 10.1074/jbc.M113.493924
   Tian YF, 2016, J BIOL CHEM, V291, P10032, DOI 10.1074/jbc.M115.690487
   Wang T, 2017, PULM CIRC, V7, P617, DOI 10.1086/689906
   Wang T, 2010, AM J RESP CELL MOL, V42, P442, DOI 10.1165/rcmb.2008-0402OC
NR 57
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 12
PY 2018
VL 13
IS 11
AR e0206251
DI 10.1371/journal.pone.0206251
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HA0PF
UT WOS:000449909200009
PM 30419037
OA DOAJ Gold
DA 2019-05-24
ER

PT J
AU Ladva, CN
   Golan, R
   Liang, DH
   Greenwald, R
   Walker, DI
   Uppal, K
   Raysoni, AU
   Tran, V
   Yu, TW
   Flanders, WD
   Miller, GW
   Jones, DP
   Sarnat, JA
AF Ladva, Chandresh Nanji
   Golan, Rachel
   Liang, Donghai
   Greenwald, Roby
   Walker, Douglas, I
   Uppal, Karan
   Raysoni, Amit U.
   ViLinh Tran
   Yu, Tianwei
   Flanders, W. Dana
   Miller, Gary W.
   Jones, Dean P.
   Sarnat, Jeremy A.
TI Particulate metal exposures induce plasma metabolome changes in a
   commuter panel study
SO PLOS ONE
LA English
DT Article
ID HIGH-RESOLUTION METABOLOMICS; C-REACTIVE PROTEIN; AIR-POLLUTION;
   OXIDATIVE STRESS; ASTHMA CONTROL; CAR COMMUTERS; MATTER; INFLAMMATION;
   ASSOCIATION; BLOOD
AB Introduction
   Advances in liquid chromatography-mass spectrometry (LC-MS) have enabled high-resolution metabolomics (HRM) to emerge as a sensitive tool for measuring environmental exposures and corresponding biological response. Using measurements collected as part of a large, panel-based study of car commuters, the current analysis examines in-vehicle air pollution concentrations, targeted inflammatory biomarker levels, and metabolomic profiles to trace potential metabolic perturbations associated with on-road traffic exposures.
   Methods
   A 60-person panel of adults participated in a crossover study, where each participant conducted a highway commute and randomized to either a side-street commute or clinic exposure session. In addition to in-vehicle exposure characterizations, participants contributed pre- and post-exposure dried blood spots for 2-hr changes in targeted proinflammatory and vascular injury biomarkers and 10-hr changes in the plasma metabolome. Samples were analyzed on a Thermo QExactive MS system in positive and negative electrospray ionization (ESI) mode. Data were processed and analyzed in R using apLCMS, xMSanalyzer, and limma. Features associated with environmental exposures or biological endpoints were identified with a linear mixed effects model and annotated through human metabolic pathway analysis in mummichog.
   Results
   HRM detected 10-hr perturbations in 110 features associated with in-vehicle, particulate metal exposures (Al, Pb, and Fe) which reflect changes in arachidonic acid, leukotriene, and tryptophan metabolism. Two-hour changes in proinflammatory biomarkers hs-CRP, IL-6, IL8, and IL-1 beta were also associated with 10-hr changes in the plasma metabolome, suggesting diverse amino acid, leukotriene, and antioxidant metabolism effects. A putatively identified metabolite, 20-OH-LTB4, decreased after in-vehicle exposure to particulate metals, suggesting a subclinical immune response.
   Conclusions
   Acute exposures to traffic-related air pollutants are associated with broad inflammatory response, including several traditional markers of inflammation.
C1 [Ladva, Chandresh Nanji; Flanders, W. Dana] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.
   [Golan, Rachel; Miller, Gary W.; Sarnat, Jeremy A.] Ben Gurion Univ Negev, Dept Publ Hlth, Beer Sheva, Israel.
   [Liang, Donghai; Raysoni, Amit U.] Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA.
   [Greenwald, Roby] Georgia State Univ, Dept Environm Hlth, Atlanta, GA 30303 USA.
   [Walker, Douglas, I; Uppal, Karan; ViLinh Tran; Yu, Tianwei] Emory Univ, Sch Med, Clin Biomarkers Lab, Div Pulm Allergy & Crit Care Med, Atlanta, GA USA.
   [Jones, Dean P.] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA.
RP Ladva, CN (reprint author), Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.
EM chandresh.ladva@emory.edu
OI Uppal, Karan/0000-0001-5985-1668
FU Clean Air Research Center grant; Georgia Institute of Technology from
   the US Environmental Protection Agency (USEPA) [RD834799]; Human
   Exposome Research Center (HERCULES) (NIH) [P30 ES019776]; National
   Institutes of Health (NIH) [OD018006]; NIH [T32 ES012870-13]; Burroughs
   Wellcome Fund through the Molecules the Mankind Doctoral Pathway at
   Emory University; Environment and Health Fund, Jerusalem, Israel
FX The presented research was supported by a Clean Air Research Center
   grant to Emory University and the Georgia Institute of Technology from
   the US Environmental Protection Agency (USEPA, RD834799) and the Human
   Exposome Research Center (HERCULES) (NIH, P30 ES019776). Shared
   instrumentation for metabolomics analysis was supported through the
   National Institutes of Health (NIH, OD018006). CL acknowledges
   pre-doctoral support from a training grant (NIH, T32 ES012870-13) and
   the Burroughs Wellcome Fund through the Molecules the Mankind Doctoral
   Pathway at Emory University. RG gratefully acknowledges support by a
   postdoctoral fellowship from the Environment and Health Fund, Jerusalem,
   Israel. The content of this publication is solely the responsibility of
   the authors and does not necessarily represent the official views of the
   National Institutes of Health or the USEPA. Further, USEPA does not
   endorse the purchase of any commercial products or services mentioned in
   the publication. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.; The authors extend their gratitude to the participants of
   this research. The presented research was supported by a Clean Air
   Research Center grant to Emory University and the Georgia Institute of
   Technology from the US Environmental Protection Agency (USEPA, RD834799)
   and the Human Exposome Research Center (HERCULES) (NIH, P30 ES019776).
   Shared instrumentation for metabolomics analysis was support through the
   National Institutes of Health (NIH, OD018006). CL acknowledges
   pre-doctoral support from a training grant (NIH, T32 ES012870-13) and
   the Burroughs Wellcome Fund through the Molecules the Mankind Doctoral
   Pathway at Emory University. RG gratefully acknowledges support by a
   post-doctoral fellowship from the Environment and Health Fund,
   Jerusalem, Israel. The content of this publication is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the National Institutes of Health or the USEPA.
   Further, USEPA does not endorse the purchase of any commercial products
   or services mentioned in the publication.
CR Accardi CJ, 2016, J OCCUP ENVIRON MED, V58, pS80, DOI 10.1097/JOM.0000000000000770
   Bates JT, 2015, ENVIRON SCI TECHNOL, V49, P13605, DOI 10.1021/acs.est.5b02967
   Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.2307/1165312
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Brown MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037044
   Ghio AJ, 2001, AM J RESP CRIT CARE, V164, P704, DOI 10.1164/ajrccm.164.4.2011089
   Golan R, 2017, AIR QUALITY ATMOSPHE
   Golan R, 2018, AIR QUAL ATMOS HLTH, V11, P123, DOI 10.1007/s11869-017-0530-8
   Greenwald R, 2014, AEROSOL SCI TECH, V48, P664, DOI 10.1080/02786826.2014.912745
   Janes H, 2008, ANN EPIDEMIOL, V18, P792, DOI 10.1016/j.annepidem.2008.06.004
   Karagulian F, 2015, ATMOS ENVIRON, V120, P475, DOI 10.1016/j.atmosenv.2015.08.087
   Krall JR, 2018, J EXPO SCI ENV EPID, V28, P337, DOI 10.1038/s41370-017-0016-7
   Ladva CN, 2018, J BREATH RES, V12, DOI 10.1088/1752-7163/aa863c
   LEWIS RA, 1984, J CLIN INVEST, V73, P889, DOI 10.1172/JCI111312
   Li SZ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003123
   Matovic V, 2015, FOOD CHEM TOXICOL, V78, P130, DOI [10.1016/j.fct.2015.02.011, 10.1016/jict.2015.02.011]
   Meier-Ewert HK, 2001, CLIN CHEM, V47, P426
   Mirabelli MC, 2015, EPIDEMIOLOGY, V26, P546, DOI 10.1097/EDE.0000000000000296
   Neophytou AM, 2013, ENV HLTH, V12, P10, DOI [10.1186/1476-069X-12-10, DOI 10.1186/1476-069X-12-10]
   Orona NS, 2016, ENVIRON POLLUT, V208, P261, DOI 10.1016/j.envpol.2015.07.020
   Pardo M, 2015, ENVIRON SCI TECHNOL, V49, P8777, DOI 10.1021/acs.est.5b01449
   Pollution HPotHEoT-RA, 2010, 17 HLTH EFF I
   Rabinovitch N, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0181-5
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Riva DR, 2011, INHAL TOXICOL, V23, P257, DOI 10.3109/08958378.2011.566290
   Rudnicka AR, 2007, CIRCULATION, V115, P996, DOI 10.1161/CIRCULATIONAHA.106.635169
   Ruckerl R, 2016, ENVIRON RES, V150, P337, DOI 10.1016/j.envres.2016.05.037
   Sarnat JA, 2014, ENVIRON RES, V133, P66, DOI 10.1016/j.envres.2014.05.004
   Sarnat SE, 2015, ENVIRON HEALTH PERSP, V123, P437, DOI 10.1289/ehp.1307776
   Sartini C, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018264
   Scalbert A, 2009, METABOLOMICS, V5, P435, DOI 10.1007/s11306-009-0168-0
   Shi JJ, 2016, ENVIRON RES, V150, P264, DOI 10.1016/j.envres.2016.06.022
   Soltow QA, 2013, METABOLOMICS, V9, pS132, DOI 10.1007/s11306-011-0332-1
   Steinvil A, 2008, ENVIRON RES, V106, P51, DOI 10.1016/j.envres.2007.08.006
   Strak M, 2012, ENVIRON HEALTH PERSP, V120, P1183, DOI 10.1289/ehp.1104389
   Uppal K, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-15
   Valko M, 2016, ARCH TOXICOL, V90, P1, DOI 10.1007/s00204-015-1579-5
   Verstraeten S, 2008, ARCH TOXICOL, V82, P789, DOI 10.1007/s00204-008-0345-3
   Vlaanderen JJ, 2017, ENVIRON RES, V156, P341, DOI 10.1016/j.envres.2017.03.042
   Vossoughi M, 2014, IMMUN AGEING, V11, DOI 10.1186/1742-4933-11-5
   Vreeland H, 2017, ATMOS ENVIRON, V165, P169, DOI 10.1016/j.atmosenv.2017.06.044
   Walker D, 2016, ACSR ADV COMPUT, V46, P167
   Walker DI, 2016, INT J EPIDEMIOL, V45, P1517, DOI 10.1093/ije/dyw218
   Walker DI, 2016, J OCCUP ENVIRON MED, V58, pS12, DOI 10.1097/JOM.0000000000000768
   Wang ZH, 2015, J PROTEOME RES, V14, P2583, DOI 10.1021/acs.jproteome.5b00134
   Ward-Caviness CK, 2016, INT J EPIDEMIOL, V45, P1528, DOI 10.1093/ije/dyw247
   Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065
   Yu TW, 2014, BIOINFORMATICS, V30, P2941, DOI 10.1093/bioinformatics/btu430
   Yu TW, 2013, J PROTEOME RES, V12, P1419, DOI 10.1021/pr301053d
   Zanobetti A, 2014, ENVIRON INT, V71, P13, DOI 10.1016/j.envint.2014.05.023
   Zora JE, 2013, SCI TOTAL ENVIRON, V448, P56, DOI 10.1016/j.scitotenv.2012.11.067
NR 51
TC 0
Z9 0
U1 4
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 19
PY 2018
VL 13
IS 9
AR e0203468
DI 10.1371/journal.pone.0203468
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GU3GJ
UT WOS:000445164300042
PM 30231074
OA DOAJ Gold
DA 2019-05-24
ER

PT J
AU Giles, LV
   Tebbutt, SJ
   Carlsten, C
   Koehle, MS
AF Giles, Luisa V.
   Tebbutt, Scott J.
   Carlsten, Christopher
   Koehle, Michael S.
TI The effect of low and high-intensity cycling in diesel exhaust on
   flow-mediated dilation, circulating NOx, endothelin-1 and blood pressure
SO PLOS ONE
LA English
DT Article
ID ULTRAFINE PARTICLE DEPOSITION; NITRIC-OXIDE; AIR-POLLUTION; VASCULAR
   FUNCTION; DYSFUNCTION; INHALATION; EXPOSURE; EXERCISE; HUMANS;
   IMPAIRMENT
AB Introduction
   Exposure to air pollution impairs aspects of endothelial function such as flow-mediated dilation (FMD). Outdoor exercisers are frequently exposed to air pollution, but how exercising in air pollution affects endothelial function and how these effects are modified by exercise intensity are poorly understood.
   Objectives
   Therefore, the purpose of this study was to determine the effects of low-intensity and high-intensity cycling with diesel exhaust (DE) exposure on FMD, blood pressure, plasma nitrite and nitrate (NOx) and endothelin-1.
   Methods
   Eighteen males performed 30-minute trials of low or high-intensity cycling (30% and 60% of power at VO2peak) or a resting control condition. For each subject, each trial was performed once while breathing filtered air (FA) and once while breathing DE (300ug/m(3) of PM2.5, six trials in total). Preceding exposure, immediately post-exposure, 1 hour and 2 hours post-exposure, FMD, blood pressure and plasma endothelin-1 and NOx concentrations were measured. Data were analyzed using repeated-measures ANOVA and linear mixed model.
   Results
   Following exercise in DE, plasma NOx significantly increased and was significantly greater than FA (p<0.05). Two hours following DE exposure, endothelin-1 was significantly less than FA (p = 0.037) but exercise intensity did not modify this response. DE exposure did not affect FMD or blood pressure.
   Conclusion
   Our results suggest that exercising in DE did not adversely affect plasma NOX, endothelin-1, FMD and blood pressure. Therefore, recommendations for healthy individuals to moderate or avoid exercise during bouts of high pollution appear to have no acute protective effect.
C1 [Giles, Luisa V.; Koehle, Michael S.] Univ British Columbia, Sch Kinesiol, Vancouver, BC, Canada.
   [Tebbutt, Scott J.; Carlsten, Christopher] Univ British Columbia, Dept Med, Vancouver, BC, Canada.
   [Tebbutt, Scott J.; Carlsten, Christopher] Univ British Columbia, Ctr Heart Lung Innovat, Vancouver, BC, Canada.
   [Tebbutt, Scott J.; Carlsten, Christopher] St Pauls Hosp, Vancouver, BC, Canada.
   [Carlsten, Christopher] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.
   [Koehle, Michael S.] Univ British Columbia, Div Sports Med, Vancouver, BC, Canada.
   [Giles, Luisa V.] Douglas Coll, Sports Sci Dept, New Westminster, BC, Canada.
RP Giles, LV (reprint author), Univ British Columbia, Sch Kinesiol, Vancouver, BC, Canada.; Giles, LV (reprint author), Douglas Coll, Sports Sci Dept, New Westminster, BC, Canada.
EM gilesl@douglascollege.ca
FU Canadian Academy of Sport and Exercise Medicine [15R44931]; Health
   Canada [15R66575]; Fraser Basin Council BC Clean Air Research Fund (BC
   CLEAR) [15R44554]; Natural Science and Engineering Research Council
   (NSERC) [15R65329]
FX This work was supported by the Canadian Academy of Sport and Exercise
   Medicine: http://casem-acmse.org/ 15R44931 to MSK; Health Canada:
   http://www.hc-sc.gc.ca/index-eng.php 15R66575 to MSK; Fraser Basin
   Council BC Clean Air Research Fund (BC CLEAR):
   http://www.fraserbasin.bc.ca/ 15R44554 to MSK; Natural Science and
   Engineering Research Council (NSERC):
   http://www.nserc-crsng.gc.ca/index_eng.asp 15R65329 to MSK. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Atkinson G, 2013, ATHEROSCLEROSIS, V226, P425, DOI 10.1016/j.atherosclerosis.2012.11.027
   Birger N, 2011, INHAL TOXICOL, V23, P219, DOI 10.3109/08958378.2011.562256
   Brauner EV, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-13
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   BUGA GM, 1993, CIRC RES, V73, P808, DOI 10.1161/01.RES.73.5.808
   Cannon RO, 2001, J CLIN INVEST, V108, P279, DOI 10.1172/JCI200112761
   Chalupa DC, 2004, ENVIRON HEALTH PERSP, V112, P879, DOI 10.1289/ehp.6851
   Cherng TW, 2009, AM J PHYSIOL-REG I, V297, pR640, DOI 10.1152/ajpregu.90899.2008
   Cutrufello PT, 2011, INHAL TOXICOL, V23, P658, DOI 10.3109/08958378.2011.604106
   Daigle CC, 2003, INHAL TOXICOL, V15, P539, DOI 10.1080/08958370390205065
   de Geus B, 2007, BRIT J SPORT MED, V41, P8, DOI 10.1136/bjsm.2006.027615
   Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859
   DeSouza CA, 2000, CIRCULATION, V102, P1351, DOI 10.1161/01.CIR.102.12.1351
   Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA
   Giles LV, 2014, MED SCI SPORT EXER, V46, P1999, DOI 10.1249/MSS.0000000000000309
   Giles LV, 2014, SPORTS MED, V44, P223, DOI 10.1007/s40279-013-0108-z
   Gokce N, 2002, AM J CARDIOL, V90, P124, DOI 10.1016/S0002-9149(02)02433-5
   GOODMAN C, 1985, EUR J APPL PHYSIOL O, V54, P436, DOI 10.1007/BF02337191
   Hansen CS, 2007, TOXICOL APPL PHARM, V219, P24, DOI 10.1016/j.taap.2006.10.032
   HAYNES WG, 1994, LANCET, V344, P852, DOI 10.1016/S0140-6736(94)92827-4
   Knuckles TL, 2008, TOXICOL APPL PHARM, V230, P346, DOI 10.1016/j.taap.2008.03.010
   Knuckles TL, 2011, J TOXICOL ENV HEAL A, V74, P828, DOI 10.1080/15287394.2011.570225
   Langrish JP, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004309
   Langrish JP, 2009, HYPERTENSION, V54, P910, DOI 10.1161/HYPERTENSIONAHA.109.135947
   Mills NL, 2011, EUR HEART J, V32, P2660, DOI 10.1093/eurheartj/ehr195
   Mills NL, 2005, CIRCULATION, V112, P3930, DOI 10.1161/CIRCULATIONAHA.105.588962
   Neunteufl T, 2000, J AM COLL CARDIOL, V35, P277, DOI 10.1016/S0735-1097(99)00542-2
   Nurkiewicz TR, 2009, TOXICOL SCI, V110, P191, DOI 10.1093/toxsci/kfp051
   Patrician PA, 2002, RES NURS HEALTH, V25, P76, DOI 10.1002/nur.10015
   Peretz A, 2008, ENVIRON HEALTH PERSP, V116, P937, DOI 10.1289/ehp.11027
   Peretz Alon, 2007, BMC Cardiovasc Disord, V7, P11, DOI 10.1186/1471-2261-7-11
   Rakhit RD, 2001, HEART, V86, P368, DOI 10.1136/heart.86.4.368
   Rundell KW, 2007, INHAL TOXICOL, V19, P133, DOI 10.1080/08958370601051727
   Rundell KW, 2010, INHAL TOXICOL
   SAGAI M, 1993, FREE RADICAL BIO MED, V14, P37, DOI 10.1016/0891-5849(93)90507-Q
   Sun QH, 2008, ARTERIOSCL THROM VAS, V28, P1760, DOI 10.1161/ATVBAHA.108.166967
   Thijssen DHJ, 2008, AM J PHYSIOL-HEART C, V295, pH1594, DOI 10.1152/ajpheart.00669.2008
   Toborek M, 1999, BASIC RES CARDIOL, V94, P295, DOI 10.1007/s003950050156
   U. S. EPA, 2002, HLTH ASS DOC DIES EN
   VITA JA, 1989, J AM COLL CARDIOL, V14, P1193, DOI 10.1016/0735-1097(89)90416-6
   Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351
   Wauters A, 2012, ACTA CARDIOLOGICA
   Wauters A, 2013, HYPERTENSION, V62, P352, DOI 10.1161/HYPERTENSIONAHA.111.00991
   Weinberger B, 2001, TOXICOL SCI, V59, P5, DOI 10.1093/toxsci/59.1.5
   West B. T, 2015, LINEAR MIXED MODELS
   Wilcox CS, 2003, ACTA PHYSIOL SCAND, V179, P217, DOI 10.1046/j.0001-6772.2003.01205.x
   Yang YM, 2009, AM J PHYSIOL-HEART C, V297, pH1829, DOI 10.1152/ajpheart.00230.2009
NR 47
TC 1
Z9 1
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 21
PY 2018
VL 13
IS 2
AR e0192419
DI 10.1371/journal.pone.0192419
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FW8RO
UT WOS:000425604300057
PM 29466393
OA Other Gold
DA 2019-05-24
ER

PT J
AU Ultee, KHJ
   Tjeertes, EKM
   Goncalves, FB
   Rouwet, EV
   Hoofwijk, AGM
   Stolker, RJ
   Verhagen, HJM
   Hoeks, SE
AF Ultee, Klaas H. J.
   Tjeertes, Elke K. M.
   Goncalves, Frederico Bastos
   Rouwet, Ellen V.
   Hoofwijk, Anton G. M.
   Stolker, Robert Jan
   Verhagen, Hence J. M.
   Hoeks, Sanne E.
TI The relation between household income and surgical outcome in the Dutch
   setting of equal access to and provision of healthcare
SO PLOS ONE
LA English
DT Article
ID ALL-CAUSE MORTALITY; CORONARY-HEART-DISEASE; SOCIOECONOMIC-STATUS;
   CARDIOVASCULAR MORTALITY; RACIAL DISPARITIES; COLORECTAL-CANCER;
   AIR-POLLUTION; RISK-FACTOR; INEQUALITIES; SURGERY
AB Background
   The impact of socioeconomic disparities on surgical outcome in the absence of healthcare inequality remains unclear. Therefore, we set out to determine the association between socioeconomic status (SES), reflected by household income, and overall survival after surgery in the Dutch setting of equal access and provision of care. Additionally, we aim to assess whether SES is associated with cause-specific survival and major 30-day complications.
   Methods
   Patients undergoing surgery between March 2005 and December 2006 in a general teaching hospital in the Netherlands were prospectively included. Adjusted logistic and cox regression analyses were used to assess the independent association of SES +/- quantified by gross household income +/- with major 30-day complications and long-term postoperative survival.
   Results
   A total of 3929 patients were included, with a median follow-up of 6.3 years. Low household income was associated with worse survival in continuous analysis (HR: 1.05 per 10.000 euro decrease in income, 95% CI: 1.01 +/- 1.10) and in income quartile analysis (HR: 1.58, 95% CI: 1.08 +/- 2.31, first [i.e. lowest] quartile relative to the fourth quartile). Similarly, low income patients were at higher risk of cardiovascular death (HR: 1.26 per 10.000 decrease in income, 95% CI: 1.07 +/- 1.48, first income quartile: HR: 3.10, 95% CI: 1.04 +/- 9.22). Household income was not independently associated with cancer-related mortality and major 30day complications.
   Conclusions
   Low SES, quantified by gross household income, is associated with increased overall and cardiovascular mortality risks among surgical patients. Considering the equality of care provided by this study setting, the associated survival hazards can be attributed to patient and provider factors, rather than disparities in healthcare. Increased physician awareness of SES as a risk factor in preoperative decision-making and focus on improving established SES-related risk factors may improve surgical outcome of low SES patients.
C1 [Ultee, Klaas H. J.; Goncalves, Frederico Bastos; Rouwet, Ellen V.; Verhagen, Hence J. M.] Erasmus Univ, Med Ctr, Dept Surg, Rotterdam, Netherlands.
   [Tjeertes, Elke K. M.; Stolker, Robert Jan; Hoeks, Sanne E.] Erasmus Univ, Med Ctr, Dept Anaesthesiol, Rotterdam, Netherlands.
   [Goncalves, Frederico Bastos] Ctr Hosp Lisboa Cent, Hosp Santa Marta, Dept Surg, Lisbon, Portugal.
   [Hoofwijk, Anton G. M.] Zuyderland, Dept Surg, Sittard, Netherlands.
RP Hoeks, SE (reprint author), Erasmus Univ, Med Ctr, Dept Anaesthesiol, Rotterdam, Netherlands.
EM s.hoeks@erasmusmc.nl
CR Ancona C, 2000, J EPIDEMIOL COMMUN H, V54, P930, DOI 10.1136/jech.54.12.930
   Artinian NT, 2002, HEART LUNG, V31, P161, DOI 10.1067/mhl.2002.123672
   Bach PB, 1999, NEW ENGL J MED, V341, P1198, DOI 10.1056/NEJM199910143411606
   Baquet CR, 2000, CANCER, V88, P1256, DOI 10.1002/(SICI)1097-0142(20000301)88:5+<1256::AID-CNCR13>3.0.CO;2-3
   Begaj I, 2013, KIDNEY INT, V84, P803, DOI 10.1038/ki.2013.176
   Begley C, 2011, EPILEPSIA, V52, P957, DOI 10.1111/j.1528-1167.2010.02968.x
   Birkmeyer NJO, 2008, MED CARE, V46, P893, DOI 10.1097/MLR.0b013e31817925b0
   Boersma E, 2005, AM J MED, V118, P1134, DOI 10.1016/j.amjmed.2005.01.064
   Braveman PA, 2003, J HEALTH POPUL NUTR, V21, P181
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Brown LM, 2001, AM J EPIDEMIOL, V153, P114
   Burgess DJ, 2004, J GEN INTERN MED, V19, P1154, DOI 10.1111/j.1525-1497.2004.30227.x
   Davis PD CS Karen, 2010, MIRROR WALL PERFORMA
   Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae
   Du XL, 2007, CANCER, V110, P660, DOI 10.1002/cncr.22826
   Durkin M, 1999, BRIT J SURG, V86, P702
   Forrest LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001376
   Freimuth VS, 2004, AM J PUBLIC HEALTH, V94, P2053, DOI 10.2105/AJPH.94.12.2053
   Gallo V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039013
   Geyer S, 2000, J EPIDEMIOL COMMUN H, V54, P299, DOI 10.1136/jech.54.4.299
   GHALI JK, 1988, ARCH INTERN MED, V148, P2013, DOI 10.1001/archinte.148.9.2013
   Gornick ME, 1996, NEW ENGL J MED, V335, P791, DOI 10.1056/NEJM199609123351106
   Hajat A, 2013, ENVIRON HEALTH PERSP, V121, P1325, DOI 10.1289/ehp.1206337
   Hall WJ, 2015, AM J PUBLIC HEALTH, V105, pE60, DOI 10.2105/AJPH.2015.302903
   Harteloh P, 2010, EUR J EPIDEMIOL, V25, P531, DOI 10.1007/s10654-010-9445-5
   Henry AJ, 2011, J VASC SURG, V53, P330, DOI 10.1016/j.jvs.2010.08.077
   Hines R, 2014, AM J PUBLIC HEALTH, V104, pE63, DOI 10.2105/AJPH.2013.301572
   Horton TC, 2007, J HAND SURG-BRIT EUR, V32E, P256, DOI 10.1016/j.jhsb.2006.10.005
   Johnson RL, 2004, AM J PUBLIC HEALTH, V94, P2084, DOI 10.2105/AJPH.94.12.2084
   Johnson-Lawrence V, 2013, ANN EPIDEMIOL, V23, P167, DOI 10.1016/j.annepidem.2013.02.004
   Kapral MK, 2002, STROKE, V33, P268, DOI 10.1161/hs0102.101169
   Kilbourne AM, 2006, AM J PUBLIC HEALTH, V96, P2113, DOI 10.2105/AJPH.077628
   Kuper H, 2003, J EPIDEMIOL COMMUN H, V57, P147, DOI 10.1136/jech.57.2.147
   Lantz PM, 2005, J HEALTH SOC BEHAV, V46, P274, DOI 10.1177/002214650504600305
   Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703
   Lazzarino AI, 2013, JAMA INTERN MED, V173, P22, DOI 10.1001/2013.jamainternmed.951
   Lynch JW, 1996, AM J EPIDEMIOL, V144, P934
   Marmot MG, 2008, DIABETOLOGIA, V51, P1980, DOI 10.1007/s00125-008-1144-3
   Matthews KA, 2011, ANNU REV PSYCHOL, V62, P501, DOI 10.1146/annurev.psych.031809.130711
   Moore SC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001335
   Morris AM, 2010, J AM COLL SURGEONS, V211, P105, DOI 10.1016/j.jamcollsurg.2010.02.051
   Murray TC, 2012, J BEHAV MED, V35, P63, DOI 10.1007/s10865-011-9327-7
   Nguyen LL, 2010, J VASC SURG, V51, p36S, DOI 10.1016/j.jvs.2010.02.003
   Rautio N, 2012, PRIM CARE DIABETES, V6, P277, DOI 10.1016/j.pcd.2012.07.002
   Ricciuto LE, 2007, SOC SCI MED, V64, P186, DOI 10.1016/j.socscimed.2006.08.020
   Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x
   Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205
   Roy M, 2014, INT J ENV RES PUB HE, V11, P4825, DOI 10.3390/ijerph110504825
   Russ TC, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4933
   Saban KL, 2014, AGING DIS, V5, P346, DOI 10.14336/AD.2014.0500346
   Sabanayagam C, 2012, J HEALTH POPUL NUTR, V30, P82, DOI 10.3329/jhpn.v30i1.11280
   Schafer W, 2010, HLTH SYSTEMS TRANSIT, V12, P1
   Sharpe KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089513
   Spark JI, 2002, EUR J VASC ENDOVASC, V24, P535, DOI 10.1053/ejvs.2002.1755
   Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110
   Stringhini S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102858
   Tjeertes EEKM, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0096-7
   Tsong WH, 2007, BRIT J CANCER, V96, P821, DOI 10.1038/sj.bjc.6603623
   Ultee KHJ, 2015, EUR J VASC ENDOVASC, V50, P615, DOI 10.1016/j.ejvs.2015.07.006
   Wamala S, 2007, INT J QUAL HEALTH C, V19, P134, DOI 10.1093/intqhc/mzm011
   Wang DD, 2014, JAMA INTERN MED, V174, P1587, DOI 10.1001/jamainternmed.2014.3422
   WILENSKY GR, 1991, JAMA-J AM MED ASSOC, V266, P3404
   Woodside JV, 2012, PREV MED, V54, P247, DOI 10.1016/j.ypmed.2012.01.017
   Yang R, 2010, CANCER-AM CANCER SOC, V116, P2437, DOI 10.1002/cncr.24986
NR 64
TC 1
Z9 1
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 22
PY 2018
VL 13
IS 1
AR e0191464
DI 10.1371/journal.pone.0191464
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FT1TP
UT WOS:000422919500015
PM 29357383
OA DOAJ Gold, Green Published
DA 2019-05-24
ER

PT J
AU Azuma, K
   Uchiyama, I
AF Azuma, Kenichi
   Uchiyama, Iwao
TI Association between environmental noise and subjective symptoms related
   to cardiovascular diseases among elderly individuals in Japan
SO PLOS ONE
LA English
DT Article
ID IRRITABLE-BOWEL-SYNDROME; POPULATION-BASED SURVEY;
   ISCHEMIC-HEART-DISEASE; AIR-POLLUTION; TRAFFIC NOISE; UNITED-STATES;
   EXPOSURE; HEALTH; PREVALENCE
AB Noise in housing environments may increase the risk of cardiovascular diseases (CVDs); however, the most significant sources of noise among elderly individuals remain poorly understood. A nationwide cross-sectional study comprised of 6,181 elderly people (age >= 65 years) was conducted using a web-based self-reported questionnaire in 2014. Questions pertaining to CVD-related subjective symptoms within the past year addressed symptoms of chest pain, disturbances in pulse, acute impaired tongue movement, limb paralysis, and foot pain or numbness during walking. Questions concerning noise included awakening during the night due to noise, automobile, neighborhood, construction, railway, and aircraft noise. The multivariable analyses revealed that all symptoms were significantly associated with awakening during the night due to noise. Automobile, construction, railway, and aircraft noise were significantly associated with more CVD-related symptoms at nighttime than at daytime. Our results suggest that noise at nighttime is an important risk factor for CVDs. Although several different sources of environmental noise, including automobile, neighborhood, construction, railway, and aircraft noise were found to be significantly associated with CVD-related symptoms, the strongest association was observed for construction noise, followed by neighborhood and automobile noise. The adjusted odds ratios (95% confidence intervals) for construction noise at nighttime were 1.12 (1.06-1.19) with disturbances in pulse, 1.21 (1.08-1.35) in acute impaired tongue movement, 1.25 (1.15-1.36) in limb paralysis, and 1.19 (1.12-1.28) in foot pain or numbness during walking. The associations with railway and aircraft noise were found to be weaker than those with automobile, neighborhood, and construction noise. Our study suggests that CVD-related symptoms may exhibit a greater association with construction, neighborhood, and automobile noise than with railway and aircraft noise.
C1 [Azuma, Kenichi] Kindai Univ, Fac Med, Dept Environm Med & Behav Sci, Osakasayama, Osaka, Japan.
   [Azuma, Kenichi; Uchiyama, Iwao] Louis Pasteur Ctr Med Res, Sick House Med Sci Lab, Div Basic Res, Kyoto, Japan.
RP Azuma, K (reprint author), Kindai Univ, Fac Med, Dept Environm Med & Behav Sci, Osakasayama, Osaka, Japan.; Azuma, K (reprint author), Louis Pasteur Ctr Med Res, Sick House Med Sci Lab, Div Basic Res, Kyoto, Japan.
EM kenazuma@med.kindai.ac.jp
OI Azuma, Kenichi/0000-0002-6382-9807
FU Japan Automobile Research Institute
FX This work was financially supported by Research Grants FY 2014 and FY
   2015 provided by Japan Automobile Research Institute. The funder had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Andrews EB, 2005, ALIMENT PHARM THER, V22, P935, DOI 10.1111/j.1365-2036.2005.02671.x
   [Anonymous], 2003, ISOTC43WG
   Azuma K, 2015, ARCH ENVIRON OCCUP H, V70, P341, DOI 10.1080/19338244.2014.926855
   Bareinboim E, 2016, P NATL ACAD SCI USA, V113, P7345, DOI 10.1073/pnas.1510507113
   Basner M, 2014, LANCET, V383, P1325, DOI 10.1016/S0140-6736(13)61613-X
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Chum A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1788-0
   Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x
   Fields JM, 2001, J SOUND VIB, V242, P641, DOI 10.1006/jsvi.2000.3384
   Gan WQ, 2011, OCCUP ENVIRON MED, V68, P183, DOI 10.1136/oem.2010.055269
   Golmohammadi R, 2013, J RES HEALTH SCI, V13, P201
   Heritier H, 2017, EUR J EPIDEMIOL, V32, P307, DOI [10.1007/s10654, 10.1007/s10654-017-0234-2]
   Ishii S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139639
   Ito M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122969
   Johannes CB, 2010, J PAIN, V11, P1230, DOI 10.1016/j.jpain.2010.07.002
   Kalsch H, 2014, EUR HEART J, V35, P853, DOI 10.1093/eurheartj/eht426
   Konishi M, 2001, J Epidemiol, V11, pS57
   Krogsgaard LR, 2013, SCAND J GASTROENTERO, V48, P523, DOI 10.3109/00365521.2013.775328
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Macromill, 2013, LIF SURV
   McAloon CJ, 2016, INT J CARDIOL, V224, P256, DOI 10.1016/j.ijcard.2016.09.026
   Ministry of Health, 2014, SUMM REP COMPR SURV
   Ministry of Internal Affairs and Communications (MIAC), 2011, 2010 POP CENS
   Munzel T, 2014, EUR HEART J, V35, P829, DOI 10.1093/eurheartj/ehu030
   Nafiu OO, 2014, J PERIANESTH NURS, V29, P84, DOI 10.1016/j.jopan.2013.03.010
   Pyko A, 2015, OCCUP ENVIRON MED, V72, P594, DOI 10.1136/oemed-2014-102516
   Reimer C, 2009, SCAND J GASTROENTERO, V44, P394, DOI 10.1080/00365520802600987
   Roux AVD, 2003, J URBAN HEALTH, V80, P569, DOI 10.1093/jurban/jtg065
   Sasaki M, 2016, ALLERGOL INT, V65, P420, DOI 10.1016/j.alit.2016.03.007
   Stansfeld S, 2000, Rev Environ Health, V15, P43
   Tetreault LF, 2013, INT J PUBLIC HEALTH, V58, P649, DOI 10.1007/s00038-013-0489-7
   van Kempen EEMM, 2002, ENVIRON HEALTH PERSP, V110, P307, DOI 10.1289/ehp.02110307
   Vandasova Z, 2016, NOISE HEALTH, V18, P338, DOI 10.4103/1463-1741.195800
   Vienneau D, 2015, ENVIRON RES, V138, P372, DOI 10.1016/j.envres.2015.02.023
   WHO Europe, 2009, NIGHT NOIS GUID EUR
   WHO Europe, 2011, BURDEN DIS ENV NOISE
   Xiao J, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111045
NR 37
TC 1
Z9 1
U1 2
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 16
PY 2017
VL 12
IS 11
AR e0188236
DI 10.1371/journal.pone.0188236
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FM8YO
UT WOS:000415378800098
PM 29145457
OA DOAJ Gold, Green Published
DA 2019-05-24
ER

PT J
AU Pui, M
   Nicol, AM
   Brauer, M
   Palad, F
   Carlsten, C
AF Pui, Mandy
   Nicol, Anne-Marie
   Brauer, Michael
   Palad, Farshad
   Carlsten, Christopher
TI A qualitative study of the knowledge, attitudes, and behaviors of people
   exposed to diesel exhaust at the workplace in British Columbia, Canada
SO PLOS ONE
LA English
DT Article
ID AIR-POLLUTION; PARTICULATE MATTER; ASSOCIATION; MANAGEMENT; WORKERS;
   ASTHMA
AB Purpose
   To identify exposure-related knowledge, attitudes and behaviors of individuals occupationally exposed to diesel exhaust (DE); to reveal strengths, knowledge gaps and misperceptions therein.
   Methods
   A Mental Models approach was used to gather information about current scientific understanding of DE exposure hazards and the ways in which exposure can be reduced. Thirty individuals in British Columbia who were regularly exposed to occupational DE were interviewed. The audio was recorded and transcribed. Data was grouped together and examined to draw out themes around DE awareness, hazard assessment and risk reduction behaviors. These themes were then compared and contrasted with existing grey and research literature in order to reveal strengths, gaps and misperceptions regarding DE exposure.
   Results
   Study participants were aware and concerned about their exposure to DE but had incomplete and sometimes incorrect understanding of exposure pathways, health effects, and effective strategies to reduce their exposures. The perceived likelihood of exposure to DE was significantly greater compared to that of other work hazards (p<0.01), whereas the difference for their perceived severity of consequences was not significant. There was no universally perceived main source of information regarding DE, and participants generally distrusted sources of information based on their past experience with the source. Most of the actions that were taken to address DE exposure fell into the area of administrative controls such as being aware of sources of DE and avoiding these sources.
   Conclusions
   This study of the knowledge, attitude, and behavior of those occupationally exposed to DE found, most notably, that more education and training and the creation of a health effects inventory regarding DE exposure were desired.
C1 [Pui, Mandy; Brauer, Michael; Carlsten, Christopher] Univ British Columbia, Dept Med, Vancouver, BC, Canada.
   [Nicol, Anne-Marie; Palad, Farshad] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada.
   [Brauer, Michael; Carlsten, Christopher] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.
RP Pui, M; Carlsten, C (reprint author), Univ British Columbia, Dept Med, Vancouver, BC, Canada.; Carlsten, C (reprint author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.
EM dieselworkers@gmail.com; carlsten@mail.ubc.ca
OI Brauer, Michael/0000-0002-9103-9343
CR Alfaro-Moreno E, 2007, CURR OPIN PULM MED, V13, P98, DOI 10.1097/MCP.0b013e328013f47e
   [Anonymous], 2006, AM J IND MED, V49, P423
   Baccarelli A, 2007, J THROMB HAEMOST, V5, P252, DOI 10.1111/j.1538-7836.2007.02300.x
   Baranowski T, 2003, OBESITY RES, V11
   Brook RD, 2010, OCCUP ENV MED
   Brook RD, 2008, CLIN SCI, V115, P175, DOI 10.1042/CS20070444
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Bull ER D S, 2014, BMJ OPEN, V4
   Calderon-Garciduenas L, 2008, BRAIN COGNITION, V68, P117, DOI 10.1016/j.bandc.2008.04.008
   Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011
   Canada H, 2013, FUELS AIR POLLUTION
   Canada S., EMPLOYMENT IND SEX C
   CAREX, 2014, PROF EST BURN
   Carlsten C, 2007, THROMB RES
   CCOHS, 2012, HLTH SAF REP, V10
   CCOHS, 2008, OH S LEG CAN BAS RES
   Centre CP, 2012, REDUCING EXPOSURES O
   Chen JC, 2009, NEUROTOXICOLOGY, V30, P231, DOI 10.1016/j.neuro.2008.12.011
   CupeBC, HLTH SAF MATT BRIT
   Demers P., 2007, CARCINOGEN SURVEILLA
   Freire C, 2010, J EPIDEMIOL COMMUN H, V64, P223, DOI 10.1136/jech.2008.084574
   GAMBLE J, 1987, ENVIRON RES, V44, P6, DOI 10.1016/S0013-9351(87)80082-8
   Kim J, 2014, OCCUP ENV MED S1, V71
   McCreanor J, 2007, NEW ENGL J MED, V357, P2348, DOI 10.1056/NEJMoa071535
   Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409
   Miller PG, 2015, AM J DRUG ALCOHOL AB, V41, P16, DOI 10.3109/00952990.2014.966199
   Morgan MG, 2002, RISK COMMUNICATION M
   Nicol AM HA, 2008, EUR SAF REL C VAL SP
   NIOSH, MIN TOP DIES EXH 201
   NTP, 12 REP CARC DIES EXH
   Organization WH, 2008, AD COMM SOC MOB TB C, P116
   OSHA, 2015, SAF HAZ
   OSHA, 2013, HAZ AL DIES EXH DIES
   Sadhra S, 2002, OCCUP ENVIRON MED, V59, P689, DOI 10.1136/oem.59.10.689
   Santos MS, 2007, CHEST, V131, P1768, DOI 10.1378/chest.06-2787
   Society CC, 2015, LUNG CANC STAT CAN
   STEENLAND K, 1992, AM J IND MED, V21, P887, DOI 10.1002/ajim.4700210612
   Strauss A., 1998, BASICS QUALITATIVE R
   Wood M, 2012, RISK ANAL, V32, P1349, DOI 10.1111/j.1539-6924.2012.01832.x
   WorkSafeBC, WORKSAFEBC 2012 STAT
   WorkSafeBC, 2010, OHS REG GUID 5
   Zaksek M, 2004, RISK ANAL, V24, P1503, DOI 10.1111/j.0272-4332.2004.00545.x
NR 42
TC 1
Z9 1
U1 1
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 25
PY 2017
VL 12
IS 8
AR e0182890
DI 10.1371/journal.pone.0182890
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FE7EP
UT WOS:000408370700014
PM 28841707
OA Green Published, Other Gold
DA 2019-05-24
ER

PT J
AU Tessum, CW
   Hill, JD
   Marshall, JD
AF Tessum, Christopher W.
   Hill, Jason D.
   Marshall, Julian D.
TI InMAP: A model for air pollution interventions
SO PLOS ONE
LA English
DT Article
ID CHEMICAL-TRANSPORT MODEL; GASEOUS DRY DEPOSITION; PUBLIC-HEALTH IMPACTS;
   SURFACE RESISTANCES; QUALITY MODELS; BOUNDARY-LAYER; UNITED-STATES;
   GLOBAL-SCALE; PART I; PM2.5
AB Mechanistic air pollution modeling is essential in air quality management, yet the extensive expertise and computational resources required to run most models prevent their use in many situations where their results would be useful. Here, we present InMAP (Intervention Model for Air Pollution), which offers an alternative to comprehensive air quality models for estimating the air pollution health impacts of emission reductions and other potential interventions. InMAP estimates annual-average changes in primary and secondary fine particle (PM2.5) concentrations-the air pollution outcome generally causing the largest monetized health damages-attributable to annual changes in precursor emissions. InMAP leverages pre-processed physical and chemical information from the output of a state-of-the-science chemical transport model and a variable spatial resolution computational grid to perform simulations that are several orders of magnitude less computationally intensive than comprehensive model simulations. In comparisons run here, InMAP recreates comprehensive model predictions of changes in total PM2.5 concentrations with population-weighted mean fractional bias (MFB) of -17% and population-weighted R-2 = 0.90. Although InMAP is not specifically designed to reproduce total observed concentrations, it is able to do so within published air quality model performance criteria for total PM2.5. Potential uses of InMAP include studying exposure, health, and environmental justice impacts of potential shifts in emissions for annual-average PM2.5. InMAP can be trained to run for any spatial and temporal domain given the availability of appropriate simulation output from a comprehensive model. The InMAP model source code and input data are freely available online under an open-source license.
C1 [Tessum, Christopher W.; Marshall, Julian D.] Univ Washington, Seattle, WA 98195 USA.
   [Hill, Jason D.] Univ Minnesota, Dept Bioprod & Biosyst Engn, St Paul, MN USA.
RP Tessum, CW (reprint author), Univ Washington, Seattle, WA 98195 USA.
EM ctessum@uw.edu
RI Hill, Jason/A-8919-2008
OI Hill, Jason/0000-0001-7609-6713; Tessum, Christopher/0000-0002-8864-7436
FU University of Minnesota Institute on the Environment Initiative
   [R1-0026-09]; US Department of Energy [DE-EE0004397]; US Department of
   Agriculture NIFA/AFRI Grant [2011-68005-30411]; U.S. Environmental
   Protection Agency [R835873]; US Environmental Protection Agency
   [R835873]
FX The authors thank Andrew Goodkind, Dylan Millet, Dev Millstein, David
   Paolella, Arvind Singh, and Vaughan Voller for feedback and input into
   model development, and John Michalakes for assistance with WRF-Chem
   performance tuning. We also thank the anonymous reviewers whose comments
   on previous versions of this manuscript have greatly improved its
   quality. We additionally acknowledge the University of Minnesota
   Institute on the Environment Initiative for Renewable Energy and the
   Environment Grants No. R1-0026-09 and RO-0002-11, the US Department of
   Energy Award No. DE-EE0004397, and the US Department of Agriculture
   NIFA/AFRI Grant No. 2011-68005-30411 for funding; and the Minnesota
   Super computing Institute and the Department of Energy National Center
   for Computational Sciences Award No. DD-ATM007 for computational
   resources.; This article was developed under Assistance Agreement No.
   R835873 awarded by the U.S. Environmental Protection Agency. It has not
   been formally reviewed by EPA. The views expressed in this document are
   solely those of authors and do not necessarily reflect those of the
   Agency. EPA does not endorse any products or commercial services
   mentioned in this publication.; We received funding from the University
   of Minnesota Institute on the Environment Initiative for Renewable
   Energy and the Environment Grants No. RI-0026-09 (JDM) and RO-0002-11
   (JDH), the US Department of Energy Award No. DE-EE0004397 (JDH), the US
   Department of Agriculture NIFA/AFRI Grant No. 2011-68005 30411 (JDH),
   and the US Environmental Protection Agency Award No. R835873 (JDM, JDH)
   for funding; and the Minnesota Supercomputing Institute (JDM) and the
   Department of Energy National Center for Computational Sciences Award
   No. DD-ATM007 (JDH) for computational resources. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ahmadov R, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016831
   American Society of Mechanical Engineers (ASME), 1973, REC GUID PRED DISP A
   Anel JA, 2011, COMMUN ACM, V54, P40, DOI 10.1145/1941487.1941502
   [Anonymous], 2006, TECHN SUPP DOC PROP
   Boylan JW, 2006, ATMOS ENVIRON, V40, P4946, DOI 10.1016/j.atmonsenv.2005.09.087
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Buonocore JJ, 2014, ENVIRON INT, V68, P200, DOI 10.1016/j.envint.2014.03.031
   Byun D, 1999, EPA600R99030, P20460
   Carnevale C, 2009, ATMOS ENVIRON, V43, P4811, DOI 10.1016/j.atmosenv.2008.07.064
   Chow JC, 2006, J AIR WASTE MANAGE, V56, P707, DOI 10.1080/10473289.2006.10464484
   Cimorelli AJ, 2005, J APPL METEOROL, V44, P682, DOI 10.1175/JAM2227.1
   Cohon JL, 2010, HIDD COSTS EN UNPR C
   Courant R, 1928, MATH ANN, V100, P32, DOI 10.1007/BF01448839
   Dedoussi IC, 2014, ATMOS ENVIRON, V99, P610, DOI 10.1016/j.atmosenv.2014.10.033
   Delucchi MA, 2000, J TRANSP ECON POLICY, V34, P135
   Draxler R.R, 2004, ARL224 ERL NOAA
   ENVIRON, 2011, US GUID COMPR AIR QU
   Environmental Systems Research Institute, 1998, ESRI SHAP TECHN DESC
   Foley KM, 2014, ATMOS ENVIRON, V98, P283, DOI 10.1016/j.atmosenv.2014.08.046
   Fountoukis C, 2013, ATMOS ENVIRON, V68, P24, DOI 10.1016/j.atmosenv.2012.11.008
   Grell GA, 2005, ATMOS ENVIRON, V39, P6957, DOI 10.1016/j.atmosenv.2005.04.027
   Guttikunda SK, 2009, SIM AIR MODELING TOO
   Hakami A, 2007, ENVIRON SCI TECHNOL, V41, P7807, DOI 10.1021/es070944p
   Heo J, 2016, ATMOS ENVIRON, V137, P80, DOI 10.1016/j.atmosenv.2016.04.026
   Jacobson MZ, 2001, J GEOPHYS RES-ATMOS, V106, P5385, DOI 10.1029/2000JD900560
   Kunzli N, 2001, AM J EPIDEMIOL, V153, P1050, DOI 10.1093/aje/153.11.1050
   Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371
   Li Y, 2016, AIR QUAL ATMOS HLTH, V9, P51, DOI 10.1007/s11869-015-0321-z
   Liang M, 2015, EARTH SURF DYNAM, V3, P67, DOI 10.5194/esurf-3-67-2015
   Liang M. Y., 2013, THESIS
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Logue JM, 2011, ATMOS ENVIRON, V45, P476, DOI 10.1016/j.atmosenv.2010.09.053
   Muller N. Z., 2006, AIR POLLUTION EMISSI
   Pleim JE, 2007, J APPL METEOROL CLIM, V46, P1383, DOI 10.1175/JAM2539.1
   Scire J.G., 2000, USERS GUIDE CALPUFF
   Seinfeld J.H., 2006, ATMOSPHERIC CHEM PHY
   Simpson D., 2003, TRANSBOUNDARY ACID 1
   Tessum CW, 2015, GEOSCI MODEL DEV, V8, P957, DOI 10.5194/gmd-8-957-2015
   Tessum CW, 2014, P NATL ACAD SCI USA, V111, P18490, DOI 10.1073/pnas.1406853111
   Tessum CW, 2012, ENVIRON SCI TECHNOL, V46, P11408, DOI 10.1021/es3010514
   Thunis P, 2012, ATMOS ENVIRON, V59, P476, DOI 10.1016/j.atmosenv.2012.05.043
   United States Environmental Protect ion Agency (EPA), 2012, US MAN COB RISK ASS
   US EPA, 2004, EPA452R04011
   US EPA, 2005, AIRDATA
   Wagstrom KM, 2008, ATMOS ENVIRON, V42, P5650, DOI 10.1016/j.atmosenv.2008.03.012
   Walmsley JL, 1996, ATMOS ENVIRON, V30, P1181, DOI 10.1016/1352-2310(95)00403-3
   WESELY ML, 1989, ATMOS ENVIRON, V23, P1293, DOI 10.1016/0004-6981(89)90153-4
   Wilson R, 2004, ANN GEOPHYS-GERMANY, V22, P3869, DOI 10.5194/angeo-22-3869-2004
   Zhang W, 2012, GEOSCI MODEL DEV, V5, P355, DOI 10.5194/gmd-5-355-2012
NR 49
TC 9
Z9 9
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 19
PY 2017
VL 12
IS 4
AR e0176131
DI 10.1371/journal.pone.0176131
PG 26
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ES9KK
UT WOS:000399875600092
PM 28423049
OA Other Gold, Green Published
DA 2019-05-24
ER

PT J
AU Ward-Caviness, CK
   Neas, LM
   Blach, C
   Haynes, CS
   LaRocque-Abramson, K
   Grass, E
   Dowdy, ZE
   Devlin, RB
   Diaz-Sanchez, D
   Cascio, WE
   Miranda, ML
   Gregory, SG
   Shah, SH
   Kraus, WE
   Hauser, ER
AF Ward-Caviness, Cavin K.
   Neas, Lucas M.
   Blach, Colette
   Haynes, Carol S.
   LaRocque-Abramson, Karen
   Grass, Elizabeth
   Dowdy, Z. Elaine
   Devlin, Robert B.
   Diaz-Sanchez, David
   Cascio, Wayne E.
   Miranda, Marie Lynn
   Gregory, Simon G.
   Shah, Svati H.
   Kraus, William E.
   Hauser, Elizabeth R.
TI A genome-wide trans-ethnic interaction study links the PIGR-FCAMR locus
   to coronary atherosclerosis via interactions between genetic variants
   and residential exposure to traffic
SO PLOS ONE
LA English
DT Article
ID AIR-POLLUTION; CARDIOVASCULAR-DISEASE; ENVIRONMENT INTERACTIONS;
   ULTRAFINE PARTICLES; ASSOCIATION; ROADWAY; RISK; EXPRESSION; RECEPTORS;
   IMMUNE
AB Air pollution is a worldwide contributor to cardiovascular disease mortality and morbidity. Traffic-related air pollution is a widespread environmental exposure and is associated with multiple cardiovascular outcomes such as coronary atherosclerosis, peripheral arterial disease, and myocardial infarction. Despite the recognition of the importance of both genetic and environmental exposures to the pathogenesis of cardiovascular disease, studies of how these two contributors operate jointly are rare. We performed a genome-wide interaction study (GWIS) to examine gene-traffic exposure interactions associated with coronary atherosclerosis. Using race-stratified cohorts of 538 African-Americans (AA) and 1562 European-Americans (EA) from a cardiac catheterization cohort (CATHGEN), we identify gene by-traffic exposure interactions associated with the number of significantly diseased coronary vessels as a measure of chronic atherosclerosis. We found five suggestive (P<1x10(-5)) interactions in the AA GWIS, of which two (rs1856746 and rs2791713) replicated in the EA cohort (P < 0.05). Both SNPs are in the PIGR-FCAMR locus and are eQTLs in lymphocytes. The protein products of both PIGR and FCAMR are implicated in inflammatory processes. In the EA GWIS, there were three suggestive interactions; none of these replicated in the AA GWIS. All three were intergenic; the most significant interaction was in a regulatory region associated with SAMSN1, a gene previously associated with atherosclerosis and B cell activation. In conclusion, we have uncovered several novel genes associated with coronary atherosclerosis in individuals chronically exposed to increased ambient concentrations of traffic air pollution. These genes point towards inflammatory pathways that may modify the effects of air pollution on cardiovascular disease risk.
C1 [Ward-Caviness, Cavin K.; Blach, Colette; Haynes, Carol S.; LaRocque-Abramson, Karen; Grass, Elizabeth; Dowdy, Z. Elaine; Gregory, Simon G.; Shah, Svati H.; Kraus, William E.; Hauser, Elizabeth R.] Duke Univ, Sch Med, Duke Mol Physiol Inst, Durham, NC USA.
   [Ward-Caviness, Cavin K.] Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany.
   [Ward-Caviness, Cavin K.; Neas, Lucas M.; Devlin, Robert B.; Diaz-Sanchez, David; Cascio, Wayne E.] US EPA, Natl Hlth & Environm Effects Res Lab, Chapel Hill, NC USA.
   [Miranda, Marie Lynn] Rice Univ, Natl Ctr Geospatial Med, Houston, TX USA.
   [Shah, Svati H.; Kraus, William E.] Duke Univ, Sch Med, Div Cardiol, Durham, NC USA.
   [Hauser, Elizabeth R.] Duke Univ, Sch Med, Dept Biostat & Bioinformat, Durham, NC 27708 USA.
   [Hauser, Elizabeth R.] Vet Affairs Med Ctr, Cooperat Studies Program Epidemiol Ctr Durham, Durham, NC 27705 USA.
RP Hauser, ER (reprint author), Duke Univ, Sch Med, Duke Mol Physiol Inst, Durham, NC USA.; Hauser, ER (reprint author), Duke Univ, Sch Med, Dept Biostat & Bioinformat, Durham, NC 27708 USA.; Hauser, ER (reprint author), Vet Affairs Med Ctr, Cooperat Studies Program Epidemiol Ctr Durham, Durham, NC 27705 USA.
EM elizabeth.hauser@duke.edu
FU National Institutes of Health [HL095987, HL10621, HL36587]; Office of
   Research and Development, U.S. Environmental Protection Agency; Health
   Effects Institute [R-82811201]; National Institutes of Health [HL095987,
   HL10621, HL36587]; Office of Research and Development, U.S.
   Environmental Protection Agency; Health Effects Institute [R-82811201]
FX This work was supported by the following grants from the National
   Institutes of Health (nih. gov): HL095987, HL10621, and HL36587. This
   project was supported in part by an appointment to the Research
   Participation Program at the Office of Research and Development, U.S.
   Environmental Protection Agency (http://orise.orau.gov/epa/
   applicants/current-research-opportunties.aspx). This work was supported
   in part by a grant from the Health Effects Institute (healtheffects.org)
   award number R-82811201. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110
   Ballinger SW, 2005, FREE RADICAL BIO MED, V38, P1278, DOI 10.1016/j.freeradbiomed.2005.02.014
   Barratt J, 2004, PATHOGENESIS IGA NEP, P197
   Beckerman BS, 2012, J TOXICOL ENV HEAL A, V75, P402, DOI 10.1080/15287394.2012.670899
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Cassandrini D, 2013, J INHERIT METAB DIS, V36, P43, DOI 10.1007/s10545-012-9487-9
   Cesaroni G., 2014, BMJ, V348
   Christensen Rune Haubo Bojesen, 2010, ORDINAL REGRESSION M
   Claudio J, 2001, ONCOGENE, V20, P5373, DOI 10.1038/sj.onc.1204698
   Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480
   ESRI, 2011, ARCGIS DESKT REL 10
   Fu SJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-369
   Gan WQ, 2012, AM J EPIDEMIOL, V175, P898, DOI 10.1093/aje/kwr424
   Ghosh R, 2016, ENVIRON HEALTH PERSP, V124, P193, DOI 10.1289/ehp.1408865
   Hagler GSW, 2009, ATMOS ENVIRON, V43, P1229, DOI 10.1016/j.atmosenv.2008.11.024
   Hoffmann B, 2007, EPIDEMIOLOGY, V18, pS75
   Hoffmann B, 2007, CIRCULATION, V116, P489, DOI 10.1161/CIRCULATIONAHA.107.693622
   Hoffmann B, 2009, BIOMARKERS, V14, P74, DOI 10.1080/13547500902965096
   Hoffmann B, 2009, EPIDEMIOLOGY, V20, P280, DOI 10.1097/EDE.0b013e3181961ac2
   HOOD L, 1985, CELL, V40, P225, DOI 10.1016/0092-8674(85)90133-3
   Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578
   Kaufman J.D., 2016, LANCET
   Kraus WE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005553
   Kraus WE, 2015, J CARDIOVASC TRANSL, V8, P449, DOI 10.1007/s12265-015-9648-y
   Lanktree MB, 2009, GENOME MED, V1, DOI 10.1186/gm28
   Li N, 2003, ENVIRON HEALTH PERSP, V111, P455, DOI 10.1289/ehp.6000
   Li W, 2016, OBESITY
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Masud R, 2012, J CLINICAL BIOINFORM, V2
   Maurano MT, 2015, NAT GENET, V47, P1393, DOI 10.1038/ng.3432
   McDonald KJ, 2002, BIOCHEM BIOPH RES CO, V290, P438, DOI 10.1006/bbrc.2001.6218
   McGuinn LA, 2016, ENVIRON RES, V145, P9, DOI 10.1016/j.envres.2015.10.026
   Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355
   Mukerjee S, 2015, ATMOS POLLUT RES, V6, P82, DOI 10.5094/APR.2015.010
   Murcray CE, 2009, AM J EPIDEMIOL, V169, P219, DOI 10.1093/aje/kwn353
   NCDOT (North Carolina Department of Transportation), 2015, GIS DAT LAY STAT PRI
   Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396
   Ohlmeier S, 2012, J PROTEOME RES, V11, P599, DOI 10.1021/pr2006395
   Polfus LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074642
   Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847
   R Development Core Team, 2012, R LANG ENV STAT COMP
   Rosenlund M, 2008, EPIDEMIOLOGY, V19, P121, DOI 10.1097/EDE.0b0e31815c1921
   Shah SH, 2012, AM HEART J, V163, P844, DOI 10.1016/j.ahj.2012.02.005
   Shah SH, 2010, CIRC-CARDIOVASC GENE, V3, P207, DOI 10.1161/CIRCGENETICS.109.852814
   Sheffield NC, 2013, GENOME RES, V23, P777, DOI 10.1101/gr.152140.112
   Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308
   Tabas I, 2011, NAT MED, V17, P791, DOI 10.1038/nm0711-791
   U.S. Census Bureau, 2013, TIGER LIN SHAP TIGER
   Wang Y, 2016, AM J EPIDEMIOLOGY
   Ward-Caviness CK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152670
   Ward-Caviness CK, 2015, ENVIRON HEALTH PERSP, V123, P1007, DOI 10.1289/ehp.1306980
   Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340
   Wines BD, 2006, TISSUE ANTIGENS, V68, P103, DOI 10.1111/j.1399-0039.2006.00613.x
   Zanobetti A, 2011, PROG CARDIOVASC DIS, V53, P344, DOI 10.1016/j.pcad.2011.01.001
   Zhu YF, 2002, J AIR WASTE MANAGE, V52, P1032, DOI 10.1080/10473289.2002.10470842
   Zhu YX, 2004, J EXP MED, V200, P737, DOI 10.1084/jem.20031816
   Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109
NR 58
TC 3
Z9 3
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 29
PY 2017
VL 12
IS 3
AR e0173880
DI 10.1371/journal.pone.0173880
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ER9VG
UT WOS:000399174600029
PM 28355232
OA DOAJ Gold, Green Published
DA 2019-05-24
ER

PT J
AU Huang, KL
   Liu, SY
   Chou, CCK
   Lee, YH
   Cheng, TJ
AF Huang, Kuo-Liang
   Liu, Szu-Yuan
   Chou, Charles C. K.
   Lee, Yi-Hsin
   Cheng, Tsun-Jen
TI The effect of size-segregated ambient particulate matter on Th1/Th2-like
   immune responses in mice
SO PLOS ONE
LA English
DT Article
ID AIR-POLLUTION; DENDRITIC CELLS; CHEMICAL-COMPOSITION; ADJUVANT ACTIVITY;
   UNITED-STATES; MOUSE MODELS; ASTHMA; LUNG; EXPOSURE; HEALTH
AB Background
   Particulate matter (PM) has been associated with increased pulmonary and cardiovascular mortality and morbidity. Additionally, PM is known to exacerbate asthma. However, whether ambient PM exposure contributes to the onset of asthma, especially in non-atopic children and adults, is less conclusive. The current study aimed to evaluate the effects of size-fractioned PM on lung immune responses in healthy BALB/c mice.
   Methods and principal findings We collected PM10, PM2.5, PM1 and PM0.1 samples from October 2012 to August 2013 in the Taipei Basin. These PM samples were representative of urban traffic pollution. The samples were extracted and sonicated in phosphate-buffered saline (PBS). Female BALB/c mice were exposed to the samples via intratracheal instillation at three different doses: 1.75 mg/kg (35 mu g/per mouse), 5 mg/kg (100 mu g/per mouse), and 12.5 mg/kg (250 mu g/per mouse). The mice were exposed on days 0 and 7, and PBS alone was used as a control. Following the exposures, the expression profiles of inflammatory cells and cytokines in bronchoalveolar lavage fluid (BALF) were assessed. Exposure to PM10 resulted in inflammatory responses, including the recruitment of neutrophils and the induction of T helper 1 (Th1) cell-related cytokine release, such as TNF-alpha and IFN-gamma. Furthermore, an allergic immune response, including the recruitment of eosinophils and the up-regulation of T helper 2 (Th2) cell-related cytokine release, such as IL-5 and IL-13, was also observed in the BALF of mice exposed to PM10.
   Conclusions
   Our study showed that exposure to PM alone caused mixed Th1/Th2 inflammatory responses in healthy mice. These findings support the hypothesis that PM may contribute to the onset of asthma.
C1 [Huang, Kuo-Liang] Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Div Pulm Med, New Taipei, Taiwan.
   [Huang, Kuo-Liang; Liu, Szu-Yuan; Cheng, Tsun-Jen] Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei, Taiwan.
   [Chou, Charles C. K.] Acad Sinica, Res Ctr Environm Change, Taipei, Taiwan.
   [Lee, Yi-Hsin] Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Pathol, New Taipei, Taiwan.
RP Cheng, TJ (reprint author), Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei, Taiwan.
EM tcheng@ntu.edu.tw
RI Chou, Charles C.-K./R-3578-2016
OI Chou, Charles C.-K./0000-0003-3960-5333; CHENG,
   TSUN-JEN/0000-0002-2613-8230
FU National Science Council of Taiwan [NSC 101-2314-B-002-005-116-MY2]
FX This study was supported by the National Science Council of Taiwan
   (https://www.most.gov.tw/) (grant number NSC
   101-2314-B-002-005-116-MY2). The funders had no role in the study
   design, data collection, analysis and interpretation, decision to
   publish or preparation of the manuscript.
CR Alexis NE, 2006, J ALLERGY CLIN IMMUN, V117, P1396, DOI 10.1016/j.jaci.2006.02.030
   Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495
   Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0
   Barbe F, 2014, CYTOKINE GROWTH F R, V25, P681, DOI 10.1016/j.cytogfr.2014.07.001
   Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707
   Bezemer GFG, 2011, J INNATE IMMUN, V3, P150, DOI 10.1159/000321725
   Bousquet J, 2005, B WORLD HEALTH ORGAN, V83, P548
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Brunekreef B, 2005, EUR RESPIR J, V26, P309, DOI 10.1183/09031936.05.00001805
   Celedon JC, 2007, J ALLERGY CLIN IMMUN, V120, P144, DOI 10.1016/j.jaci.2007.03.037
   Chesne J, 2014, AM J RESP CRIT CARE, V190, P1094, DOI 10.1164/rccm.201405-0859PP
   Cho SH, 2009, ENVIRON HEALTH PERSP, V117, P1682, DOI 10.1289/ehp.0900730
   Clark NA, 2010, ENVIRON HEALTH PERSP, V118, P284, DOI 10.1289/ehp.0900916
   de Haar C, 2008, J ALLERGY CLIN IMMUN, V121, P1246, DOI 10.1016/j.jaci.2008.01.010
   Delfino RJ, 1997, ENVIRON HEALTH PERSP, V105, P622, DOI 10.1289/ehp.97105622
   Dong GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022470
   Dye JA, 2001, ENVIRON HEALTH PERSP, V109, P395, DOI 10.2307/3434787
   Gauderman WJ, 2004, NEW ENGL J MED, V351, P1057, DOI 10.1056/NEJMoa040610
   Gavett SH, 2003, ENVIRON HEALTH PERSP, V111, P1471, DOI 10.1289/ehp.6300
   Ghio AJ, 2012, J TOXICOL ENV HEAL B, V15, P1, DOI 10.1080/10937404.2012.632359
   Gilmour MI, 2007, INHAL TOXICOL, V19, P7, DOI 10.1080/08958370701490379
   Goldsmith Carroll-Ann W., 1999, Reviews on Environmental Health, V14, P121
   Gugamsetty B, 2012, AEROSOL AIR QUAL RES, V12, P476, DOI 10.4209/aaqr.2012.04.0084
   Hao N, 2013, BIOCHEM PHARMACOL, V86, P561, DOI 10.1016/j.bcp.2013.07.004
   Happo MS, 2010, INHAL TOXICOL, V22, P17, DOI 10.3109/08958370902862426
   Happo MS, 2008, INHAL TOXICOL, V20, P1215, DOI 10.1080/08958370802147282 
   Heinrich J, 1999, ENVIRON HEALTH PERSP, V107, P53, DOI 10.2307/3434289
   Hirota JA, 2015, AM J RESP CELL MOL, V52, P96, DOI 10.1165/rcmb.2014-0158OC
   Huang KL, 2015, J HAZARD MATER, V297, P304, DOI 10.1016/j.jhazmat.2015.05.023
   Ingram JL, 2012, J ALLERGY CLIN IMMUN, V130, P829, DOI 10.1016/j.jaci.2012.06.034
   Kelly FJ, 2012, ATMOS ENVIRON, V60, P504, DOI 10.1016/j.atmosenv.2012.06.039
   Kim YK, 2007, J IMMUNOL, V178, P5375, DOI 10.4049/jimmunol.178.8.5375
   Lambrecht BN, 2010, LANCET, V376, P835, DOI 10.1016/S0140-6736(10)61226-3
   Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007
   Landrigan PJ, 2004, ENVIRON HEALTH PERSP, V112, P731, DOI 10.1289/ehp.6702
   Lee YL, 2007, PEDIATR ALLERGY IMMU, V18, P188, DOI 10.1111/j.1399-3038.2006.00504.x
   Li N, 2010, AM J PHYSIOL-LUNG C, V299, pL374, DOI 10.1152/ajplung.00115.2010
   Li N, 2009, ENVIRON HEALTH PERSP, V117, P1116, DOI 10.1289/ehp.0800319
   Lin M, 2002, ENVIRON HEALTH PERSP, V110, P575, DOI 10.1289/ehp.02110575
   Ling Sean H, 2009, Int J Chron Obstruct Pulmon Dis, V4, P233
   Maes T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-7
   Matthews NC, 2016, AM J RESP CELL MOL, V54, P250, DOI 10.1165/rcmb.2015-0084OC
   Ostro B, 2001, EPIDEMIOLOGY, V12, P200, DOI 10.1097/00001648-200103000-00012
   Park YM, 2010, ALLERGY ASTHMA IMMUN, V2, P87, DOI 10.4168/aair.2010.2.2.87
   Peel JL, 2005, EPIDEMIOLOGY, V16, P164, DOI 10.1097/01.ede.0000152905.42113.db
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132
   Riedl M, 2005, J ALLERGY CLIN IMMUN, V115, P221, DOI 10.1016/j.jaci.2004.11.047
   Rosenberg HF, 2007, J ALLERGY CLIN IMMUN, V119, P1303, DOI 10.1016/j.jaci.2007.03.048
   Saunders V, 2010, ENVIRON HEALTH PERSP, V118, P640, DOI 10.1289/ehp.0901461
   Schlesinger RB, 2003, INHAL TOXICOL, V15, P197, DOI 10.1080/08958370390168247
   Steerenberg PA, 2005, INHAL TOXICOL, V17, P133, DOI 10.1080/08958370590904490
   STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259
   Strieter RM, 2002, J CLIN INVEST, V109, P699, DOI 10.1172/JCI200215277
   Thorne PS, 2005, AM J RESP CRIT CARE, V172, P1371, DOI 10.1164/rccm.200505-758OC
   US EPA, 2004, AIR QUAL CRIT PART M
   van Voorhis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082545
   Vermaelen K, 2005, AM J RESP CRIT CARE, V172, P530, DOI 10.1164/rccm.200410.138450
   Williams MA, 2007, J ALLERGY CLIN IMMUN, V119, P488, DOI 10.1064/j.jaci.2006.10.022
   Zhu Z, 2010, CLIN EXP ALLERGY, V40, P536, DOI 10.1111/j.1365-2222.2010.03477.x
NR 59
TC 6
Z9 8
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 28
PY 2017
VL 12
IS 2
AR e0173158
DI 10.1371/journal.pone.0173158
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN4LY
UT WOS:000395980200057
PM 28245275
OA Green Published, Other Gold
DA 2019-05-24
ER

PT J
AU Di Pilla, M
   Bruno, RM
   Stea, F
   Massetti, L
   Taddei, S
   Ghiadoni, L
   Modesti, PA
AF Di Pilla, Marina
   Bruno, Rosa Maria
   Stea, Francesco
   Massetti, Luciano
   Taddei, Stefano
   Ghiadoni, Lorenzo
   Modesti, Pietro Amedeo
TI Impact of seasonality and air pollutants on carotid-femoral pulse wave
   velocity and wave reflection in hypertensive patients
SO PLOS ONE
LA English
DT Article
ID LONG-TERM EXPOSURE; BLOOD-PRESSURE; ARTERIAL STIFFNESS; VITAMIN-D;
   CARDIOVASCULAR-DISEASE; INDEPENDENT RELATIONSHIP; OUTDOOR TEMPERATURE;
   VASCULAR FUNCTION; POLLUTION; MORTALITY
AB Objective
   The effects of seasonality on blood pressure (BP) and cardiovascular (CV) events are well established, while the influence of seasonality and other environmental factors on arterial stiffness and wave reflection has never been analyzed. This study evaluated whether seasonality (daily number of hours of light) and acute variations in outdoor temperature and air pollutants may affect carotid-femoral pulse wave velocity (PWV) and pressure augmentation.
   Design and method
   731 hypertensive patients (30-88 years, 417 treated) were enrolled in a cross-sectional study during a 5-year period. PWV, central BP, Augmentation Index (AIx) and Augmentation Pressure (AP) were measured in a temperature-controlled (22-24 degrees C) room. Data of the local office of the National Climatic Data Observatory were used to estimate meteorological conditions and air pollutants (PM10, O-3, CO, N2O) exposure on the same day.
   Results
   PWV (mean value 8.5 +/- 1.8 m/s) was related to age (r = 0.467, p<0.001), body mass index (r = 0.132, p<0.001), central systolic (r = 0.414, p<0.001) and diastolic BP (r = 0.093, p = 0.013), daylight hours (r = -0.176, p<0.001), mean outdoor temperature (r = -0.082, p = 0.027), O-3 (r = -0.135, p<0.001), CO (r = 0.096, p = 0.012), N2O (r = 0.087, p = 0.022). In multiple linear regression analysis, adjusted for confounders, PWV remained independently associated only with daylight hours (beta = -0.170; 95% CI: -0.273 to -0.067, p = 0.001). No significant correlation was found between pressure augmentation and daylight hours, mean temperature or air pollutants. The relationship was stronger in untreated patients and women. Furthermore, a positive, independent association between O-3 levels and PWV emerged in untreated patients (beta: 0.018; p = 0.029; CI: 0.002 to 0.034) and in women (beta: 0.027; p = 0.004; CI: 0.009 to 0.045).
   Conclusions
   PWV showed a marked seasonality in hypertensive patients. Environmental O-3 levels may acutely reduce arterial stiffness in hypertensive women and in untreated patients.
C1 [Di Pilla, Marina; Bruno, Rosa Maria; Taddei, Stefano; Ghiadoni, Lorenzo] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy.
   [Stea, Francesco] CNR, Inst Clin Physiol, Pisa, Italy.
   [Massetti, Luciano] CNR, Inst Biometeorol, Florence, Italy.
   [Modesti, Pietro Amedeo] Univ Florence, Dept Expt & Clin Med, Florence, Italy.
RP Di Pilla, M (reprint author), Univ Pisa, Dept Clin & Expt Med, Pisa, Italy.
EM m.dipilla.md@gmail.com
RI Bruno, Rosa Maria/C-3594-2015; Massetti, Luciano/L-5060-2019; Modesti,
   Pietro Amedeo/B-2638-2012
OI Bruno, Rosa Maria/0000-0002-6107-3356; Massetti,
   Luciano/0000-0002-0941-5347; Modesti, Pietro Amedeo/0000-0002-9511-2173
CR AirBase, 2015, EUR AIR QUAL DAT
   Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266
   Andrukhova O, 2014, MOL ENDOCRINOL, V28, P53, DOI 10.1210/me.2013-1252
   Barath S, 2013, TOXICOL SCI, V135, P292, DOI 10.1093/toxsci/kft157
   Beelen R, 2008, ENVIRON HEALTH PERSP, V116, P196, DOI 10.1289/ehp.10767
   Ben-Shlomo Y, 2014, J AM COLL CARDIOL, V63, P636, DOI 10.1016/j.jacc.2013.09.063
   Beveridge LA, 2015, JAMA INTERN MED, V175, P745, DOI 10.1001/jamainternmed.2015.0237
   Brook RD, 2002, CIRCULATION, V105, P1534, DOI 10.1161/01.CIR.0000013838.94747.64
   Brook RD, 2011, J CLIN HYPERTENS, V13, P881, DOI 10.1111/j.1751-7176.2011.00545.x
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Bruno M, 2015, EUR HEART J, V36, P1152, DOI 10.1093/eurheartj/ehv024
   Bruno RM, 2012, DIABETOLOGIA, V55, P1847, DOI 10.1007/s00125-012-2517-1
   Bruno RM, 2013, J HYPERTENS, V31, P1456, DOI 10.1097/HJH.0b013e328360f773
   Bruno RM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00284
   Carvalho LSF, 2015, ATHEROSCLEROSIS, V241, P729, DOI 10.1016/j.atherosclerosis.2015.06.034
   Cheng XS, 2010, EUR J INTERN MED, V21, P164, DOI 10.1016/j.ejim.2010.03.001
   Danet S, 1999, CIRCULATION, V100, pE11, DOI 10.1161/01.CIR.100.1.e1
   Edwards DG, 2006, J APPL PHYSIOL, V100, P1210, DOI 10.1152/japplphysiol.01154.2005
   *EUR GROUP, 1997, LANCET, V349, P1341, DOI DOI 10.1016/S0140-6736(96)12338-2
   Fedecostante M, 2012, J HYPERTENS, V30, P1392, DOI 10.1097/HJH.0b013e328354668a
   Fortier C, 2017, HYPERTENSION, V69, P96, DOI 10.1161/HYPERTENSIONAHA.116.08409
   Gavhed D, 2000, EUR J APPL PHYSIOL, V83, P449, DOI 10.1007/s004210000262
   Ghiadoni L, 2009, CURR HYPERTENS REP, V11, P190, DOI 10.1007/s11906-009-0034-5
   Giallauria F, 2012, J CLIN ENDOCR METAB, V97, P3717, DOI 10.1210/jc.2012-1584
   Hamilton SL, 2008, ANN HUM BIOL, V35, P154, DOI 10.1080/03014460801908058
   Kaess BM, 2012, JAMA-J AM MED ASSOC, V308, P875, DOI 10.1001/2012.jama.10503
   Laden F, 2006, AM J RESP CRIT CARE, V173, P667, DOI 10.1164/rccm.200503-443OC
   Lenters V, 2010, EPIDEMIOLOGY, V21, P512, DOI 10.1097/EDE.0b013e3181dec3a7
   Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002
   Lewington S, 2012, J HYPERTENS, V30, P1383, DOI 10.1097/HJH.0b013e32835465b5
   Lundback M, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-7
   Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc
   Marti-Soler H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113500
   Mehta AJ, 2014, AM J EPIDEMIOL, V179, P192, DOI 10.1093/aje/kwt271
   Mercer JB, 2003, ENVIRON RES, V92, P8, DOI 10.1016/S0013-9351(02)00009-9
   Modesti PA, 2013, HYPERTENSION, V61, P908, DOI 10.1161/HYPERTENSIONAHA.111.00315
   Munzel T, 2016, EUR HEART J
   Paffett ML, 2015, TOXICOL SCI, V146, P244, DOI 10.1093/toxsci/kfv093
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132
   Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078
   Rostand SG, 1997, HYPERTENSION, V30, P150, DOI 10.1161/01.HYP.30.2.150
   Safar ME, 2000, CARDIOVASC RES, V46, P269, DOI 10.1016/S0008-6363(99)00426-5
   Selander J, 2009, ENVIRON HEALTH PERSP, V117, P1713, DOI 10.1289/ehp.0900933
   Swierblewska E, 2010, J HYPERTENS, V28, P979, DOI 10.1097/HJH.0b013e328336ed9a
   Vlachopoulos C, 2010, EUR HEART J, V31, P1865, DOI 10.1093/eurheartj/ehq024
   Yang L, 2015, EUR HEART J, V36, P1178, DOI 10.1093/eurheartj/ehv023
   Ye XF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151119
NR 47
TC 1
Z9 1
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 23
PY 2017
VL 12
IS 2
AR e0172550
DI 10.1371/journal.pone.0172550
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EL5SX
UT WOS:000394682400054
PM 28231259
OA Green Published, Other Gold
DA 2019-05-24
ER

PT J
AU Ji, J
   Hedelin, A
   Malmlof, M
   Kessler, V
   Seisenbaeva, G
   Gerde, P
   Palmberg, L
AF Ji, Jie
   Hedelin, Anna
   Malmlof, Maria
   Kessler, Vadim
   Seisenbaeva, Gulaim
   Gerde, Per
   Palmberg, Lena
TI Development of Combining of Human Bronchial Mucosa Models with XposeALI
   (R) for Exposure of Air Pollution Nanoparticles
SO PLOS ONE
LA English
DT Article
ID OBSTRUCTIVE PULMONARY-DISEASE; EPITHELIAL-CELLS; LIQUID INTERFACE;
   INHALATION EXPOSURES; IN-VITRO; LUNG; PARTICLES; EXACERBATION;
   PALLADIUM; STATEMENT
AB Background
   Exposure to agents via inhalation is of great concerns both in workplace environment and in the daily contact with particles in the ambient air. Reliable human airway exposure systems will most likely replace animal experiment in future toxicity assessment studies of inhaled agents.
   Methods
   In this study, we successfully established a combination of an exposure system (XposeALI) with 3D models mimicking both healthy and chronic bronchitis-like mucosa by co-culturing human primary bronchial epithelial cells (PBEC) and fibroblast at air-liquid interface (ALI). Light-, confocal microscopy, scanning-and transmission electron microscopy, transepithelial electrical resistance (TEER) measurement and RT-PCR were performed to identify how the PBEC differentiated under ALI culture condition. Both models were exposed to palladium (Pd) nanoparticles which sized 6 - 10 nm, analogous to those released from modern car catalysts, at three different concentrations utilizing the XposeALI module of the PreciseInhale (R) exposure system.
   Results
   Exposing the 3D models to Pd nanoparticles induced increased secretion of IL-8, yet the chronic bronchitis-like model released significantly more IL-8 than the normal model. The levels of IL-8 in basal medium (BM) and apical lavage medium (AM) were in the same ranges, but the secretion of MMP-9 was significantly higher in the AM compared to the BM.
   Conclusion
   This combination of relevant human bronchial mucosa models and sophisticated exposure system can mimic in vivo conditions and serve as a useful alternative animal testing tool
C1 [Ji, Jie; Hedelin, Anna; Palmberg, Lena] Karolinska Inst, Inst Environm Med, Lung & Airway Res, Stockholm, Sweden.
   [Malmlof, Maria; Gerde, Per] Inhalat Sci Sweden AB, Stockholm, Sweden.
   [Malmlof, Maria; Gerde, Per] Karolinska Inst, Inst Environm Med, Expt Asthma & Allergy Res, Stockholm, Sweden.
   [Kessler, Vadim; Seisenbaeva, Gulaim] Swedish Univ Agr Sci, SLU, Dept Chem & Biotechnol, Inorgan Bionanotechnol Unit, Uppsala, Sweden.
RP Ji, J (reprint author), Karolinska Inst, Inst Environm Med, Lung & Airway Res, Stockholm, Sweden.
EM jie.ji@ki.se
RI JI, JIE/H-2394-2017
OI JI, JIE/0000-0002-0280-5801
FU Swedish Fund for Research without Animal Experiments [22/10, 40/11,
   F35/12, F25/13, F34-14, F36/15]; Swedish Research Council
   [521-2010-2801, 2014-02767]; Swedish Heart-lung Foundation [20100180,
   20120376, 20120818, 20150328, 20150329, 20150330]; Karolinska Insitutet
FX Support was provided to: LP by the Swedish Fund for Research without
   Animal Experiments (grant no. 22/10, 40/11, F35/12, F25/13, F34-14 and
   F36/15); LP, VK, PG by: Swedish Research Council (grant no.
   521-2010-2801 and 2014-02767); LP by the Swedish Heart-lung Foundation
   (grant no. 20100180, 20120376, 20120818, 20150328, 20150329 and
   20150330); and LP by the Karolinska Insitutet. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Atherton HC, 2003, AM J PHYSIOL-LUNG C, V285, pL730, DOI 10.1152/ajplung.00089.2003
   Atkinson JJ, 2003, AM J RESP CELL MOL, V28, P12, DOI 10.1165/rcmb.2002-0166TR
   Atkinson RW, 2001, AM J RESP CRIT CARE, V164, P1860, DOI 10.1164/ajrccm.164.10.2010138
   Aufderheide M, 2004, EXP TOXICOL PATHOL, V55, P451, DOI 10.1078/0940-2993-00348
   Aufderheide M, 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/734137
   Bitterle E, 2006, CHEMOSPHERE, V65, P1784, DOI 10.1016/j.chemosphere.2006.04.035
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4
   Eisner MD, 2010, AM J RESP CRIT CARE, V182, P693, DOI 10.1164/rccm.200811-1757ST
   Geiser M, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-2
   Gerde P, 2004, INHAL TOXICOL, V16, P45, DOI 10.1080/08958370490258381
   Hurst JR, 2011, AM J RESP CRIT CARE, V184, P625, DOI 10.1164/rccm.201106-1136ED
   Ji J, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0104-3
   Kanitsar K, 2003, J ANAL ATOM SPECTROM, V18, P239, DOI 10.1039/b212218a
   Larsson K, 1998, EUR RESPIR J, V12, P825, DOI 10.1183/09031936.98.12040825
   Lenz AG, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-32
   Mathis C, 2013, AM J PHYSIOL-LUNG C, V304, pL489, DOI 10.1152/ajplung.00181.2012
   Monteiller C, 2007, OCCUP ENVIRON MED, V64, P609, DOI 10.1136/oem.2005.024802
   Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2
   Rauch S, 2005, ENVIRON SCI TECHNOL, V39, P8156, DOI 10.1021/es050784m
   Schamberger AC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08163
   Scheffler S, 2015, INT J ENV RES PUB HE, V12, P12466, DOI 10.3390/ijerph121012466
   Selg E, 2013, J AEROSOL MED PULM D, V26, P181, DOI 10.1089/jamp.2012.0971
   Sint T, 2008, INHAL TOXICOL, V20, P25, DOI [10.1080/08958370701758759, 10.1080/08958370701758759 ]
   Stan MS, 2015, FEBS J, V282, P2914, DOI 10.1111/febs.13330
   Wilkinson KE, 2011, ACS NANO, V5, P5312, DOI 10.1021/nn1032664
   Yoshisue H, 2004, BIOSCI BIOTECH BIOCH, V68, P2024, DOI 10.1271/bbb.68.2024
   Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC
NR 28
TC 4
Z9 4
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 20
PY 2017
VL 12
IS 1
AR e0170428
DI 10.1371/journal.pone.0170428
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EI3QC
UT WOS:000392405300134
PM 28107509
OA DOAJ Gold, Green Published
DA 2019-05-24
ER

PT J
AU Christophersen, DV
   Jacobsen, NR
   Jensen, DM
   Kermanizadeh, A
   Sheykhzade, M
   Loft, S
   Vogel, U
   Wallin, H
   Moller, P
AF Christophersen, Daniel Vest
   Jacobsen, Nicklas Raun
   Jensen, Ditte Marie
   Kermanizadeh, Ali
   Sheykhzade, Majid
   Loft, Steffen
   Vogel, Ulla
   Wallin, Hakan
   Moller, Peter
TI Inflammation and Vascular Effects after Repeated Intratracheal
   Instillations of Carbon Black and Lipopolysaccharide
SO PLOS ONE
LA English
DT Article
ID LUNG EPITHELIAL-CELLS; ACUTE-PHASE RESPONSE; AMERICAN-HEART-ASSOCIATION;
   KILLER T-CELLS; PARTICULATE MATTER; ENDOTHELIAL DYSFUNCTION; OXIDATIVE
   STRESS; DIESEL EXHAUST; AIR-POLLUTION; CARDIOVASCULAR-DISEASE
AB Inflammation and oxidative stress are considered the main drivers of vasomotor dysfunction and progression of atherosclerosis after inhalation of particulate matter. In addition, new studies have shown that particle exposure can induce the level of bioactive mediators in serum, driving vascular-and systemic toxicity. We aimed to investigate if pulmonary inflammation would accelerate nanoparticle-induced atherosclerotic plaque progression in Apolipoprotein E knockout (ApoE(-/-)) mice. ApoE(-/-) mice were exposed to vehicle, 8.53 or 25.6 mu g nanosized carbon black (CB) alone or spiked with LPS (0.2 mu g/mouse/exposure; once a week for 10 weeks). Inflammation was determined by counting cells in bronchoalveolar lavage fluid. Serum Amyloid A3 (Saa3) expression and glutathione status were determined in lung tissue. Plaque progression was assessed in the aorta and the brachiocephalic artery. The effect of vasoactive mediators in plasma of exposed ApoE(-/-) mice was assessed in aorta rings isolated from naive C57BL/6 mice. Pulmonary exposure to CB and/or LPS resulted in pulmonary inflammation with a robust influx of neutrophils. The CB exposure did not promote plaque progression in aorta or BCA. Incubation with 0.5% plasma extracted from CB-exposed ApoE(-/-) mice caused vasoconstriction in aorta rings isolated from naive mice; this effect was abolished by the treatment with the serotonin receptor antagonist Ketanserin. In conclusion, repeated pulmonary exposure to nanosized CB and LPS caused lung inflammation without progression of atherosclerosis in ApoE(-/-) mice. Nevertheless, plasma extracted from mice exposed to nanosized CB induced vasoconstriction in aortas of naive wild-type mice, an effect possibly related to increased plasma serotonin.
C1 [Christophersen, Daniel Vest; Jensen, Ditte Marie; Kermanizadeh, Ali; Loft, Steffen; Wallin, Hakan; Moller, Peter] Univ Copenhagen, Environm Hlth Sect, Dept Publ Hlth, Copenhagen K, Denmark.
   [Jacobsen, Nicklas Raun; Vogel, Ulla; Wallin, Hakan] Natl Res Ctr Working Environm, Copenhagen, Denmark.
   [Sheykhzade, Majid] Univ Copenhagen, Fac Hlth Sci, Sect Mol & Cellular Pharmacol, Dept Drug Design & Pharmacol, Copenhagen, Denmark.
   [Vogel, Ulla] Tech Univ Denmark, Dept Micro & Nanotechnol, Lyngby, Denmark.
RP Moller, P (reprint author), Univ Copenhagen, Environm Hlth Sect, Dept Publ Hlth, Copenhagen K, Denmark.
EM Pemo@sund.ku.dk
RI Wallin, Hakan/I-6459-2012; Kermanizadeh, Ali/L-9691-2017
OI Wallin, Hakan/0000-0001-7716-0166; Jensen, Ditte
   Marie/0000-0003-2623-6882; Kermanizadeh, Ali/0000-0002-2989-9078; Loft,
   Steffen/0000-0001-9552-8518; Sheykhzade, Majid/0000-0002-4561-0326
FU Danish Nanosafety Centre from the Danish Working Environment Research
   Foundation [20110092173-3]
FX The work was supported by the Danish Nanosafety Centre (grant no.
   20110092173-3) from the Danish Working Environment Research Foundation.
   The funder had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Andoh Y, 2013, IMMUNOBIOLOGY, V218, P561, DOI 10.1016/j.imbio.2012.07.022
   Aragon MJ, 2016, CARDIOVASC TOXICOL, V16, P163, DOI 10.1007/s12012-015-9325-z
   Araujo JA, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-24
   Bakker ENTP, 2000, AM J PHYSIOL-HEART C, V278, pH1233
   Bourdon JA, 2012, ENVIRON MOL MUTAGEN, V53, P462, DOI 10.1002/em.21706
   Bourdon JA, 2012, TOXICOL SCI, V127, P474, DOI 10.1093/toxsci/kfs119
   Bourdon JA, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-5
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Brown DM, 2001, TOXICOL APPL PHARM, V175, P191, DOI 10.1006/taap.2001.9240
   Cai XN, 2013, NANOMED-NANOTECHNOL, V9, P583, DOI 10.1016/j.nano.2012.09.004
   Corbel M, 2001, INFLAMM RES, V50, P129, DOI 10.1007/s000110050736
   Courtois A, 2008, ENVIRON HEALTH PERSP, V116, P1294, DOI 10.1289/ehp.11021
   DEMEY JGR, 1989, CIRC RES, V65, P1125, DOI 10.1161/01.RES.65.4.1125
   Folkmann JK, 2012, TOXICOL SCI, V129, P98, DOI 10.1093/toxsci/kfs180
   Fuks KB, 2014, ENVIRON HEALTH PERSP, V122, P896, DOI 10.1289/ehp.1307725
   Gilmour PS, 2004, TOXICOL APPL PHARM, V195, P35, DOI 10.1016/j.taap.2003.10.003
   Gitlin JM, 2009, CARDIOVASC RES, V81, P400, DOI 10.1093/cvr/cvn286
   Hansen CS, 2007, TOXICOL APPL PHARM, V219, P24, DOI 10.1016/j.taap.2006.10.032
   Harder V, 2005, INHAL TOXICOL, V17, P29, DOI 10.1080/08958370590885681
   Hogsberg T, 2013, EXP DERMATOL, V22, P464, DOI 10.1111/exd.12178
   Holzer M, 2014, J APPL TOXICOL, V34, P1167, DOI 10.1002/jat.2996
   Jackson P, 2012, NANOTOXICOLOGY, V6, P486, DOI 10.3109/17435390.2011.587902
   Jacobsen NR, 2008, ENVIRON MOL MUTAGEN, V49, P476, DOI 10.1002/em.20406
   Jacobsen NR, 2007, ENVIRON MOL MUTAGEN, V48, P451, DOI 10.1002/em.20300
   Jacobsen NR, 2015, FOOD CHEM TOXICOL, V85, P84, DOI 10.1016/j.fct.2015.08.008
   Jacobsen NR, 2011, ENVIRON MOL MUTAGEN, V52, P331, DOI 10.1002/em.20629
   Jacobsen NR, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-2
   Kennedy AJ, 2010, DIS MODEL MECH, V3, P156, DOI 10.1242/dmm.003467
   Kermanizadeh A, 2015, CRIT REV TOXICOL, V45, P837, DOI 10.3109/10408444.2015.1058747
   Kido T, 2011, AM J RESP CELL MOL, V44, P197, DOI 10.1165/rcmb.2009-0427OC
   Kim H, 2012, J TOXICOL ENV HEAL A, V75, P1471, DOI 10.1080/15287394.2012.722519
   Kim JK, 2011, SAF HEALTH WORK, V2, P282, DOI 10.5491/SHAW.2011.2.3.282
   KOCH DD, 1980, ANAL CHEM, V52, P27, DOI 10.1021/ac50051a008
   Kyjovska ZO, 2015, MUTAGENESIS, V30, P499, DOI 10.1093/mutage/gev009
   Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236
   Lee GS, 2014, J BONE MINER RES, V29, P976, DOI 10.1002/jbmr.2086
   Lee KS, 2007, EXP MOL MED, V39, P756, DOI 10.1038/emm.2007.82
   Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mikkelsen L, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-32
   Moller P, 2016, CRIT REV TOXICOL, V46, P437, DOI 10.3109/10408444.2016.1149451
   Moller P, 2014, ARCH TOXICOL, V88, P1939, DOI 10.1007/s00204-014-1356-x
   Moller P, 2011, CRIT REV TOXICOL, V41, P339, DOI 10.3109/10408444.2010.533152
   Moller P, 2010, FREE RADICAL RES, V44, P1, DOI 10.3109/10715760903300691
   Niwa Y, 2007, CIRC J, V71, P1157, DOI 10.1253/circj.71.1157
   Nurkiewicz TR, 2006, ENVIRON HEALTH PERSP, V114, P412, DOI 10.1289/ehp.8413
   Ostos MA, 2002, FEBS LETT, V519, P23, DOI 10.1016/S0014-5793(02)02692-3
   Paffett ML, 2015, TOXICOL SCI, V146, P244, DOI 10.1093/toxsci/kfv093
   Provost EB, 2016, ENVIRON INT, V88, P228, DOI 10.1016/j.envint.2015.12.023
   Robertson S, 2013, TOXICOL SCI, V134, P304, DOI 10.1093/toxsci/kft107
   Saber AT, 2014, WIRES NANOMED NANOBI, V6, P517, DOI 10.1002/wnan.1279
   Saber AT, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-12
   Saber AT, 2012, NANOTOXICOLOGY, V6, P453, DOI 10.3109/17435390.2011.587900
   Saber AT, 2012, NANOTOXICOLOGY, V6, P776, DOI 10.3109/17435390.2011.620745
   Saber AT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069020
   Senft AP, 2000, ANAL BIOCHEM, V280, P80, DOI 10.1006/abio.2000.4498
   STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355
   Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003
   Tin-Tin-Win-Shwe, 2005, TOXICOL APPL PHARM, V209, P51, DOI 10.1016/j.taap.2005.03.014
   Tong HY, 2009, TOXICOL APPL PHARM, V239, P224, DOI 10.1016/j.taap.2009.05.019
   VANHOUTTE P, 1988, HYPERTENSION, V11, P111, DOI 10.1161/01.HYP.11.2.111
   Vesterdal LK, 2014, NANOTOXICOLOGY, V8, P61, DOI 10.3109/17435390.2012.750385
   Vesterdal LK, 2012, TOXICOL LETT, V214, P19, DOI 10.1016/j.toxlet.2012.07.022
   Vesterdal LK, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-33
   Vesterdal LK, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-5
NR 66
TC 6
Z9 6
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 29
PY 2016
VL 11
IS 8
AR e0160731
DI 10.1371/journal.pone.0160731
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DV4DZ
UT WOS:000382876700006
PM 27571356
OA Green Published, Other Gold
DA 2019-05-24
ER

PT J
AU Neophytou, AM
   Noth, EM
   Liu, S
   Costello, S
   Hammond, SK
   Cullen, MR
   Eisen, EA
AF Neophytou, Andreas M.
   Noth, Elizabeth M.
   Liu, Sa
   Costello, Sadie
   Hammond, S. Katharine
   Cullen, Mark R.
   Eisen, Ellen A.
TI Ischemic Heart Disease Incidence in Relation to Fine versus Total
   Particulate Matter Exposure in a US Aluminum Industry Cohort
SO PLOS ONE
LA English
DT Article
ID MARGINAL STRUCTURAL MODELS; AIR-POLLUTION; OCCUPATIONAL-EXPOSURE;
   ULTRAFINE PARTICLES; CARDIOVASCULAR-DISEASE; MORTALITY; ASSOCIATION;
   HEALTH; EPIDEMIOLOGY; MORBIDITY
AB Ischemic heart disease (IHD) has been linked to exposures to airborne particles with an aerodynamic diameter < 2.5 mu m (PM2.5) in the ambient environment and in occupational settings. Routine industrial exposure monitoring, however, has traditionally focused on total particulate matter (TPM). To assess potential benefits of PM2.5 monitoring, we compared the exposure-response relationships between both PM2.5 and TPM and incidence of IHD in a cohort of active aluminum industry workers. To account for the presence of time varying confounding by health status we applied marginal structural Cox models in a cohort followed with medical claims data for IHD incidence from 1998 to 2012. Analyses were stratified by work process into smelters (n = 6,579) and fabrication (n = 7,432). Binary exposure was defined by the 10th-percentile cut-off from the respective TPM and PM2.5 exposure distributions for each work process. Hazard Ratios (HR) comparing always exposed above the exposure cut-off to always exposed below the cut-off were higher for PM2.5, with HRs of 1.70 (95% confidence interval (CI): 1.11-2.60) and 1.48 (95% CI: 1.02-2.13) in smelters and fabrication, respectively. For TPM, the HRs were 1.25 (95% CI: 0.89-1.77) and 1.25 (95% CI: 0.88-1.77) for smelters and fabrication respectively. Although TPM and PM2.5 were highly correlated in this work environment, results indicate that, consistent with biologic plausibility, PM2.5 is a stronger predictor of IHD risk than TPM. Cardiovascular risk management in the aluminum industry, and other similar work environments, could be better guided by exposure surveillance programs monitoring PM2.5.
C1 [Neophytou, Andreas M.; Noth, Elizabeth M.; Liu, Sa; Costello, Sadie; Hammond, S. Katharine; Eisen, Ellen A.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA.
   [Cullen, Mark R.] Stanford Univ, Div Gen Med Disciplines, Sch Med, Stanford, CA 94305 USA.
RP Neophytou, AM (reprint author), Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA.
EM aneophytou@berkeley.edu
FU National Institutes of Health, Institute of Aging [R01AG026291-01];
   Centers for Disease Control and Prevention, National Institute of
   Occupational Safety and Health [R01 OH009939-01]
FX This work was supported by the National Institutes of Health, Institute
   of Aging (grant R01AG026291-01) and the Centers for Disease Control and
   Prevention, National Institute of Occupational Safety and Health (grant
   R01 OH009939-01). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Benke G, 1998, ANN OCCUP HYG, V42, P173, DOI 10.1016/S0003-4878(98)00020-9
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Brown DM, 2015, EPIDEMIOLOGY, V26, P806, DOI 10.1097/EDE.0000000000000329
   Chow JC, 2006, J AIR WASTE MANAGE, V56, P707, DOI 10.1080/10473289.2006.10464484
   Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164
   Costello S, 2014, J EXPO SCI ENV EPID, V24, P82, DOI 10.1038/jes.2013.47
   Debia M, 2012, ENVIRON POLLUT, V1, P2
   Delfino RJ, 2005, ENVIRON HEALTH PERSP, V113, P934, DOI 10.1289/ehp.7938
   DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401
   Donoghue AM, 2011, AM J IND MED, V54, P224, DOI 10.1002/ajim.20925
   Fang SC, 2010, INT J ENV RES PUB HE, V7, P1773, DOI 10.3390/ijerph7041773
   Franck U, 2011, SCI TOTAL ENVIRON, V409, P4217, DOI 10.1016/j.scitotenv.2011.05.049
   Hamad R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126054
   Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012
   Hopke PK, 2008, ATMOS ENVIRON, V42, P3192, DOI 10.1016/j.atmosenv.2008.03.002
   Kampstra P., 2008, J STAT SOFTW, V28, P1, DOI DOI 10.18637/JSS.V028.C01
   Liu Sa, 2014, Environ Pollut (Tor), V3, P79
   Magari SR, 2001, CIRCULATION, V104, P986, DOI 10.1161/hc3401.095038
   Neophytou AM, 2014, AM J EPIDEMIOL, V180, P608, DOI 10.1093/aje/kwu175
   Nieboer E, 2005, J ENVIRON MONITOR, V7, P412
   Noth E, 2014, OCCUPATIONAL ENV S1, V71, pA14
   Noth EM, 2014, J EXPO SCI ENV EPID, V24, P89, DOI 10.1038/jes.2013.53
   Occupational Safety & Health Administration [OSHA], 2012, CHEM SAMPL INF
   Ostro B, 2015, ENVIRON HEALTH PERSP, V123, P549, DOI 10.1289/ehp.1408565
   Peng RD, 2008, JAMA-J AM MED ASSOC, V299, P2172, DOI 10.1001/jama.299.18.2172
   Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888
   Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011
   RONNEBERG A, 1995, OCCUP ENVIRON MED, V52, P250, DOI 10.1136/oem.52.4.250
   Simkhovich BZ, 2008, J AM COLL CARDIOL, V52, P719, DOI 10.1016/j.jacc.2008.05.029
   Stayner L, 2003, SCAND J WORK ENV HEA, V29, P317, DOI 10.5271/sjweh.737
   Thomassen Y, 2006, J ENVIRON MONITOR, V8, P127, DOI 10.1039/b514939h
   Toren K, 2007, OCCUP ENVIRON MED, V64, P515, DOI 10.1136/oem.2006.029488
   USEPA, 2012, NAT AMB AIR QUAL STA
   Weichenthal S, 2012, ENVIRON RES, V115, P26, DOI 10.1016/j.envres.2012.03.001
NR 34
TC 9
Z9 9
U1 1
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 1
PY 2016
VL 11
IS 6
AR e0156613
DI 10.1371/journal.pone.0156613
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DN6KZ
UT WOS:000377184700059
PM 27249060
OA DOAJ Gold, Green Published
DA 2019-05-24
ER

PT J
AU Garza, JL
   Mittleman, MA
   Zhang, JM
   Christiani, DC
   Cavallari, JM
AF Garza, Jennifer L.
   Mittleman, Murray A.
   Zhang, Jinming
   Christiani, David C.
   Cavallari, Jennifer M.
TI Time Course of Heart Rate Variability Response to PM2.5 Exposure from
   Secondhand Smoke
SO PLOS ONE
LA English
DT Article
ID ENVIRONMENTAL TOBACCO-SMOKE; PARTICULATE AIR-POLLUTION;
   CARDIOVASCULAR-DISEASE; ASSOCIATION; WORKERS; HEALTH
AB Purpose: Exposure to secondhand smoke (SHS) has been associated with decreased heart rate variability (HRV). However, the time course of this association is unclear. Therefore, the objective of this study was to investigate the association between 15-240 minute SHS-related fine particulate matter (PM2.5) moving averages and indices of HRV. Methods: With a panel study design, we used personal monitors to continuously measure PM2.5 and HRV of 35 participants who were exposed to SHS for approximately 6 hours. Results: We observed negative, significant associations between 5-minute HRV indices and 15 minute PM2.5 moving averages and 240 minute PM2.5 moving averages: there was a significant (p<0.01) 7.5% decrease in the 5-minute square root of the mean squared differences of successive normal heart beats associated with (RMSSD), and a significant (p<0.01) 14.7% decrease in the 5-minute high frequency (HF) power associated with the 15 minute PM2.5 moving averages; there was also a significant (p<0.01) 46.9% decrease in the 5-minute RMSSD, and a significant (p<0.01) 77.7% decrease in the 5-minute high frequency (HF) power associated with the 240 minute PM2.5 moving averages. Conclusions: Our findings that exposure to SHS related PM2.5 was associated with HRV support the hypothesis that SHS can affect the cardiovascular system. The negative associations reported between short and longer term PM2.5 and HRV indicate adverse effects of SHS on the cardiovascular system.
C1 [Garza, Jennifer L.; Cavallari, Jennifer M.] UConn Hlth, Div Occupat & Environm Med, Farmington, CT USA.
   [Mittleman, Murray A.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [Mittleman, Murray A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Cardiovasc Epidemiol Res Unit, Boston, MA 02215 USA.
   [Zhang, Jinming; Christiani, David C.; Cavallari, Jennifer M.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
   [Christiani, David C.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA USA.
RP Cavallari, JM (reprint author), UConn Hlth, Div Occupat & Environm Med, Farmington, CT USA.; Cavallari, JM (reprint author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
EM Cavallari@uchc.edu
RI Cavallari, Jennifer/L-4349-2017
OI Cavallari, Jennifer/0000-0001-8414-8704
FU Flight Attendants Medical Research Institute [YCSA2009-82114]; Harvard
   Catalyst, The Harvard Clinical and Translational Science Center
   (National Center for Research Resources) [UL1 TR001102]; Harvard
   Catalyst, The Harvard Clinical and Translational Science Center
   (National Center for Advancing Translational Sciences, National
   Institutes of Health) [UL1 TR001102]; Harvard University and its
   affiliated academic healthcare centers
FX This study was funded by the Flight Attendants Medical Research
   Institute (FAMRI.org) through a Young Clinical Scientist Award
   (Cavallari - YCSA2009-82114). This work was conducted with support from
   Harvard Catalyst, The Harvard Clinical and Translational Science Center
   (National Center for Research Resources and the National Center for
   Advancing Translational Sciences, National Institutes of Health Award
   UL1 TR001102) and financial contributions from Harvard University and
   its affiliated academic healthcare centers. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Camm AJ, 1996, EUR HEART J, V17, P354
   Cavallari JM, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-36
   Chow JC, 2006, J AIR WASTE MANAGE, V56, P707, DOI 10.1080/10473289.2006.10464484
   Dietrich DF, 2007, INT J EPIDEMIOL, V36, P834, DOI 10.1093/ije/dymo31
   Faught Brent E., 2009, Inflammation & Allergy Drug Targets, V8, P321
   Grashow R, 2014, J OCCUP ENVIRON HYG, V11, P397, DOI 10.1080/15459624.2013.875182
   He F, 2011, J EXPO SCI ENV EPID, V21, P65, DOI 10.1038/jes.2010.21
   Huang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089969
   Klepeis NE, 2007, J AIR WASTE MANAGE, V57, P522, DOI 10.3155/1047-3289.57.5.522
   Magari SR, 2002, EPIDEMIOLOGY, V13, P305, DOI 10.1097/00001648-200205000-00011
   Magari SR, 2001, CIRCULATION, V104, P986, DOI 10.1161/hc3401.095038
   Perez CM, 2015, CARDIOVASC TOXICOL, V15, P69, DOI 10.1007/s12012-014-9272-0
   Pope CA, 2001, ENVIRON HEALTH PERSP, V109, P711, DOI 10.2307/3454788
   Rajkumar S, 2014, INT J PUBLIC HEALTH, V59, P577, DOI 10.1007/s00038-014-0545-y
   Raupach T, 2006, EUR HEART J, V27, P386, DOI 10.1093/eurheartj/ehi601
   Shields KN, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-7
   Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009
   Wilson MD, 2010, J OCCUP ENVIRON HYG, V7, pD44, DOI 10.1080/15459624.2010.483980
   Wu SW, 2010, ENVIRON HEALTH PERSP, V118, P87, DOI 10.1289/ehp.0900818
   Zhang JM, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-83
NR 22
TC 1
Z9 1
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 25
PY 2016
VL 11
IS 5
AR e0154783
DI 10.1371/journal.pone.0154783
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DN2GI
UT WOS:000376881700009
PM 27223894
OA Green Published, Other Gold
DA 2019-05-24
ER

PT J
AU Ward-Caviness, CK
   Neas, LM
   Blach, C
   Haynes, CS
   LaRocque-Abramson, K
   Grass, E
   Dowdy, E
   Devlin, RB
   Diaz-Sanchez, D
   Cascio, WE
   Miranda, ML
   Gregory, SG
   Shah, SH
   Kraus, WE
   Hauser, ER
AF Ward-Caviness, Cavin K.
   Neas, Lucas M.
   Blach, Colette
   Haynes, Carol S.
   LaRocque-Abramson, Karen
   Grass, Elizabeth
   Dowdy, Elaine
   Devlin, Robert B.
   Diaz-Sanchez, David
   Cascio, Wayne E.
   Miranda, Marie Lynn
   Gregory, Simon G.
   Shah, Svati H.
   Kraus, William E.
   Hauser, Elizabeth R.
TI Genetic Variants in the Bone Morphogenic Protein Gene Family Modify the
   Association between Residential Exposure to Traffic and Peripheral
   Arterial Disease
SO PLOS ONE
LA English
DT Article
ID CORONARY-HEART-DISEASE; AIR-POLLUTION; DNA METHYLATION;
   CARDIOVASCULAR-DISEASE; VASCULAR CALCIFICATION; RISK-FACTOR;
   ATHEROSCLEROSIS; SPERMATOGENESIS; PROGRESSION; INHIBITION
AB There is a growing literature indicating that genetic variants modify many of the associations between environmental exposures and clinical outcomes, potentially by increasing susceptibility to these exposures. However, genome-scale investigations of these interactions have been rarely performed particularly in the case of air pollution exposures. We performed race-stratified genome-wide gene-environment interaction association studies on European-American (EA, N = 1623) and African-American (AA, N = 554) cohorts to investigate the joint influence of common single nucleotide polymorphisms (SNPs) and residential exposure to traffic ("traffic exposure")-a recognized vascular disease risk factor-on peripheral arterial disease (BMP8A eQTLs in tissue types highlight relevant for PAD such as rs755249 (tibial nerve, eQTL P = 3.6x10(-6)) and rs1180341 (tibial artery, eQTL P = 5.3x10(-6)). Together these results reveal a novel gene, and possibly gene family, associated with PAD via an interaction with traffic air pollution exposure. These results also highlight the potential for interactions studies, particularly at the genome scale, to reveal novel biology linking environmental exposures to clinical outcomes.PAD). Traffic exposure was estimated via the distance from the primary residence to the nearest major roadway, defined as the nearest limited access highways or major arterial. The rs755249-traffic exposure interaction was associated with PAD at a genome-wide significant level (P = 2.29x10(-8)) in European-Americans. Rs755249 is located in the 3' untranslated region of BMP8A, a member of the bone morphogenic protein (BMP) gene family. Further investigation revealed several variants in BMP genes associated with PAD via an interaction with traffic exposure in both the EA and AA cohorts; this included interactions with non-synonymous variants in BMP2, which is regulated by air pollution exposure. The BMP family of genes is linked to vascular growth and calcification and is a novel gene family for the study of PAD pathophysiology. Further investigation of BMP8A using the Genotype Tissue Expression Database revealed multiple variants with nominally significant (P < 0.05) interaction P-values in our EA cohort were significant BMP8A eQTLs in tissue types highlight relevant for PAD such as rs755249 (tibial nerve, eQTL P = 3.6x10(-6)) and rs1180341 (tibial artery, eQTL P = 5.3x10(-6)). Together these results reveal a novel gene, and possibly gene family, associated with PAD via an interaction with traffic air pollution exposure. These results also highlight the potential for interactions studies, particularly at the genome scale, to reveal novel biology linking environmental exposures to clinical outcomes.
C1 [Ward-Caviness, Cavin K.; Blach, Colette; Haynes, Carol S.; LaRocque-Abramson, Karen; Grass, Elizabeth; Dowdy, Elaine; Gregory, Simon G.; Shah, Svati H.; Kraus, William E.; Hauser, Elizabeth R.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27710 USA.
   [Ward-Caviness, Cavin K.] Helmholtz Ctr Munich, Inst Epidemiol 2, D-85764 Neuherberg, Germany.
   [Neas, Lucas M.; Devlin, Robert B.; Diaz-Sanchez, David; Cascio, Wayne E.] US Environm Protect Agcy, Natl Hlth & Environm Effects Res Lab, Chapel Hill, NC 27514 USA.
   [Miranda, Marie Lynn] Rice Univ, Natl Ctr Geospatial Med, Houston, TX 77005 USA.
   [Shah, Svati H.; Kraus, William E.] Duke Univ, Med Ctr, Div Cardiovasc Med, Durham, NC 27710 USA.
   [Hauser, Elizabeth R.] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA.
   [Hauser, Elizabeth R.] Vet Affairs Med Ctr, Cooperat Studies Program, Epidemiol Ctr Durham, Durham, NC 27701 USA.
RP Hauser, ER (reprint author), Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27710 USA.; Hauser, ER (reprint author), Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA.; Hauser, ER (reprint author), Vet Affairs Med Ctr, Cooperat Studies Program, Epidemiol Ctr Durham, Durham, NC 27701 USA.
EM elizabeth.hauser@gmail.com
FU NIH [HL095987, HL10621, HL36587]; United States Environmental Protection
   Agency (EPA) [R-82811201]
FX This work was supported by the following NIH grants: HL095987, HL10621,
   and HL36587. This project was supported in part by an appointment to the
   Research Participation Program at the Office of Research and
   Development, U.S. Environmental Protection Agency. Research described in
   this article was conducted under contract to the Health Effects
   Institute (HEI), and organization jointly funded by the United States
   Environmental Protection Agency (EPA) (Assistance Award No. R-82811201)
   and certain motor vehicle and engine manufacturers. The contents of this
   article do not necessarily reflect the views of HEI, or its sponsors,
   nor do they necessarily reflect the view and policies of the EPA or
   motor vehicle and engine manufacturers.; This work was supported by the
   following NIH grants: HL095987, HL10621, and HL36587. This project was
   supported in part by an appointment to the Research Participation
   Program at the Office of Research and Development, U.S. Environmental
   Protection Agency. The views expressed in this article are those of the
   authors and do not necessarily reflect the views or policies of the EPA.
   Mention of trade names or commercial products does not constitute
   endorsement or recommendation for use. The contents of this article do
   not necessarily reflect the views of the Health Effects Institute (HEI),
   an organization jointly funded by the United States Environmental
   Protection Agency (EPA) (Assistance Award No. R-82811201) and certain
   motor vehicle and engine manufacturers, nor do they necessarily reflect
   the views and policies of its sponsors.
CR Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110
   Baccarelli A, 2009, CIRCULATION, V119, P3118, DOI 10.1161/CIRCULATIONAHA.108.836163
   Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC
   Bera AK, 2001, J STAT PLAN INFER, V97, P9, DOI 10.1016/S0378-3758(00)00343-8
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Brunekreef B, 2009, RES REP HLTH EFF I, V139, P73
   Brunekreef Bert, 2009, Res Rep Health Eff Inst, P5
   Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292
   Chahine T, 2007, ENVIRON HEALTH PERSP, V115, P1617, DOI 10.1289/ehp.10318
   Chung JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029100
   Criqui MH, 2008, J AM COLL CARDIOL, V52, P1736, DOI 10.1016/j.jacc.2008.07.060
   David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001
   DeJarnett N, 2015, ARTERIOSCL THROM VAS, V35, P2468, DOI 10.1161/ATVBAHA.115.305724
   Derwall M, 2012, ARTERIOSCL THROM VAS, V32, P613, DOI 10.1161/ATVBAHA.111.242594
   Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129
   Dong CM, 2002, J NUTR, V132, p2406S, DOI 10.1093/jn/132.8.2406S
   Eraso LH, 2014, EUR J PREV CARDIOL, V21, P704, DOI 10.1177/2047487312452968
   ESRI, 2011, ARCGIS DESKT REL 10
   Federal Highway Administration, 2015, HIGHW STAT SER
   Hagler GSW, 2009, ATMOS ENVIRON, V43, P1229, DOI 10.1016/j.atmosenv.2008.11.024
   Hoek G, 2002, LANCET, V360, P1203, DOI 10.1016/S0140-6736(02)11280-3
   Hoffmann B, 2007, EPIDEMIOLOGY, V18, pS75
   Hoffmann B, 2007, CIRCULATION, V116, P489, DOI 10.1161/CIRCULATIONAHA.107.693622
   Hoffmann B, 2009, BIOMARKERS, V14, P74, DOI 10.1080/13547500902965096
   Hoffmann B, 2009, EPIDEMIOLOGY, V20, P280, DOI 10.1097/EDE.0b013e3181961ac2
   Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c
   Jamaluddin MS, 2007, CLIN CHEM LAB MED, V45, P1660, DOI 10.1515/CCLM.2007.350
   Jardim MJ, 2011, MUTAT RES-FUND MOL M, V717, P38, DOI 10.1016/j.mrfmmm.2011.03.014
   Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1463, DOI 10.1289/ehp.11290
   Kim J, 2015, ARTERIOSCLEROSIS THR
   Kim JH, 2015, ARTERIOSCL THROM VAS, V35, P2384, DOI 10.1161/ATVBAHA.115.306102
   Knowles JW, 2007, ARTERIOSCL THROM VAS, V27, P2068, DOI 10.1161/01.ATV.0000282199.66398.8c
   Kraus WE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005553
   Kraus WE, 2015, J CARDIOVASC TRANSL, V8, P449, DOI 10.1007/s12265-015-9648-y
   Lennon FE, 2011, AM J PHYSIOL-LUNG C, V301, pL137, DOI 10.1152/ajplung.00071.2010
   Liberman M, 2011, BIOCHEM BIOPH RES CO, V413, P436, DOI [10.1016/j.bbrc.2011.083.114, 10.1016/j.bbrc.2011.08.114]
   London Stephanie J, 2007, Proc Am Thorac Soc, V4, P217, DOI 10.1513/pats.200701-031AW
   Loveland KL, 2007, INT J ANDROL, V30, P377, DOI 10.1111/j.1365-2605.2007.00785.x
   Madrigano J, 2011, ENVIRON HEALTH PERSP, V119, P977, DOI 10.1289/ehp.1002773
   Mahoney SE, 2012, EPIGENETICS-US, V7, P400, DOI 10.4161/epi.19463
   McGuinn LA, 2016, ENVIRON RES, V145, P9, DOI 10.1016/j.envres.2015.10.026
   Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355
   Nawrot TS, 2009, AM J RESP CRIT CARE, V179, P523, DOI 10.1164/rccm.200812-1900ED
   NCDOT (North Carolina Department of Transportation), 2015, GIS DAT LAYERS STAT
   Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159
   OTTMAN R, 1990, GENET EPIDEMIOL, V7, P177, DOI 10.1002/gepi.1370070302
   Polfus LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074642
   Pollard KS, 2008, HUM GENET, V122, P625, DOI 10.1007/s00439-007-0440-1
   Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847
   Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419
   R Core Development Team, 2009, R LANG ENV STAT COMP
   Radhakrishna Rao C, 1948, LARGE SAMPLE TESTS S, P50
   Rivas MA, 2015, SCIENCE, V348, P666, DOI 10.1126/science.1261877
   Rostama B, 2015, ARTERIOSCL THROM VAS, V35, P2626, DOI 10.1161/ATVBAHA.115.306541
   Sartori R, 2013, NAT GENET, V45, P1309, DOI 10.1038/ng.2772
   Sheffield NC, 2013, GENOME RES, V23, P777, DOI 10.1101/gr.152140.112
   Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308
   Smadja DM, 2008, ARTERIOSCL THROM VAS, V28, P2137, DOI 10.1161/ATVBAHA.108.168815
   Smith FB, 2000, BLOOD COAGUL FIBRIN, V11, P43, DOI 10.1097/00001721-200011010-00005
   Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100
   Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846
   Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232
   Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002
   U.S. Census Bureau, 2013, TIGER LIN SHAP TIGER
   Wahlgren CM, 2011, ARTERIOSCL THROM VAS, V31, P678, DOI 10.1161/ATVBAHA.110.210385
   Ward-Caviness CK, 2015, ENV HLTH PERSPECT, V123, P8
   Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340
   Yamawaki H, 2006, CIRC J, V70, P129, DOI 10.1253/circj.70.129
   Yan MS, 2015, ARTERIOSCL THROM VAS, V35, P2297, DOI 10.1161/ATVBAHA.115.305043
   Yao YC, 2010, CIRC RES, V107, P485, DOI 10.1161/CIRCRESAHA.110.219071
   Zanobetti A, 2011, PROG CARDIOVASC DIS, V53, P344, DOI 10.1016/j.pcad.2011.01.001
   Zhao GQ, 1998, DEVELOPMENT, V125, P1103
NR 72
TC 5
Z9 5
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 15
PY 2016
VL 11
IS 4
AR e0152670
DI 10.1371/journal.pone.0152670
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ6AH
UT WOS:000374291800007
PM 27082954
OA Other Gold, Green Published
DA 2019-05-24
ER

PT J
AU Stiegel, MA
   Pleil, JD
   Sobus, JR
   Madden, MC
AF Stiegel, Matthew A.
   Pleil, Joachim D.
   Sobus, Jon R.
   Madden, Michael C.
TI Inflammatory Cytokines and White Blood Cell Counts Response to
   Environmental Levels of Diesel Exhaust and Ozone Inhalation Exposures
SO PLOS ONE
LA English
DT Article
ID AIR-POLLUTION; PARTICULATE MATTER; BREATH CONDENSATE; NO2 EMISSIONS;
   LUNG-FUNCTION; BIOMARKERS; DISEASE; DYSFUNCTION; VOLUNTEERS; PARTICLES
AB Epidemiological observations of urban inhalation exposures to diesel exhaust (DE) and ozone (O-3) have shown pre-clinical cardiopulmonary responses in humans. Identifying the key biological mechanisms that initiate these health bioindicators is difficult due to variability in environmental exposure in time and from person to person. Previously, environmentally controlled human exposure chambers have been used to study DE and O-3 dose-response patterns separately, but investigation of co-exposures has not been performed under controlled conditions. Because a mixture is a more realistic exposure scenario for the general public, in this study we investigate the relationships of urban levels of urban-level DE exposure (300 mu g/m(3)), O-3 (0.3 ppm), DE + O-3 co-exposure, and innate immune system responses. Fifteen healthy human volunteers were studied for changes in ten inflammatory cytokines (interleukins 1 beta, 2, 4, 5, 8, 10, 12p70 and 13, IFN-gamma, and TNF-alpha) and counts of three white blood cell types (lymphocytes, monocytes, and neutrophils) following controlled exposures to DE, O3, and DE+O-3. The results show subtle cytokines responses to the diesel-only and ozone-only exposures, and that a more complex (possibly synergistic) relationship exists in the combination of these two exposures with suppression of IL-5, IL-12p70, IFN-gamma, and TNF-alpha that persists up to 22-hours for IFN-gamma and TNF-alpha. The white blood cell differential counts showed significant monocyte and lymphocyte decreases and neutrophil increases following the DE + O3 exposure; lymphocytes and neutrophils changes also persist for at least 22-hours. Because human studies must be conducted under strict safety protocols at environmental levels, these effects are subtle and are generally only seen with detailed statistical analysis. This study indicates that the observed associations between environmental exposures and cardiopulmonary effects are possibly mediated by inflammatory response mechanisms.
C1 [Stiegel, Matthew A.] Duke Univ, Med Ctr, Dept Occupat & Environm Safety, Div Occupat Hyg & Safety, Durham, NC USA.
   [Pleil, Joachim D.; Sobus, Jon R.] US EPA, Natl Exposure Res Lab, Human Exposure & Atmospher Sci Div, Res Triangle Pk, NC 27711 USA.
   [Madden, Michael C.] US EPA, Natl Hlth & Environm Effects Res Lab, Environm Publ Hlth Div, Chapel Hill, NC USA.
RP Pleil, JD (reprint author), US EPA, Natl Exposure Res Lab, Human Exposure & Atmospher Sci Div, Res Triangle Pk, NC 27711 USA.
EM pleil.joachim@epa.gov
OI Sobus, Jon/0000-0003-0740-6604
FU US Government
FX The authors JDP, JRS, MCM and the study were fully funded by the US
   Government as part of their employment.
CR Alexis NE, 2010, INHAL TOXICOL, V22, P593, DOI 10.3109/08958371003596587
   Alexis NE, 2009, J ALLERGY CLIN IMMUN, V124, P1222, DOI 10.1016/j.jaci.2009.07.036
   Amann A, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/3/034001
   Angrish MM, 2016, J TOXICOL ENV HLT 25, V25, P1
   Bao AH, 2013, FRONT BIOSCI-LANDMRK, V18, P838, DOI 10.2741/4147
   Bar-Ilan A, 2010, J AIR WASTE MANAGE, V60, P977, DOI 10.3155/1047-3289.60.8.977
   Bean HD, 2015, BIOMARKERS, V20, P1, DOI 10.3109/1354750X.2014.985254
   Bosson J, 2008, EUR RESPIR J, V31, P1234, DOI 10.1183/09031936.00078407
   Bosson J, 2009, INHAL TOXICOL, V21, P913, DOI 10.1080/08958370802657389
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8
   Buzzard NA, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-13
   Chow JC, 2006, J AIR WASTE MANAGE, V56, P707, DOI 10.1080/10473289.2006.10464484
   Chuang KJ, 2007, AM J RESP CRIT CARE, V176, P370, DOI 10.1164/rccm.200611-1627OC
   Chung KF, 1999, THORAX, V54, P825, DOI 10.1136/thx.54.9.825
   Cousins DJ, 2002, J IMMUNOL, V169, P2498, DOI 10.4049/jimmunol.169.5.2498
   Devlin RB, 2012, CIRCULATION, V126, P104, DOI 10.1161/CIRCULATIONAHA.112.094359
   Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103
   Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h
   Faustini A, 2013, EUR RESPIR J, V42, P304, DOI 10.1183/09031936.00128712
   Gilliland FD, 2002, AM J RESP CRIT CARE, V166, P457, DOI 10.1164/rccm.2112064
   Gold DR, 2000, CIRCULATION, V101, P1267, DOI 10.1161/01.CIR.101.11.1267
   HATCH GE, 1994, AM J RESP CRIT CARE, V150, P676, DOI 10.1164/ajrccm.150.3.8087337
   Holgate Stephen T, 2003, Res Rep Health Eff Inst, P1
   Huang YCT, 2012, INHAL TOXICOL, V24, P790, DOI 10.3109/08958378.2012.718809
   Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894
   Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012
   Kim CS, 2011, AM J RESP CRIT CARE, V183, P1215, DOI 10.1164/rccm.201011-1813OC
   Knudsen Thomas, 2013, Methods Mol Biol, V947, P343, DOI 10.1007/978-1-62703-131-8_26
   Kodavanti UP, 2011, ENVIRON HEALTH PERSP, V119, P312, DOI 10.1289/ehp.1002386
   Kurtenbach Ralf, 2012, Environmental Sciences Europe, V24, P21, DOI 10.1186/2190-4715-24-21
   Laskin Debra L, 2010, Res Rep Health Eff Inst, P3
   Madden MC, 2014, PART FIBRE TOXICOL, V11, DOI [10.1186/s12989-014-0037, 10.1186/s12989-014-0037-5]
   Meso Scale Discovery, 2012, MSD BIOM ASS HUM TH1
   Nordenhall C, 2000, EUR RESPIR J, V15, P1046, DOI 10.1034/j.1399-3003.2000.01512.x
   Oakes JL, 2013, AM J RESP CELL MOL, V48, P27, DOI 10.1165/rcmb.2012-0187OC
   Pleil JD, 2015, J BREATH RES, V9, DOI 10.1088/1752-7155/9/4/047108
   Pleil JD, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/2/029001
   Pleil JD, 2013, ANAL CHEM, V85, P9984, DOI 10.1021/ac402306f
   Pleil JD, 2012, J TOXICOL ENV HEAL B, V15, P264, DOI 10.1080/10937404.2012.672148
   Pleil JD, 2011, BIOMARKERS, V16, P99, DOI 10.3109/1354750X.2010.541565
   Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957
   Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603
   Romagnani S, 2000, ANN ALLERG ASTHMA IM, V85, P9, DOI 10.1016/S1081-1206(10)62426-X
   Saito Y, 2002, EXP LUNG RES, V28, P201, DOI 10.1080/019021402753570509
   Sawyer K, 2010, J TOXICOL ENV HEAL A, V73, P41, DOI 10.1080/15287390903248901
   SCHELEGLE ES, 1991, AM REV RESPIR DIS, V143, P1353, DOI 10.1164/ajrccm/143.6.1353
   Setlow VP, 1998, GENDER DIFFERENCES S
   Stevens T, 2008, TOXICOL SCI, V102, P359, DOI 10.1093/toxsci/kfn006
   Stevens T, 2009, TOXICOL SCI, V107, P522, DOI 10.1093/toxsci/kfn248
   Stiegel MA, 2015, BIOMARKERS, V20, P35, DOI 10.3109/1354750X.2014.988646
   Sydbom A, 2001, EUR RESPIR J, V17, P733, DOI 10.1183/09031936.01.17407330
   Tornqvist H, 2007, AM J RESP CRIT CARE, V176, P395, DOI 10.1164/rccm.200606-872OC
   U.S. Environmental Protection Agency (EPA), 2002, EPA600890057F NAT CT
   Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456
   WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694
   Xu YY, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-60
   Yang HM, 2001, ENVIRON HEALTH PERSP, V109, P515, DOI 10.2307/3454711
NR 58
TC 15
Z9 15
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 8
PY 2016
VL 11
IS 4
AR e0152458
DI 10.1371/journal.pone.0152458
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DI6JK
UT WOS:000373604800006
PM 27058360
OA DOAJ Gold, Green Published
DA 2019-05-24
ER

PT J
AU Kuhn, R
   Rothman, DS
   Turner, S
   Solorzano, J
   Hughes, B
AF Kuhn, Randall
   Rothman, Dale S.
   Turner, Sara
   Solorzano, Jose
   Hughes, Barry
TI Beyond Attributable Burden: Estimating the Avoidable Burden of Disease
   Associated with Household Air Pollution
SO PLOS ONE
LA English
DT Article
ID SOLID-FUEL USE; PARTICULATE MATTER; BIOMASS FUELS; RISK; EXPOSURE;
   COMBUSTION; PNEUMONIA; COOKING
AB Background
   The Global Burden of Disease (GBD) studies have transformed global understanding of health risks by producing comprehensive estimates of attributable disease burden, or the current disease that would be eliminated if a risk factor did not exist. Yet many have noted the greater policy significance of avoidable burden, or the future disease that could actually be eliminated if a risk factor were eliminated today. Avoidable risk may be considerably lower than attributable risk if baseline levels of exposure or disease are declining, or if a risk factor carries lagged effects on disease. As global efforts to deliver clean cookstoves accelerate, a temporal estimation of avoidable risk due to household air pollution (HAP) becomes increasingly important, particularly in light of the rapid uptake of modern stoves and ongoing epidemiologic transitions in regions like South and Southeast Asia.
   Methods and Findings
   We estimate the avoidable burden associated with HAP using International Futures (IFs), an integrated forecasting system that has been used to model future global disease burdens and risk factors. Building on GBD and other estimates, we integrated a detailed HAP exposure estimation and exposure-response model into IFs. We then conducted a counterfactual experiment in which HAP exposure is reduced to theoretical minimum levels in 2015. We evaluated avoidable mortality and DALY reductions for the years 2015 to 2024 relative to a Base Case scenario in which only endogenous changes occurred. We present results by cause and region, looking at impacts on acute lower respiratory infection (ALRI) and four noncommunicable diseases (NCDs). We found that just 2.6% of global DALYs would be averted between 2015 and 2024, compared to 4.5% of global DALYs attributed to HAP in the 2010 GBD study, due in large part to the endogenous tendency towards declining traditional stove usage in the IFs base case forecast. The extent of diminished impact was comparable for ALRI and affected NCDs, though for different reasons. ALRI impacts diminish due to the declining burden of ALRI in the base case forecast, particularly apparent in South Asia and Southeast Asia. Although NCD burdens are rising in regions affected by HAP, the avoidable risk of NCD nonetheless diminishes due to lagged effects. Because the stove transition and the decline of ALRI are proceeding more slowly in Sub-Saharan Africa, avoidable impacts would also be more persistent (3.9% of total DALY due to HAP) compared to South Asia (3.6%) or Southeast Asia (2.5%).
   Conclusions
   Our results illustrate how a temporal dynamic calculation of avoidable risk may yield different estimates, compared to a static attributable risk estimate, of the global and regional burden of disease. Our results suggest a window of rising and falling opportunity for HAP interventions that may have already closed in Southeast Asia and may be closing quickly in South Asia, but may remain open longer in Sub-Saharan Africa. A proper accounting of global health priorities should apply an avoidable risk framework that considers the role of ongoing social, economic and health transitions in constantly altering the disease and risk factor landscape.
C1 [Kuhn, Randall] Univ Denver, Josef Korbel Sch Int Studies, Global Hlth Affairs Program, Denver, CO USA.
   [Rothman, Dale S.; Turner, Sara; Solorzano, Jose; Hughes, Barry] Univ Denver, Frederick S Pardee Ctr Int Futures, Josef Korbel Sch Int Studies, Denver, CO USA.
RP Kuhn, R (reprint author), Univ Denver, Josef Korbel Sch Int Studies, Global Hlth Affairs Program, Denver, CO USA.
EM rkuhn@du.edu
OI Kuhn, Randall/0000-0001-5664-6933
FU Population Services International (PSI)
FX This study was funded in part by Population Services International (PSI)
   through the grant "New impact models for global health service delivery:
   Tobacco-related disease and cook stoves" to the University of Denver.
   Other support came from the University of Denver and the Frederick S.
   Pardee Center for International Futures. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Andrews KG, 2013, LANCET, V381, P8
   Balakrishnan K, 2002, ENVIRON HEALTH PERSP, V110, P1069, DOI 10.1289/ehp.021101069
   Balakrishnan K, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-77
   Bonjour S, 2013, ENVIRON HEALTH PERSP, V121, P784, DOI 10.1289/ehp.1205987
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049
   Chafe ZA, 2014, ENVIRON HEALTH PERSP, V122, P1314, DOI 10.1289/ehp.1206340
   Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529
   Ezzati M, 2001, LANCET, V358, P619, DOI 10.1016/S0140-6736(01)05777-4
   Global Burden of Disease, 2012, GLOB BURD DIS STUD 2
   Hanna R, 2012, 18033 NAT BUR EC RES, P1
   Hughes B., 2006, EXPLORING SHAPING IN
   Hughes B. B, 2011, IMPROVING GLOBAL HLT
   Hughes BB, 2011, B WORLD HEALTH ORGAN, V89, P478, DOI 10.2471/BLT.10.083766
   Hughes BB, 2009, FORECASTING LONG TER, V2009
   Kim KH, 2011, J HAZARD MATER, V192, P425, DOI 10.1016/j.jhazmat.2011.05.087
   Lee MS, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-18
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Mishra V K, 1999, Int J Infect Dis, V3, P119, DOI 10.1016/S1201-9712(99)90032-2
   Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1
   OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375
   Pillarisetti A, 2016, BROKEN PUMPS AND PROMISES: INCENTIVIZING IMPACT IN ENVIRONMENTAL HEALTH, P147, DOI 10.1007/978-3-319-28643-3_10
   Pope CA, 2011, AIR QUAL ATMOS HLTH, V4, P5, DOI 10.1007/s11869-010-0082-7
   Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132
   Rajagopalan S, 2012, GLOB HEART, V7, P207, DOI 10.1016/j.gheart.2012.06.009
   Rothman D, 2014, BUILDING GLOBAL INFR
   Smith KR, 2014, ANNU REV PUBL HEALTH, V35, P185, DOI 10.1146/annurev-publhealth-032013-182356
   Smith KR, 2011, LANCET, V378, P1717, DOI 10.1016/S0140-6736(11)60921-5
   Smith KR, 2005, ANNU REV ENV RESOUR, V30, P291, DOI 10.1146/annurev.energy.30.050504.144424
   Smith KR, 1995, ASSESSING MANAGING H, P3
   UNSTATS, 2013, POP US SOL FUELS PER
   WHO, 2013, HOUS FUEL DAT
   Wilkinson P, 2009, LANCET, V374, P1917, DOI 10.1016/S0140-6736(09)61713-X
NR 34
TC 2
Z9 2
U1 1
U2 21
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 16
PY 2016
VL 11
IS 3
AR e0149669
DI 10.1371/journal.pone.0149669
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DH1WF
UT WOS:000372574900018
PM 26982804
OA DOAJ Gold, Green Published
DA 2019-05-24
ER

PT J
AU Ye, XF
   Peng, L
   Kan, HD
   Wang, WB
   Geng, FH
   Mu, Z
   Zhou, J
   Yang, DD
AF Ye, Xiaofang
   Peng, Li
   Kan, Haidong
   Wang, Weibing
   Geng, Fuhai
   Mu, Zhe
   Zhou, Ji
   Yang, Dandan
TI Acute Effects of Particulate Air Pollution on the Incidence of Coronary
   Heart Disease in Shanghai, China
SO PLOS ONE
LA English
DT Article
ID ACUTE MYOCARDIAL-INFARCTION; EMERGENCY HOSPITAL ADMISSIONS;
   CASE-CROSSOVER ANALYSIS; DAILY MORTALITY; CARDIOVASCULAR MORTALITY;
   ULTRAFINE PARTICLES; TRANSPORT PATHWAYS; POTENTIAL SOURCES;
   PUBLIC-HEALTH; BLACK CARBON
AB Introduction
   Evidence based on ecological studies in China suggests that short-term exposure to particulate matter (PM) is associated with cardiovascular mortality. However, there is less evidence of PM-related morbidity for coronary heart disease (CHD) in China. This study aims to investigate the relationship between acute PM exposure and CHD incidence in people aged above 40 in Shanghai.
   Methods
   Daily CHD events during 2005-2012 were identified from outpatient and emergency department visits. Daily average concentrations for particulate matter with aerodynamic diameter less than 10 microns (PM10) were collected over the 8-year period. Particulate matter with aerodynamic diameter less than 2.5 microns (PM2.5) were measured from 2009 to 2012. Analyses were performed using quasi-poisson regression models adjusting for confounders, including long-term trend, seasonality, day of the week, public holiday and meteorological factors. The effects were also examined by gender and age group (41-65 years, and >65 years).
   Results
   There were 619928 CHD outpatient and emergency department visits. The average concentrations of PM10 and PM2.5 were 81.7 mu g/m(3) and 38.6 mu g/m(3), respectively. Elevated exposure to PM10 and PM2.5 was related with increased risk of CHD outpatients and emergency department visits in a short time course. A 10 mu g/m(3) increase in the 2-day PM10 and PM2.5 was associated with increase of 0.23% (95% CI: 0.12%, 0.34%) and 0.74% (95% CI: 0.44%, 1.04%) in CHD morbidity, respectively. The associations appeared to be more evident in the male and the elderly.
   Conclusion
   Short-term exposure to high levels of PM10 and PM2.5 was associated with increased risk of CHD outpatient and emergency department visits. Season, gender and age were effect modifiers of their association.
C1 [Ye, Xiaofang] Fudan Univ, Sch Publ Hlth, Dept Environm Hlth, Shanghai 200433, Peoples R China.
   [Ye, Xiaofang; Peng, Li; Geng, Fuhai; Mu, Zhe; Zhou, Ji; Yang, Dandan] Shanghai Meteorol Serv, Shanghai Key Lab Meteorol & Hlth, Shanghai, Peoples R China.
   [Kan, Haidong; Wang, Weibing] Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China.
   [Kan, Haidong; Wang, Weibing] Fudan Univ, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China.
   [Wang, Weibing] Fudan Tyndall Ctr, Shanghai, Peoples R China.
RP Ye, XF (reprint author), Fudan Univ, Sch Publ Hlth, Dept Environm Hlth, Shanghai 200433, Peoples R China.; Ye, XF (reprint author), Shanghai Meteorol Serv, Shanghai Key Lab Meteorol & Hlth, Shanghai, Peoples R China.
EM tideye@163.com
FU Scientific Research Program Science and Technology Commission of
   Shanghai Municipality [12dz1202600]; Global Environment Change Research
   of Fudan University Tyndall Centre [EZH1829007/003]; Scientific Research
   Program Science and Technology Commission of Shanghai Municipality
   [12dz1202600]; Global Environment Change Research of Fudan University
   Tyndall Centre [EZH1829007/003]
FX This study was funded by the Scientific Research Program Science and
   Technology Commission of Shanghai Municipality (Grant No. 12dz1202600)
   and the Global Environment Change Research of Fudan University Tyndall
   Centre (Grant No. EZH1829007/003). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR [Anonymous], 2012, SHANGHAI STAT YB 201
   Belleudi V, 2010, EPIDEMIOLOGY, V21, P414, DOI 10.1097/EDE.0b013e3181d5c021
   Bhaskaran K, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5531
   Breitner S, 2011, SCI TOTAL ENVIRON, V409, P5196, DOI 10.1016/j.scitotenv.2011.08.023
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Cao JJ, 2012, ENVIRON HEALTH PERSP, V120, P373, DOI 10.1289/ehp.1103671
   Chen RJ, 2012, AM J EPIDEMIOL, V175, P1173, DOI 10.1093/aje/kwr425
   Chen RJ, 2010, SCI TOTAL ENVIRON, V408, P6086, DOI 10.1016/j.scitotenv.2010.09.018
   Clougherty JE, 2010, ENVIRON HEALTH PERSP, V118, P167, DOI 10.1289/ehp.0900994
   Dai LZ, 2014, ENVIRON HEALTH PERSP, V122, P837, DOI 10.1289/ehp.1307568
   Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127
   Guo YM, 2010, SCI TOTAL ENVIRON, V409, P300, DOI 10.1016/j.scitotenv.2010.10.013
   Hoffmann B, 2012, ENVIRON HEALTH PERSP, V120, P241, DOI 10.1289/ehp.1103647
   Huang D, 2012, AM HEART J, V164, P394, DOI 10.1016/j.ahj.2012.06.015
   Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1183, DOI 10.1289/ehp.10851
   Kyobutungi C, 2005, EUR J EPIDEMIOL, V20, P693, DOI 10.1007/s10654-005-0703-x
   Li MM, 2012, SCI TOTAL ENVIRON, V414, P525, DOI 10.1016/j.scitotenv.2011.10.054
   Liu Jiangmei, 2015, Zhonghua Yu Fang Yi Xue Za Zhi, V49, P315
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Lu F, 2015, ENVIRON RES, V136, P196, DOI 10.1016/j.envres.2014.06.029
   Ma Z, 2015, ENV HLTH PERSPECT
   Martinelli N, 2013, EUR J INTERN MED, V24, P295, DOI 10.1016/j.ejim.2013.04.001
   Milojevic A, 2014, HEART, V100, P1093, DOI 10.1136/heartjnl-2013-304963
   Mustafic H, 2012, JAMA-J AM MED ASSOC, V307, P713, DOI 10.1001/jama.2012.126
   Nawrot TS, 2007, J EPIDEMIOL COMMUN H, V61, P146, DOI 10.1136/jech.2005.044263
   Nawrot TS, 2011, LANCET, V377, P732, DOI 10.1016/S0140-6736(10)62296-9
   Nuvolone D, 2011, AM J EPIDEMIOL, V174, P63, DOI 10.1093/aje/kwr046
   Perez MI, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006743.pub2
   Peters A, 2001, CIRCULATION, V103, P2810
   Pieters N, 2012, HEART, V98, P1127, DOI 10.1136/heartjnl-2011-301505
   Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888
   Pun VC, 2014, ENVIRON HEALTH PERSP, V122, P391, DOI 10.1289/ehp.1307213
   Qiu H, 2013, INT J CARDIOL, V168, P500, DOI 10.1016/j.ijcard.2012.09.199
   Ridker Paul M., 2003, Cardiology Clinics, V21, P315, DOI 10.1016/S0733-8651(03)00079-1
   Ruckerl R, 2007, ENVIRON HEALTH PERSP, V115, P1072, DOI 10.1289/ehp.10021
   Schicker B, 2009, EUR J APPL PHYSIOL, V105, P771, DOI 10.1007/s00421-008-0962-9
   Sorensen M, 2003, ENVIRON HEALTH PERSP, V111, P161, DOI 10.1289/ehp.5646
   Strandmark R, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0188-x
   Wang HQ, 2015, PARTICUOLOGY, V20, P89, DOI 10.1016/j.partic.2014.07.003
   Wang L, 2015, BIOMED RES INT, DOI 10.1155/2015/382086
   Wang RP, 2015, TOB INDUC DIS, V13, DOI 10.1186/s12971-015-0043-x
   Wang X, 2013, SCI TOTAL ENVIRON, V458, P1, DOI 10.1016/j.scitotenv.2013.04.008
   Wolf K, 2015, INT J HYG ENVIR HEAL, V218, P535, DOI 10.1016/j.ijheh.2015.05.002
   Wu SW, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-49
   Xie J, 2014, J EPIDEMIOL, V24, P452, DOI 10.2188/jea.JE20140044
   Xie WX, 2015, HEART, V101, P257, DOI 10.1136/heartjnl-2014-306165
   Yu ITS, 2013, INT J CARDIOL, V168, P2831, DOI 10.1016/j.ijcard.2013.03.082
   Zanobetti A, 2005, ENVIRON HEALTH PERSP, V113, P978, DOI 10.1289/ehp.7550
   Zanobetti A, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-58
   Zhang HB, 2015, AM HEART J, V170, P506, DOI 10.1016/j.ahj.2015.05.012
   Zhang PF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020827
   Zhang YJ, 2012, SCI TOTAL ENVIRON, V435, P14, DOI 10.1016/j.scitotenv.2012.06.092
   Zhao J., 2013, OCCUP ENV MED
   Zhao JZ, 2010, TOXICOL LETT, V193, P50, DOI 10.1016/j.toxlet.2009.12.002
   Zhao MF, 2015, ATMOS RES, V158, P66, DOI 10.1016/j.atmosres.2015.02.003
NR 55
TC 26
Z9 28
U1 1
U2 45
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 4
PY 2016
VL 11
IS 3
AR e0151119
DI 10.1371/journal.pone.0151119
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DG0FG
UT WOS:000371739400081
PM 26942767
OA Green Published, Other Gold
DA 2019-05-24
ER

PT J
AU Austin, E
   Novosselov, I
   Seto, E
   Yost, MG
AF Austin, Elena
   Novosselov, Igor
   Seto, Edmund
   Yost, Michael G.
TI Laboratory Evaluation of the Shinyei PPD42NS Low-Cost Particulate Matter
   Sensor
SO PLOS ONE
LA English
DT Article
ID AMERICAN-HEART-ASSOCIATION; AIR-POLLUTION; CARDIOVASCULAR-DISEASE; US
   CITIES; MORTALITY; EXPOSURE; POPULATION; STATEMENT; QUALITY; PM2.5
AB Objective
   Finely resolved PM2.5 exposure measurements at the level of individual participants or over a targeted geographic area can be challenging due to the cost, size and weight of the monitoring equipment. We propose re-purposing the low-cost, portable and lightweight Shinyei PPD42NS particle counter as a particle counting device. Previous field deployment of this sensor suggests that it captures trends in ambient PM2.5 concentrations, but important characteristics of the sensor response have yet to be determined. Laboratory testing was undertaken in order to characterize performance.
   Methods
   The Shinyei sensors, in-line with a TSI Aerosol Particle Sizer (APS) model 3321, tracked particle decay within an aerosol exposure chamber. Test atmospheres were composed of monodisperse polystyrene spheres with diameters of 0.75, 1, 2 3 and 6 um as well as a polydisperse atmosphere of ASHRAE test dust #1.
   Results
   Two-minute block averages of the sensor response provide a measurement with low random error, within sensor, for particles in the 0.75-6 mu m range with a limit of detection of 1 mu g/m(3). The response slope of the sensors is idiomatic, and each sensor requires a unique response curve. A linear model captures the sensor response for concentrations below 50 mu g/m(3) and for concentrations above 50 mu g/m(3) a non-linear function captures the response and saturates at 800 mu g/m(3). The Limit of Detection (LOD) is 1 mu g/m(3). The response time is on the order of minutes, making it appropriate for tracking short-term changes in concentration.
   Conclusions
   When paired with prior evaluation, these sensors are appropriate for use as ambient particle counters for low and medium concentrations of respirable particles (< 100 ug/m(3)). Multiple sensors deployed over a spatial grid would provide valuable spatio-temporal variability in PM2.5 and could be used to validate exposure models. When paired with GPS tracking, these devices have the potential to provide time and space resolved exposure measurements for a large number of participants, thus increasing the power of a study.
C1 [Austin, Elena; Seto, Edmund; Yost, Michael G.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.
   [Novosselov, Igor] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA.
RP Austin, E (reprint author), Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.
EM elaustin@uw.edu
FU Department of Environmental and Occupational Health Sciences at the
   University of Washington; National Institute of Environmental Health
   Sciences of the National Institutes of Health [T32ES015459, R21ES024715]
FX The authors would like to thank the Department of Environmental and
   Occupational Health Sciences at the University of Washington for its
   support of this project. Research reported in this article was supported
   by the National Institute of Environmental Health Sciences of the
   National Institutes of Health under award number T32ES015459 and award
   number R21ES024715. Disclaimer: The content is solely the responsibility
   of the authors and does not necessarily represent the official views of
   the National Institutes of Health.
CR [Anonymous], 2013, FIN PART PM2 5 DES
   Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   California Environmental Protection Agency Air Resources Board, 2005, AIR QUAL LAND US HDB
   Chow JC, 2006, J AIR WASTE MANAGE, V56, P707, DOI 10.1080/10473289.2006.10464484
   Clougherty JE, 2013, J EXPO SCI ENV EPID, V23, P232, DOI 10.1038/jes.2012.125
   Cohen AJ, 2005, J TOXICOL ENV HEAL A, V68, P1301, DOI 10.1080/15287390590936166
   DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401
   Evans J, 2013, ENVIRON RES, V120, P33, DOI 10.1016/j.envres.2012.08.005
   Gao ML, 2015, ENVIRON POLLUT, V199, P56, DOI 10.1016/j.envpol.2015.01.013
   Holstius D., 2014, ATMOS MEAS TECH DISC, V7, P605, DOI DOI 10.5194/AMTD-7-605-2014
   Jerrett M, 2005, J EXPO ANAL ENV EPID, V15, P185, DOI 10.1038/sj.jea.7500388
   Karner AA, 2010, ENVIRON SCI TECHNOL, V44, P5334, DOI 10.1021/es100008x
   Krewski D., 2000, REANALYSIS HARVARD 6, P295
   Krewski D., 2009, EXTENDED FOLLOW UP S
   Lipfert FW, 2006, ATMOS ENVIRON, V40, P154, DOI 10.1016/j.atmosenv.2005.09.027
   Osman LM, 2007, AM J RESP CRIT CARE, V176, P465, DOI 10.1164/rccm.200605-589OC
   Peng RD, 2005, AM J EPIDEMIOL, V161, P585, DOI 10.1093/aje/kwi075
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132
   Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401
   Siddiqui AR, 2009, INDOOR AIR, V19, P75, DOI 10.1111/j.1600-0668.2008.00563.x
   Simkhovich BZ, 2008, J AM COLL CARDIOL, V52, P719, DOI 10.1016/j.jacc.2008.05.029
   Stein SW, 2003, J AEROSOL MED, V16, P107, DOI 10.1089/089426803321919870
   van Donkelaar A, 2010, ENVIRON HEALTH PERSP, V118, P847, DOI 10.1289/ehp.0901623
   Volckens J, 2005, J AEROSOL SCI, V36, P1400, DOI 10.1016/j.jaerosci.2005.03.009
   Zeger SL, 2008, ENVIRON HEALTH PERSP, V116, P1614, DOI 10.1289/ehp.11449
NR 26
TC 25
Z9 25
U1 3
U2 47
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 14
PY 2015
VL 10
IS 9
AR e0137789
DI 10.1371/journal.pone.0137789
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CR8KS
UT WOS:000361601100137
PM 26367264
OA Other Gold, Green Published
DA 2019-05-24
ER

PT J
AU Joo, YH
   Lee, SS
   Han, KD
   Park, KH
AF Joo, Young-Hoon
   Lee, Seong-Soo
   Han, Kyung-do
   Park, Kyung-Ho
TI Association between Chronic Laryngitis and Particulate Matter Based on
   the Korea National Health and Nutrition Examination Survey 2008-2012
SO PLOS ONE
LA English
DT Article
ID AIR-POLLUTION EXPOSURE; CIGARETTE-SMOKING; INFECTION; CHILDREN; ASTHMA;
   SIZE
AB Background
   Chronic laryngitis (CL) has been described as chronic inflammation of the larynx. CL have various causes such as long-term smoking, acid reflux, voice overuse, bronchitis, allergies, pneumonia, excessive exposure to toxic chemicals and complications from the flu or a chronic cold. However, the prevalence of CL and role of air pollution in the etiology is uncertain.
   Objective
   The aim of this study was to investigate the relationship between CL and particulate matter with aerodynamic diameter less than 10 mu m (PM10) in South Korea using data from the Korea National Health and Nutrition Examination Surveys (KNHANES) during 2008-2012.
   Methods
   KNHANES is a cross-sectional survey of the civilian, non-institutionalized population of South Korea (n = 21,116). A field survey team that included an otolaryngologist moved with a mobile examination unit and performed interviews and physical examinations. The mean annual concentrations of ambient PM10, SO2, O3, NO2, and CO levels in Korea were determined from monitoring station data. Multiple logistic regression was used to examine the relationship of air pollution to CL.
   Results
   Among the population >= 19 years of age, the weighted prevalence of CL was 3.37 +/- 0.30% (95% confidence interval, 2.79-3.95%). CL was more prevalent in men, current smokers, and those with lower household income and prevalence increased with age. A significant decrease over time was observed in the prevalence of CL (P for trend = 0.0049) and the annual average concentrations of PM10 (P for trend < 0.0001) from 2008 to 2012. In a multivariate model, the factors associated with CL included PM10 (odds ratio [OR], 1.378, p = 0.0457), age (OR, 1.020, p<0.0001), sex (OR, 0.734, p = 0.0179), and smoking status (OR, 1.438, p = 0.0054).
   Conclusion
   Elevated PM10 exposures could be associated with increased risk of CL in South Koreans. Further epidemiological and experimental studies are necessary to clarify the impact of chronic PM10 exposure on CL.
C1 [Joo, Young-Hoon; Park, Kyung-Ho] Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.
   [Lee, Seong-Soo] Catholic Univ Korea, Coll Med, Dept Endocrinol, Seoul, South Korea.
   [Han, Kyung-do] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea.
RP Park, KH (reprint author), Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.
EM khpent@catholic.ac.kr
CR Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206
   Baletic N, 2005, IND HEALTH, V43, P302, DOI 10.2486/indhealth.43.302
   Bitar K, 2011, NEUROGASTROENT MOTIL, V23, P490, DOI 10.1111/j.1365-2982.2011.01678.x
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011
   Carvalho-Oliveira R, 2005, ENVIRON RES, V98, P349, DOI 10.1016/j.envres.2004.10.002
   Chen HK, 2012, AUSTRALAS MED J, V5, P175, DOI 10.4066/AMJ.2012.1101
   Coyle SM, 2001, J VOICE, V15, P424, DOI 10.1016/S0892-1997(01)00043-1
   Delfino RJ, 1997, ENVIRON HEALTH PERSP, V105, P622, DOI 10.1289/ehp.97105622
   Dua K, 2002, GUT, V51, P771, DOI 10.1136/gut.51.6.771
   Dworkin JP, 2008, OTOLARYNG CLIN N AM, V41, P419, DOI 10.1016/j.otc.2007.11.011
   Fukuda K, 2011, AUST NZ J PUBL HEAL, V35, P163, DOI 10.1111/j.1753-6405.2010.00620.x
   Joo YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131247
   Kelly FJ, 2012, ATMOS ENVIRON, V60, P504, DOI 10.1016/j.atmosenv.2012.06.039
   Kim KH, 2015, ENVIRON INT, V74, P136, DOI 10.1016/j.envint.2014.10.005
   Kim Yangho, 2013, J Prev Med Public Health, V46, P96, DOI 10.3961/jpmph.2013.46.2.96
   Korean Association of Smoking and Health, NAT SMOK PREV SURV
   MARCY TW, 1987, CLIN CHEST MED, V8, P381
   Merati AL, 2010, CUMMINGS OTOLARYNGOL, V5th, P901
   Murin S, 2005, CLEV CLIN J MED, V72, P916, DOI 10.3949/ccjm.72.10.916
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Neupane B, 2010, AM J RESP CRIT CARE, V181, P47, DOI [10.1164/rccm.200901-0160oc, 10.1164/rccm.200901-0160OC]
   Ostro B, 2001, EPIDEMIOLOGY, V12, P200, DOI 10.1097/00001648-200103000-00012
   Park SU, 2004, ATMOS ENVIRON, V38, P2155, DOI 10.1016/j.atmosenv.2004.01.024
   Soukup JM, 2000, INHAL TOXICOL, V12, P401
   Stanek LW, 2011, TOXICOL SCI, V120, pS8, DOI 10.1093/toxsci/kfq367
   Stein DJ, 2013, ANN OTO RHINOL LARYN, V122, P771, DOI 10.1177/000348941312201207
   Sun QH, 2010, CIRCULATION, V121, P2755, DOI 10.1161/CIRCULATIONAHA.109.893461
NR 28
TC 7
Z9 7
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 15
PY 2015
VL 10
IS 7
AR e0133180
DI 10.1371/journal.pone.0133180
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN1RL
UT WOS:000358197600226
PM 26177353
OA DOAJ Gold, Green Published
DA 2019-05-24
ER

PT J
AU Li, HQ
   Hedmer, M
   Karedal, M
   Bjork, J
   Stockfelt, L
   Tinnerberg, H
   Albin, M
   Broberg, K
AF Li, Huiqi
   Hedmer, Maria
   Karedal, Monica
   Bjork, Jonas
   Stockfelt, Leo
   Tinnerberg, Hakan
   Albin, Maria
   Broberg, Karin
TI A Cross-Sectional Study of the Cardiovascular Effects of Welding Fumes
SO PLOS ONE
LA English
DT Article
ID PARTICULATE AIR-POLLUTION; ISCHEMIC-HEART-DISEASE; INCREASES ARTERIAL
   STIFFNESS; WORKPLACE PROTECTION FACTORS; SHORT-TERM EXPOSURE;
   ENDOTHELIAL FUNCTION; ULTRAFINE PARTICLES; VASCULAR FUNCTION;
   RATE-VARIABILITY; OCCUPATIONAL-EXPOSURE
AB Objectives
   Occupational exposure to particulate air pollution has been associated with an increased risk of cardiovascular disease. However, the risk to welders working today remains unclear. We aimed to elucidate the cardiovascular effects of exposure to welding fumes.
   Methods
   In a cross-sectional study, structured interviews and biological sampling were conducted for 101 welders and 127 controls (all non-smoking males) from southern Sweden. Personal breathing zone sampling of respirable dust was performed. Blood pressure (BP) and endothelial function (using peripheral arterial tonometry) were measured. Plasma and serum samples were collected from peripheral blood for measurement of C-reactive protein, low-density lipoprotein, homocysteine, serum amyloid A, and cytokines.
   Results
   Welders were exposed to 10-fold higher levels of particles than controls. Welders had significantly higher BP compared to controls, an average of 5 mm Hg higher systolic and diastolic BP (P <= 0.001). IL-8 was 3.4 ng/L higher in welders (P=0.010). Years working as a welder were significantly associated with increased BP (beta=0.35, 95%CI 0.13 - 0.58, P=0.0024 for systolic BP; beta=0.32, 95%CI 0.16-0.48, P<0.001 for diastolic BP, adjusted for BMI) but exposure to respirable dust was not associated with BP. No clear associations occurred between welding and endothelial function, or other effect markers.
   Conclusions
   A modest increase in BP was found among welders compared to controls suggesting that low-to-moderate exposure to welding fumes remains a risk factor for cardiovascular disease.
C1 [Li, Huiqi; Hedmer, Maria; Karedal, Monica; Tinnerberg, Hakan; Albin, Maria; Broberg, Karin] Lund Univ, Div Occupat & Environm Med, Lab Med, Lund, Sweden.
   [Bjork, Jonas] Lund Univ, Competence Ctr Clin Res, Lund, Sweden.
   [Stockfelt, Leo] Univ Gothenburg, Sahlgrenska Univ Hosp & Acad, Dept Occupat & Environm Med, Gothenburg, Sweden.
   [Broberg, Karin] Karolinska Inst, Inst Environm Med, Unit Met & Hlth, S-10401 Stockholm, Sweden.
RP Broberg, K (reprint author), Lund Univ, Div Occupat & Environm Med, Lab Med, Lund, Sweden.
EM karin.broberg@ki.se
OI Li, Huiqi/0000-0002-1127-0829; Hedmer, Maria/0000-0002-7422-2621;
   Broberg, Karin/0000-0002-5862-468X; Bjork, Jonas/0000-0003-1883-2000
FU Swedish Council for Working Life and Social Research [2009-1888]
FX This work was supported by The Swedish Council for Working Life and
   Social Research [2009-1888]. http://www.forte.se/. KB received the
   funding.
CR Allen RW, 2011, AM J RESP CRIT CARE, V183, P1222, DOI 10.1164/rccm.201010-1572OC
   Andujar P, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-23
   Antonini JM, 2003, CRIT REV TOXICOL, V33, P61, DOI 10.1080/713611032
   Auchincloss AH, 2008, ENVIRON HEALTH PERSP, V116, P486, DOI 10.1289/ehp.10899
   Barregard L, 2006, INHAL TOXICOL, V18, P845, DOI 10.1080/08958370600685798
   Bonetti PO, 2011, ATHEROSCLEROSIS, V215, P218, DOI 10.1016/j.atherosclerosis.2010.12.011
   Brauner EV, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-13
   Brauner EV, 2008, AM J RESP CRIT CARE, V177, P419, DOI 10.1164/rccm.200704-632OC
   Brauner EV, 2007, ENVIRON HEALTH PERSP, V115, P1177, DOI 10.1289/ehp.9984
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Brook RD, 2009, J AM SOC HYPERTENS, V3, P332, DOI 10.1016/j.jash.2009.08.005
   Chen LH, 2005, ENVIRON HEALTH PERSP, V113, P1723, DOI 10.1289/ehp.8190
   Chow JC, 2006, J AIR WASTE MANAGE, V56, P707, DOI 10.1080/10473289.2006.10464484
   de Ruijter W, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3083
   Delfino RJ, 2008, ENVIRON HEALTH PERSP, V116, P898, DOI 10.1289/ehp.11189
   Delfino RJ, 2005, ENVIRON HEALTH PERSP, V113, P934, DOI 10.1289/ehp.7938
   Egan BM, 2008, CURR HYPERTENS REP, V10, P359, DOI 10.1007/s11906-008-0068-0
   Fang SC, 2008, EPIDEMIOLOGY, V19, P217, DOI 10.1097/EDE.0b013e31816334dc
   Forchhammer L, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-7
   Gidhagen L, 2013, J EXPO SCI ENV EPID, V23, P306, DOI 10.1038/jes.2012.122
   GOLLER JW, 1985, AM IND HYG ASSOC J, V46, P89, DOI 10.1080/15298668591394455
   Han DH, 2002, IND HEALTH, V40, P328, DOI 10.2486/indhealth.40.328
   Hedmer M, 2014, INT ARCH OCC ENV HEA, V87, P623, DOI 10.1007/s00420-013-0896-3
   Ibfelt E, 2010, OCCUP ENVIRON MED, V67, P772, DOI 10.1136/oem.2009.051086
   Janssen LL, 2007, J OCCUP ENVIRON HYG, V4, P698, DOI 10.1080/15459620701517764
   Jarvela M, 2013, INT J OCCUP MED ENV, V26, P220, DOI 10.2478/s13382-013-0097-z
   Johnson BD, 2004, CIRCULATION, V109, P726, DOI 10.1161/01.CIR.0000115516.54550.B1
   Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1183, DOI 10.1289/ehp.10851
   Kim JY, 2005, OCCUP ENVIRON MED, V62, P157, DOI 10.1136/oem.2004.014795
   Konttinen J, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-83
   Kuvin JT, 2003, AM HEART J, V146, P168, DOI 10.1016/S0002-8703(03)00094-2
   Lehnert M, 2012, ANN OCCUP HYG, V56, P557, DOI 10.1093/annhyg/mes025
   Lin CP, 2009, FRONT BIOSCI-LANDMRK, V14, P3836, DOI 10.2735/3492
   Lundback M, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-7
   Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c
   Meier R, 2014, ENVIRON HEALTH PERSP, V122, P726, DOI 10.1289/ehp.1307100
   Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409
   Mocevic E, 2015, INT ARCH OCC ENV HEA, V88, P259, DOI 10.1007/s00420-014-0965-2
   Myers GL, 2009, CLIN CHEM, V55, P378, DOI 10.1373/clinchem.2008.115899
   Nurkiewicz TR, 2009, TOXICOL SCI, V110, P191, DOI 10.1093/toxsci/kfp051
   O'Neill MS, 2005, CIRCULATION, V111, P2913, DOI 10.1161/CIRCULATIONAHA.104.517110
   Park SK, 2008, AM J RESP CRIT CARE, V178, P283, DOI 10.1164/rccm.200708-1286OC
   Pope CA, 2011, J AIR WASTE MANAGE, V61, P858, DOI 10.3155/1047-3289.61.8.858
   Pope CA, 2004, ENVIRON HEALTH PERSP, V112, P339, DOI 10.1289/ehp.6588
   Robinson SC, 1939, ARCH INTERN MED, V62, P409
   Romieu I, 2005, AM J RESP CRIT CARE, V172, P1534, DOI 10.1164/rccm.200503-372OC
   Scharrer E, 2007, INT ARCH OCC ENV HEA, V80, P265, DOI 10.1007/s00420-006-0127-2
   Schneider A, 2008, ENVIRON HEALTH PERSP, V116, P1666, DOI 10.1289/ehp.11666
   Shah ASV, 2013, LANCET, V382, P1039, DOI 10.1016/S0140-6736(13)60898-3
   Simkhovich BZ, 2008, J AM COLL CARDIOL, V52, P719, DOI 10.1016/j.jacc.2008.05.029
   Sjogren B, 2002, INT J OCCUP ENV HEAL, V8, P309
   St-Pierre AC, 2005, ATHEROSCLEROSIS, V182, P315, DOI 10.1016/j.atherosclerosis.2005.02.009
   Stark M, 2009, CYTOKINE, V46, P290, DOI 10.1016/j.cyto.2009.02.012
   Suadicani P, 2002, J CARDIOVASC RISK, V9, P191, DOI 10.1097/00043798-200208000-00003
   Swedish Work Environment Authority, 2011, OCC EXP LIM, P18
   Tornqvist H, 2007, AM J RESP CRIT CARE, V176, P395, DOI 10.1164/rccm.200606-872OC
   Unosson J, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-20
   Vinzents PS, 2005, ENVIRON HEALTH PERSP, V113, P1485, DOI 10.1289/ehp.7562
   Wiebert P, 2012, OCCUP ENVIRON MED, V69, P651, DOI 10.1136/oemed-2011-100285
   Xu Y, 2014, EUR HEART J-CARD IMG, V15, P736, DOI 10.1093/ehjci/jet256
NR 60
TC 7
Z9 7
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 6
PY 2015
VL 10
IS 7
AR e0131648
DI 10.1371/journal.pone.0131648
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN1DQ
UT WOS:000358157600117
PM 26147298
OA Green Published, Other Gold
DA 2019-05-24
ER

PT J
AU Eze, IC
   Schaffner, E
   Foraster, M
   Imboden, M
   von Eckardstein, A
   Gerbase, MW
   Rothe, T
   Rochat, T
   Kunzli, N
   Schindler, C
   Probst-Hensch, N
AF Eze, Ikenna C.
   Schaffner, Emmanuel
   Foraster, Maria
   Imboden, Medea
   von Eckardstein, Arnold
   Gerbase, Margaret W.
   Rothe, Thomas
   Rochat, Thierry
   Kuenzli, Nino
   Schindler, Christian
   Probst-Hensch, Nicole
TI Long-Term Exposure to Ambient Air Pollution and Metabolic Syndrome in
   Adults
SO PLOS ONE
LA English
DT Article
ID PARTICULATE MATTER; DIESEL-EXHAUST; CARDIOVASCULAR EVENTS;
   INSULIN-RESISTANCE; DIABETES-MELLITUS; BLOOD-PRESSURE; SWISS COHORT;
   DIAGNOSIS; RISK; ASSOCIATIONS
AB Air pollutants (AP) play a role in subclinical inflammation, and are associated with cardiovascular morbidity and mortality. Metabolic syndrome (MetS) is inflammatory and precedes cardiovascular morbidity and type 2 diabetes. Thus, a positive association between AP and MetS may be hypothesized. We explored this association, (taking into account, pathway-specific MetS definitions), and its potential modifiers in Swiss adults. We studied 3769 participants of the Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults, reporting at least four-hour fasting time before venepuncture. AP exposures were 10-year mean residential PM10 (particulate matter <10 mu m in diameter) and NO2 (nitrogen dioxide). Outcomes included MetS defined by World Health Organization (MetS-W), International Diabetes Federation (MetS-I) and Adult Treatment Panel-III (MetS-A) using four-and eight-hour fasting time limits. We also explored associations with individual components of MetS. We applied mixed logistic regression models to explore these associations. The prevalence of MetS-W, MetS-I and MetS-A were 10%, 22% and 18% respectively. Odds of MetS-W, MetS-I and MetS-A increased by 72% (51-102%), 31% (11-54%) and 18% (4-34%) per 10 mu g/m(3) increase in 10-year mean PM10. We observed weaker associations with NO2. Associations were stronger among physically-active, ever-smokers and non-diabetic participants especially with PM10 (p<0.05). Associations remained robust across various sensitivity analyses including ten imputations of missing observations and exclusion of diabetes cases. The observed associations between AP exposure and MetS were sensitive to MetS definitions. Regarding the MetS components, we observed strongest associations with impaired fasting glycemia, and positive but weaker associations with hypertension and waist-circumference-based obesity. Cardio-metabolic effects of AP may be majorly driven by impairment of glucose homeostasis, and to a less-strong extent, visceral adiposity. Well-designed prospective studies are needed to confirm these findings.
C1 [Eze, Ikenna C.; Schaffner, Emmanuel; Foraster, Maria; Imboden, Medea; Kuenzli, Nino; Schindler, Christian; Probst-Hensch, Nicole] Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
   [Eze, Ikenna C.; Schaffner, Emmanuel; Foraster, Maria; Kuenzli, Nino; Schindler, Christian; Probst-Hensch, Nicole] Univ Basel, Basel, Switzerland.
   [von Eckardstein, Arnold] Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland.
   [Gerbase, Margaret W.; Rochat, Thierry] Univ Hosp Geneva, Div Pneumol, Geneva, Switzerland.
   [Rothe, Thomas] Zurcher Hohenklin, Davos, Switzerland.
RP Probst-Hensch, N (reprint author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
EM Nicole.Probst@unibas.ch
RI Kuenzli, Nino/F-7195-2014
OI Kuenzli, Nino/0000-0001-8360-080X; Eze, Ikenna/0000-0001-9748-2162;
   Foraster, Maria/0000-0003-4450-4123
FU Swiss National Science Foundation [33CSCO-134276/1, 33CSCO-108796,
   3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302,
   3200-052720, 3200-042532, 4026-028099, PMPDP3_129021/1,
   PMPDP3_141671/1]; Federal Office for Environment; Federal Office of
   Public health; Federal office of Roads and Transport; cantonal
   government of Aargau; cantonal government of Basel-Stadt; cantonal
   government of Basel-Land; cantonal government of Geneva; cantonal
   government of Luzem; cantonal government of Ticino; cantonal government
   of Zurich; Swiss Lung League; Lung Leagues of
   Basel-Stadt/Basel-Landschaft, Geneva, Ticino and Zurich
FX This study was supported by the Swiss National Science Foundation
   [grants no. 33CSCO-134276/1, 33CSCO-108796, 3247BO-104283,
   3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720,
   3200-042532, 4026-028099, PMPDP3_129021/1, PMPDP3_141671/1]; the Federal
   Office for Environment; the Federal Office of Public health; the Federal
   office of Roads and Transport; the cantonal governments of Aargau,
   Basel-Stadt, Basel-Land, Geneva, Luzem, Ticino and Zurich; the Swiss
   Lung League and the Lung Leagues of Basel-Stadt/Basel-Landschaft,
   Geneva, Ticino and Zurich. The funders had no role in study design, data
   collection and analysis, decision to publish, or prepare the manuscript.
CR Ackermann-Liebrich U, 2005, SOZ PRAVENTIV MED, V50, P245, DOI 10.1007/s00038-005-4075-5
   Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8
   Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   Andersen ZJ, 2012, DIABETES CARE, V35, P92, DOI 10.2337/dc11-1155
   Babisch W, 2014, ENVIRON HEALTH PERSP, V122, P492, DOI 10.1289/ehp.1306981
   Badyda AJ, 2013, ADV EXP MED BIOL, V788, P229, DOI 10.1007/978-94-007-6627-3_33
   Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309
   Brauner EV, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-13
   Brocato J, 2014, J TOXICOL ENV HEAL A, V77, P751, DOI 10.1080/15287394.2014.892446
   Brook RD, 2013, DIABETES CARE, V36, P3313, DOI 10.2337/dc12-2189
   Brook RD, 2013, SCI TOTAL ENVIRON, V448, P66, DOI 10.1016/j.scitotenv.2012.07.034
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Chen JC, 2008, ENVIRON HEALTH PERSP, V116, P612, DOI 10.1289/ehp.10565
   Chuang KJ, 2010, J OCCUP ENVIRON MED, V52, P258, DOI 10.1097/JOM.0b013e3181ceff7a
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Devlin RB, 2014, TOXICOL SCI, V140, P61, DOI 10.1093/toxsci/kfu063
   Eeftens M, 2012, ATMOS ENVIRON, V62, P303, DOI 10.1016/j.atmosenv.2012.08.038
   Eze IC, 2015, ENVIRON HEALTH PERSP, V123, P381, DOI 10.1289/ehp.1307823
   Eze IC, 2014, ENVIRON INT, V70, P95, DOI 10.1016/j.envint.2014.05.014
   Fuks KB, 2014, ENVIRON HEALTH PERSP, V122, P896, DOI 10.1289/ehp.1307725
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Krishnan RM, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-7
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Liu CQ, 2013, TOXICOL PATHOL, V41, P361, DOI 10.1177/0192623312464531
   Liu LJS, 2007, ENVIRON HEALTH PERSP, V115, P1638, DOI 10.1289/ehp.10177
   Liu LJS, 2012, ATMOS ENVIRON, V46, P460, DOI 10.1016/j.atmosenv.2011.09.021
   MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211
   Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409
   Miller MR, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-61
   Mills NL, 2007, NEW ENGL J MED, V357, P1075, DOI 10.1056/NEJMoa066314
   Panczak R, 2012, J EPIDEMIOL COMMUN H, V66, P1129, DOI 10.1136/jech-2011-200699
   Park SK, 2010, ENVIRON HEALTH PERSP, V118, P1406, DOI 10.1289/ehp.0901778
   Peters A, 2004, NEW ENGL J MED, V351, P1721, DOI 10.1056/NEJMoa040203
   Rahill AA, 1996, AVIAT SPACE ENVIR MD, V67, P640
   Rajagopalan S, 2012, DIABETES, V61, P3037, DOI 10.2337/db12-0190
   Roberts JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090143
   Sun QH, 2009, CIRCULATION, V119, P538, DOI 10.1161/CIRCULATIONAHA.108.799015
   Swiss Agency for the Environment Forests and Landscape, 2003, ENV DOC, V169, P47
   Thiering E, 2013, DIABETOLOGIA, V56, P1696, DOI 10.1007/s00125-013-2925-x
   Tong HY, 2012, ENVIRON HEALTH PERSP, V120, P952, DOI 10.1289/ehp.1104472
   Troisi RJ, 2000, JAMA-J AM MED ASSOC, V284, P3157, DOI 10.1001/jama.284.24.3157
   Villeneuve PJ, 2011, OCCUP ENVIRON MED, V68, P920, DOI 10.1136/oem.2010.062521
   Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654
   Xie B, 2010, NICOTINE TOB RES, V12, P198, DOI 10.1093/ntr/ntp194
   Xu XH, 2010, ARTERIOSCL THROM VAS, V30, P2518, DOI 10.1161/ATVBAHA.110.215350
NR 45
TC 31
Z9 31
U1 1
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 23
PY 2015
VL 10
IS 6
AR e0130337
DI 10.1371/journal.pone.0130337
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CL4DD
UT WOS:000356901900036
PM 26103580
OA Green Published, Other Gold
DA 2019-05-24
ER

PT J
AU Cui, YQ
   Jia, FP
   He, JF
   Xie, XY
   Li, ZH
   Fu, MH
   Hao, H
   Liu, Y
   Liu, DZ
   Cowan, PJ
   Zhu, H
   Sun, QH
   Liu, ZG
AF Cui, Yuqi
   Jia, Fengpeng
   He, Jianfeng
   Xie, Xiaoyun
   Li, Zhihong
   Fu, Minghuan
   Hao, Hong
   Liu, Ying
   Liu, Dylan Z.
   Cowan, Peter J.
   Zhu, Hua
   Sun, Qinghua
   Liu, Zhenguo
TI Ambient Fine Particulate Matter Suppresses In Vivo Proliferation of Bone
   Marrow Stem Cells through Reactive Oxygen Species Formation
SO PLOS ONE
LA English
DT Article
ID ENDOTHELIAL PROGENITOR CELLS; AIR-POLLUTION EXPOSURE; OXIDATIVE STRESS;
   CIGARETTE-SMOKE; PREIMPLANTATION DEVELOPMENT; INHIBITS ANGIOGENESIS;
   NEOINTIMA FORMATION; SIGNALING PATHWAYS; REDOX REGULATION; STROMAL CELLS
AB Aims
   Some environmental insults, such as fine particulate matter (PM) exposure, significantly impair the function of stem cells. However, it is unknown if PM exposure could affect the population of bone marrow stem cells (BMSCs). The present study was to investigate the effects of PM on BMSCs population and related mechanism(s).
   Main Metheods
   PM was intranasally distilled into male C57BL/6 mice for one month. Flow cytometry with antibodies for BMSCs, Annexin V and BrdU ware used to determine the number of BMSCs and the levels of their apoptosis and proliferation in vivo. Phosphorylated Akt (P-Akt) level was determined in the BM cells with western blotting. Intracellular reactive oxygen species (ROS) formation was quantified using flow cytometry analysis. To determine the role of PM-induced ROS in BMSCs population, proliferation, and apotosis, experiments were repeated using N-acetylcysteine (NAC)-treated wild type mice or a triple transgenic mouse line with overexpression of antioxidant network (AON) composed of superoxide dismutase (SOD) 1, SOD3, and glutathione peroxidase-1 with decreased in vivo ROS production.
   Key Findings
   PM treatment significantly reduced BMSCs population in association with increased ROS formation, decreased P-Akt level, and inhibition of proliferation of BMSCs without induction of apoptosis. NAC treatment or AON overexpression with reduced ROS formation effectively prevented PM-induced reduction of BMSCs population and proliferation with partial recovery of P-Akt level.
   Significance
   PM exposure significantly decreased the population of BMSCs due to diminished proliferation via ROS-mediated mechanism (could be partially via inhibition of Akt signaling).
C1 [Cui, Yuqi; Jia, Fengpeng; He, Jianfeng; Xie, Xiaoyun; Li, Zhihong; Fu, Minghuan; Hao, Hong; Liu, Ying; Liu, Dylan Z.; Zhu, Hua; Sun, Qinghua; Liu, Zhenguo] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Div Cardiovasc Med, Columbus, OH 43210 USA.
   [Cui, Yuqi] Shandong Univ, Shandong Prov Hosp, Dept Cardiol, Jinan 250021, Shandong, Peoples R China.
   [Zhu, Hua] Ohio State Univ, Dept Surg, Wexner Med Ctr, Columbus, OH 43210 USA.
   [Cowan, Peter J.] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia.
   [Jia, Fengpeng] Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Chongqing 400016, Peoples R China.
RP Liu, ZG (reprint author), Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Div Cardiovasc Med, Columbus, OH 43210 USA.
EM zhenguo.liu@osumc.edu
RI Cui, Yuqi/U-5914-2017; Zhu, Hua/G-4409-2010
FU US NIH grant [NIH R01 HL094650]; American Heart Association grant (AHA)
   [12SDG12070174]
FX US NIH grant to Zhenguo Liu (NIH R01 HL094650) for experiment design and
   American Heart Association grant to HZ (AHA 12SDG12070174) for
   experiment design.
CR Albrecht C, 2001, INHAL TOXICOL, V13, P191
   Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135
   BENEDICT WF, 1984, MUTAT RES, V136, P73, DOI 10.1016/0165-1218(84)90136-8
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Brook RD, 2009, HYPERTENSION, V54, P659, DOI 10.1161/HYPERTENSIONAHA.109.130237
   Brunekreef B, 2005, EUR RESPIR J, V26, P309, DOI 10.1183/09031936.05.00001805
   Chang JL, 2010, DIABETES, V59, P2949, DOI 10.2337/db10-0582
   Cui YQ, 2015, CELL PHYSIOL BIOCHEM, V35, P353, DOI 10.1159/000369701
   Daher N, 2014, SCI TOTAL ENVIRON, V470, P417, DOI 10.1016/j.scitotenv.2013.09.104
   Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1016/01.CIR.0000131515.03336.f8
   De Flora S, 2012, INT J CANCER, V131, P2763, DOI 10.1002/ijc.27814
   Ebert R, 2006, STEM CELLS, V24, P1226, DOI 10.1634/stemcells.2005-0117
   Gavett SH, 2003, ENVIRON HEALTH PERSP, V111, P981, DOI 10.1289/ehp.5931
   Guo YL, 2010, STEM CELLS DEV, V19, P1321, DOI 10.1089/scd.2009.0313
   Haberzettl P, 2012, ENVIRON HEALTH PERSP, V120, P848, DOI 10.1289/ehp.1104206
   He SD, 2013, EXP LUNG RES, V39, P258, DOI 10.3109/01902148.2013.802828
   Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485
   Huang JJ, 2013, REPROD TOXICOL, V35, P89, DOI 10.1016/j.reprotox.2012.07.003
   Huang JJ, 2009, FERTIL STERIL, V92, P1456, DOI 10.1016/j.fertnstert.2008.07.1781
   Izzotti A, 2011, MUTAT RES-FUND MOL M, V717, P17, DOI 10.1016/j.mrfmmm.2010.10.003
   Jurczyszyn A, 2014, J CANCER, V5, P480, DOI 10.7150/jca.8731
   Khaldoyanidi S, 2001, BLOOD, V98, P303, DOI 10.1182/blood.V98.2.303
   Khurshid SS, 2014, ENVIRON RES, V132, P46, DOI 10.1016/j.envres.2014.03.026
   Kim GD, 2013, INT J ONCOL, V43, P600, DOI 10.3892/ijo.2013.1959
   Kolanko Emanuel, 2013, Przegl Lek, V70, P858
   Kondo T, 2009, J ATHEROSCLER THROMB, V16, P532, DOI 10.5551/jat.1255
   Lee YJ, 2012, FOOD CHEM TOXICOL, V50, P116, DOI 10.1016/j.fct.2011.10.035
   Li HL, 2011, FREE RADICAL BIO MED, V51, P30, DOI 10.1016/j.freeradbiomed.2011.04.016
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Lin S, 2009, HUM REPROD, V24, P386, DOI 10.1093/humrep/den419
   Lin S, 2010, TOXICOL SCI, V118, P202, DOI 10.1093/toxsci/kfq241
   Liszewski W, 2012, DIFFERENTIATION, V83, P169, DOI 10.1016/j.diff.2011.12.005
   Lu TW, 2010, ANTIOXID REDOX SIGN, V13, P1845, DOI 10.1089/ars.2010.3156
   Madhubabu G, 2012, INHAL TOXICOL, V24, P143, DOI 10.3109/08958378.2011.649189
   Mital R, 2011, AM J PHYSIOL-HEART C, V300, pH1960, DOI 10.1152/ajpheart.01285.2010
   Mutlu GM, 2007, J CLIN INVEST, V117, P2952, DOI 10.1172/JCI30639
   Mysore TB, 2005, DIABETES, V54, P2109, DOI 10.2337/diabetes.54.7.2109
   Nocun MS, 2013, ANAL BIOANAL CHEM, V405, P5583, DOI 10.1007/s00216-013-6957-3
   O'Toole TE, 2010, CIRC RES, V107, P200, DOI 10.1161/CIRCRESAHA.110.222679
   Ogasawara MA, 2009, ANTIOXID REDOX SIGN, V11, P1107, DOI [10.1089/ars.2008.2308, 10.1089/ARS.2008.2308]
   Ohshima M, 2009, CIRC J, V73, P162, DOI 10.1253/circj.CJ-08-0123
   Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313
   Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2777, DOI 10.1089/ars.2009.2804
   Rauscher FM, 2003, CIRCULATION, V108, P457, DOI 10.1161/01.CIR.0000082924.75945.48
   ROSENKRANZ AR, 1992, J IMMUNOL METHODS, V156, P39, DOI 10.1016/0022-1759(92)90008-H
   Shadie AM, 2014, CLIN EXP IMMUNOL, V177, P491, DOI 10.1111/cei.12348
   Shafer MM, 2010, J ENVIRON MONITOR, V12, P704, DOI 10.1039/b915008k
   Strehlow K, 2003, CIRCULATION, V107, P3059, DOI 10.1161/01.CIR.0000077911.81151.30
   Sugden PH, 2006, ANTIOXID REDOX SIGN, V8, P2111, DOI 10.1089/ars.2006.8.2111
   Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003
   Talbot P, 2011, BIOL RES, V44, P189, DOI [10.4067/S0716-97602011000200011, /S0716-97602011000200011]
   Traverse JH, 2013, JAMA-J AM MED ASSOC, V309, P343, DOI 10.1001/jama.2012.196454
   Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78
   Wang TT, 2010, CHEM BIOL DRUG DES, V75, P214, DOI 10.1111/j.1747-0285.2009.00925.x
   Wang XH, 2009, STEM CELLS, V27, P3021, DOI 10.1002/stem.230
   Werner N, 2003, CIRC RES, V93, pE17, DOI 10.1161/01.RES.0000083812.30141.74
   Xiao GG, 2003, J BIOL CHEM, V278, P50781, DOI 10.1074/jbc.M306423200
   Xiao WK, 2015, INT J ONCOL, V46, P360, DOI 10.3892/ijo.2014.2735
   Yauk CL, 2007, CANCER RES, V67, P5103, DOI 10.1158/0008-5472.CAN-07-0279
   Zhang L, 2014, TOXICOL LETT, V228, P248, DOI 10.1016/j.toxlet.2014.05.015
   Zhou YP, 2011, REPROD TOXICOL, V31, P123, DOI 10.1016/j.reprotox.2010.10.007
NR 61
TC 6
Z9 6
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 9
PY 2015
VL 10
IS 6
AR e0127309
DI 10.1371/journal.pone.0127309
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CK6PC
UT WOS:000356349000009
PM 26058063
OA Green Published, Other Gold
DA 2019-05-24
ER

PT J
AU Provost, EB
   Madhloum, N
   Panis, LI
   De Boever, P
   Nawrot, TS
AF Provost, Eline B.
   Madhloum, Narjes
   Panis, Luc Int
   De Boever, Patrick
   Nawrot, Tim S.
TI Carotid Intima-Media Thickness, a Marker of Subclinical Atherosclerosis,
   and Particulate Air Pollution Exposure: the Meta-Analytical Evidence
SO PLOS ONE
LA English
DT Article
ID LONG-TERM EXPOSURE; ARTERIAL-WALL THICKNESS; HEART-DISEASE RISK;
   MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; ASSOCIATION;
   METAANALYSIS; PREDICTION; HEALTH; MATTER
AB Introduction
   Studies on the association between atherosclerosis and long-term exposure to ambient air pollution suggest that carotid intima-media thickness (CIMT), a marker of subclinical atherosclerosis, is positively associated with particulate matter (PM) exposure. However, there is heterogeneity between the different studies concerning the magnitude of this association. We performed a meta-analysis to determine the strength of the association between CIMT and particulate air pollution.
   Methods
   We queried PubMed citation database and Web of Knowledge up to March 2015 in order to identify studies on CIMT and particulate air pollution. Two investigators selected and computerized all relevant information, independently. Eight of the reviewed epidemiological publications provided sufficient details and met our inclusion criteria. Descriptive and quantitative information was extracted from each selected study. The meta-analysis included 18,349 participants from eight cohorts for the cross-sectional association between CIMT and PM and 7,268 participants from three cohorts for the longitudinal analysis on CIMT progression and PM exposure.
   Results
   The average exposure to PM2.5 in the different study populations ranged from 4.1 to 20.8 mu g/m(3) and CIMT averaged (SD) 0.73 (0.14) mm. We computed a pooled estimate from a random-effects model. In the combined cross-sectional studies, an increase of 5 mu g/m(3) PM2.5 was associated with a 1.66%(95% CI: 0.86 to 2.46; P<0.0001) thicker CIMT, which corresponds to an average increase of 12.1 mu m. None of the studies moved the combined estimate outside the confidence interval of the overall estimate. A funnel plot suggested absence of publication bias. The combined longitudinal estimate showed for each 5 mu g/m(3) higher PM2.5 exposure, a 1.04 mu m per year (95% CI: 0.01 to 2.07; P=0.048) greater CIMT progression.
   Conclusion
   Our meta-analysis supports the evidence of a positive association between CIMT, a marker of subclinical atherosclerosis, and long-term exposure to particulate air pollution.
C1 [Provost, Eline B.; Madhloum, Narjes; De Boever, Patrick; Nawrot, Tim S.] Hasselt Univ, Ctr Environm Sci CMK, Diepenbeek, Belgium.
   [Provost, Eline B.; Panis, Luc Int; De Boever, Patrick] Flemish Inst Technol Res VITO, Environm Risk & Hlth, Mol, Belgium.
   [Panis, Luc Int] Hasselt Univ, Sch Mobil IMOB, Diepenbeek, Belgium.
   [Nawrot, Tim S.] Leuven Univ KU Leuven, Dept Publ Hlth & Primary Care, Leuven, Belgium.
RP Nawrot, TS (reprint author), Hasselt Univ, Ctr Environm Sci CMK, Diepenbeek, Belgium.
EM tim.nawrot@uhasselt.be
RI Panis, Luc Int/C-8717-2009
OI Panis, Luc Int/0000-0002-2558-4351; De Boever,
   Patrick/0000-0002-5197-8215
FU EU Program "Ideas" [ERC-2012-StG 310898]; Research Foundation - Flanders
   (FWO) [G087311N10/G0A7814N]; VITO-FWO PhD fellowship [11K1715N]
FX This work was supported by the EU Program "Ideas" [ERC-2012-StG 310898;
   http://erc.europa.eu/; TSN] and Research Foundation - Flanders (FWO)
   [G087311N10/G0A7814N; http://www.fwo.be/; TSN]; EBP has a VITO-FWO PhD
   fellowship [11K1715N; http://www.fwo.be/]. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adar SD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001430
   Araujo JA, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-24
   Armijos RX, 2015, J ENVIRON PUBLIC HEA, DOI 10.1155/2015/713540
   Ballester F, 2008, J EPIDEMIOL COMMUN H, V62, P98, DOI 10.1136/jech.2007.059857
   Bauer M, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13705
   Bauer M, 2010, J AM COLL CARDIOL, V56, P1803, DOI 10.1016/j.jacc.2010.04.065
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Chambless LE, 1997, AM J EPIDEMIOL, V146, P483
   Chen LC, 2010, INHAL TOXICOL, V22, P449, DOI 10.3109/08958370903373845
   Chow JC, 2006, J AIR WASTE MANAGE, V56, P707, DOI 10.1080/10473289.2006.10464484
   de Groot E, 2004, CIRCULATION, V109, P33, DOI 10.1161/01.CIR.0000131516.65699.ba
   Den Ruijter HM, 2012, JAMA-J AM MED ASSOC, V308, P796, DOI 10.1001/jama.2012.9630
   Erdogmus B, 2006, J CLIN ULTRASOUND, V34, P430, DOI 10.1002/jcu.20276
   Gan WQ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004743
   Gill EA, 2011, PROG CARDIOVASC DIS, V53, P353, DOI 10.1016/j.pcad.2011.02.001
   Grahame TJ, 2010, AIR QUAL ATMOS HLTH, V3, P3, DOI 10.1007/s11869-009-0047-x
   HILL AB, 1965, P ROY SOC MED, V58, P295
   Jacobs L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016200
   Jacobs L, 2010, ENVIRON HEALTH PERSP, V118, P191, DOI 10.1289/ehp.0900942
   Kim SY, 2014, AM J EPIDEMIOL, V180, P718, DOI 10.1093/aje/kwu186
   Kunzli N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009096
   Kunzli N, 2005, ENVIRON HEALTH PERSP, V113, P201, DOI 10.1289/ehp.7523
   Lenters V, 2010, EPIDEMIOLOGY, V21, P512, DOI 10.1097/EDE.0b013e3181dec3a7
   Mustafic H, 2012, JAMA-J AM MED ASSOC, V307, P713, DOI 10.1001/jama.2012.126
   Nambi V, 2010, J AM COLL CARDIOL, V55, P1600, DOI 10.1016/j.jacc.2009.11.075
   Nawrot TS, 2011, LANCET, V377, P732, DOI 10.1016/S0140-6736(10)62296-9
   Niwa Y, 2007, CIRC J, V71, P1157, DOI 10.1253/circj.71.1157
   O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103
   Painschab MS, 2013, HEART, V99, P984, DOI 10.1136/heartjnl-2012-303440
   Perez L, 2015, ENV HLTH PERSPECT
   Pieters N, 2012, HEART, V98, P1127, DOI 10.1136/heartjnl-2011-301505
   Plichart M, 2011, ATHEROSCLEROSIS, V219, P917, DOI 10.1016/j.atherosclerosis.2011.09.024
   Rivera M, 2013, ENVIRON HEALTH PERSP, V121, P223, DOI 10.1289/ehp.1205146
   Roux AVD, 2008, AM J EPIDEMIOL, V167, P667, DOI 10.1093/aje/kwm359
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Sun M, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-39
   Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003
   Suwa T, 2002, J AM COLL CARDIOL, V39, P935, DOI 10.1016/S0735-1097(02)01715-1
   Tonne C, 2012, EPIDEMIOLOGY, V23, P486, DOI 10.1097/EDE.0b013e31824e613e
   Tsao TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103231
   Wallenfeldt K, 2004, J INTERN MED, V256, P413, DOI 10.1111/j.1365-2796.2004.01402.x
   Wilker EH, 2013, ENVIRON HEALTH PERSP, V121, P1061, DOI 10.1289/ehp.1104845
NR 42
TC 18
Z9 20
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 13
PY 2015
VL 10
IS 5
AR UNSP e0127014
DI 10.1371/journal.pone.0127014
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CI1ZP
UT WOS:000354544200142
PM 25970426
OA Other Gold, Green Published
DA 2019-05-24
ER

PT J
AU Pongkan, W
   Chattipakorn, SC
   Chattipakorn, N
AF Pongkan, Wanpitak
   Chattipakorn, Siriporn C.
   Chattipakorn, Nipon
TI Chronic Testosterone Replacement Exerts Cardioprotection against Cardiac
   Ischemia-Reperfusion Injury by Attenuating Mitochondrial Dysfunction in
   Testosterone-Deprived Rats
SO PLOS ONE
LA English
DT Article
ID PERMEABILITY TRANSITION PORE; ACUTE MYOCARDIAL-INFARCTION;
   CORONARY-ARTERY-DISEASE; HEART-RATE-VARIABILITY; CARDIOVASCULAR-DISEASE;
   OXIDATIVE STRESS; SEX STEROIDS; CARDIOMYOCYTE CA2+; AIR-POLLUTION;
   CELL-DEATH
AB Background
   Although testosterone deficiency is associated with increased risks of heart disease, the benefits of testosterone therapy are controversial. Moreover, current understanding on the cardiac effect of testosterone during cardiac ischemia-reperfusion (I/R) periods is unclear. We tested the hypothesis that testosterone replacement attenuates the impairment of left ventricular (LV) function and heart rate variability (HRV), and reduces the infarct size and arrhythmias caused by I/R injury in orchiectomized (ORX) rats.
   Methodology
   ORX or sham-operated male Wistar rats (n = 24) were randomly divided and received either testosterone (2 mg/kg, subcutaneously administered) or the vehicle for 8 weeks. The ejection fraction (EF) and HRV were determined at baseline and the 4th and 8th week. I/R was performed by left anterior descending coronary artery ligation for 30 minutes, followed by a 120-minute reperfusion. LV pressure, arrhythmia scores, infarct size and cardiac mitochondrial function were determined.
   Results
   Prior to I/R, EF and HRV were impaired in the ORX group, but were restored in the testoster-one-treated group. During I/R, arrhythmia scores and the infarct size were greater, and cardiac mitochondrial function was impaired, whereas the time to 1st VT/VF onset and the LV end-systolic pressure were decreased in the ORX group when compared to the sham group. Testosterone replacement attenuated the impairment of these parameters in ORX rats during I/R injury, but did not show any benefit or adverse effect in non-ORX rats.
   Conclusions
   Testosterone replacement restores cardiac function and autonomic regulation, and exerts cardioprotective effects during the I/R period via mitochondrial protection in ORX rats.
C1 [Pongkan, Wanpitak; Chattipakorn, Siriporn C.; Chattipakorn, Nipon] Chiang Mai Univ, Fac Med, Cardiac Electrophysiol Res & Training Ctr, Chiang Mai 50000, Thailand.
   [Pongkan, Wanpitak; Chattipakorn, Nipon] Chiang Mai Univ, Cardiac Electrophysiol Unit, Dept Physiol, Fac Med, Chiang Mai 50000, Thailand.
   [Chattipakorn, Siriporn C.] Chiang Mai Univ, Fac Dent, Dept Oral Biol & Diagnost Sci, Chiang Mai 50000, Thailand.
   [Pongkan, Wanpitak; Chattipakorn, Siriporn C.; Chattipakorn, Nipon] Chiang Mai Univ, Ctr Excellence Cardiac Electrophysiol Res, Chiang Mai 50000, Thailand.
RP Chattipakorn, N (reprint author), Chiang Mai Univ, Fac Med, Cardiac Electrophysiol Res & Training Ctr, Chiang Mai 50000, Thailand.
EM nchattip@gmail.com
RI Pongkan, Wanpitak/N-8420-2018
OI Pongkan, Wanpitak/0000-0001-6788-7740; Chattipakorn,
   Nipon/0000-0003-3026-718X
FU NSTDA Research Chair Grant from the National Science and Technology
   Development Agency; Thailand Research Fund [RTA5580006, BRG5780016];
   Royal Golden Jubilee PhD program; Faculty of Medicine Endowment Fund;
   Chiang Mai University Center of Excellence Award
FX This work was supported by a NSTDA Research Chair Grant from the
   National Science and Technology Development Agency (NC), grants from the
   Thailand Research Fund RTA5580006 (NC) and BRG5780016 (SC), the Royal
   Golden Jubilee PhD program (NC and WP), Faculty of Medicine Endowment
   Fund (NC), and the Chiang Mai University Center of Excellence Award
   (NC). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200
   Apaijai N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102374
   Bell JR, 2011, CLIN EXP PHARMACOL P, V38, P717, DOI 10.1111/j.1440-1681.2011.05567.x
   Borst SE, 2010, HORM METAB RES, V42, P122, DOI 10.1055/s-0029-1241843
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Chahine T, 2007, ENVIRON HEALTH PERSP, V115, P1617, DOI 10.1289/ehp.10318
   Chen HL, 2001, EXP GERONTOL, V36, P1361, DOI 10.1016/S0531-5565(01)00118-8
   Chen YP, 2012, EUR J PHARMACOL, V684, P116, DOI 10.1016/j.ejphar.2012.03.032
   Chin LK, 2011, LAB CHIP, V11, P1856, DOI 10.1039/c0lc00651c
   Chinda K, 2014, DIABETES VASC DIS RE, V11, P75, DOI 10.1177/1479164113516134
   Corona G, 2013, WORLD J MENS HEALTH, V31, P103, DOI 10.5534/wjmh.2013.31.2.103
   Crisostomo PR, 2006, AM J PHYSIOL-REG I, V290, pR1168, DOI 10.1152/ajpregu.00833.2005
   Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233
   Curl CL, 2009, PHYSIOL RES, V58, P293
   Curtis MJ, 2013, PHARMACOL THERAPEUT, V139, P213, DOI 10.1016/j.pharmthera.2013.04.008
   CURTIS MJ, 1988, CARDIOVASC RES, V22, P656, DOI 10.1093/cvr/22.9.656
   Lima AHRD, 2011, ARQ BRAS CARDIOL, V96, P498
   Foley PL, 2005, COMMON SURG PROCEDUR
   Glos M, 2007, P ANN INT IEEE EMBS, P263, DOI 10.1109/IEMBS.2007.4352274
   Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1402, DOI 10.1016/j.bbabio.2008.12.017
   Halestrap AP, 2000, BIOCHEM SOC T, V28, P170, DOI 10.1042/bst0280170
   Haring R, 2010, EUR HEART J, V31, P1494, DOI 10.1093/eurheartj/ehq009
   HASCHE ET, 1995, CIRCULATION, V92, P710, DOI 10.1161/01.CIR.92.4.710
   Hausenloy DJ, 2003, CARDIOVASC RES, V60, P617, DOI 10.1016/j.cardiores.2003.09.025
   Huang CY, 2010, J SURG RES, V164, pE1, DOI 10.1016/j.jss.2010.07.041
   Hwang TIS, 2011, ASIAN J ANDROL, V13, P432, DOI 10.1038/aja.2010.159
   Kelly DM, 2013, J ENDOCRINOL, V217, pR47, DOI 10.1530/JOE-12-0582
   Klapcinska B, 2008, J PHYSIOL SCI, V58, P173, DOI 10.2170/physiolsci.RP002208
   Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503
   Latchman PL, 2011, CLIN AUTON RES, V21, P319, DOI 10.1007/s10286-011-0116-8
   Marin DP, 2010, CELL BIOCHEM FUNCT, V28, P394, DOI 10.1002/cbf.1669
   MILLER TD, 1995, CIRCULATION, V92, P334, DOI 10.1161/01.CIR.92.3.334
   Nam UH, 2007, J SURG RES, V142, P113, DOI 10.1016/j.jss.2006.11.019
   Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x
   Palee S, 2013, EXP PHYSIOL, V98, P1028, DOI 10.1113/expphysiol.2012.070433
   Saad F, 2012, DIABETES-METAB RES, V28, P52, DOI 10.1002/dmrr.2354
   Sanada S, 2011, AM J PHYSIOL-HEART C, V301, pH1723, DOI 10.1152/ajpheart.00553.2011
   Sripetchwandee J, 2013, ACTA PHYSL OXF
   Surinkaew S, 2013, J CARDIOVASC PHARM, V61, P133, DOI 10.1097/FJC.0b013e318279b7b1
   Thummasorn S, 2011, MITOCHONDRION, V11, P457, DOI 10.1016/j.mito.2011.01.008
   Traish AM, 2011, ATHEROSCLEROSIS, V214, P244, DOI 10.1016/j.atherosclerosis.2010.08.078
   Tsang S, 2008, BRIT J PHARMACOL, V153, P693, DOI 10.1038/sj.bjp.0707624
   Tsang Sharon, 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P119
   Uyanik BS, 1997, JPN HEART J, V38, P73
   Wang C, 2008, EUR J ENDOCRINOL, V159, P507, DOI 10.1530/EJE-08-0601
   Wang J, 2010, CELL PROLIFERAT, V43, P103, DOI 10.1111/j.1365-2184.2009.00659.x
   Wang MJ, 2009, SURGERY, V146, P138, DOI 10.1016/j.surg.2009.03.035
   Weiss EP, 2012, AGING CELL, V11, P876, DOI 10.1111/j.1474-9726.2012.00852.x
   Witayavanitkul N, 2013, AM J PHYSIOL-HEART C, V304, pH465, DOI 10.1152/ajpheart.00555.2012
   Wranicz JK, 2004, ANN NONINVAS ELECTRO, V9, P156, DOI 10.1111/j.1542-474X.2004.92539.x
   Wu FCW, 2003, ENDOCR REV, V24, P183, DOI 10.1210/er.2001-0025
   Yeap BB, 2010, CURR OPIN ENDOCRINOL, V17, P269, DOI 10.1097/MED.0b013e3283383031
   Yildirir A, 2001, EUR HEART J, V22, P612, DOI 10.1053/euhj.2000.2365
NR 53
TC 30
Z9 30
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 30
PY 2015
VL 10
IS 3
AR e0122503
DI 10.1371/journal.pone.0122503
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CE9AD
UT WOS:000352134700180
PM 25822979
OA Other Gold, Green Published
DA 2019-05-24
ER

PT J
AU Spigoni, V
   Cito, M
   Alinovi, R
   Pinelli, S
   Passeri, G
   Zavaroni, I
   Goldoni, M
   Campanini, M
   Aliatis, I
   Mutti, A
   Bonadonna, RC
   Dei Cas, A
AF Spigoni, Valentina
   Cito, Monia
   Alinovi, Rossella
   Pinelli, Silvana
   Passeri, Giovanni
   Zavaroni, Ivana
   Goldoni, Matteo
   Campanini, Marco
   Aliatis, Irene
   Mutti, Antonio
   Bonadonna, Riccardo C.
   Dei Cas, Alessandra
TI Effects of TiO2 and Co3O4 Nanoparticles on Circulating Angiogenic Cells
SO PLOS ONE
LA English
DT Article
ID ENDOTHELIAL PROGENITOR CELLS; TITANIUM-DIOXIDE NANOPARTICLES; OXIDATIVE
   STRESS; INTRATRACHEAL INSTILLATION; AIR-POLLUTION; COBALT OXIDE;
   IN-VIVO; INFLAMMATORY RESPONSE; ULTRAFINE PARTICLES; NANOSIZED TIO2
AB Background and Aim
   Sparse evidence suggests a possible link between exposure to airborne nanoparticles (NPs) and cardiovascular (CV) risk, perhaps through mechanisms involving oxidative stress and inflammation. We assessed the effects of TiO2 and Co3O4 NPs in human circulating angiogenic cells (CACs), which take part in vascular endothelium repair/replacement.
   Methods
   CACs were isolated from healthy donors' buffy coats after culturing lymphomonocytes on fibronectin-coated dishes in endothelial medium for 7 days. CACs were pre-incubated with increasing concentration of TiO2 and Co3O4 (from 1 to 100 mu g/ml) to test the effects of NP characterized by Transmission Electron Microscopy -on CAC viability, apoptosis (caspase 3/7 activation), function (fibronectin adhesion assay), oxidative stress and inflammatory cytokine gene expression.
   Results
   Neither oxidative stress nor cell death were associated with exposure to TiO2 NP (except at the highest concentration tested), which, however, induced a higher pro-inflammatory effect compared to Co3O4 NPs (p<0.01). Exposure to Co3O4 NPs significantly reduced cell viability (p<0.01) and increased caspase activity (p<0.01), lipid peroxidation end-products (p<0.05) and pro-inflammatory cytokine gene expression (p<0.05 or lower). Notably, CAC functional activity was impaired after exposure to both TiO2 (p<0.05 or lower) and Co3O4 (p<0.01) NPs.
   Conclusions
   In vitro exposure to TiO2 and Co3O4 NPs exerts detrimental effects on CAC viability and function, possibly mediated by accelerated apoptosis, increased oxidant stress (Co3O4 NPs only) and enhancement of inflammatory pathways (both TiO2 and Co3O4 NPs). Such adverse effects may be relevant for a potential role of exposure to TiO2 and Co3O4 NPs in enhancing CV risk in humans.
C1 [Spigoni, Valentina; Cito, Monia; Bonadonna, Riccardo C.; Dei Cas, Alessandra] Univ Parma, Dept Clin & Expt Med, Div Endocrinol, I-43100 Parma, Italy.
   [Spigoni, Valentina; Cito, Monia; Bonadonna, Riccardo C.; Dei Cas, Alessandra] Azienda Osped Univ Parma, Parma, Italy.
   [Alinovi, Rossella; Pinelli, Silvana; Goldoni, Matteo; Mutti, Antonio] Univ Parma, Dept Clin & Expt Med, Unit Occupat & Environm Med, I-43100 Parma, Italy.
   [Passeri, Giovanni] Univ Parma, Dept Clin & Expt Med, Unit Androl Metab Bone Dis & Endocrinol, I-43100 Parma, Italy.
   [Zavaroni, Ivana] Univ Parma, Dept Clin & Expt Med, Unit Diabet & Prevent Associated Dis, I-43100 Parma, Italy.
   [Campanini, Marco] IMEM CNR Ist Mat Elettron & Magnetismo Consiglio, Parma, Italy.
   [Aliatis, Irene] Univ Parma, Dept Phys & Earth Sci, I-43100 Parma, Italy.
RP Dei Cas, A (reprint author), Univ Parma, Dept Clin & Expt Med, Div Endocrinol, I-43100 Parma, Italy.
EM alessandra.deicas@unipr.it
RI Mutti, Antonio/C-1095-2011; Campanini, Marco/A-7428-2018; Goldoni,
   Matteo/E-9153-2011
OI Mutti, Antonio/0000-0003-2189-3808; Campanini,
   Marco/0000-0003-4312-4794; Goldoni, Matteo/0000-0002-1342-3921
FU Ministero della Salute, Ricerca Finalizzata [RF-2009-1472550]
FX This work was supported by Ministero della Salute, Ricerca Finalizzata
   2009 (Project title: Integrated approach to evaluate biological effects
   on lung, cardiovascular system and skin of occupational exposure to
   nanomaterials; RF-2009-1472550). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alarifi S, 2013, INT J NANOMED, V8, P189, DOI 10.2147/IJN.S37924
   Alinovi R, 2015, TOXICOL IN VITRO, V29, P426, DOI 10.1016/j.tiv.2014.12.007
   Bae ON, 2013, ARTERIOSCL THROM VAS, V33, P1920, DOI 10.1161/ATVBAHA.113.301609
   Baisch BL, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-5
   Bihari P, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-14
   Bisceglie F, 2012, J INORG BIOCHEM, V116, P195, DOI 10.1016/j.jinorgbio.2012.07.006
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Caiado F, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-4
   Chen T, 2013, J NANOSCI NANOTECHNO, V13, P3214, DOI 10.1166/jnn.2013.7147
   Cho WS, 2012, EUR RESPIR J, V39, P546, DOI 10.1183/09031936.00047111
   Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859
   Derlindati E, 2012, FOOD FUNCT, V3, P1144, DOI 10.1039/c2fo30127j
   Djaoued Y, 2002, J SOL-GEL SCI TECHN, V24, P255, DOI 10.1023/A:1015357313003
   Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127
   Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386
   Geiser M, 2005, ENVIRON HEALTH PERSP, V113, P1555, DOI 10.1289/ehp.8006
   Goncalves DM, 2011, INT IMMUNOPHARMACOL, V11, P1109, DOI 10.1016/j.intimp.2011.03.007
   Hafner A, 2014, INT J NANOMED, V9, P1005, DOI 10.2147/IJN.S55359
   Han SG, 2013, TOXICOLOGY, V306, P1, DOI 10.1016/j.tox.2013.01.014
   Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287
   Leonard S, 1998, J INORG BIOCHEM, V70, P239, DOI 10.1016/S0162-0134(98)10022-3
   Lindberg HK, 2012, MUTAT RES-GEN TOX EN, V745, P58, DOI 10.1016/j.mrgentox.2011.10.011
   Liu JW, 2010, J VASC RES, V47, P157, DOI 10.1159/000250094
   Liu R, 2009, PROG NAT SCI-MATER, V19, P573, DOI 10.1016/j.pnsc.2008.06.020
   McIntyre Robin A., 2012, Science Progress, V95, P1, DOI 10.3184/003685012X13294715456431
   Mikkelsen L, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-32
   Montiel-Davalos A, 2012, CHEM RES TOXICOL, V25, P920, DOI 10.1021/tx200551u
   Naya M, 2012, REGUL TOXICOL PHARM, V62, P1, DOI 10.1016/j.yrtph.2011.12.002
   Nemmar A, 2001, AM J RESP CRIT CARE, V164, P1665, DOI 10.1164/ajrccm.164.9.2101036
   Oberdorster Gunter, 2005, Part Fibre Toxicol, V2, P8, DOI 10.1186/1743-8977-2-8
   Ortega R, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-14
   Papis E, 2009, TOXICOL LETT, V189, P253, DOI 10.1016/j.toxlet.2009.06.851
   Peters K, 2007, INT J IMMUNOPATH PH, V20, P685, DOI 10.1177/039463200702000404
   Rajan S, 2008, J CELL BIOCHEM, V105, P477, DOI 10.1002/jcb.21845
   Sadiq R, 2012, MUTAT RES-GEN TOX EN, V745, P65, DOI 10.1016/j.mrgentox.2012.02.002
   Sager TM, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-17
   Schilling K, 2010, PHOTOCH PHOTOBIO SCI, V9, P495, DOI 10.1039/b9pp00180h
   Simkhovich BZ, 2008, J AM COLL CARDIOL, V52, P719, DOI 10.1016/j.jacc.2008.05.029
   Sohaebuddin SK, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-22
   Spigoni V, 2014, FOOD FUNCT, V5, P1881, DOI [10.1039/c3fo60641d, 10.1039/C3FO60641D]
   Spigoni V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048283
   Suh W, 2004, BIOCHEM BIOPH RES CO, V321, P65, DOI 10.1016/j.bbrc.2004.06.107
   Ursini CL, 2014, J APPL TOXICOL, V34, P1209, DOI 10.1002/jat.3038
   Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635
   Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953
   Wang JX, 2007, TOXICOL LETT, V168, P176, DOI 10.1016/j.toxlet.2006.12.001
   Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814
   Wu Y, 2013, CLIN EXP PHARMACOL P, V40, P626, DOI 10.1111/1440-1681.12141
   Xiong SJ, 2013, TOXICOLOGY, V304, P132, DOI 10.1016/j.tox.2012.12.015
   Yang L, 2012, INFLAMMATION, V35, P1242, DOI 10.1007/s10753-012-9434-9
   Zoroddu MA, 2014, CURR MED CHEM, V21, P3837, DOI 10.2174/0929867321666140601162314
NR 51
TC 8
Z9 8
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 24
PY 2015
VL 10
IS 3
AR e0119310
DI 10.1371/journal.pone.0119310
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CH2XV
UT WOS:000353889600021
PM 25803285
OA DOAJ Gold, Green Published
DA 2019-05-24
ER

PT J
AU Roy, A
   Gong, JC
   Thomas, DC
   Zhang, JF
   Kipen, HM
   Rich, DQ
   Zhu, T
   Huang, W
   Hu, M
   Wang, GF
   Wang, YD
   Zhu, P
   Lu, SE
   Ohman-Strickland, P
   Diehl, SR
   Eckel, SP
AF Roy, Ananya
   Gong, Jicheng
   Thomas, Duncan C.
   Zhang, Junfeng
   Kipen, Howard M.
   Rich, David Q.
   Zhu, Tong
   Huang, Wei
   Hu, Min
   Wang, Guangfa
   Wang, Yuedan
   Zhu, Ping
   Lu, Shou-En
   Ohman-Strickland, Pamela
   Diehl, Scott R.
   Eckel, Sandrah P.
TI The Cardiopulmonary Effects of Ambient Air Pollution and Mechanistic
   Pathways: A Comparative Hierarchical Pathway Analysis
SO PLOS ONE
LA English
DT Article
ID HEART-RATE-VARIABILITY; HEALTHY-YOUNG ADULTS; OXIDATIVE STRESS; BEIJING
   OLYMPICS; DIESEL EXHAUST; CARDIOVASCULAR-DISEASE; BLOOD-COAGULATION;
   ELDERLY SUBJECTS; TIME-COURSE; EXPOSURE
AB Previous studies have investigated the associations between exposure to ambient air pollution and biomarkers of physiological pathways, yet little has been done on the comparison across biomarkers of different pathways to establish the temporal pattern of biological response. In the current study, we aim to compare the relative temporal patterns in responses of candidate pathways to different pollutants. Four biomarkers of pulmonary inflammation and oxidative stress, five biomarkers of systemic inflammation and oxidative stress, ten parameters of autonomic function, and three biomarkers of hemostasis were repeatedly measured in 125 young adults, along with daily concentrations of ambient CO, PM2.5, NO2, SO2, EC, OC, and sulfate, before, during, and after the Beijing Olympics. We used a two-stage modeling approach, including Stage I models to estimate the association between each biomarker and pollutant over each of 7 lags, and Stage II mixed-effect models to describe temporal patterns in the associations when grouping the biomarkers into the four physiological pathways. Our results show that candidate pathway groupings of biomarkers explained a significant amount of variation in the associations for each pollutant, and the temporal patterns of the biomarker pollutant-lag associations varied across candidate pathways (p<0.0001) and were not linear (from lag 0 to lag 3: p=0.0629, from lag 3 to lag 6: p=0.0005). These findings suggest that, among this healthy young adult population, the pulmonary inflammation and oxidative stress pathway is the first to respond to ambient air pollution exposure (within 24 hours) and the hemostasis pathway responds gradually over a 2-3 day period. The initial pulmonary response may contribute to the more gradual systemic changes that likely ultimately involve the cardiovascular system.
C1 [Roy, Ananya] Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA.
   [Gong, Jicheng; Zhang, Junfeng] Duke Univ, Nicholas Sch Environm, Durham, NC USA.
   [Gong, Jicheng; Zhang, Junfeng] Duke Univ, Duke Global Hlth Inst, Durham, NC USA.
   [Thomas, Duncan C.; Eckel, Sandrah P.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.
   [Kipen, Howard M.] Rutgers State Univ, Rutgers Robert Wood Johnson Med Sch, Environm & Occupat Hlth Sci Inst, Piscataway, NJ USA.
   [Rich, David Q.] Univ Rochester, Sch Med & Dent, Dept Publ Hlth Sci, Rochester, NY USA.
   [Zhu, Tong; Hu, Min] Peking Univ, Coll Environm Sci & Engn, State Key Lab Environm Simulat & Pollut Control, Beijing 100871, Peoples R China.
   [Zhu, Tong; Hu, Min] Peking Univ, Ctr Environm & Hlth, Beijing 100871, Peoples R China.
   [Huang, Wei] Peking Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Beijing 100871, Peoples R China.
   [Huang, Wei] Peking Univ, Inst Environm Med, Beijing 100871, Peoples R China.
   [Wang, Guangfa] Peking Univ, Hosp 1, Dept Pulm Med, Beijing 100871, Peoples R China.
   [Wang, Yuedan] Peking Univ, Hlth Sci Ctr, Dept Immunol, Beijing 100871, Peoples R China.
   [Zhu, Ping] Peking Univ, Hosp 1, Dept Hematol, Beijing 100871, Peoples R China.
   [Lu, Shou-En; Ohman-Strickland, Pamela] Rutgers State Univ, Sch Publ Hlth, Dept Biostat, Piscataway, NJ USA.
   [Diehl, Scott R.] Rutgers State Univ, Sch Dent, Ctr Pharmacogen & Complex Dis, Newark, NJ USA.
RP Eckel, SP (reprint author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.
EM eckel@usc.edu
RI ZHU, TONG/H-6501-2011; Gong, Jicheng/I-5236-2016
OI ZHU, TONG/0000-0002-2752-7924; Gong, Jicheng/0000-0002-8943-8804
FU National Institute of Environmental Health Sciences [1R01ES015864,
   P30ES005022, 5P30ES007048]; Health Effects Institute [4760-RPFA05-3];
   Beijing Environment Protection Bureau [OITC-G08026056]; Beijing Council
   of Science and Technology [HB200504-6, HB200504-2]
FX This study was jointly funded by grants 1R01ES015864, P30ES005022, and
   5P30ES007048 from the National Institute of Environmental Health
   Sciences, 4760-RPFA05-3 from the Health Effects Institute,
   OITC-G08026056 from the Beijing Environment Protection Bureau, and
   HB200504-6, HB200504-2 from the Beijing Council of Science and
   Technology. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Baccarelli A, 2007, J THROMB HAEMOST, V5, P252, DOI 10.1111/j.1538-7836.2007.02300.x
   Baccarelli A, 2009, CIRCULATION, V119, P3118, DOI 10.1161/CIRCULATIONAHA.108.836163
   Baja ES, 2013, J EXPO SCI ENV EPID, V23, P268, DOI 10.1038/jes.2012.106
   Baja ES, 2013, ENV HLTH, V12
   Bind MA, 2012, EPIDEMIOLOGY, V23, P332, DOI 10.1097/EDE.0b013e31824523f0
   Blomberg A, 2005, J THROMB HAEMOST, V3, P2103, DOI 10.1111/j.1538-7836.2005.01559.x
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Carlsten C, 2007, THROMB RES, V120, P849, DOI 10.1016/j.thromres.2007.01.005
   Delfino RJ, 2010, EPIDEMIOLOGY, V21, P892, DOI 10.1097/EDE.0b013e3181f20e6c
   Ghio AJ, 2003, INHAL TOXICOL, V15, P1465, DOI 10.1080/08958370390249111
   Gong H, 2003, INHAL TOXICOL, V15, P305, DOI 10.1080/08958370390168300
   Gong JC, 2013, J EXPO SCI ENV EPID, V23, P322, DOI 10.1038/jes.2012.127
   He F, 2011, J EXPO SCI ENV EPID, V21, P65, DOI 10.1038/jes.2010.21
   Huang W, 2012, AM J RESP CRIT CARE, V186, P1150, DOI 10.1164/rccm.201205-0850OC
   Jia XF, 2012, INT ARCH OCC ENV HEA, V85, P97, DOI 10.1007/s00420-011-0646-3
   Kan H, 2011, J THROMB HAEMOST, V9, P672, DOI 10.1111/j.1538-7836.2011.04210.x
   Kipen H, 2010, ANN NY ACAD SCI, V1203, P160, DOI 10.1111/j.1749-6632.2010.05638.x
   Langrish JP, 2012, J INTERN MED, V272, P224, DOI 10.1111/j.1365-2796.2012.02566.x
   Laumbach RJ, 2010, ANN NY ACAD SCI, V1203, P107, DOI 10.1111/j.1749-6632.2010.05604.x
   Lucking AJ, 2008, EUR HEART J, V29, P3043, DOI 10.1093/eurheartj/ehn464
   Martinelli N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034831
   Mills NL, 2008, ENVIRON HEALTH PERSP, V116, P709, DOI 10.1289/ehp.11016
   Mills NL, 2009, NAT CLIN PRACT CARD, V6, P36, DOI 10.1038/ncpcardio1399
   Moller P, 2010, ENVIRON HEALTH PERSP, V118, P1126, DOI 10.1289/ehp.0901725
   Park SK, 2005, ENVIRON HEALTH PERSP, V113, P304, DOI 10.1289/ehp.7447
   Peters A, 1997, LANCET, V349, P1582, DOI 10.1016/S0140-6736(97)01211-7
   Pieters N, 2012, HEART, V98, P1127, DOI 10.1136/heartjnl-2011-301505
   Pope CA, 2004, ENVIRON HEALTH PERSP, V112, P339, DOI 10.1289/ehp.6588
   Rich DQ, 2012, JAMA-J AM MED ASSOC, V307, P2068, DOI 10.1001/jama.2012.3488
   Riediker M, 2004, AM J RESP CRIT CARE, V169, P934, DOI 10.1164/rccm.200310-1463OC
   Shih RA, 2011, ENVIRON HEALTH PERSP, V119, P326, DOI 10.1289/ehp.1002256
   Van Eeden S, 2012, AM J RESP CRIT CARE, V186, P11, DOI 10.1164/rccm.201203-0455PP
   Van Hee VC, 2011, EPIDEMIOLOGY, V22, P773, DOI 10.1097/EDE.0b013e31823061a9
   Wang M, 2009, ATMOS CHEM PHYS, V9, P8247, DOI 10.5194/acp-9-8247-2009
   Zanobetti A, 2009, ENVIRON HEALTH PERSP, V117, P898, DOI 10.1289/ehp.0800108
   Zhang J, 2013, CARDIORESPIRATORY BI, P174
   Zuurbier M, 2011, ENVIRON HEALTH PERSP, V119, P1384, DOI 10.1289/ehp.1003151
NR 37
TC 5
Z9 5
U1 1
U2 39
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 12
PY 2014
VL 9
IS 12
AR e114913
DI 10.1371/journal.pone.0114913
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AW6JI
UT WOS:000346375400063
PM 25502951
OA Green Published, Other Gold
DA 2019-05-24
ER

PT J
AU Golokhvast, KS
   Shvedova, AA
AF Golokhvast, Kirill S.
   Shvedova, Anna A.
TI Galvanic Manufacturing in the Cities of Russia: Potential Source of
   Ambient Nanoparticles
SO PLOS ONE
LA English
DT Article
ID IRON-OXIDE NANOPARTICLES; AMERICAN-HEART-ASSOCIATION; AIR-POLLUTION;
   PARTICULATE MATTER; HEAVY-METALS; CARDIOVASCULAR-DISEASE;
   RISK-ASSESSMENT; IN-VITRO; HEALTH; SLUDGE
AB Galvanic manufacturing is widely employed and can be found in nearly every average city in Russia. The release and accumulation of different metals (Me), depending on the technology used can be found in the vicinities of galvanic plants. Under the environmental protection act in Russia, the regulations for galvanic manufacturing do not include the regulations and safety standards for ambient ultrafine and nanosized particulate matter (PM). To assess whether Me nanoparticles (NP) are among environmental pollutants caused by galvanic manufacturing, the level of Me NP were tested in urban snow samples collected around galvanic enterprises in two cities. Employing transmission electronic microscopy, energy-dispersive X-ray spectroscopy, and a laser diffraction particle size analyzer, we found that the size distribution of tested Me NP was within 10-120 nm range. This is the first study to report that Me NP of Fe, Cr, Pb, Al, Ni, Cu, and Zn were detected around galvanic shop settings.
C1 [Golokhvast, Kirill S.] Far Eastern Fed Univ, Sci Educ Ctr Nanotechnol, Vladivostok, Russia.
   [Shvedova, Anna A.] CDC, NIOSH, Pathol & Physiol Res Branch, Morgantown, WV USA.
   [Shvedova, Anna A.] W Virginia Univ, Sch Med, Dept Physiol & Pharmacol, Morgantown, VA USA.
RP Golokhvast, KS (reprint author), Far Eastern Fed Univ, Sci Educ Ctr Nanotechnol, Vladivostok, Russia.
EM droopy@mail.ru
RI Golokhvast, Kirill Sergeevich/E-5051-2014
OI Golokhvast, Kirill Sergeevich/0000-0002-4873-2281
FU Far Eastern Federal University [13-06-0318-m_a]; Presidential Grant for
   supporting young scientists [MK-1547.2013.5]; Ministry of Education and
   Science of the Russian Federation [14.594.21.0006]
FX The work is financially supported by the Scientific Fund of the Far
   Eastern Federal University (No. 13-06-0318-m_a), the Presidential Grant
   for supporting young scientists (MK-1547.2013.5) and the Grant of the
   Ministry of Education and Science of the Russian Federation (No.
   14.594.21.0006). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Andersen ZJ, 2008, OCCUP ENVIRON MED, V65, P458, DOI 10.1136/oem.2007.033290
   Anderson JO, 2012, J MED TOXICOL, V8, P166, DOI 10.1007/s13181-011-0203-1
   Andrus M.E., 2000, MET FINISH, V11, P20, DOI DOI 10.1016/S00260576(00)83532-1
   BABICH H, 1985, ENVIRON RES, V36, P111, DOI 10.1016/0013-9351(85)90011-8
   BATES DV, 1995, ENVIRON HEALTH PERSP, V103, P49, DOI 10.2307/3432345
   Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   BURKIN AR, 1969, POWDER METALL, V12, P243, DOI 10.1179/pom.1969.12.23.012
   Cakmak S, 2014, ENVIRON POLLUT, V189, P208, DOI 10.1016/j.envpol.2014.03.004
   Campen MJ, 2001, TOXICOL SCI, V64, P243, DOI 10.1093/toxsci/64.2.243
   CANDELONE JP, 1995, J GEOPHYS RES-ATMOS, V100, P16605, DOI 10.1029/95JD00989
   Chen LC, 2009, INHAL TOXICOL, V21, P1, DOI [10.1080/08958370802105405, 10.1080/08958370802105405 ]
   Erdem M, 2011, HYDROMETALLURGY, V105, P270, DOI 10.1016/j.hydromet.2010.10.014
   Fadeel B, 2012, ADVERSE EFFECTS OF ENGINEERED NANOMATERIALS: EXPOSURE, TOXICOLOGY, AND IMPACT ON HUMAN HEALTH, pIX
   GUILIZZONI P, 1991, AQUAT BOT, V41, P87, DOI 10.1016/0304-3770(91)90040-C
   Horie M, 2013, ENVIRON TOXICOL, V28, P61, DOI 10.1002/tox.20695
   Kreyling WG, 2006, J NANOPART RES, V8, P543, DOI 10.1007/s11051-005-9068-z
   Moulin JJ, 1998, AM J EPIDEMIOL, V148, P241
   Murray AR, 2013, CELL BIOCHEM BIOPHYS, V67, P461, DOI 10.1007/s12013-012-9367-9
   Ozdemir OD, 2012, J CHEM SOC PAKISTAN, V34, P1032
   Ozverdl A, 2010, HYDROMETALLURGY, V100, P103, DOI 10.1016/j.hydromet.2009.10.011
   Raza A, 2014, EUR HEART J, V35, P861, DOI 10.1093/eurheartj/eht489
   Rossini G, 2006, J HAZARD MATER, V131, P210, DOI 10.1016/j.jhazmat.2005.09.035
   Ryabukhin AG, 2002, REPORTS CHELYABINSK, V4, P111
   Silva JE, 2005, J HAZARD MATER, V120, P113, DOI 10.1016/j.jhazmat.2004.12.008
   Soenen SJ, 2012, METHOD ENZYMOL, V509, P195, DOI 10.1016/B978-0-12-391858-1.00011-3
   Szalay B, 2012, J APPL TOXICOL, V32, P446, DOI 10.1002/jat.1779
   U.S. Imports Exports and Tariff Data, 1989, 9387 NBER
   VALLI J, 1986, J VAC SCI TECHNOL A, V4, P3007, DOI 10.1116/1.573616
   Vinogradov SS, 2002, ECOLOGICALLY SAFE GA
   Voutsa D, 2002, ATMOS ENVIRON, V36, P3583, DOI 10.1016/S1352-2310(02)00282-0
   Yanamala N, 2013, ADV DRUG DELIVER REV, V65, P2070, DOI 10.1016/j.addr.2013.05.005
   Zhang ZH, 2009, INT J ENVIRON HEAL R, V19, P175, DOI 10.1080/09603120802460392
   Zhu XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046286
NR 34
TC 2
Z9 2
U1 1
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 20
PY 2014
VL 9
IS 10
AR e110573
DI 10.1371/journal.pone.0110573
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AS0AY
UT WOS:000343942100075
PM 25329582
OA DOAJ Gold, Green Published
DA 2019-05-24
ER

PT J
AU Sancini, G
   Farina, F
   Battaglia, C
   Cifola, I
   Mangano, E
   Mantecca, P
   Camatini, M
   Palestini, P
AF Sancini, Giulio
   Farina, Francesca
   Battaglia, Cristina
   Cifola, Ingrid
   Mangano, Eleonora
   Mantecca, Paride
   Camatini, Marina
   Palestini, Paola
TI Health Risk Assessment for Air Pollutants: Alterations in Lung and
   Cardiac Gene Expression in Mice Exposed to Milano Winter Fine
   Particulate Matter (PM2.5)
SO PLOS ONE
LA English
DT Article
ID FRACTIONATED TIRE PARTICLES; PULMONARY EPITHELIAL-CELLS;
   AMERICAN-HEART-ASSOCIATION; NATRIURETIC-PEPTIDE GENE;
   CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; MESSENGER-RNA; PHYSICOCHEMICAL
   CHARACTERIZATION; HYDROCARBON RECEPTOR; CYTOCHROME P4501A1
AB Oxidative stress, pulmonary and systemic inflammation, endothelial cell dysfunction, atherosclerosis and cardiac autonomic dysfunction have been linked to urban particulate matter exposure. The chemical composition of airborne pollutants in Milano is similar to those of other European cities though with a higher PM2.5 fraction. Milano winter fine particles (PM2.5win) are characterized by the presence of nitrate, organic carbon fraction, with high amount of polycyclic aromatic hydrocarbons and elements such as Pb, Al, Zn, V, Fe, Cr and others, with a negligible endotoxin presence. In BALB/c mice, we examined, at biochemical and transcriptomic levels, the adverse effects of repeated Milano PM2.5win exposure in lung and heart. We found that ET-1, Hsp70, Cyp1A1, Cyp1B1 and Hsp-70, HO-1, MPO respectively increased within lung and heart of PM2.5win-treated mice. The PM2.5win exposure had a strong impact on global gene expression of heart tissue (181 upregulated and 178 down-regulated genes) but a lesser impact on lung tissue (14 up-regulated genes and 43 downregulated genes). Focusing on modulated genes, in lung we found two-to three-fold changes of those genes related to polycyclic aromatic hydrocarbons exposure and calcium signalling. Within heart the most striking aspect is the twofold to threefold increase in collagen and laminin related genes as well as in genes involved in calcium signaling. The current study extends our previous findings, showing that repeated instillations of PM2.5win trigger systemic adverse effects. PM2.5win thus likely poses an acute threat primarily to susceptible people, such as the elderly and those with unrecognized coronary artery or structural heart disease. The study of genomic responses will improve understanding of disease mechanisms and enable future clinical testing of interventions against the toxic effects of air pollutant.
C1 [Sancini, Giulio; Farina, Francesca; Palestini, Paola] Univ Milano Bicocca, POLARIS Res Ctr, Dept Hlth Sci, Monza, Italy.
   [Battaglia, Cristina] Univ Milan, Dept Med Biotechnol & Translat Med BIOMETRA, Segrate, Italy.
   [Mantecca, Paride; Camatini, Marina] Univ Milano Bicocca, POLARIS Res Ctr, Dept Environm Sci, Milan, Italy.
   [Battaglia, Cristina; Cifola, Ingrid; Mangano, Eleonora] CNR, Inst Biomed Technol, Segrate, Italy.
RP Farina, F (reprint author), Univ Milano Bicocca, POLARIS Res Ctr, Dept Hlth Sci, Monza, Italy.
EM francesca.farina1@unimib.it
RI Battaglia, Cristina/E-5166-2017; Mangano, Eleonora/P-7028-2018
OI Battaglia, Cristina/0000-0003-3025-9657; Mangano,
   Eleonora/0000-0002-4040-4654
FU TOSCA Project, Cariplo Foundation
FX This work is funded by TOSCA Project (MC, PP), Cariplo Foundation,
   http://www.fondazionecariplo.it/it/index.html. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abbas I, 2013, J APPL TOXICOL, V33, P109, DOI 10.1002/jat.1722
   ARAI M, 1993, CIRC RES, V72, P463, DOI 10.1161/01.RES.72.2.463
   Backes C, 2007, GENETRAIL ADV GENE S
   BARRY WH, 1993, CIRCULATION, V87, P1806, DOI 10.1161/01.CIR.87.6.1806
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Bessette EE, 2009, J BIOCHEM MOL TOXIC, V23, P222, DOI 10.1002/jbt.20283
   Billet S, 2007, ENVIRON RES, V105, P212, DOI 10.1016/j.envres.2007.03.001
   BOLUYT MO, 1994, CIRC RES, V75, P23, DOI 10.1161/01.RES.75.1.23
   Bourotte Christine Laure Marie, 2011, Rev. bras. meteorol., V26, P419, DOI 10.1590/S0102-77862011000300008
   Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Cao Q, 2007, TOXICOL LETT, V171, P126, DOI 10.1016/j.toxlet.2007.05.007
   Chen Qing-Wen, 2004, Yaoxue Xuebao, V39, P500
   Choi BM, 2003, FREE RADICAL BIO MED, V34, P1136, DOI 10.1016/S0891-5849(03)00064-9
   Clark NA, 2010, ENVIRON HEALTH PERSP, V118, P284, DOI 10.1289/ehp.0900916
   Dergham M, 2012, CHEM RES TOXICOL, V25, P904, DOI 10.1021/tx200529v
   Dieme D, 2012, ENVIRON RES, V113, P1, DOI 10.1016/j.envres.2011.11.009
   DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401
   Farina F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056636
   Farina F, 2011, TOXICOL LETT, V202, P209, DOI 10.1016/j.toxlet.2011.01.031
   FELDMAN AM, 1991, CIRCULATION, V83, P1866, DOI 10.1161/01.CIR.83.6.1866
   Franchini M, 2009, SEMIN THROMB HEMOST, V35, P665, DOI 10.1055/s-0029-1242720
   Frank KF, 2003, CARDIOVASC RES, V57, P20, DOI 10.1016/S0008-6363(02)00694-6
   Garcon G, 2006, TOXICOL IN VITRO, V20, P519, DOI 10.1016/j.tiv.2005.09.012
   Goldie RG, 1999, RESP PHARM PHARMACOT
   Golubinskaya V, 2014, BIOMED RES INT, DOI 10.1155/2014/128046
   Graff DW, 2004, ENVIRON HEALTH PERSP, V112, P792, DOI 10.1289/txg.6865
   Gualtieri M, 2012, TOXICOL LETT, V209, P136, DOI 10.1016/j.toxlet.2011.11.015
   Gualtieri M, 2009, TOXICOL LETT, V188, P52, DOI 10.1016/j.toxlet.2009.03.003
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Happo MS, 2010, INHAL TOXICOL, V22, P402, DOI 10.3109/08958370903527908
   Harrigan JA, 2004, TOXICOL SCI, V77, P307, DOI 10.1093/toxsci/kfh030
   Holloway JW, 2012, RESPIROLOGY, V17, P590, DOI 10.1111/j.1440-1843.2012.02164.x
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Ito T, 2008, TOXICOLOGY, V243, P271, DOI 10.1016/j.tox.2007.10.013
   JACQUIERSARLIN MR, 1994, EXPERIENTIA, V50, P1031, DOI 10.1007/BF01923458
   Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012
   Kim GB, 1998, ENVIRON POLLUT, V99, P255, DOI 10.1016/S0269-7491(97)00121-8
   Kress S, 1997, CANCER RES, V57, P1264
   Lin P, 2003, LUNG CANCER-J IASLC, V42, P255, DOI 10.1016/S0169-5002(03)00359-3
   Liu W, 2009, EXP LUNG RES, V35, P29, DOI 10.1080/01902140802395757
   LOGAN WPD, 1953, LANCET, V264, P336
   Longhin E, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-63
   Mantecca P, 2010, TOXICOL LETT, V198, P244, DOI 10.1016/j.toxlet.2010.07.002
   Mantecca P, 2009, TOXICOL LETT, V189, P206, DOI 10.1016/j.toxlet.2009.05.023
   MATSUBARA H, 1988, BIOCHEM BIOPH RES CO, V156, P619, DOI 10.1016/S0006-291X(88)80888-X
   Mossman Brooke T, 2007, Part Fibre Toxicol, V4, P4, DOI 10.1186/1743-8977-4-4
   Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015
   Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X
   Nemery B, 2001, LANCET, V357, P704, DOI 10.1016/S0140-6736(00)04135-0
   Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P1102, DOI 10.1161/01.ATV.0000163262.83456.6d
   Oh SM, 2011, MUTAT RES-GEN TOX EN, V723, P142, DOI 10.1016/j.mrgentox.2011.04.003
   Peacock JL, 2011, THORAX, V66, P591, DOI 10.1136/thx.2010.155358
   Perrone MG, 2012, SCI TOTAL ENVIRON, V414, P343, DOI 10.1016/j.scitotenv.2011.11.026
   Perrone MG, 2010, CHEMOSPHERE, V78, P1368, DOI 10.1016/j.chemosphere.2009.12.071
   Pessah IN, 2001, PEST MANAG SCI, V57, P941, DOI 10.1002/ps.391
   Pessah IN, 2001, MOL PHARMACOL, V59, P506
   Pleil JD, 2010, J CHROMATOGR B, V878, P1753, DOI 10.1016/j.jchromb.2010.04.035
   POPE CA, 1995, AM J RESP CRIT CARE, V151, P669
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132
   Rojas M, 2001, CARCINOGENESIS, V22, P1015, DOI 10.1093/carcin/22.7.1015
   Rudolph V, 2010, CLIN CHEM, V56, P881, DOI 10.1373/clinchem.2010.147231
   Saarikoski ST, 1998, INT J CANCER, V77, P33, DOI 10.1002/(SICI)1097-0215(19980703)77:1<33::AID-IJC7>3.0.CO;2-0
   Saunders V, 2010, ENVIRON HEALTH PERSP, V118, P640, DOI 10.1289/ehp.0901461
   Shah SJ, 2014, AM J PHYSIOL-HEART C, V306, pH88, DOI 10.1152/ajpheart.00642.2013
   Shimada T, 1999, CARCINOGENESIS, V20, P1607, DOI 10.1093/carcin/20.8.1607
   Tankersley CG, 2013, TOXICOL SCI, V131, P95, DOI 10.1093/toxsci/kfs273
   Tsukue N, 2010, TOXICOL IN VITRO, V24, P363, DOI 10.1016/j.tiv.2009.11.004
   Wang T, 2008, ENVIRON HEALTH PERSP, V116, P1500, DOI 10.1289/ehp.11229
   Watterson TL, 2007, J TOXICOL ENV HEAL A, V70, P1731, DOI 10.1080/15287390701457746
   Watterson TL, 2009, TOXICOL SCI, V112, P111, DOI 10.1093/toxsci/kfp186
   Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103
   Wong Simon S, 2011, Res Rep Health Eff Inst, P3
   Zhang YY, 2013, AQUAT TOXICOL, V142, P26, DOI 10.1016/j.aquatox.2013.07.014
NR 74
TC 33
Z9 34
U1 1
U2 46
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 8
PY 2014
VL 9
IS 10
AR e109685
DI 10.1371/journal.pone.0109685
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AT8TE
UT WOS:000345204000093
PM 25296036
OA Other Gold, Green Published
DA 2019-05-24
ER

PT J
AU Rizzo, AM
   Corsetto, PA
   Farina, F
   Montorfano, G
   Pani, G
   Battaglia, C
   Sancini, G
   Palestini, P
AF Rizzo, Angela Maria
   Corsetto, Paola Antonia
   Farina, Francesca
   Montorfano, Gigliola
   Pani, Giuseppe
   Battaglia, Cristina
   Sancini, Giulio
   Palestini, Paola
TI Repeated Intratracheal Instillation of PM10 Induces Lipid Reshaping in
   Lung Parenchyma and in Extra-Pulmonary Tissues
SO PLOS ONE
LA English
DT Article
ID FRACTIONATED TIRE PARTICLES; AMERICAN-HEART-ASSOCIATION; PARTICULATE
   MATTER PM10; BREAST-CANCER CELLS; AIR-POLLUTION; OXIDATIVE STRESS;
   ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; SYSTEMIC CIRCULATION;
   ULTRAFINE PARTICLES
AB Adverse health effects of air pollution attributed mainly to airborne particulate matter have been well documented in the last couple of decades. Short term exposure, referring to a few hours exposure, to high ambient PM10 concentration is linked to increased hospitalization rates for cardiovascular events, typically 24 h after air pollution peaks. Particulate matter exposure is related to pulmonary and cardiovascular diseases, with increased oxidative stress and inflammatory status. Previously, we have demonstrated that repeated intratracheal instillation of PM10sum in BALB/c mice leads to respiratory tract inflammation, creating in lung a condition which could potentially evolve in a systemic toxic reaction. Additionally, plasma membrane and tissue lipids are easily affected by oxidative stress and directly correlated with inflammatory products. With this aim, in the present investigation using the same model, we analyzed the toxic potential of PM10sum exposure on lipid plasma membrane composition, lipid peroxidation and the mechanisms of cells protection in multiple organs such as lung, heart, liver and brain. Obtained results indicated that PM10 exposure led to lung lipid reshaping, in particular phospholipid and cholesterol content increases; concomitantly, the generation of oxidative stress caused lipid peroxidation. In liver we found significant changes in lipid content, mainly due to an increase of phosphatidylcholine, and in total fatty acid composition with a more pronounced level of docosahexaenoic acid; these changes were statistically correlated to lung molecular markers. Heart and brain were similarly affected; heart was significantly enriched in triglycerides in half of the PM10sum treated mice. These results demonstrated a direct involvement of PM10sum in affecting lipid metabolism and oxidative stress in peripheral tissues that might be related to the serious systemic air-pollution effects on human health.
C1 [Rizzo, Angela Maria; Corsetto, Paola Antonia; Montorfano, Gigliola; Pani, Giuseppe] Univ Milan, Dept Pharmacol & Biomol Sci DiSFEB, Lab Membrane Biochem & Appl Nutr, Milan, Italy.
   [Farina, Francesca; Sancini, Giulio; Palestini, Paola] Univ Milano Bicocca, POLARIS Res Ctr, Dept Hlth Sci DISS, Monza, Italy.
   [Battaglia, Cristina] Univ Milan, Lab Genom Technol, Dept Med Biotechnol & Translat Med BIOMETRA, Segrate, Italy.
RP Rizzo, AM (reprint author), Univ Milan, Dept Pharmacol & Biomol Sci DiSFEB, Lab Membrane Biochem & Appl Nutr, Milan, Italy.
EM angelamaria.rizzo@unimi.it
RI CORSETTO, PAOLA ANTONIA/O-2244-2015; Battaglia, Cristina/E-5166-2017;
   RIzzo, Angela Maria/E-4786-2012
OI CORSETTO, PAOLA ANTONIA/0000-0003-3849-8548; Battaglia,
   Cristina/0000-0003-3025-9657; RIzzo, Angela Maria/0000-0002-8582-0432;
   PANI, GIUSEPPE/0000-0001-5198-8205; Palestini, Paola/0000-0002-1045-8838
FU CARIPLO Foundation
FX This research received financial support from CARIPLO Foundation to the
   projects: 1) Toxicity of particulate matter and marker of risk; 2)
   Biological effects and human health impacts of ultrafine particles
   sources. The funder had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Angrish MM, 2013, TOXICOL SCI, V131, P108, DOI 10.1093/toxsci/kfs277
   Asgharian B, 2006, INHAL TOXICOL, V18, P795, DOI 10.1080/08958370600748687
   Bahat-Stroomza M, 2005, EUR J NEUROSCI, V21, P637, DOI 10.1111/j.1460-9568.2005.03889.x
   Basso M, 2004, PROTEOMICS, V4, P3943, DOI 10.1002/pmic.200400848
   Bengalli R, 2013, BIOMED RES INT, DOI 10.1155/2013/801214
   Beretta E, 2007, TOXICOL LETT, V173, P191, DOI 10.1016/j.toxlet.2007.07.012
   Bessette EE, 2009, J BIOCHEM MOL TOXIC, V23, P222, DOI 10.1002/jbt.20283
   Block ML, 2012, NEUROTOXICOLOGY, V33, P972, DOI 10.1016/j.neuro.2012.08.014
   Block ML, 2009, TRENDS NEUROSCI, V32, P506, DOI 10.1016/j.tins.2009.05.009
   Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004
   Brandenberger C, 2010, SMALL, V6, P1669, DOI 10.1002/smll.201000528
   Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Calderon-Garciduenas L, 2013, BIOMED RES INT, V32, P650, DOI [10.1155/2013/161687, DOI 10.1155/2013/161687]
   Camatini M, 2012, ENVIRON TOXICOL, V27, P63, DOI 10.1002/tox.20611
   CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666
   Case SR, 2011, EXP LUNG RES, V37, P500, DOI 10.3109/01902148.2011.596895
   Chen JM, 2006, TOXICOLOGY, V222, P195, DOI 10.1016/j.tox.2006.02.016
   Choi BM, 2003, FREE RADICAL BIO MED, V34, P1136, DOI 10.1016/S0891-5849(03)00064-9
   Conklin DJ, 2013, J HEPATOL, V58, P8, DOI 10.1016/j.jhep.2012.10.008
   CORRIN B, 1978, THORAX, V33, P565, DOI 10.1136/thx.33.5.565
   Corsetto PA, 2012, CELL BIOCHEM BIOPHYS, V64, P45, DOI 10.1007/s12013-012-9365-y
   Cortie CH, 2012, INT J MOL SCI, V13, P15447, DOI 10.3390/ijms131115447
   Costa DL, 1997, ENVIRON HEALTH PERSP, V105, P1053, DOI 10.2307/3433509
   Cotogni P, 2011, JPEN-PARENTER ENTER, V35, P114, DOI 10.1177/0148607110372392
   Damaceno-Rodrigues NR, 2009, INHAL TOXICOL, V21, P1129, DOI 10.1080/08958370902798430
   DINARELLO CA, 1994, FASEB J, V8, P1314
   Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X
   El Kossi MMH, 2000, STROKE, V31, P1889, DOI 10.1161/01.STR.31.8.1889
   ESTERBAUER H, 1985, BIOCHEM J, V228, P363, DOI 10.1042/bj2280363
   Fajersztajn L, 2013, NAT REV CANCER, V13, P674, DOI 10.1038/nrc3572
   Farina F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056636
   Farina F, 2011, TOXICOL LETT, V202, P209, DOI 10.1016/j.toxlet.2011.01.031
   Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300
   Franchini M, 2009, SEMIN THROMB HEMOST, V35, P665, DOI 10.1055/s-0029-1242720
   Franzetti A, 2011, APPL MICROBIOL BIOT, V90, P745, DOI 10.1007/s00253-010-3048-7
   Furuichi K, 2006, CRIT CARE MED, V34, P2447, DOI 10.1097/01.CCM.0000233878.36340.10
   Graff DW, 2009, ENVIRON HEALTH PERSP, V117, P1089, DOI 10.1289/ehp0900558
   Gualtieri M, 2009, TOXICOL LETT, V188, P52, DOI 10.1016/j.toxlet.2009.03.003
   Guo L, 2012, J HAZARD MATER, V213, P28, DOI 10.1016/j.jhazmat.2012.01.034
   Henderson RF, 2005, EXP TOXICOL PATHOL, V57, P155, DOI 10.1016/j.etp.2005.05.004
   JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2
   Jung YY, 2013, KOREAN J PHYSIOL PHA, V17, P209, DOI 10.4196/kjpp.2013.17.3.209
   Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041
   Kampfrath T, 2011, CIRC RES, V108, P716, DOI 10.1161/CIRCRESAHA.110.237560
   Kelly FJ, 2003, OCCUP ENVIRON MED, V60, P612, DOI 10.1136/oem.60.8.612
   Kendall M, 2007, AM J PHYSIOL-LUNG C, V293, pL1053, DOI 10.1152/ajplung.00131.2007
   Kido T, 2011, AM J RESP CELL MOL, V44, P197, DOI 10.1165/rcmb.2009-0427OC
   Kloog I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034664
   Levesque S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-105
   Li N, 2003, ENVIRON HEALTH PERSP, V111, P455, DOI 10.1289/ehp.6000
   Li N, 2008, FREE RADICAL BIO MED, V44, P1689, DOI 10.1016/j.freeradbiomed.2008.01.028
   Liu Q, 2005, FREE RADICAL BIO MED, V38, P746, DOI 10.1016/j.freeradbiomed.2004.11.005
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MacNee W, 2003, EUR RESPIR J, V21, p47S, DOI 10.1183/09031936.03.00403203
   MANRIQUE M, 2013, ENDOCRINOLOGY, V154, P3632, DOI DOI 10.1210/EN.2013-1256
   Mantecca P, 2010, TOXICOL LETT, V198, P244, DOI 10.1016/j.toxlet.2010.07.002
   Mantecca P, 2009, TOXICOL LETT, V189, P206, DOI 10.1016/j.toxlet.2009.05.023
   Miyata R, 2013, TOXICOL APPL PHARM, V272, P1, DOI 10.1016/j.taap.2013.05.033
   MohanKumar SMJ, 2008, NEUROTOXICOLOGY, V29, P479, DOI 10.1016/j.neuro.2007.12.004
   Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240
   Muhlfeld C, 2008, SWISS MED WKLY, V138, P387, DOI 2008/27/smw-12153
   Nel A, 2005, SCIENCE, V308, P804, DOI 10.1126/science.1108752
   Nemmar A, 2001, AM J RESP CRIT CARE, V164, P1665, DOI 10.1164/ajrccm.164.9.2101036
   NISHIMURA I, 1995, TOXICOL LETT, V75, P185, DOI 10.1016/0378-4274(94)03184-9
   Orsini F, 2012, BBA-BIOMEMBRANES, V1818, P2943, DOI 10.1016/j.bbamem.2012.07.024
   Perluigi M, 2005, FREE RADICAL BIO MED, V38, P960, DOI 10.1016/j.freeradbiomed.2004.12.021
   Peters Annette, 2006, Part Fibre Toxicol, V3, P13, DOI 10.1186/1743-8977-3-13
   Pleil JD, 2010, J CHROMATOGR B, V878, P1753, DOI 10.1016/j.jchromb.2010.04.035
   Puthanveetil P, 2011, FREE RADICAL BIO MED, V51, P352, DOI 10.1016/j.freeradbiomed.2011.04.009
   Qin LY, 2004, J BIOL CHEM, V279, P1415, DOI 10.1074/jbc.M307657200
   Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805
   Rizzo AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032361
   Ruge CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040775
   RYDER SW, 2000, FREE RADICAL BIO MED, V28, P289
   Schicker B, 2009, EUR J APPL PHYSIOL, V105, P771, DOI 10.1007/s00421-008-0962-9
   Schwarze PE, 2006, HUM EXP TOXICOL, V25, P559, DOI 10.1177/096032706072520
   Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294
   Shah KB, 2009, CLIN CHEM, V55, P59, DOI 10.1373/clinchem.2008.108159
   Shannahan JH, 2012, INHAL TOXICOL, V24, P320, DOI 10.3109/08958378.2012.668229
   Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828
   Simkhovich BZ, 2008, J AM COLL CARDIOL, V52, P719, DOI 10.1016/j.jacc.2008.05.029
   SPALDING JW, 1988, NATL TOXICOL PROGRAM, V331, P5
   Takahashi HK, 2013, EUR J PHARMACOL, V701, P194, DOI 10.1016/j.ejphar.2012.11.058
   Taniguchi N, 2003, ARTHRITIS RHEUM, V48, P971, DOI 10.1002/art.10859
   Treutiger CJ, 2003, J INTERN MED, V254, P375, DOI 10.1046/j.1365-2796.2003.01204.x
   Valencak TG, 2013, AGE, V35, P2303, DOI 10.1007/s11357-013-9533-z
   Wallenborn JG, 2007, TOXICOL SCI, V98, P231, DOI 10.1093/toxsci/kfm088
   WOLPE SD, 1989, P NATL ACAD SCI USA, V86, P612, DOI 10.1073/pnas.86.2.612
   YAU TM, 1979, MECH AGEING DEV, V11, P137, DOI 10.1016/0047-6374(79)90031-9
   Zheng Z, 2013, J HEPATOL, V58, P148, DOI 10.1016/j.jhep.2012.08.009
NR 91
TC 7
Z9 7
U1 1
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 26
PY 2014
VL 9
IS 9
AR e106855
DI 10.1371/journal.pone.0106855
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AQ3IP
UT WOS:000342685600010
PM 25259850
OA DOAJ Gold, Green Published
DA 2019-05-24
ER

PT J
AU Moller, KL
   Thygesen, LC
   Schipperijn, J
   Loft, S
   Bonde, JP
   Mikkelsen, S
   Brauer, C
AF Moller, Karina Lauenborg
   Thygesen, Lau Caspar
   Schipperijn, Jasper
   Loft, Steffen
   Bonde, Jens Peter
   Mikkelsen, Sigurd
   Brauer, Charlotte
TI Occupational Exposure to Ultrafine Particles among Airport Employees -
   Combining Personal Monitoring and Global Positioning System
SO PLOS ONE
LA English
DT Article
ID AIR-POLLUTION; CARDIOVASCULAR-DISEASE; PARTICULATE MATTER; TERM
   EXPOSURE; ASSOCIATION; WORKERS
AB Background: Exposure to ultrafine particles (UFP) has been linked to cardiovascular and lung diseases. Combustion of jet fuel and diesel powered handling equipment emit UFP resulting in potentially high exposure levels among employees working at airports. High levels of UFP have been reported at several airports, especially on the apron, but knowledge on individual exposure profiles among different occupational groups working at an airport is lacking.
   Purpose: The aim of this study was to compare personal exposure to UFP among five different occupational groups working at Copenhagen Airport (CPH).
   Method: 30 employees from five different occupational groups (baggage handlers, catering drivers, cleaning staff and airside and landside security) at CPH were instructed to wear a personal monitor of particle number concentration in real time and a GPS device. The measurements were carried out on 8 days distributed over two weeks in October 2012. The overall differences between the groups were assessed using linear mixed model.
   Results: Data showed significant differences in exposure levels among the groups when adjusted for variation within individuals and for effect of time and date (p < 0.01). Baggage handlers were exposed to 7 times higher average concentrations (geometric mean, GM: 37 x 10(3) UFP/cm(3), 95% CI: 25-55 x 10(3) UFP/cm(3)) than employees mainly working indoors (GM: 5 x 10(3) UFP/cm(3), 95% CI: 2-11 x 10(3) UFP/cm(3)). Furthermore, catering drivers, cleaning staff and airside security were exposed to intermediate concentrations (GM: 12 to 20 x 10(3) UFP/cm(3)).
   Conclusion: The study demonstrates a strong gradient of exposure to UFP in ambient air across occupational groups of airport employees.
C1 [Moller, Karina Lauenborg; Thygesen, Lau Caspar] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark.
   [Schipperijn, Jasper] Univ Southern Denmark, Inst Sports Sci & Clin Biomech, Odense, Denmark.
   [Loft, Steffen] Univ Copenhagen, Dept Publ Hlth, Environm Hlth Sect, Copenhagen, Denmark.
   [Bonde, Jens Peter; Mikkelsen, Sigurd; Brauer, Charlotte] Copenhagen Univ Hosp Bispebjerg, Dept Occupat & Environm Med, Copenhagen, Denmark.
RP Moller, KL (reprint author), Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark.
EM Kalm@si-folkesundhed.dk
RI ; Thygesen, Lau/L-3812-2016
OI Moller, Karina/0000-0002-1430-5580; Loft, Steffen/0000-0001-9552-8518;
   Schipperijn, Jasper/0000-0002-6558-7610; Thygesen,
   Lau/0000-0001-8375-5211
FU Danish Working Environment Research Fund [20110081336]; Center for
   Indoor air and Health in dwellings (CISBO)
FX This study was supported by a grant from The Danish Working Environment
   Research Fund (Journal no: 20110081336). The three Nano Tracers were
   purchased with funds from Center for Indoor air and Health in dwellings
   (CISBO). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Andersen ZJ, 2011, AM J RESP CRIT CARE, V183, P455, DOI 10.1164/rccm.201006-0937OC
   Andersen ZJ, 2010, EUR HEART J, V31, P2034, DOI 10.1093/eurheartj/ehq188
   Asbach C, 2012, ANN OCCUP HYG, V56, P606, DOI 10.1093/annhyg/mes033
   Beko G, 2013, ENVIRON SCI TECHNOL, V47, P10240, DOI 10.1021/es402429h
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Buonanno G, 2012, ENVIRON POLLUT, V170, P78, DOI 10.1016/j.envpol.2012.05.027
   Cavallo D, 2006, TOXICOLOGY, V223, P26, DOI 10.1016/j.tox.2006.03.003
   Donaldson K, 2001, ENVIRON HEALTH PERSP, V109, P523, DOI 10.2307/3454663
   Duncan S, 2013, AM J PREV MED, V44, pE19, DOI 10.1016/j.amepre.2012.10.013
   Fang SC, 2010, INT J ENV RES PUB HE, V7, P1773, DOI 10.3390/ijerph7041773
   Franck U, 2011, SCI TOTAL ENVIRON, V409, P4217, DOI 10.1016/j.scitotenv.2011.05.049
   Kerr J NG, 2012, MED SCI SPORT EXER
   Kerr J, 2011, AM J PREV MED, V41, P532, DOI 10.1016/j.amepre.2011.07.017
   Krenn PJ, 2011, AM J PREV MED, V41, P508, DOI 10.1016/j.amepre.2011.06.046
   Morabia A, 2009, AM J PREV MED, V37, P72, DOI 10.1016/j.amepre.2009.03.014
   Nemmar A, 2002, CIRCULATION, V105, P411, DOI 10.1161/hc0402.104118
   Raaschou-Nielsen O, 2011, ENVIRON HEALTH PERSP, V119, P860, DOI 10.1289/ehp.1002353
   Tandon PS, 2013, AM J PREV MED, V44, P85, DOI 10.1016/j.amepre.2012.09.052
   Thomas Ellermann AM, 2011, MEASUREMENT ULTRAFIN
   Touri L, 2013, EUR RESPIR REV, P124
   Tunnicliffe WS, 1999, OCCUP ENVIRON MED, V56, P118, DOI 10.1136/oem.56.2.118
   Weichenthal S, 2012, ENVIRON RES, V115, P26, DOI 10.1016/j.envres.2012.03.001
   Wu J, 2010, ENVIRON HEALTH INSIG, V4, P93, DOI 10.4137/EHI.S6246
   Yang CY, 2003, J TOXICOL ENV HEAL A, V66, P799, DOI 10.1080/15287390390156218
NR 24
TC 9
Z9 9
U1 0
U2 30
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 9
PY 2014
VL 9
IS 9
AR e106671
DI 10.1371/journal.pone.0106671
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AQ3IF
UT WOS:000342684500035
PM 25203510
OA Other Gold, Green Published
DA 2019-05-24
ER

PT J
AU Adam, M
   Imboden, M
   Boes, E
   Schaffner, E
   Kunzli, N
   Phuleria, HC
   Kronenberg, F
   Gaspoz, JM
   Carballo, D
   Probst-Hensch, N
AF Adam, Martin
   Imboden, Medea
   Boes, Eva
   Schaffner, Emmanuel
   Kuenzli, Nino
   Phuleria, Harish Chandra
   Kronenberg, Florian
   Gaspoz, Jean-Michel
   Carballo, David
   Probst-Hensch, Nicole
TI Modifying Effect of a Common Polymorphism in the Interleukin-6 Promoter
   on the Relationship between Long-Term Exposure to Traffic-Related
   Particulate Matter and Heart Rate Variability
SO PLOS ONE
LA English
DT Article
ID PLASMA IL-6 LEVELS; AIR-POLLUTION; MYOCARDIAL-INFARCTION;
   CARDIOVASCULAR-DISEASE; SYSTEMIC INFLAMMATION; LUNG-DISEASES; SWISS
   COHORT; RISK-FACTORS; ASSOCIATION; GENE
AB Background: Exposure to particulate matter (PM) has been associated with an increase in many inflammatory markers, including interleukin 6 (IL6). Air pollution exposure has also been suggested to induce an imbalance in the autonomic nervous system (ANS), such as a decrease in heart rate variability (HRV). In this study we aimed to investigate the modifying effect of polymorphisms in a major proinflammatory marker gene, interleukin 6 (IL6), on the relationship between long-term exposure to traffic-related PM10 (TPM10) and HRV.
   Methods: For this cross-sectional study we analysed 1552 participants of the SAPALDIA cohort aged 50 years and older. Included were persons with valid genotype data, who underwent ambulatory 24-hr electrocardiogram monitoring, and reported on medical history and lifestyle. Main effects of annual average TPM10 and IL6 gene variants (rs1800795; rs2069827; rs2069840; rs10242595) on HRV indices and their interaction with average annual exposure to TPM10 were tested, applying a multivariable mixed linear model.
   Results: No overall association of TPM10 on HRV was found. Carriers of two proinflammatory G-alleles of the functional IL6 - 174 G/C (rs1800795) polymorphism exhibited lower HRV. An inverse association between a 1 mu g/m(3) increment in yearly averaged TPM10 and HRV was restricted to GG genotypes at this locus with a standard deviation of normal-to-normal intervals (SDNN) (GG-carriers: -1.8%; 95% confidence interval -3.5 to 0.01; p(interaction(additive)) = 0.028); and low frequency power (LF) (GG-carriers: -5.7%; 95% CI: -10.4 to 20.8; p(interaction(dominant)) = 0.049).
   Conclusions: Our results are consistent with the hypothesis that traffic-related air pollution decreases heart rate variability through inflammatory mechanisms.
C1 [Adam, Martin; Imboden, Medea; Boes, Eva; Schaffner, Emmanuel; Kuenzli, Nino; Phuleria, Harish Chandra; Probst-Hensch, Nicole] Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
   [Adam, Martin; Imboden, Medea; Boes, Eva; Schaffner, Emmanuel; Kuenzli, Nino; Phuleria, Harish Chandra; Probst-Hensch, Nicole] Univ Basel, Basel, Switzerland.
   [Boes, Eva; Kronenberg, Florian] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, A-6020 Innsbruck, Austria.
   [Gaspoz, Jean-Michel] Univ Hosp, Dept Community Med Primary Care & Emergency Med, Geneva, Switzerland.
   [Carballo, David] Univ Hosp, Dept Internal Med Specialties, Geneva, Switzerland.
RP Adam, M (reprint author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
EM martin.adam@unibas.ch
RI Kronenberg, Florian/B-1736-2008; Kuenzli, Nino/F-7195-2014
OI Kronenberg, Florian/0000-0003-2229-1120; Kuenzli,
   Nino/0000-0001-8360-080X
FU Swiss National Science Foundation [33CSCO-108796, 3247BO-104283,
   3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720,
   3200-042532, 4026-028099]; Federal Office for Forest, Environment and
   Landscape; Federal Office of Public Health; Federal Office of Roads and
   Transport; canton's government of Aargau; canton's government of
   Basel-Stadt; canton's government of Basel-Land; canton's government of
   Geneva; canton's government of Luzern; canton's government of Ticino;
   canton's government of Valais; canton's government of Zurich; Swiss Lung
   League; canton's Lung League of Basel Stadt/Basel Landschaft; canton's
   Lung League of Geneva; canton's Lung League of Ticino; canton's Lung
   League of Valais; canton's Lung League of Zurich
FX This work was supported by the Swiss National Science Foundation (grant
   numbers 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284,
   3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099), the
   Federal Office for Forest, Environment and Landscape, the Federal Office
   of Public Health, the Federal Office of Roads and Transport, the
   canton's government of Aargau, Basel-Stadt, Basel-Land, Geneva, Luzern,
   Ticino, Valais and Zurich, the Swiss Lung League and the canton's Lung
   League of Basel Stadt/Basel Landschaft, Geneva, Ticino, Valais and
   Zurich. No form of payment was given to any of the authors to produce
   the manuscript. The study received funding through peer-reviewed grants
   and donations from non-profit organizations as listed above. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Ackermann-Liebrich U, 2005, SOZ PRAVENTIV MED, V50, P245, DOI 10.1007/s00038-005-4075-5
   Adam M, 2012, ENVIRON INT, V48, P9, DOI 10.1016/j.envint.2012.06.016
   Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0
   BIGGER JT, 1993, J AM COLL CARDIOL, V21, P729, DOI 10.1016/0735-1097(93)90106-B
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Brull DJ, 2001, ARTERIOSCL THROM VAS, V21, P1458, DOI 10.1161/hq0901.094280
   Chan KHK, 2011, CLIN CHEM, V57, P317, DOI 10.1373/clinchem.2010.154526
   Danesh J, 2008, PLOS MED, V5, P600, DOI 10.1371/journal.pmed.0050078
   Dekker JM, 2000, CIRCULATION, V102, P1239, DOI 10.1161/01.CIR.102.11.1239
   Delfino RJ, 2010, EPIDEMIOLOGY, V21, P892, DOI 10.1097/EDE.0b013e3181f20e6c
   Delfino RJ, 2009, ENVIRON HEALTH PERSP, V117, P1232, DOI 10.1289/ehp.0800194
   Dietrich DF, 2008, ENVIRON HEALTH PERSP, V116, P1357, DOI 10.1289/ehp.11377
   Dietrich DF, 2006, EUROPACE, V8, P521, DOI 10.1093/europace/eul063
   *EL NASOPA, 1996, CIRCULATION, V93, P1043
   Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629
   Haensel A, 2008, PSYCHONEUROENDOCRINO, V33, P1305, DOI 10.1016/j.psyneuen.2008.08.007
   Hulkkonen J, 2001, RHEUMATOLOGY, V40, P656, DOI 10.1093/rheumatology/40.6.656
   Hulkkonen J, 2009, ATHEROSCLEROSIS, V203, P454, DOI 10.1016/j.atherosclerosis.2008.07.014
   Humphries SE, 2001, EUR HEART J, V22, P2243, DOI 10.1053/euhj.2001.2678
   Imboden M, 2006, Clin Mol Allergy, V4, P9, DOI 10.1186/1476-7961-4-9
   Kaptoge S, 2014, EUR HEART J, V35, P578, DOI 10.1093/eurheartj/eht367
   Kelberman D, 2004, BBA-MOL BASIS DIS, V1688, P160, DOI 10.1016/j.bbadis.2003.11.010
   KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8
   Kormann MSD, 2005, AM J RESP CRIT CARE, V171, P1358, DOI 10.1164/rccm.200410-1312OC
   Kunzli N, 2009, THORAX, V64, P664, DOI 10.1136/thx.2008.110031
   Lalouschek W, 2006, CLIN CHEM LAB MED, V44, P918, DOI 10.1515/CCLM.2006.165
   Lampert R, 2008, AM HEART J, V156, DOI 10.1016/j.ahj.2008.07.009
   Lee JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034218
   Lieb DC, 2012, EXP DIABETES RES, DOI 10.1155/2012/878760
   Link MS, 2010, CURR OPIN CARDIOL, V25, P16, DOI 10.1097/HCO.0b013e32833358cd
   Liu LJS, 2007, ENVIRON HEALTH PERSP, V115, P1638, DOI 10.1289/ehp.10177
   Ljungman P, 2009, THROMB RES, V124, P57, DOI 10.1016/j.thromres.2008.10.009
   Luttmann-Gibson H, 2010, OCCUP ENVIRON MED, V67, P625, DOI 10.1136/oem.2009.050625
   Martin BW, 1997, SOZ PRAVENTIV MED, V42, P67, DOI 10.1007/BF01318136
   Mayosi BM, 2005, STROKE, V36, P2215, DOI 10.1161/01.STR.0000182254.47941.96
   Mills NL, 2011, HEART, V97, P544, DOI 10.1136/hrt.2010.199042
   Nolan J, 1998, CIRCULATION, V98, P1510, DOI 10.1161/01.CIR.98.15.1510
   Park SK, 2006, CIRCULATION, V114, P2798, DOI 10.1161/CIRCULATIONAHA.106.643197
   Pieters N, 2012, HEART, V98, P1127, DOI 10.1136/heartjnl-2011-301505
   Pope CA, 2004, ENVIRON HEALTH PERSP, V112, P339, DOI 10.1289/ehp.6588
   Probst-Hensch NM, 2008, ENVIRON HEALTH PERSP, V116, P1494, DOI 10.1289/ehp.11402
   Ren CZ, 2010, EPIDEMIOLOGY, V21, P198, DOI 10.1097/EDE.0b013e3181cc8bfc
   Riikola A, 2009, ATHEROSCLEROSIS, V207, P466, DOI 10.1016/j.atherosclerosis.2009.06.004
   Ruckerl R, 2007, ENVIRON HEALTH PERSP, V115, P1072, DOI 10.1289/ehp.10021
   Sie MPS, 2008, VASC HEALTH RISK MAN, V4, P863
   Sie MPS, 2006, ARTERIOSCL THROM VAS, V26, P212, DOI 10.1161/01.ATV.0000194099.65024.17
   Zanobetti A, 2011, PROG CARDIOVASC DIS, V53, P344, DOI 10.1016/j.pcad.2011.01.001
NR 47
TC 9
Z9 9
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 18
PY 2014
VL 9
IS 8
AR UNSP e104978
DI 10.1371/journal.pone.0104978
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AO4JF
UT WOS:000341302700058
PM 25133672
OA Other Gold, Green Published
DA 2019-05-24
ER

PT J
AU Tsao, TM
   Tsai, MJ
   Wang, YN
   Lin, HL
   Wu, CF
   Hwang, JS
   Hsu, SHJ
   Chao, H
   Chuang, KJ
   Chou, CCK
   Su, TC
AF Tsao, Tsung-Ming
   Tsai, Ming-Jer
   Wang, Ya-Nan
   Lin, Heng-Lun
   Wu, Chang-Fu
   Hwang, Jing-Shiang
   Hsu, Sandy-H. J.
   Chao, Hsing
   Chuang, Kai-Jen
   Chou, Charles-C. K.
   Su, Ta-Chen
TI The Health Effects of a Forest Environment on Subclinical Cardiovascular
   Disease and Heath-Related Quality of Life
SO PLOS ONE
LA English
DT Article
ID PARTICULATE AIR-POLLUTION; NATURAL-KILLER ACTIVITY; INTIMA-MEDIA
   THICKNESS; EPIDEMIOLOGIC EVIDENCE; ANTICANCER PROTEINS; ARTERIAL
   STIFFNESS; PLASMA-FIBRINOGEN; PERSONAL EXPOSURE; TERM EXPOSURE;
   YOUNG-ADULTS
AB Background: Assessment of health effects of a forest environment is an important emerging area of public health and environmental sciences.
   Purpose: To demonstrate the long-term health effects of living in a forest environment on subclinical cardiovascular diseases (CVDs) and health-related quality of life (HRQOL) compared with that in an urban environment.
   Materials and Methods: This study included the detailed health examination and questionnaire assessment of 107 forest staff members (FSM) and 114 urban staff members (USM) to investigate the long-term health effects of a forest environment. Air quality monitoring between the forest and urban environments was compared. In addition, work-related factors and HRQOL were evaluated.
   Results: Levels of total cholesterol, low-density lipoprotein cholesterol, and fasting glucose in the USM group were significantly higher than those in the FSM group. Furthermore, a significantly higher intima-media thickness of the internal carotid artery was found in the USM group compared with that in the FSM group. Concentrations of air pollutants, such as NO, NO2, NOx, SO2, CO, PM2.5, and PM10 in the forest environment were significantly lower compared with those in the outdoor urban environment. Working hours were longer in the FSM group; however, the work stress evaluation as assessed by the job content questionnaire revealed no significant differences between FSM and USM. HRQOL evaluated by the World Health Organization Quality of Life-BREF questionnaire showed FSM had better HRQOL scores in the physical health domain.
   Conclusions: This study provides evidence of the potential beneficial effects of forest environments on CVDs and HRQOL.
C1 [Tsao, Tsung-Ming; Tsai, Ming-Jer; Wang, Ya-Nan] Natl Taiwan Univ, Nantou, Taiwan.
   [Tsai, Ming-Jer; Wang, Ya-Nan] Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei 10764, Taiwan.
   [Lin, Heng-Lun; Su, Ta-Chen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.
   [Lin, Heng-Lun; Su, Ta-Chen] Natl Taiwan Univ Hosp, Cardiovasc Ctr, Taipei, Taiwan.
   [Wu, Chang-Fu] Natl Taiwan Univ, Dept Publ Hlth, Taipei 10764, Taiwan.
   [Hwang, Jing-Shiang] Acad Sinica, Inst Stat Sci, Taipei 115, Taiwan.
   [Hsu, Sandy-H. J.] Natl Taiwan Univ Hosp, Taipei, Taiwan.
   [Chao, Hsing; Chuang, Kai-Jen] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan.
   [Chou, Charles-C. K.] Acad Sinica, Res Ctr Environm Changes, Taipei 115, Taiwan.
RP Tsai, MJ (reprint author), Natl Taiwan Univ, Nantou, Taiwan.
EM tachensu@ntu.edu.tw; tmj@ntu.edu.tw
RI Chou, Charles C.-K./R-3578-2016
OI Chou, Charles C.-K./0000-0003-3960-5333; SU,
   TA-CHEN/0000-0001-7523-7166; Wu, Chang-fu/0000-0003-2244-1934
FU Experimental Forest, National Taiwan University [A14]; National Science
   Council, Taiwan (NSC) [101-2314-B-002-184-NY3]; National Taiwan
   University [NTU-CESRP-102R7620]
FX This study was financially supported by the Experimental Forest,
   National Taiwan University under grant no. A14 and no. 3 projects.
   National Science Council, Taiwan (NSC 101-2314-B-002-184-NY3) and
   National Taiwan University (NTU-CESRP-102R7620) also partially supported
   this study. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Atherton PJ, 2006, LANCET ONCOL, V7, P883, DOI 10.1016/S1470-2045(06)70914-7
   Bauer M, 2010, J AM COLL CARDIOL, V56, P1803, DOI 10.1016/j.jacc.2010.04.065
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Brunekreef B, 2005, EUR RESPIR J, V26, P309, DOI 10.1183/09031936.05.00001805
   Central Weather Bureau (CWB), 2010, MONTHL CLIM DAT
   Chen SY, 2014, ENVIRON RES, V131, P1, DOI 10.1016/j.envres.2014.01.009
   Chen SY, 2012, EPIDEMIOLOGY, V23, P341, DOI 10.1097/EDE.0b013e3182452f1d
   Chiu MH, 2012, ARCH PHYS MED REHAB, V93, P512, DOI 10.1016/j.apmr.2011.11.001
   CHOW JC, 1995, J AIR WASTE MANAGE, V45, P320, DOI 10.1080/10473289.1995.10467369
   Chuang KJ, 2007, AM J RESP CRIT CARE, V176, P370, DOI 10.1164/rccm.200611-1627OC
   Elderon L, 2013, PROG CARDIOVASC DIS, V55, P511, DOI 10.1016/j.pcad.2013.03.010
   Groessl EJ, 2007, AM J PREV MED, V33, P214, DOI 10.1016/j.amerpe.2007.04.031
   Horng YS, 2005, SPINE, V30, P551, DOI 10.1097/01.brs.0000154623.20778.f0
   Huang CL, 2007, INT J CLIN PRACT, V61, P397, DOI 10.1111/j.1742-1241.2006.01227.x
   Hwang HF, 2003, AGE AGEING, V32, P593, DOI 10.1093/ageing/afg102
   Ito K, 2011, ENVIRON HEALTH PERSP, V119, P467, DOI 10.1289/ehp.1002667
   Jia HM, 2010, AM J PREV MED, V39, P220, DOI 10.1016/j.amepre.2010.03.026
   Kim C, 2004, AM J PREV MED, V27, P1, DOI 10.1016/j.amepre.2004.03.008
   Kunzli N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009096
   Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068
   Lee J, 2011, PUBLIC HEALTH, V125, P93, DOI 10.1016/j.puhe.2010.09.005
   Lee J, 2009, SCAND J FOREST RES, V24, P227, DOI 10.1080/02827580902903341
   Leidy NK, 2006, VALUE HEALTH, V9, P394, DOI 10.1111/j.1524-4733.2006.00132.x
   Li Q, 2008, J BIOL REG HOMEOS AG, V22, P45
   Li Q, 2008, INT J IMMUNOPATH PH, V21, P117, DOI 10.1177/039463200802100113
   Li Q, 2007, Int J Immunopathol Pharmacol, V20, P3
   Lin CY, 2013, INT J CARDIOL, V168, P3309, DOI 10.1016/j.ijcard.2013.04.042
   Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4
   Morita E, 2007, PUBLIC HEALTH, V121, P54, DOI 10.1016/j.puhe.2006.05.024
   Mulle JG, 2013, PROG CARDIOVASC DIS, V55, P557, DOI 10.1016/j.pcad.2013.03.005
   Ostro B, 2010, ENVIRON HEALTH PERSP, V118, P363, DOI 10.1289/ehp.0901181
   Pope CA, 2006, CIRCULATION, V114, P2443, DOI 10.1161/CIRCULATIONAHA.106.636977
   Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F
   Shin WS, 2007, SCAND J FOREST RES, V22, P248, DOI 10.1080/02827580701262733
   Silva RA, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034005
   Strine TW, 2005, AM J PREV MED, V28, P182, DOI 10.1016/j.ampre.2004.10.002
   Su T. C., 2014, ENV HLTH PE IN PRESS
   Su TC, 2006, EUR J CARDIOV PREV R, V13, P849, DOI 10.1097/01.hjr.0000219116.25415.c4
   Su TC, 2012, J ATHEROSCLER THROMB, V19, P872, DOI 10.5551/jat.10728
   Su TC, 2011, INT J CARDIOL, V153, P100, DOI 10.1016/j.ijcard.2011.09.019
   The World Health Organization, 1955, HDB BAS DOC
   Vaccarino V, 2012, BRAUNWALDS HEART DIS
   Wu CF, 2012, SCI TOTAL ENVIRON, V431, P176, DOI 10.1016/j.scitotenv.2012.05.015
   Wu CF, 2010, AM J EPIDEMIOL, V171, P1299, DOI 10.1093/aje/kwq060
   Yao G, 2002, J FORMOS MED ASSOC, V101, P342
NR 45
TC 9
Z9 9
U1 1
U2 32
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 28
PY 2014
VL 9
IS 7
AR e103231
DI 10.1371/journal.pone.0103231
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AM6RZ
UT WOS:000339993700049
PM 25068265
OA DOAJ Gold, Green Published
DA 2019-05-24
ER

PT J
AU Bard, D
   Kihal, W
   Schillinger, C
   Fermanian, C
   Segala, C
   Glorion, S
   Arveiler, D
   Weber, C
AF Bard, Denis
   Kihal, Wahida
   Schillinger, Charles
   Fermanian, Christophe
   Segala, Claire
   Glorion, Sophie
   Arveiler, Dominique
   Weber, Christiane
TI Traffic-Related Air Pollution and the Onset of Myocardial Infarction:
   Disclosing Benzene as a Trigger? A Small-Area Case-Crossover Study
SO PLOS ONE
LA English
DT Article
ID PARTICULATE MATTER; HOSPITAL ADMISSIONS; HEART-DISEASE; EXPOSURE;
   MORTALITY; RISK; POLLUTANTS; EMISSIONS; GASOLINE
AB Background and Objectives: Exposure to traffic is an established risk factor for the triggering of myocardial infarction (MI). Particulate matter, mainly emitted by diesel vehicles, appears to be the most important stressor. However, the possible influence of benzene from gasoline-fueled cars has not been explored so far.
   Methods and Results: We conducted a case-crossover study from 2,134 MI cases recorded by the local Coronary Heart Disease Registry (2000-2007) in the Strasbourg Metropolitan Area (France). Available individual data were age, gender, previous history of ischemic heart disease and address of residence at the time of the event. Nitrogen dioxide, particles of median aerodynamic diameter,10 mm (PM10), ozone, carbon monoxide and benzene air concentrations were modeled on an hourly basis at the census block level over the study period using the deterministic ADMS-Urban air dispersion model. Model input data were emissions inventories, background pollution measurements, and meteorological data. We have found a positive, statistically significant association between concentrations of benzene and the onset of MI: per cent increase in risk for a 1 mu g/m(3) increase in benzene concentration in the previous 0, 0-1 and 1 day was 10.4 (95% confidence interval 3-18.2), 10.7 (2.7-19.2) and 7.2 (0.3-14.5), respectively. The associations between the other pollutants and outcome were much lower and in accordance with the literature.
   Conclusion: We have observed that benzene in ambient air is strongly associated with the triggering of MI. This novel finding needs confirmation. If so, this would mean that not only diesel vehicles, the main particulate matter emitters, but also gasoline-fueled cars-main benzene emitters-, should be taken into account for public health action.
C1 [Bard, Denis; Kihal, Wahida; Fermanian, Christophe; Glorion, Sophie] Ecole Hautes Etud Sante Publ, Dept Epidemiol & Biostat, Rennes, France.
   [Bard, Denis; Kihal, Wahida; Fermanian, Christophe; Glorion, Sophie] Sorbonne Paris Cite, Paris, France.
   [Schillinger, Charles] Assoc Surveillance Qual Air Alsace ASPA, Schiltigheim, France.
   [Segala, Claire] SEPIA Sante, Baud, France.
   [Arveiler, Dominique] Univ Strasbourg, Dept Epidemiol & Publ Hlth, EA3430, Strasbourg, France.
   [Weber, Christiane] Univ Strasbourg, CNRS, Fac Geog & Amenagement, LIVE,UMR7362, Strasbourg, France.
RP Bard, D (reprint author), Ecole Hautes Etud Sante Publ, Dept Epidemiol & Biostat, Rennes, France.
EM denis.bard@ehesp.fr
RI bard, denis/O-4189-2019
FU French Agency for Food, Environmental and Occupational Health Safety
   (ANSES); Institute for Public Health Research (IRESP); Fondation Coeur
   et Arteres; French Environment and Energy Management Agency (ADEME);
   SITA Corporation
FX This work was supported by French Agency for Food, Environmental and
   Occupational Health & Safety (ANSES); Institute for Public Health
   Research (IRESP); Fondation Coeur et Arteres; French Environment and
   Energy Management Agency (ADEME); and SITA Corporation. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Baccarelli A, 2011, LANCET, V377, P694, DOI 10.1016/S0140-6736(10)62348-3
   Bhaskaran K, 2009, HEART, V95, P1746, DOI 10.1136/hrt.2009.175018
   Bhaskaran K, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8050
   Bhatnagar A, 2006, CIRC RES, V99, P692, DOI 10.1161/01.RES.0000243586.99701.cf
   Billionnet C, 2012, ANN EPIDEMIOL, V22, P126, DOI 10.1016/j.annepidem.2011.11.004
   Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Carruthers D, 1998, INT J ENVIRON POLLUT, V14, P2000
   Delfino RJ, 2003, ENVIRON HEALTH PERSP, V111, P647, DOI 10.1289/ehp.5992
   European Environment Agency, 2012, AIR QUAL EUR 2012 RE
   Farron O, 2008, TOXICOL IND HEALTH, V24, P261, DOI 10.1177/0748233708098504
   Flahault A, 2006, STAT METHODS MED RES, V15, P413, DOI 10.1177/0962280206071639
   Fusco D, 2001, EUR RESPIR J, V17, P1143, DOI 10.1183/09031936.01.00005501
   Havard S, 2009, EPIDEMIOLOGY, V20, P223, DOI 10.1097/EDE.0b013e31819464e1
   Huang C, 2013, ATMOS ENVIRON, V77, P703, DOI 10.1016/j.atmosenv.2013.05.059
   Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.edu.0000181315.18836.9d
   Keenan JJ, 2010, CHEM-BIOL INTERACT, V184, P293, DOI 10.1016/j.cbi.2010.01.016
   Kotseva K, 1998, INT ARCH OCC ENV HEA, V71, pS87
   KURPPA K, 1984, SCAND J WORK ENV HEA, V10, P381, DOI 10.5271/sjweh.2316
   Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193
   Marcazzan GM, 2001, ATMOS ENVIRON, V35, P4639, DOI 10.1016/S1352-2310(01)00124-8
   McHale CM, 2012, CARCINOGENESIS, V33, P240, DOI 10.1093/carcin/bgr297
   Murugesan K, 2013, PROTEOMICS, V13, P3211, DOI 10.1002/pmic.201300126
   Mustafic H, 2012, JAMA-J AM MED ASSOC, V307, P713, DOI 10.1001/jama.2012.126
   Nawrot TS, 2011, LANCET, V377, P732, DOI 10.1016/S0140-6736(10)62296-9
   Pant P, 2013, ATMOS ENVIRON, V77, P78, DOI 10.1016/j.atmosenv.2013.04.028
   Peters A, 2004, NEW ENGL J MED, V351, P1721, DOI 10.1056/NEJMoa040203
   Peters A, 2002, LANCET, V360, P1184, DOI 10.1016/S0140-6736(02)11289-X
   Peters A, 2001, CIRCULATION, V103, P2810
   Sacks JD, 2012, AM J EPIDEMIOL, V176, P622, DOI 10.1093/aje/kws135
   Schwartz J, 1999, EPIDEMIOLOGY, V10, P17, DOI 10.1097/00001648-199901000-00005
   Tsai DH, 2010, SCI TOTAL ENVIRON, V408, P1818, DOI 10.1016/j.scitotenv.2010.01.044
   TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583
NR 33
TC 14
Z9 14
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 16
PY 2014
VL 9
IS 6
AR e100307
DI 10.1371/journal.pone.0100307
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AJ5PV
UT WOS:000337738600108
PM 24932584
OA DOAJ Gold, Green Published
DA 2019-05-24
ER

PT J
AU Levinsson, A
   Olin, AC
   Modig, L
   Dahgam, S
   Bjorck, L
   Rosengren, A
   Nyberg, F
AF Levinsson, Anna
   Olin, Anna-Carin
   Modig, Lars
   Dahgam, Santosh
   Bjorck, Lena
   Rosengren, Annika
   Nyberg, Fredrik
TI Interaction Effects of Long-Term Air Pollution Exposure and Variants in
   the GSTP1, GSTT1 and GSTCD Genes on Risk of Acute Myocardial Infarction
   and Hypertension: A Case-Control Study
SO PLOS ONE
LA English
DT Article
ID GLUTATHIONE-S-TRANSFERASE; CARDIOVASCULAR-DISEASE; PARTICULATE MATTER;
   OXIDATIVE STRESS; HEART-DISEASE; ATHEROSCLEROSIS; ASSOCIATION;
   MORTALITY; COHORT
AB Introducion: Experimental and epidemiological studies have reported associations between air pollution exposure, in particular related to vehicle exhaust, and cardiovascular disease. A potential pathophysiological pathway is pollution-induced pulmonary oxidative stress, with secondary systemic inflammation. Genetic polymorphisms in genes implicated in oxidative stress, such as GSTP1, GSTT1 and GSTCD, may contribute to determining individual susceptibility to air pollution as a promoter of coronary vulnerability.
   Aims: We aimed to investigate effects of long-term traffic-related air pollution exposure, as well as variants in GSTP1, GSTT1 and GSTCD, on risk of acute myocardial infarction (AMI) and hypertension. In addition, we studied whether air pollution effects were modified by the investigated genetic variants.
   Methods: Genotype data at 7 single nucleotide polymorphisms (SNPs) in the GSTP1 gene, and one in each of the GSTT1 and GSTCD genes, as well as air pollution exposure estimates, were available for 119 AMI cases and 1310 randomly selected population controls. Population control individuals with systolic blood pressure >= 140 mmHg, diastolic blood pressure >= 90 mmHg or on daily antihypertensive medication were defined as hypertensive (n = 468). Individual air pollution exposure levels were modeled as annual means of NO2 (marker of vehicle exhaust pollutants) using central monitoring data and dispersion models, linking to participants' home addresses.
   Results: Air pollution was significantly associated with risk of AMI: OR 1.78 (95%CI 1.04-3.03) per 10 mu g/m(3) of long-term NO2 exposure. Three GSTP1 SNPs were significantly associated with hypertension. The effect of air pollution on risk of AMI varied by genotype strata, although the suggested interaction was not significant. We saw no obvious interaction between genetic variants in the GST genes and air pollution exposure for hypertension.
   Conclusion: Air pollution exposure entails an increased risk of AMI, and this risk differed over genotype strata for variants in the GSTP1, GSTT1 and GSTCD genes, albeit not statistically-significantly.
C1 [Levinsson, Anna; Olin, Anna-Carin; Dahgam, Santosh; Nyberg, Fredrik] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Publ Hlth & Community Med, Gothenburg, Sweden.
   [Modig, Lars] Umea Univ, Dept Publ Hlth & Clin Med Occupat & Environm Med, Umea, Sweden.
   [Bjorck, Lena; Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden.
   [Nyberg, Fredrik] AstraZeneca R&D, Molndal, Sweden.
RP Levinsson, A (reprint author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Publ Hlth & Community Med, Gothenburg, Sweden.
EM anna.levinsson@amm.gu.se
OI Rosengren, Annika/0000-0002-5409-6605
FU Vastra Gotaland County Council; Swedish Council for Working Life and
   Social Research; Swedish Research Council; Swedish Research Council for
   Environment and Spatial Planning; Swedish Heart and Lung Foundation;
   AstraZeneca R D Sweden
FX This research was supported by grants from the Vastra Gotaland County
   Council, the Swedish Council for Working Life and Social Research, the
   Swedish Research Council, the Swedish Research Council for Environment
   and Spatial Planning, the Swedish Heart and Lung Foundation, and
   AstraZeneca R & D Sweden. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Bazo Ana Paula, 2011, Cardiovasc Pathol, V20, pe9, DOI 10.1016/j.carpath.2009.12.004
   Berg CM, 2005, EUR J CARDIOV PREV R, V12, P115, DOI 10.1097/00149831-200504000-00005
   Bessa SS, 2009, EUR J INTERN MED, V20, P625, DOI 10.1016/j.ejim.2009.06.003
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Brunekreef B, 2007, J EXPO SCI ENV EPID, V17, pS61, DOI 10.1038/sj.jes.7500628
   Campen MJ, 2012, CURR OPIN PULM MED, V18, P155, DOI 10.1097/MCP.0b013e32834f210a
   Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500
   Huttunen K, 2012, ENVIRON RES, V116, P44, DOI 10.1016/j.envres.2012.04.004
   Jerrett M, 2005, EPIDEMIOLOGY, V16, P727, DOI 10.1097/01.ede.0000181630.15826.7d
   Johansson CSG, 2006, EXPOSE EXPOSURE COMP
   Kunzli N, 2011, PROG CARDIOVASC DIS, V53, P334, DOI 10.1016/j.pcad.2010.12.006
   Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217
   Mordukhovich I, 2009, ENVIRON HEALTH PERSP, V117, P1767, DOI 10.1289/ehp.0900591
   Nebert Daniel W., 2004, Human Genomics, V1, P460
   PEMBLE S, 1994, BIOCHEM J, V300, P271, DOI 10.1042/bj3000271
   Peters Annette, 2006, Part Fibre Toxicol, V3, P13, DOI 10.1186/1743-8977-3-13
   Peters Annette, 2005, Toxicol Appl Pharmacol, V207, P477, DOI 10.1016/j.taap.2005.04.030
   Probst-Hensch NM, 2008, ENV HLTH PERSPECT, V116
   Raaschou-Nielsen O, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-60
   Raza H, 2011, FEBS J, V278, P4243, DOI 10.1111/j.1742-4658.2011.08358.x
   Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501
   Rosenlund M, 2006, EPIDEMIOLOGY, V17, P383, DOI 10.1097/01.ede.0000219722.25569.0f
   Ruckerl R, 2011, INHAL TOXICOL, V23, P555, DOI 10.3109/08958378.2011.593587
   Schulz H, 2005, J AEROSOL MED, V18, P1, DOI 10.1089/jam.2005.18.1
   Shrey K, 2011, ENVIRON TOXICOL PHAR, V31, P1, DOI 10.1016/j.etap.2010.09.002
   Stephens JW, 2008, ATHEROSCLEROSIS, V200, P229, DOI 10.1016/j.atherosclerosis.2008.04.003
   Wang J, 2010, MUTAGENESIS, V25, P365, DOI 10.1093/mutage/geq014
   Yang IA, 2008, THORAX, V63, P555, DOI 10.1136/thx.2007.079426
NR 28
TC 14
Z9 14
U1 0
U2 27
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 10
PY 2014
VL 9
IS 6
AR e99043
DI 10.1371/journal.pone.0099043
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AN9SD
UT WOS:000340947700053
PM 24915237
OA DOAJ Gold, Green Published
DA 2019-05-24
ER

PT J
AU Bind, MA
   Coull, B
   Suh, H
   Wright, R
   Baccarelli, A
   Vokonas, P
   Schwartz, J
AF Bind, Marie-Abele
   Coull, Brent
   Suh, Helen
   Wright, Robert
   Baccarelli, Andrea
   Vokonas, Pantel
   Schwartz, Joel
TI A Novel Genetic Score Approach Using Instruments to Investigate
   Interactions between Pathways and Environment: Application to Air
   Pollution
SO PLOS ONE
LA English
DT Article
ID CORONARY-HEART-DISEASE; PARTICULATE MATTER; RATE-VARIABILITY;
   NITRIC-OXIDE; CARDIOVASCULAR-DISEASE; ULTRAFINE PARTICLES;
   ELDERLY-COHORT; INFLAMMATION; ATHEROSCLEROSIS; ASSOCIATION
AB Air pollution has been associated with increased systemic inflammation markers. We developed a new pathway analysis approach to investigate whether gene variants within relevant pathways (oxidative stress, endothelial function, and metal processing) modified the association between particulate air pollution and fibrinogen, C-reactive protein (CRP), intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1). Our study population consisted of 822 elderly participants of the Normative Aging Study (1999-2011). To investigate the role of biological mechanisms and to reduce the number of comparisons in the analysis, we created pathway-specific scores using gene variants related to each pathway. To select the most appropriate gene variants, we used the least absolute shrinkage and selection operator (Lasso) to relate independent outcomes representative of each pathway (8-hydroxydeoxyguanosine for oxidative stress, augmentation index for endothelial function, and patella lead for metal processing) to gene variants. A high genetic score corresponds to a higher allelic risk profile. We fit mixed-effects models to examine modification by the genetic score of the weekly air pollution association with the outcome. Among participants with higher genetic scores within the oxidative stress pathway, we observed significant associations between particle number and fibrinogen, while we did not find any association among participants with lower scores (p(interaction)=0.04). Compared to individuals with low genetic scores of metal processing gene variants, participants with higher scores had greater effects of particle number on fibrinogen (p(interaction)=0.12), CRP (p(interaction)=0.02), and ICAM-1 (p(interaction)=0.08). This two-stage penalization method is easy to implement and can be used for large-scale genetic applications.
C1 [Bind, Marie-Abele; Suh, Helen; Wright, Robert; Baccarelli, Andrea; Schwartz, Joel] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
   [Bind, Marie-Abele; Coull, Brent] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.
   [Baccarelli, Andrea; Schwartz, Joel] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [Vokonas, Pantel] Boston Univ, Sch Med, VA Normat Aging Study, Boston, MA 02118 USA.
RP Bind, MA (reprint author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
EM bind@mail.harvard.edu
OI Suh, Helen/0000-0001-7355-6104; Baccarelli, Andrea/0000-0002-3436-0640
FU U.S. Environmental Protection Agency [EPA RD-827353, RD-832416];
   National Institute of Environmental Health Sciences (NIEHS)
   [RO1-ES015172, ES014663, ES00002, PO1-ES008925]; Clean Air Act (CLARC)
   [RD83479701]; Cooperative Studies Program/Epidemiology Research and
   Information Center of the U. S. Department of Veterans Affairs;
   Massachusetts Veterans Epidemiology Research and Information Center,
   Boston, Massachusetts
FX This study was supported by the U.S. Environmental Protection Agency
   grants EPA RD-827353 and RD-832416; National Institute of Environmental
   Health Sciences (NIEHS) grants RO1-ES015172, ES014663, ES00002,
   PO1-ES008925, and Clean Air Act (CLARC) grant RD83479701. The VA
   Normative Aging Study (NAS) is supported by the Cooperative Studies
   Program/Epidemiology Research and Information Center of the U. S.
   Department of Veterans Affairs and is a component of the Massachusetts
   Veterans Epidemiology Research and Information Center, Boston,
   Massachusetts. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Agarwal A, 2003, FERTIL STERIL, V79, P829, DOI 10.1016/S0015-0282(02)004948-8
   Alexeeff SE, 2011, ENVIRON HEALTH PERSP, V119, P481, DOI 10.1289/ehp.1002560
   Baja ES, 2010, ENVIRON HEALTH PERSP, V118, P840, DOI 10.1289/ehp.0901396
   Bind MA, 2012, EPIDEMIOLOGY, V23, P332, DOI 10.1097/EDE.0b013e31824523f0
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Chahine T, 2007, ENVIRON HEALTH PERSP, V115, P1617, DOI 10.1289/ehp.10318
   Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477
   Delfino RJ, 2008, ENVIRON HEALTH PERSP, V116, P898, DOI 10.1289/ehp.11189
   Delfino RJ, 2010, ENVIRON HEALTH PERSP, V118, P756, DOI 10.1289/ehp.0901407
   Delfino RJ, 2009, ENVIRON HEALTH PERSP, V117, P1232, DOI 10.1289/ehp.0800194
   Efron B, 2004, ANN STAT, V32, P407
   Ghio AJ, 2005, AM J PHYSIOL-LUNG C, V289, pL460, DOI 10.1152/ajplung.00154.2005
   Ghio AJ, 1998, TOXICOL PATHOL, V26, P388, DOI 10.1177/019262339802600313
   Hennig B, 2007, NUTR METAB CARDIOVAS, V17, P162, DOI 10.1016/j.numecd.2006.01.003
   Hwang SJ, 1997, CIRCULATION, V96, P4219
   Kang CM, 2010, J AIR WASTE MANAGE, V60, P1327, DOI 10.3155/1047-3289.60.11.1327
   Lee S, 2011, WORLD J CARDIOL, V3, P18, DOI 10.4330/wjc.v3.i1.18
   Lim S, 2010, NEUROTOXICOLOGY, V31, P10, DOI 10.1016/j.neuro.2009.10.001
   Ljungman P, 2009, ENVIRON HEALTH PERSP, V117, P1373, DOI 10.1289/ehp.0800370
   Madrigano J, 2010, OCCUP ENVIRON MED, V67, P312, DOI 10.1136/oem.2009.046193
   Mazzoli-Rocha F, 2010, CELL BIOL TOXICOL, V26, P481, DOI 10.1007/s10565-010-9158-2
   Miller MR, 2009, ENVIRON HEALTH PERSP, V117, P611, DOI 10.1289/ehp.0800235
   Molinelli AR, 2002, INHAL TOXICOL, V14, P1069, DOI 10.1080/08958370290084737
   Mordukhovich I, 2009, ENVIRON HEALTH PERSP, V117, P1767, DOI 10.1289/ehp.0900591
   Mustafa S, 2008, J VASC SURG, V47, P566, DOI 10.1016/j.jvs.2007.09.060
   Nemmar A, 2002, AM J RESP CRIT CARE, V166, P998, DOI 10.1164/rccm.200110-026OC
   Park SK, 2005, ENVIRON HEALTH PERSP, V113, P304, DOI 10.1289/ehp.7447
   Park SK, 2006, CIRCULATION, V114, P2798, DOI 10.1161/CIRCULATIONAHA.106.643197
   Peters A, 2009, AM J RESP CRIT CARE, V179, P484, DOI 10.1164/rccm.200805-751OC
   Ren C, 2010, J EPIDEMIOL COMMUN H, V64, P49, DOI 10.1136/jech.2008.083295
   Ren CZ, 2010, EPIDEMIOLOGY, V21, P198, DOI 10.1097/EDE.0b013e3181cc8bfc
   Ruckerl R, 2006, AM J RESP CRIT CARE, V173, P432, DOI 10.1164/rccm.200507-1123OC
   Runge Marschall S, 2010, Trans Am Clin Climatol Assoc, V121, P52
   Safran M, 2010, DATABASE-OXFORD, V5, P2010, DOI DOI 10.1093/DATABASE/BAQ020
   Sangani RG, 2010, INHAL TOXICOL, V22, P621, DOI 10.3109/08958371003599037
   Spanier AJ, 2009, PEDIATR PULM, V44, P812, DOI 10.1002/ppul.21071
   Thomson EM, 2007, ENVIRON RES, V105, P224, DOI 10.1016/j.envres.2007.06.005
   Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267
   Van Hee VC, 2010, ENVIRON HEALTH PERSP, V118, P962, DOI 10.1289/ehp.0901535
   Zanobetti A, 2011, PROG CARDIOVASC DIS, V53, P344, DOI 10.1016/j.pcad.2011.01.001
   Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382
NR 41
TC 20
Z9 20
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 22
PY 2014
VL 9
IS 4
AR e96000
DI 10.1371/journal.pone.0096000
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AG2IS
UT WOS:000335240300130
PM 24755831
OA DOAJ Gold, Green Published
DA 2019-05-24
ER

PT J
AU Tamayo, T
   Rathmann, W
   Kramer, U
   Sugiri, D
   Grabert, M
   Holl, RW
AF Tamayo, Teresa
   Rathmann, Wolfgang
   Kraemer, Ursula
   Sugiri, Dorothea
   Grabert, Matthias
   Holl, Reinhard W.
TI Is Particle Pollution in Outdoor Air Associated with Metabolic Control
   in Type 2 Diabetes?
SO PLOS ONE
LA English
DT Article
ID AMERICAN-HEART-ASSOCIATION; LONG-TERM EXPOSURE; CARDIOVASCULAR-DISEASE;
   OBESITY; PREECLAMPSIA; MORTALITY; STATEMENT; MELLITUS; HEALTH; COHORT
AB Background: There is growing evidence that air pollutants are associated with the risk of type 2 diabetes. Subclinical inflammation may be a mechanism linking air pollution with diabetes. Information is lacking whether air pollution also contributes to worse metabolic control in newly diagnosed type 2 diabetes. We examined the hypothesis that residential particulate matter (PM10) is associated with HbA(1c) concentration in newly diagnosed type 2 diabetes.
   Methods: Nationwide regional levels of particulate matter with a diameter of <= 10 mu m (PM10) were obtained in 2009 from background monitoring stations in Germany (Federal Environmental Agency) and assigned to place of residency of 9,102 newly diagnosed diabetes patients registered in the DPV database throughout Germany (age 65.5 +/- 13.5 yrs; males: 52.1%). Mean HbA(1c) (%) levels stratified for air pollution quartiles (PM10 in mu g/m(3)) were estimated using linear regression models adjusting for age, sex, BMI, diabetes duration, geographic region, year of ascertainment, and social indicators.
   Findings: In both men and women, adjusted HbA(1c) was significantly lower in the lowest quartile of PM10 exposure in comparison to quartiles Q2-Q4. Largest differences in adjusted HbA(1c) (95% CI) were seen comparing lowest quartiles of exposure with highest quartiles (men %: -0.42 (-0.62; -0.23)/mmol/mol: -28.11 (-30.30; -26.04), women, %: -0.28 (-0.47; -0.09)/mmol/mol: -0.28 (-0.47; -0.09)).
   Interpretation: Air pollution may be associated with higher HbA(1c) levels in newly diagnosed type 2 diabetes patients. Further studies are warranted to examine this association.
C1 [Tamayo, Teresa; Rathmann, Wolfgang] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany.
   [Kraemer, Ursula; Sugiri, Dorothea] Univ Dusseldorf, Leibniz Ctr, Inst Environm Med IUF, Dusseldorf, Germany.
   [Grabert, Matthias; Holl, Reinhard W.] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany.
RP Tamayo, T (reprint author), Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany.
EM teresa.tamayo@ddz.uni-duesseldorf.de
FU Competence Network for Diabetes mellitus of the Federal Ministry of
   Education and Research [01GI1110D/01GI1106]
FX Data are part of the BMBF Diabetes Meta-Database project which was
   funded by the Competence Network for Diabetes mellitus of the Federal
   Ministry of Education and Research (support codes 01GI1110D/01GI1106).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR [Anonymous], 2013, DIABETES CARE, V36, P4
   Awa WL, 2012, EUR J ENDOCRINOL, V167, P245, DOI 10.1530/EJE-12-0143
   Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8
   Brook RD, 2008, J OCCUP ENVIRON MED, V50, P32, DOI 10.1097/JOM.0b013e31815dba70
   Brook RD, 2013, SCI TOTAL ENVIRON, V448, P66, DOI 10.1016/j.scitotenv.2012.07.034
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Chuang KJ, 2011, OCCUP ENVIRON MED, V68, P64, DOI 10.1136/oem.2009.052704
   Cohen BE, 2009, DIABETES RES CLIN PR, V86, P67, DOI 10.1016/j.diabres.2009.07.006
   Coogan PF, 2012, CIRCULATION, V125, P767, DOI 10.1161/CIRCULATIONAHA.111.052753
   Dijkema MBA, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-76
   Flemming J, 2002, ITM AIR POLLUTION MO
   Kowall B, 2011, EUR J EPIDEMIOL, V26, P637, DOI 10.1007/s10654-011-9609-y
   Kramer U, 2010, ENVIRON HEALTH PERSP, V118, P1273, DOI 10.1289/ehp.0901689
   Malmqvist E, 2013, ENVIRON HEALTH PERSP, V121, P488, DOI 10.1289/ehp.1205736
   Pope CA, 2007, INHAL TOXICOL, V19, P33, DOI 10.1080/08958370701492961
   Puett RC, 2011, ENVIRON HEALTH PERSP, V119, P384, DOI 10.1289/ehp.1002344
   Raaschou-Nielsen O, 2013, DIABETOLOGIA, V56, P36, DOI 10.1007/s00125-012-2698-7
   Rajagopalan S, 2012, DIABETES, V61, P3037, DOI 10.2337/db12-0190
   Salvi S, 1999, AM J RESP CRIT CARE, V159, P702, DOI 10.1164/ajrccm.159.3.9709083
   Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)17987-2
   Stern R., 2004, FORMULATION CRITERIA
   Sun QH, 2009, CIRCULATION, V119, P538, DOI 10.1161/CIRCULATIONAHA.108.799015
   Teichert T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083042
   The Diabetes Control and Complications Trial Research Group, 1993, NEW ENGL J MED, V329, P977, DOI [10.1056/NEJM199309303291401, DOI 10.1056/NEJM199309303291401]
   Xu XH, 2010, ARTERIOSCL THROM VAS, V30, P2518, DOI 10.1161/ATVBAHA.110.215350
   Zanobetti A, 2002, EPIDEMIOLOGY, V13, P588, DOI 10.1097/01.EDE.0000020321.67963.7B
   Zheng Z, 2013, J HEPATOL, V58, P148, DOI 10.1016/j.jhep.2012.08.009
   Zoungas S, 2012, DIABETOLOGIA, V55, P636, DOI 10.1007/s00125-011-2404-1
NR 28
TC 21
Z9 23
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 11
PY 2014
VL 9
IS 3
AR e91639
DI 10.1371/journal.pone.0091639
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AC9GM
UT WOS:000332842400110
PM 24619127
OA DOAJ Gold, Green Published
DA 2019-05-24
ER

PT J
AU Roberts, JD
   Voss, JD
   Knight, B
AF Roberts, Jennifer D.
   Voss, Jameson D.
   Knight, Brandon
TI The Association of Ambient Air Pollution and Physical Inactivity in the
   United States
SO PLOS ONE
LA English
DT Article
ID WITHIN-URBAN VARIABILITY; FINE PARTICULATE MATTER; LONG-TERM EXPOSURE;
   EXERCISE PERFORMANCE; DEPRESSIVE SYMPTOMS; HEART-DISEASE; LUNG-FUNCTION;
   OBESITY; MORTALITY; HEALTH
AB Background: Physical inactivity, ambient air pollution and obesity are modifiable risk factors for non-communicable diseases, with the first accounting for 10% of premature deaths worldwide. Although community level interventions may target each simultaneously, research on the relationship between these risk factors is lacking.
   Objectives: After comparing spatial interpolation methods to determine the best predictor for particulate matter (PM2.5; PM10) and ozone (O-3) exposures throughout the U. S., we evaluated the cross-sectional association of ambient air pollution with leisure-time physical inactivity among adults.
   Methods: In this cross-sectional study, we assessed leisure-time physical inactivity using individual self-reported survey data from the Centers for Disease Control and Prevention's 2011 Behavioral Risk Factor Surveillance System. These data were combined with county-level U. S. Environmental Protection Agency air pollution exposure estimates using two interpolation methods (Inverse Distance Weighting and Empirical Bayesian Kriging). Finally, we evaluated whether those exposed to higher levels of air pollution were less active by performing logistic regression, adjusting for demographic and behavioral risk factors, and after stratifying by body weight category.
   Results: With Empirical Bayesian Kriging air pollution values, we estimated a statistically significant 16-35% relative increase in the odds of leisure-time physical inactivity per exposure class increase of PM2.5 in the fully adjusted model across the normal weight respondents (p-value < 0.0001). Evidence suggested a relationship between the increasing dose of PM2.5 exposure and the increasing odds of physical inactivity.
   Conclusions: In a nationally representative, cross-sectional sample, increased community level air pollution is associated with reduced leisure-time physical activity particularly among the normal weight. Although our design precludes a causal inference, these results provide additional evidence that air pollution should be investigated as an environmental determinant of inactivity.
C1 [Roberts, Jennifer D.; Voss, Jameson D.; Knight, Brandon] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA.
   [Voss, Jameson D.] US Air Force Sch Aerosp Med, Epidemiol Consult Serv, Wright Patterson AFB, OH USA.
RP Roberts, JD (reprint author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA.
EM jennifer.roberts@usuhs.edu
RI Voss, Jameson/P-8392-2017
OI Voss, Jameson/0000-0002-4104-1744; Knight, Brandon/0000-0003-4953-7194
FU Uniformed Services University of the Health Sciences
FX Funding for this study was provided by a Uniformed Services University
   of the Health Sciences intramural start-up grant for newly appointed
   faculty. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Alexeeff SE, 2007, CHEST, V132, P1890, DOI 10.1378/chest.07-1126
   Arsenault BJ, 2010, INT J OBESITY, V34, P340, DOI 10.1038/ijo.2009.229
   Awatef M, 2011, CANCER EPIDEMIOL, V35, P540, DOI 10.1016/j.canep.2011.02.011
   Battaglia MP, 2008, SURVEY RES METHODS, V2, P11
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8
   Cakmak S, 2011, ENVIRON RES, V111, P1309, DOI 10.1016/j.envres.2011.09.016
   Casazza K, 2013, NEW ENGL J MED, V368, P446, DOI 10.1056/NEJMsa1208051
   CDC, 2012, MMWR-MORBID MORTAL W, P410
   Centers for Disease Control and Prevention, 2011, OB RAT LOW INC PRESC
   Cutrufello PT, 2011, INHAL TOXICOL, V23, P658, DOI 10.3109/08958378.2011.604106
   Delfino RJ, 2010, EPIDEMIOLOGY, V21, P396, DOI 10.1097/EDE.0b013e3181d5e19b
   EPA, 2008, APP G HLTH BAS COST
   EPA, 2011, AQS DAT DICT
   Fryar CD, 2012, PREVALENCE OVERWEIGH
   Gent JF, 2003, JAMA-J AM MED ASSOC, V290, P1859, DOI 10.1001/jama.290.14.1859
   Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458
   Hankey S, 2012, ENVIRON HEALTH PERSP, V120, P247, DOI 10.1289/ehp.1103806
   Herring MP, 2012, ARCH INTERN MED, V172, P101, DOI 10.1001/archinternmed.2011.696
   Hystad P, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-22
   Krivoruchko K, 2012, EMPIRICAL BAYESIAN K
   Laden F, 2000, ENVIRON HEALTH PERSP, V108, P941, DOI 10.2307/3435052
   Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9
   Lee IM, 2010, JAMA-J AM MED ASSOC, V303, P1173, DOI 10.1001/jama.2010.312
   Marr LC, 2010, MED SCI SPORT EXER, V42, P585, DOI 10.1249/MSS.0b013e3181b84a85
   Marshall JD, 2008, ATMOS ENVIRON, V42, P1359, DOI 10.1016/j.atmosenv.2007.08.012
   Mokdad Ali H, 2003, MMWR Recomm Rep, V52, P1
   Motl RW, 2004, PSYCHOSOM MED, V66, P336, DOI 10.1097/01.psy.0000126205.35683.0a
   Nelson DE, 1998, AM STAT ASS 1998 P S, P214
   Ogden C. L., 2012, PREVALENCE OBESITY U
   Peters A, 2000, EPIDEMIOLOGY, V11, P11, DOI 10.1097/00001648-200001000-00005
   Pietilainen KH, 2008, OBESITY, V16, P409, DOI 10.1038/oby.2007.72
   Pilz J, 2008, STOCH ENV RES RISK A, V22, P621, DOI 10.1007/s00477-007-0165-7
   Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132
   Pratt M, 2012, LANCET, V380, P282, DOI 10.1016/S0140-6736(12)60736-3
   Rundell KW, 2008, J STRENGTH COND RES, V22, P2, DOI 10.1519/JSC.0b013e31815ef98b
   Singh GK, 2010, ARCH PEDIAT ADOL MED, V164, P598, DOI 10.1001/archpediatrics.2010.84
   Son JY, 2010, ENVIRON RES, V110, P739, DOI 10.1016/j.envres.2010.08.003
   US EPA, 2004, DEV SPAT INT SURF ES
   VDH, 2012, BRFSS METH
   Voss JD, 2013, INT J OBES LOND, DOI [10.1038/ijo.2013.5, DOI 10.1038/IJ0.2013.5]
   Wen XJ, 2009, J ENVIRON HEALTH, V72, P40
NR 43
TC 34
Z9 34
U1 1
U2 33
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 5
PY 2014
VL 9
IS 3
AR e90143
DI 10.1371/journal.pone.0090143
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AC4GP
UT WOS:000332479400049
PM 24598907
OA Green Published, Bronze, Other Gold
DA 2019-05-24
ER

PT J
AU Huang, YL
   Chen, HW
   Han, BC
   Liu, CW
   Chuang, HC
   Lin, LY
   Chuang, KJ
AF Huang, Ya-Li
   Chen, Hua-Wei
   Han, Bor-Cheng
   Liu, Chien-Wei
   Chuang, Hsiao-Chi
   Lin, Lian-Yu
   Chuang, Kai-Jen
TI Personal Exposure to Household Particulate Matter, Household Activities
   and Heart Rate Variability among Housewives
SO PLOS ONE
LA English
DT Article
ID AIR-POLLUTION; ENVIRONMENTAL EXPOSURE; DISEASE; ASSOCIATION;
   INFLAMMATION; PARTICLES; WORKERS; SMOKE; PM2.5; RISK
AB Background: The association between indoor air pollution and heart rate variability (HRV) has been well-documented. Little is known about effects of household activities on indoor air quality and HRV alteration. To investigate changes in HRV associated with changes in personal exposure to household particulate matter (PM) and household activities.
   Methods: We performed 24-h continuous monitoring of electrocardiography and measured household PM exposure among 50 housewives. The outcome variables were log(10)-transformed standard deviation of normal-to-normal (NN) intervals (SDNN) and the square root of the mean of the sum of the squares of differences between adjacent NN intervals (r-MSSD). ,Household PM was measured as the mass concentration of PM with an aerodynamic diameter <2.5 mu m (PM2.5). We used mixed-effects models to examine the association between household PM2.5 exposure and log(10)-transformed HRV indices.
   Results: After controlling for potential confounders, an interquartile range change in household PM2.5 with 1- to 4-h mean was associated with 1.25-4.31% decreases in SDNN and 0.12-3.71% decreases in r-MSSD. Stir-frying, cleaning with detergent and burning incense may increase household PM2.5 concentrations and modify the effects of household PM2.5 on HRV indices among housewives.
   Conclusions: Indoor PM2.5 exposures were associated with decreased SDNN and r-MSSD among housewives, especially during stir-frying, cleaning with detergent and burning incense.
C1 [Huang, Ya-Li; Chuang, Kai-Jen] Taipei Med Univ, Coll Med, Sch Med, Dept Publ Hlth, Taipei, Taiwan.
   [Huang, Ya-Li; Han, Bor-Cheng; Chuang, Kai-Jen] Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Publ Hlth, Taipei, Taiwan.
   [Chen, Hua-Wei] St Marys Jr Coll Med Nursing & Management, Dept Cosmet Applicat & Management, Yilan, Taiwan.
   [Liu, Chien-Wei] St Marys Jr Coll Med Nursing & Management, Dept Informat Management, Yilan, Taiwan.
   [Chuang, Hsiao-Chi] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan.
   [Chuang, Hsiao-Chi] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan.
   [Lin, Lian-Yu] Natl Taiwan Univ Hosp, Dept Internal Med, Div Cardiol, Taipei 100, Taiwan.
RP Chuang, KJ (reprint author), Taipei Med Univ, Coll Med, Sch Med, Dept Publ Hlth, Taipei, Taiwan.
EM kjc@tmu.edu.tw
RI Chuang, Hsiao-Chi/E-7912-2010
OI Chuang, Hsiao-Chi/0000-0003-4651-5192; LIN, LIAN-YU/0000-0001-7505-6429;
   Han, Bor-Cheng/0000-0002-8493-8199
FU National Science Council of Taiwan [NSC 101-2314-B-038-053-MY3,
   TMU101-AE1-B08]; Taipei Medical University
FX This study was supported by grants (NSC 101-2314-B-038-053-MY3 and
   TMU101-AE1-B08) from the National Science Council of Taiwan and Taipei
   Medical University. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Behera D, 2006, CANCER RES, V66, P4961
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Chan CC, 2004, ENVIRON HEALTH PERSP, V112, P1063, DOI 10.1289/chp.6897
   Chow JC, 2006, J AIR WASTE MANAGE, V56, P707, DOI 10.1080/10473289.2006.10464484
   Chuang KJ, 2007, AM J RESP CRIT CARE, V176, P370, DOI 10.1164/rccm.200611-1627OC
   Chuang KJ, 2007, J OCCUP ENVIRON MED, V49, P610, DOI 10.1097/JOM.0b013e318058205b
   Chuang KJ, 2005, ENVIRON HEALTH PERSP, V113, P1693, DOI 10.1289/ehp.8145
   Gold DR, 2000, CIRCULATION, V101, P1267, DOI 10.1161/01.CIR.101.11.1267
   Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165
   Lanki T, 2007, J EXPO SCI ENV EPID, V17, P124, DOI 10.1038/sj.jes.7500470
   Lee GS, 2010, AUTON NEUROSCI-BASIC, V155, P94, DOI 10.1016/j.autneu.2009.12.008
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Lin LY, 2012, SCI TOTAL ENVIRON, V414, P68, DOI 10.1016/j.scitotenv.2011.08.050
   Lung SC, 1999, COMMUNITY AIR QUALIT
   Magari SR, 2002, EPIDEMIOLOGY, V13, P305, DOI 10.1097/00001648-200205000-00011
   Magari SR, 2001, CIRCULATION, V104, P986, DOI 10.1161/hc3401.095038
   McCracken J, 2011, ENVIRON HEALTH PERSP, V119, P1562, DOI 10.1289/ehp.1002834
   Pan CH, 2008, CANCER EPIDEM BIOMAR, V17, P3351, DOI 10.1158/1055-9965.EPI-08-0075
   Polidori A, 2006, J EXPO SCI ENV EPID, V16, P321, DOI 10.1038/sj.jes.7500476
   Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F
   Svendsen K, 2003, AM J IND MED, V43, P436, DOI 10.1002/ajim.10197
   Syazwan AI, 2012, DRUG HEALTHC PATIENT, V4, P107, DOI 10.2147/DHPS.S33400
   Tse LA, 2011, ENVIRON HEALTH PERSP, V119, P1641, DOI 10.1289/ehp.1002790
   WHO Europe, 2006, AIR QUAL GUID GLOB U
NR 24
TC 23
Z9 23
U1 2
U2 19
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 3
PY 2014
VL 9
IS 3
AR e89969
DI 10.1371/journal.pone.0089969
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AC4CT
UT WOS:000332468900050
PM 24594880
OA Green Published, Other Gold
DA 2019-05-24
ER

PT J
AU Weldy, CS
   Liu, YG
   Liggitt, HD
   Chin, MT
AF Weldy, Chad S.
   Liu, Yonggang
   Liggitt, H. Denny
   Chin, Michael T.
TI In Utero Exposure to Diesel Exhaust Air Pollution Promotes Adverse
   Intrauterine Conditions, Resulting in Weight Gain, Altered Blood
   Pressure, and Increased Susceptibility to Heart Failure in Adult Mice
SO PLOS ONE
LA English
DT Article
ID LONG-TERM EXPOSURE; ISCHEMIA-REPERFUSION INJURY; ENDOTHELIAL-CELL
   ACTIVATION; GROWTH-RETARDED RAT; PKC-EPSILON GENE; UTEROPLACENTAL
   INSUFFICIENCY; CARDIOVASCULAR-DISEASE; GESTATIONAL-AGE; GLUTATHIONE GSH;
   BIRTH-WEIGHT
AB Exposure to fine particulate air pollution (PM2.5) is strongly associated with cardiovascular morbidity and mortality. Exposure to PM2.5 during pregnancy promotes reduced birthweight, and the associated adverse intrauterine conditions may also promote adult risk of cardiovascular disease. Here, we investigated the potential for in utero exposure to diesel exhaust (DE) air pollution, a major source of urban PM2.5, to promote adverse intrauterine conditions and influence adult susceptibility to disease. We exposed pregnant female C57Bl/6J mice to DE (approximate to 300 mu g/m(3) PM2.5, 6 hrs/day, 5 days/week) from embryonic day (E) 0.5 to 17.5. At E17.5 embryos were collected for gravimetric analysis and assessed for evidence of resorption. Placental tissues underwent pathological examination to assess the extent of injury, inflammatory cell infiltration, and oxidative stress. In addition, some dams that were exposed to DE were allowed to give birth to pups and raise offspring in filtered air (FA) conditions. At 10-weeks of age, body weight and blood pressure were measured. At 12-weeks of age, cardiac function was assessed by echocardiography. Susceptibility to pressure overload-induced heart failure was then determined after transverse aortic constriction surgery. We found that in utero exposure to DE increases embryo resorption, and promotes placental hemorrhage, focal necrosis, compaction of labyrinth vascular spaces, inflammatory cell infiltration and oxidative stress. In addition, we observed that in utero DE exposure increased body weight, but counterintuitively reduced blood pressure without any changes in baseline cardiac function in adult male mice. Importantly, we observed these mice to have increased susceptibility to pressure-overload induced heart failure, suggesting this in utero exposure to DE 'reprograms' the heart to a heightened susceptibility to failure. These observations provide important data to suggest that developmental exposure to air pollution may strongly influence adult susceptibility to cardiovascular disease.
C1 [Weldy, Chad S.; Liu, Yonggang; Chin, Michael T.] Univ Washington, Sch Med, Dept Med, Div Cardiol, Seattle, WA 98195 USA.
   [Weldy, Chad S.; Chin, Michael T.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA.
   [Liggitt, H. Denny] Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA.
RP Chin, MT (reprint author), Univ Washington, Sch Med, Dept Med, Div Cardiol, Seattle, WA 98195 USA.
EM mtchin@u.washington.edu
FU NIEHS DISCOVER Center [P50 ES015915]; Experimental Pathology of
   Cardiovascular Disease Training Grant [T32HL007312]; NIEHS Center for
   Ecogenetics and Environmental Health [P30ES007033]
FX YL and MTC were supported by NIEHS DISCOVER Center grant P50 ES015915
   and CSW was supported by the Experimental Pathology of Cardiovascular
   Disease Training Grant (T32HL007312). Additional support was provided by
   the NIEHS Center for Ecogenetics and Environmental Health though a pilot
   project award funded by grant P30ES007033. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Arck PC, 2013, NAT MED, V19, P548, DOI 10.1038/nm.3160
   Auten RL, 2012, AM J RESP CELL MOL, V46, P454, DOI 10.1165/rcmb.2011-0256OC
   Bae S, 2005, J PHYSIOL-LONDON, V565, P149, DOI 10.1113/jphysiol.2005.082701
   Bae S, 2005, BRIT J PHARMACOL, V144, P900, DOI 10.1038/sj.bjp.0706129
   Bagley HN, 2013, J OBES, DOI 10.1155/2013/312153
   Bai N, 2011, ATHEROSCLEROSIS, V216, P299, DOI 10.1016/j.atherosclerosis.2011.02.019
   BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564
   Bolton JL, 2012, FASEB J, V26, P4743, DOI 10.1096/fj.12-210989
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   BUSSEY ME, 1985, PEDIATR RES, V19, P363, DOI 10.1203/00006450-198519040-00010
   Campen MJ, 2010, TOXICOL APPL PHARM, V242, P310, DOI 10.1016/j.taap.2009.10.021
   Channell MM, 2012, TOXICOL SCI, V127, P179, DOI 10.1093/toxsci/kfs084
   Cherng TW, 2011, ENVIRON HEALTH PERSP, V119, P98, DOI 10.1289/ehp.1002286
   Cherng TW, 2009, AM J PHYSIOL-REG I, V297, pR640, DOI 10.1152/ajpregu.90899.2008
   Dadvand P, 2013, ENVIRON HEALTH PERSP, V121, P367, DOI 10.1289/ehp.1205575
   Dorr J, 2011, ADV EXP MED BIOL, V704, P909, DOI 10.1007/978-94-007-0265-3_47
   ECONOMIDES DL, 1989, AM J OBSTET GYNECOL, V160, P385, DOI 10.1016/0002-9378(89)90453-5
   ECONOMIDES DL, 1989, AM J OBSTET GYNECOL, V161, P1004, DOI 10.1016/0002-9378(89)90772-2
   Eriksson J, 2000, HYPERTENSION, V36, P790, DOI 10.1161/01.HYP.36.5.790
   Fariss MW, 2013, TOXICOL SCI, V132, P253, DOI 10.1093/toxsci/kft001
   Feldt K, 2007, J HUM HYPERTENS, V21, P401, DOI 10.1038/sj.jhh.1002176
   Godfrey K M, 2001, Public Health Nutr, V4, P611
   Gould T, 2008, INHAL TOXICOL, V20, P49, DOI [10.1080/08958370701758478, 10.1080/08958370701758478 ]
   Hazari MS, 2011, ENVIRON HEALTH PERSP, V119, P951, DOI 10.1289/ehp.1003200
   Janssen BG, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-22
   Janssen BG, 2012, ENVIRON HEALTH PERSP, V120, P1346, DOI 10.1289/ehp.1104458
   Kampfrath T, 2011, CIRC RES, P1
   Ke X, 2006, PHYSIOL GENOMICS, V25, P16, DOI 10.1152/physiolgenomics.00093.2005
   Knuckles TL, 2008, TOXICOL APPL PHARM, V230, P346, DOI 10.1016/j.taap.2008.03.010
   Lane RH, 2001, AM J PHYSIOL-REG I, V280, pR183
   Lane RH, 2001, PEDIATR RES, V50, P83, DOI 10.1203/00006450-200107000-00016
   LAW CM, 1993, BRIT MED J, V306, P24, DOI 10.1136/bmj.306.6869.24
   Lewtas J, 2007, MUTAT RES-REV MUTAT, V636, P95, DOI 10.1016/j.mrrev.2007.08.003
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Liu YG, 2013, PART FIBRE TOXICOL, V10, DOI [10.1186/1743-8977-10, 10.1186/1743-8977-10-49]
   Liu YG, 2010, AM J PHYSIOL-HEART C, V298, pH2082, DOI 10.1152/ajpheart.00747.2009
   MacLennan NK, 2004, PHYSIOL GENOMICS, V18, P43, DOI 10.1152/physiolgenomics.00042.2004
   MARTYN CN, 1995, BRIT HEART J, V73, P116
   Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409
   OGATA ES, 1986, METABOLISM, V35, P970, DOI 10.1016/0026-0495(86)90064-8
   OGATA ES, 1985, PEDIATR RES, V19, P32, DOI 10.1203/00006450-198501000-00010
   Patterson AJ, 2012, CARDIOVASC RES, V93, P302, DOI 10.1093/cvr/cvr322
   Patterson AJ, 2010, CIRC RES, V107, P365, DOI 10.1161/CIRCRESAHA.110.221259
   Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132
   Quan CL, 2010, INHAL TOXICOL, V22, P738, DOI 10.3109/08958371003728057
   Shaw CA, 2011, AM J RESP CELL MOL, V44, P840, DOI 10.1165/rcmb.2010-0011OC
   Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003
   Sun QH, 2008, ARTERIOSCL THROM VAS, V28, P1760, DOI 10.1161/ATVBAHA.108.166967
   Torres SM, 2010, CARDIOVASC TOXICOL, V10, P87, DOI 10.1007/s12012-010-9065-z
   Torres SM, 2010, CARDIOVASC TOXICOL, V10, P37, DOI 10.1007/s12012-010-9061-3
   Tsirka AE, 2001, J ENDOCRINOL, V169, P373, DOI 10.1677/joe.0.1690373
   VIJAYAKUMAR M, 1995, BRIT HEART J, V73, P363
   Wagner JG, 2013, ENVIRON HEALTH PERSP, V122, P27
   Wang JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053400
   Ward JM, 2012, VET PATHOL, V49, P71, DOI 10.1177/0300985811429811
   Webster William S., 2007, Birth Defects Research, V81, P215, DOI 10.1002/bdrc.20102
   Weldy CS, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-59
   Weldy CS, 2013, INHAL TOXICOL, V25, P444, DOI 10.3109/08958378.2013.801004
   Weldy CS, 2012, FREE RADICAL BIO MED, V53, P1264, DOI 10.1016/j.freeradbiomed.2012.07.006
   Weldy CS, 2011, TOXICOL IN VITRO, V25, P2064, DOI 10.1016/j.tiv.2011.08.008
   Wendler CC, 2009, FASEB J, V23, P1272, DOI 10.1096/fj.08-124941
   Wold LE, 2012, CIRC-HEART FAIL, V5, P452, DOI 10.1161/CIRCHEARTFAILURE.112.966580
   Xiao DL, 2009, HYPERTENSION, V54, P1123, DOI 10.1161/HYPERTENSIONAHA.109.138024
   Yin F, 2013, ARTERIOSCL THROM VAS, V33, P1153, DOI 10.1161/ATVBAHA.112.300552
   Ying ZK, 2009, AM J PHYSIOL-HEART C, V296, pH1540, DOI 10.1152/ajpheart.01270.2008
   Yu M, 2009, OMICS, V13, P501, DOI 10.1089/omi.2009.0086
NR 67
TC 42
Z9 44
U1 1
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 12
PY 2014
VL 9
IS 2
AR e88582
DI 10.1371/journal.pone.0088582
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AA7FJ
UT WOS:000331262600075
PM 24533117
OA Other Gold, Green Published
DA 2019-05-24
ER

PT J
AU Teichert, T
   Vossoughi, M
   Vierkotter, A
   Sugiri, D
   Schikowski, T
   Schulte, T
   Roden, M
   Luckhaus, C
   Herder, C
   Kramer, U
AF Teichert, Tom
   Vossoughi, Mohammad
   Vierkoetter, Andrea
   Sugiri, Dorothea
   Schikowski, Tamara
   Schulte, Thomas
   Roden, Michael
   Luckhaus, Christian
   Herder, Christian
   Kraemer, Ursula
TI Association between Traffic-Related Air Pollution, Subclinical
   Inflammation and Impaired Glucose Metabolism: Results from the SALIA
   Study
SO PLOS ONE
LA English
DT Article
ID LONG-TERM EXPOSURE; FINE PARTICULATE MATTER; USE REGRESSION-MODELS;
   C-REACTIVE PROTEIN; INSULIN-RESISTANCE; DIABETES PREVALENCE; OXIDATIVE
   STRESS; PM2.5 ABSORBENCY; RISK-FACTORS; PARTICLES
AB Background: Environmental and lifestyle factors regulate the expression and release of immune mediators. It has been hypothesised that ambient air pollution may be such an external factor and that the association between air pollution and impaired glucose metabolism may be attributable to inflammatory processes. Therefore, we assessed the associations between air pollution, circulating immune mediators and impaired glucose metabolism.
   Methods: We analysed concentrations of 14 pro- and anti-inflammatory immune mediators as well as fasting glucose and insulin levels in plasma of 363 women from the Study on the influence of Air pollution on Lung function, Inflammation and Aging (SALIA, Germany). Exposure data for a group of pollutants such as nitrogen oxides (NO2, NOx) and different fractions of particulate matter were available for the participants' residences. We calculated the association between the pollutants and impaired glucose metabolism by multiple regression models.
   Results: The study participants had a mean age of 74.1 (SD 2.6) years and 48% showed impaired glucose metabolism based on impaired fasting glucose or previously diagnosed type 2 diabetes. Only long-term exposure NO2 and NOx concentrations showed positive associations (NO2: OR 1.465, 95% CI 1.049-2.046, NOx: OR 1.409, 95% CI 1.010-1.967) per increased interquartile range of NO2 (14.65 mu g/m(3)) or NOx (43.16 mu g/m(3)), respectively, but statistical significance was lost after correction for multiple comparisons. Additional adjustment for circulating immune mediators or the use of anti-inflammatory medication had hardly any impact on the observed ORs.
   Conclusions: Our results suggest that exposure to nitrogen oxides may contribute to impaired glucose metabolism, but the associations did not reach statistical significance so that further studies with larger sample sizes are required to substantiate our findings. Our data do not preclude a role of inflammatory mechanisms in adipose or other tissues which may not be reflected by immune mediators in plasma.
C1 [Teichert, Tom; Roden, Michael; Herder, Christian] Univ Dusseldorf, Inst Clin Diabetol, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany.
   [Vossoughi, Mohammad; Vierkoetter, Andrea; Sugiri, Dorothea; Schikowski, Tamara; Kraemer, Ursula] Univ Dusseldorf, IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany.
   [Schikowski, Tamara] Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
   [Schikowski, Tamara] Univ Basel, Basel, Switzerland.
   [Schulte, Thomas; Luckhaus, Christian] Univ Dusseldorf, Fac Med, Dept Psychiat & Psychotherapy, Dusseldorf, Germany.
   [Roden, Michael] Univ Dusseldorf, Univ Hosp Dusseldorf, Dept Endocrinol & Diabetol, Dusseldorf, Germany.
   [Roden, Michael; Herder, Christian] German Ctr Diabet Res DZD eV, Dusseldorf, Germany.
RP Herder, C (reprint author), Univ Dusseldorf, Inst Clin Diabetol, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany.
EM christian.herder@ddz.uni-duesseldorf.de
FU Deutsche Forschungsgemeinschaft (DFG) [HE-4510/2-1, KR 1938/3-1, LU
   691/4-1]; Ministry of the Environment of the state North
   Rhine-Westphalia (Dusseldorf, Germany); Federal Ministry of the
   Environment (Berlin, Germany); DGUV (German statutory accident
   assurance) [VT 266.1]; European Community [211250]; German Federal
   Ministry of Health (Berlin, Germany); Ministry of Innovation, Science
   and Research of the State of North Rhine-Westphalia (Dusseldorf,
   Germany); German Federal Ministry of Education and Research (BMBF)
FX This study was supported by research grants from the Deutsche
   Forschungsgemeinschaft (DFG; HE-4510/2-1, KR 1938/3-1, LU 691/4-1).
   SALIA received funds from the Ministry of the Environment of the state
   North Rhine-Westphalia (Dusseldorf, Germany) and the Federal Ministry of
   the Environment (Berlin, Germany). The follow-up investigation was
   funded by the DGUV (German statutory accident assurance) VT 266.1.
   Exposure assessment (ESCAPE-data) was funded by the European Community's
   Seventh Framework Program (FP7/2007-2011) under grant agreement number
   211250. The German Diabetes Center is funded by the German Federal
   Ministry of Health (Berlin, Germany) and the Ministry of Innovation,
   Science and Research of the State of North Rhine-Westphalia (Dusseldorf,
   Germany). This study was supported in part by a grant from the German
   Federal Ministry of Education and Research (BMBF) to the German Center
   for Diabetes Research (DZD e.V.). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI 10.2337/dc13-S067
   Andersen ZJ, 2012, DIABETES CARE, V35, P92, DOI 10.2337/dc11-1155
   Beelen R, 2013, ATMOS ENVIRON, V72, P10, DOI 10.1016/j.atmosenv.2013.02.037
   Belvisi MG, 2003, PULM PHARMACOL THER, V16, P1, DOI 10.1016/S1094-5539(02)00180-3
   Brook RD, 2008, J OCCUP ENVIRON MED, V50, P32, DOI 10.1097/JOM.0b013e31815dba70
   Brook RD, 2013, SCI TOTAL ENVIRON, V448, P66, DOI 10.1016/j.scitotenv.2012.07.034
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Brown DM, 2001, TOXICOL APPL PHARM, V175, P191, DOI 10.1006/taap.2001.9240
   Carstensen M, 2010, DIABETES, V59, P1222, DOI 10.2337/db09-1199
   Chen H, 2013, ENVIRON HEALTH PERSP, V121, P804, DOI 10.1289/ehp.1205958
   Chuang KJ, 2011, OCCUP ENVIRON MED, V68, P64, DOI 10.1136/oem.2009.052704
   Coogan PF, 2012, CIRCULATION, V125, P767, DOI 10.1161/CIRCULATIONAHA.111.052753
   Cyrys J, 2003, J EXPO ANAL ENV EPID, V13, P134, DOI 10.1038/sj.jea.7500262
   Cyrys J, 2012, ATMOS ENVIRON, V62, P374, DOI 10.1016/j.atmosenv.2012.07.080
   Dijkema MBA, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-76
   Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925
   Eeftens M, 2012, ATMOS ENVIRON, V62, P303, DOI 10.1016/j.atmosenv.2012.08.038
   Eeftens M, 2012, ENVIRON SCI TECHNOL, V46, P11195, DOI 10.1021/es301948k
   Fonken LK, 2011, MOL PSYCHIATR, V16, P987, DOI 10.1038/mp.2011.76
   Herder C, 2013, DIABETES OBES METAB, V15, P39, DOI 10.1111/dom.12155
   Herder C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019852
   Herder C, 2009, DIABETES CARE, V32, P1921, DOI 10.2337/dc09-0476
   Huang HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037412
   Jain M, 2011, AM J RESP CRIT CARE, V183, P1490, DOI 10.1164/rccm.201009-1409OC
   Jansen F, 2013, CARDIOVASC RES, V98, P94, DOI 10.1093/cvr/cvt013
   Kelishadi R, 2009, ATHEROSCLEROSIS, V203, P311, DOI 10.1016/j.atherosclerosis.2008.06.022
   Khafaie MA, 2013, DIABETES CARE, V36, P625, DOI 10.2337/dc12-0388
   Kramer U, 2010, ENVIRON HEALTH PERSP, V118, P1273, DOI 10.1289/ehp.0901689
   Mossman Brooke T, 2007, Part Fibre Toxicol, V4, P4, DOI 10.1186/1743-8977-4-4
   Nemmar A, 2002, CIRCULATION, V105, P411, DOI 10.1161/hc0402.104118
   Nemmar A, 2001, AM J RESP CRIT CARE, V164, P1665, DOI 10.1164/ajrccm.164.9.2101036
   Pearson JF, 2010, DIABETES CARE, V33, P2196, DOI 10.2337/dc10-0698
   Peters A, 2001, EUR HEART J, V22, P1198, DOI 10.1053/euhj.2000.2483
   Puett RC, 2011, ENVIRON HEALTH PERSP, V119, P384, DOI 10.1289/ehp.1002344
   Ranft U, 2009, ENVIRON RES, V109, P1004, DOI 10.1016/j.envres.2009.08.003
   Roux AVD, 2006, AM J EPIDEMIOL, V164, P437, DOI 10.1093/aje/kwj186
   Ruckerl R, 2006, AM J RESP CRIT CARE, V173, P432, DOI 10.1164/rccm.200507-1123OC
   Ruckerl R, 2007, ENVIRON HEALTH PERSP, V115, P1072, DOI 10.1289/ehp.10021
   Salomaa V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010100
   Sattar N, 2008, DIABETOLOGIA, V51, P926, DOI 10.1007/s00125-008-0954-7
   Schikowski T, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-152
   Schulz H, 2005, J AEROSOL MED, V18, P1, DOI 10.1089/jam.2005.18.1
   Seagrave J, 2008, TOXICOL APPL PHARM, V232, P469, DOI 10.1016/j.taap.2008.08.001
   Seaton A, 1999, THORAX, V54, P1027, DOI 10.1136/thx.54.11.1027
   Sorensen M, 2013, ENVIRON HEALTH PERSP, V121, P217, DOI 10.1289/ehp.1205503
   Steinvil A, 2008, ENVIRON RES, V106, P51, DOI 10.1016/j.envres.2007.08.006
   Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003
   Sun QH, 2009, CIRCULATION, V119, P538, DOI 10.1161/CIRCULATIONAHA.108.799015
   Valavanidis A, 2008, J ENVIRON SCI HEAL C, V26, P339, DOI 10.1080/10590500802494538
   van Eeden SF, 2001, AM J RESP CRIT CARE, V164, P826, DOI 10.1164/ajrccm.164.5.2010160
   Xu XH, 2011, TOXICOL SCI, V124, P88, DOI 10.1093/toxsci/kfr211
NR 51
TC 30
Z9 30
U1 1
U2 20
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 10
PY 2013
VL 8
IS 12
AR UNSP e83042
DI 10.1371/journal.pone.0083042
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 275VW
UT WOS:000328707400114
PM 24340078
OA Other Gold, Green Published
DA 2019-05-24
ER

PT J
AU Horie, M
   Noguchi, S
   Tanaka, W
   Goto, Y
   Yoshihara, H
   Kawakami, M
   Suzuki, M
   Sakamoto, Y
AF Horie, Masafumi
   Noguchi, Satoshi
   Tanaka, Wakae
   Goto, Yasushi
   Yoshihara, Hisanao
   Kawakami, Masaki
   Suzuki, Masaru
   Sakamoto, Yoshio
TI Relationships among Smoking Habits, Airflow Limitations, and Metabolic
   Abnormalities in School Workers
SO PLOS ONE
LA English
DT Article
ID OBSTRUCTIVE PULMONARY-DISEASE; NUTRITION EXAMINATION SURVEY;
   CARDIOVASCULAR-DISEASE; CIGARETTE-SMOKING; NATIONAL-HEALTH;
   LUNG-FUNCTION; FUNCTION IMPAIRMENT; SEX-DIFFERENCES; UNITED-STATES; COPD
AB Background: Chronic obstructive pulmonary disease is caused mainly by habitual smoking and is common among elderly individuals. It involves not only airflow limitation but also metabolic disorders, leading to increased cardiovascular morbidity and mortality. Objective: We evaluated relationships among smoking habits, airflow limitation, and metabolic abnormalities.
   Methods: Between 2001 and 2008, 15,324 school workers (9700 males, 5624 females; age: >= 30 years) underwent medical checkups, including blood tests and spirometry. They also responded to a questionnaire on smoking habits and medical history.
   Results: Airflow limitation was more prevalent in current smokers than in ex-smokers and never-smokers in men and women. The frequency of hypertriglyceridemia was higher in current smokers in all age groups, and those of low high-density-lipoprotein cholesterolemia and diabetes mellitus were higher in current smokers in age groups >= 40 s in men, but not in women. There were significant differences in the frequencies of metabolic abnormalities between subjects with airflow limitations and those without in women, but not in men. Smoking index was an independent factor associated with increased frequencies of hypertriglyceridemia (OR 1.015; 95% CI: 1.012-1.018; p<0.0001) and low high-density-lipoprotein cholesterolemia (1.013; 1.010-1.016; p<0.0001) in men. Length of smoking cessation was an independent factor associated with a decreased frequency of hypertriglyceridemia (0.984; 0.975-0.994; p = 0.007).
   Conclusions: Habitual smoking causes high incidences of airflow limitation and metabolic abnormalities. Women, but not men, with airflow limitation had higher frequencies of metabolic abnormalities.
C1 [Horie, Masafumi; Noguchi, Satoshi; Tanaka, Wakae; Goto, Yasushi] Univ Tokyo, Grad Sch Med, Dept Resp Med, Bunkyo Ku, Tokyo, Japan.
   [Yoshihara, Hisanao] Teikyo Univ, Dept Allergy & Resp Med, Itabashi Ku, Tokyo 173, Japan.
   [Kawakami, Masaki; Suzuki, Masaru; Sakamoto, Yoshio] Kanto Cent Hosp, Dept Resp Med, Tokyo, Japan.
RP Horie, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Resp Med, Bunkyo Ku, Tokyo, Japan.
EM mhorie-tky@umin.ac.jp
CR Almagro P, 2010, RESP MED, V104, P253, DOI 10.1016/j.rmed.2009.09.019
   *AM THOR SOC, 1995, AM J RESP CRIT CARE, V152, pS77
   [Anonymous], 2004, NIHON KOKVUKI GAKK S, P1
   Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P675, DOI 10.1164/rccm.2112096
   ASHLEY F, 1975, ANN INTERN MED, V82, P739, DOI 10.7326/0003-4819-82-6-739
   Basili S, 1999, ATHEROSCLEROSIS, V147, P249, DOI 10.1016/S0021-9150(99)00192-6
   Ben-Zaken Cohen Sigal, 2007, Am J Respir Crit Care Med, V176, P113
   BENOWITZ NL, 1988, NEW ENGL J MED, V319, P1318
   BOLTON CH, 1989, J ROY SOC MED, V82, P91, DOI 10.1177/014107688908200212
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4
   Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304
   CHAJEKSHAUL T, 1990, EUR J CLIN INVEST, V20, P299, DOI 10.1111/j.1365-2362.1990.tb01859.x
   CRAIG WY, 1989, BRIT MED J, V298, P784, DOI 10.1136/bmj.298.6676.784
   de Torres JP, 2009, EUR RESPIR J, V33, P528, DOI 10.1183/09031936.00096108
   Decramer M, 2009, LANCET, V374, P1171, DOI 10.1016/S0140-6736(09)61298-8
   FEKETE T, 1987, HORM METAB RES, V19, P661, DOI 10.1055/s-2007-1011903
   Ferguson GT, 2000, CHEST, V117, P1146, DOI 10.1378/chest.117.4.1146
   Force USPST, 2008, ANN INTERN MED, V148, P529
   Ford ES, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-115
   Freeman DJ, 1998, EUR J CLIN INVEST, V28, P584
   Freiberg JJ, 2008, JAMA-J AM MED ASSOC, V300, P2142, DOI 10.1001/jama.2008.621
   Fukuchi Y, 2004, RESPIROLOGY, V9, P458, DOI 10.1111/j.1440-1843.2004.00637.x
   GERACE TA, 1991, PREV MED, V20, P602, DOI 10.1016/0091-7435(91)90058-C
   Global Initiative for Chronic Obstructive Lung Disease, UPD 2013 GLOB STRAT
   Han MK, 2007, AM J RESP CRIT CARE, V176, P1179, DOI 10.1164/rccm.200704-553CC
   Hanson C, 2013, TRANSL RES
   Kirkpatrick DP, 2009, CURR OPIN PULM MED, V15, P100, DOI 10.1097/MCP.0b013e3283232825
   Kuzuya M, 2006, ATHEROSCLEROSIS, V185, P183, DOI 10.1016/j.atherosclerosis.2005.05.040
   LANGE P, 1991, EUR RESPIR J, V4, P1080
   Leone N, 2009, AM J RESP CRIT CARE, V179, P509, DOI 10.1164/rccm.200807-1195OC
   Maeda K, 2003, PREV MED, V37, P283, DOI 10.1016/S0091-7435(03)00110-5
   Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408
   Mannino DM, 2003, THORAX, V58, P388, DOI 10.1136/thorax.58.5.388
   National Institute of Health and Nutrition, 2007, NAT HLTH NUTR SURV J
   Paek YJ, 2010, METABOLISM, V59, P1300, DOI 10.1016/j.metabol.2009.12.005
   Patel A, 2004, CIRCULATION, V110, P2678, DOI 10.1161/01.CIR.0000145615.33955.83
   Petty Thomas L, 2004, Respir Care, V49, P678
   Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO
   Rajagopalan S, 2012, DIABETES, V61, P3037, DOI 10.2337/db12-0190
   Rennard SI, 2006, LANCET, V367, P1216, DOI 10.1016/S0140-6736(06)68516-4
   Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9
   Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793
   Sidney S, 2005, CHEST, V128, P2068, DOI 10.1378/chest.128.4.2068
   Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003
   Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800
   Villablanca AC, 2000, CLIN CHEST MED, V21, P159, DOI 10.1016/S0272-5231(05)70015-0
   Yeatts K, 2007, ENVIRON HEALTH PERSP, V115, P709, DOI 10.1289/ehp.9499
NR 48
TC 2
Z9 2
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 29
PY 2013
VL 8
IS 11
AR e81145
DI 10.1371/journal.pone.0081145
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 261MX
UT WOS:000327670300025
PM 24312268
OA DOAJ Gold, Green Published
DA 2019-05-24
ER

PT J
AU Lin, HL
   Zhang, YH
   Xu, YJ
   Liu, T
   Xiao, JP
   Luo, Y
   Xu, XJ
   He, YH
   Ma, WJ
AF Lin, Hualiang
   Zhang, Yonghui
   Xu, Yanjun
   Liu, Tao
   Xiao, Jianpeng
   Luo, Yuan
   Xu, Xiaojun
   He, Yanhui
   Ma, Wenjun
TI Large Daily Stock Variation Is Associated with Cardiovascular Mortality
   in Two Cities of Guangdong, China
SO PLOS ONE
LA English
DT Article
ID CORONARY-ARTERY-DISEASE; AMBIENT AIR-POLLUTION; PSYCHOLOGICAL STRESS;
   MENTAL STRESS; TIME-SERIES; RISK-FACTOR; GUANGZHOU; EVENTS; DEATH;
   SEPTEMBER-11
AB Objective: The current study aimed to examine the effects of daily change of the Shenzhen Stock Exchange Index on cardiovascular mortality in Guangzhou and Taishan, China.
   Methods: Daily mortality and stock performance data during 2006-2010 were collected to construct the time series for the two cities. A distributed lag non-linear model was utilized to examine the effect of daily stock index changes on cardiovascular mortality after controlling for potential confounding factors.
   Results: We observed a delayed non-linear effect of the stock index change on cardiovascular mortality: both rising and declining of the stock index were associated with increased cardiovascular deaths. In Guangzhou, the 15-25 lag days cumulative relative risk of an 800 index drop was 2.08 (95% CI: 1.38-3.14), and 2.38 (95% CI: 1.31-4.31) for an 800 stock index increase on the cardiovascular mortality, respectively. In Taishan, the cumulative relative risk over 15-25 days lag was 1.65 (95% CI: 1.13-2.42) for an 800 index drop and 2.08 (95% CI: 1.26-3.42) for an 800 index rising, respectively.
   Conclusions: Large ups and downs in daily stock index might be important predictor of cardiovascular mortality.
C1 [Lin, Hualiang; Xu, Yanjun; Liu, Tao; Xiao, Jianpeng; Luo, Yuan; Xu, Xiaojun; He, Yanhui; Ma, Wenjun] Guangdong Prov Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China.
   [Lin, Hualiang; Zhang, Yonghui; Liu, Tao; Xiao, Jianpeng; Luo, Yuan; He, Yanhui; Ma, Wenjun] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China.
RP Ma, WJ (reprint author), Guangdong Prov Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China.
EM mwj68@vip.tom.com
RI Lin, Hualiang/E-6622-2010
OI Lin, Hualiang/0000-0002-2462-5158
FU National Natural Science Foundation of China [81202176]; National Major
   Research Program of China [2012CB955500]
FX This study was partly supported by the National Natural Science
   Foundation of China (No.: 81202176) and National Major Research Program
   of China (No.: 2012CB955500). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adinaro DJ, 2008, J EMERG MED, V34, P311, DOI 10.1016/j.jemermed.2007.05.014
   Austin AW, 2011, ANN BEHAV MED, V42, P153, DOI 10.1007/s12160-011-9274-0
   Borjesson M, 2011, EUR HEART J, V32, P2119, DOI 10.1093/eurheartj/ehr178
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Chen CC, 2012, SOCIAL SCI MED
   Chen R., 2012, ENV RES
   Chen RJ, 2012, AM J EPIDEMIOL, V175, P1173, DOI 10.1093/aje/kwr425
   Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685
   DAKAK N, 1995, AM J CARDIOL, V76, P125, DOI 10.1016/S0002-9149(99)80043-5
   Dimsdale JE, 2008, J AM COLL CARDIOL, V51, P1237, DOI 10.1016/j.jacc.2007.12.024
   Fan CC, 2001, ENVIRON PLANN A, V33, P479, DOI 10.1068/a33150
   Ferketich AK, 2005, EUR HEART J, V26, P1923, DOI 10.1093/eurheartj/ehi329
   Fiuzat M, 2010, AM J CARDIOL, V106, P1545, DOI 10.1016/j.amjcard.2010.07.027
   Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940
   Gasparrini A, 2010, ENVIRON RES, V110, P633, DOI 10.1016/j.envres.2010.06.005
   Goldberg MS, 2011, ENVIRON RES, V111, P853, DOI 10.1016/j.envres.2011.05.022
   Goldberg MS, 2006, ENVIRON RES, V100, P255, DOI 10.1016/j.envres.2005.04.007
   Granados JAT, 2009, P NATL ACAD SCI USA, V106, P17290, DOI 10.1073/pnas.0904491106
   Guo F, 2010, INT REV ECON FINANC, V19, P452, DOI 10.1016/j.iref.2009.10.014
   Ha J, 2011, SCI TOTAL ENVIRON, V409, P3274, DOI 10.1016/j.scitotenv.2011.05.034
   Holman EA, 2008, ARCH GEN PSYCHIAT, V65, P73, DOI 10.1001/archgenpsychiatry.2007.6
   Huang K, 2010, CLIN CARDIOL, V34, P755
   Jouven X, 2001, CARDIOVASC RES, V50, P373, DOI 10.1016/S0008-6363(01)00230-9
   Kop WJ, 2001, J AM COLL CARDIOL, V37, P1359, DOI 10.1016/S0735-1097(01)01136-6
   Leeder S, 2004, RACE TIME CHALLENGE
   Lin HL, 2013, ATMOS ENVIRON, V76, P68, DOI 10.1016/j.atmosenv.2012.08.043
   Lu L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-395
   Ma WJ, 2011, EUR HEART J, V32, P1006, DOI 10.1093/eurheartj/ehq495
   Peng RD, 2006, J R STAT SOC A STAT, V169, P179, DOI 10.1111/j.1467-985X.2006.00410.x
   Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0
   Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192
   Schlenger WE, 2002, JAMA-J AM MED ASSOC, V288, P581, DOI 10.1001/jama.288.5.581
   Schwartz BG, 2012, AM J CARDIOL, V109, P1445, DOI 10.1016/j.amjcard.2012.01.354
   Sofia S, 2012, AM J HYPERTENS, V25, P556, DOI 10.1038/ajh.2012.4
   Sosa Liprandi MI, 2012, REV ARGENT CARDIOL, V80, P137
   Steptoe A, 2009, NEUROSCI BIOBEHAV R, V33, P63, DOI 10.1016/j.neubiorev.2008.04.010
   Stuckler D, 2011, J EPIDEMIOL COMMUNIT, V66, P410
   Tao Y, 2012, ENV HLTH PERSPECT, V120.
   Thorin E, 2012, CARDIOVASC RES, V93, P537, DOI 10.1093/cvr/cvs083
   Walczewska J, 2011, EUR HEART J, V32, P730, DOI 10.1093/eurheartj/ehq354
   Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8
   Wilbert-Lampen U, 2008, NEW ENGL J MED, V358, P475, DOI 10.1056/NEJMoa0707427
   Yu ITS, 2012, ATMOS ENVIRON, V46, P528, DOI 10.1016/j.atmosenv.2011.07.055
   Zhang Y, 2013, J CARDIOVASCULAR MED
NR 44
TC 2
Z9 2
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 16
PY 2013
VL 8
IS 7
AR e68417
DI 10.1371/journal.pone.0068417
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 186SF
UT WOS:000322064300031
PM 23874619
OA DOAJ Gold, Green Published
DA 2019-05-24
ER

PT J
AU Chiu, HH
   Whittaker, P
AF Chiu, Holly H.
   Whittaker, Peter
TI Venous Thromboembolism in an Industrial North American City: Temporal
   Distribution and Association with Particulate Matter Air Pollution
SO PLOS ONE
LA English
DT Article
ID CARDIOVASCULAR-DISEASE; SEASONAL-VARIATION; TIME-SERIES; MORTALITY;
   DETROIT; PM10
AB Background: Emerging evidence, mainly from Europe and Asia, indicates that venous thromboembolism (VTE) occurs most often in winter. Factors implicated in such seasonality are low temperature-mediated exacerbation of coagulation and high levels of particulate matter (PM) air pollution. However, in contrast to most European and Asian cities, particulate matter pollution peaks in the summer in many North American cities.
   Objectives: We aimed to exploit this geographical difference and examine the temporal distribution of VTE in a cold-weather, North American city, Detroit, with a summer PM peak. Our goal was thereby to resolve the influence of temperature and PM levels on VTE.
   Methods: Our retrospective, analytical semi-ecological study used chart review to confirm 1,907 acute, ambulatory VTE cases, divided them by location (Detroit versus suburban), and plotted monthly VTE frequency distributions. We used Environmental Protection Agency data to determine the temporal distribution of PM pollution components in Detroit. Suburban PM air pollution is presumed negligible and therefore not monitored.
   Results: Acute VTE cases in Detroit (1,490) exhibited a summer peak (June 24th) and differed from both a uniform distribution (P < 0.01) and also that of 1,123 no-VTE cases (P < 0.02). Levels of 10 mu m diameter PM and coarse particle (2.5 to 10 mu m) PM also exhibited summer peaks versus a winter peak for 2.5 mu m diameter PM. Contrary to their urban counterparts, suburban cases of acute VTE (417) showed no monthly variation
   . Conclusions: The summer peak of acute VTE in Detroit indicates that low temperature is not a major factor in VTE pathogenesis. In contrast, concordance of the 10 mu m diameter PM, coarse particle, and the Detroit VTE monthly distributions, combined with no monthly suburban VTE variation, is consistent with a role for PM pollution. Furthermore, divergence of the VTE and 2.5 mu m PM distributions suggests that particle size may play a role.
C1 [Chiu, Holly H.] Harper Univ Hosp, Detroit Med Ctr, Dept Pharm, Detroit, MI USA.
   [Whittaker, Peter] Wayne State Univ, Cardiovasc Res Inst, Detroit, MI 48202 USA.
   [Whittaker, Peter] Wayne State Univ, Dept Emergency Med, Detroit, MI USA.
RP Whittaker, P (reprint author), Wayne State Univ, Cardiovasc Res Inst, Detroit, MI 48202 USA.
EM peter.whittaker@wayne.edu
RI Whittaker, Peter/O-9830-2019; Whittaker, Peter/F-1234-2011
OI Whittaker, Peter/0000-0002-5627-2166; Whittaker,
   Peter/0000-0002-5627-2166
CR Angchaisuksiri P, 2011, THROMB HAEMOSTASIS, V106, P585, DOI 10.1160/TH11-03-0184
   Ayd Y., 2011, ADV TOP ENVIR HEALTH, P251, DOI DOI 10.5772/20016
   Baccarelli A, 2008, ARCH INTERN MED, V168, P920, DOI 10.1001/archinte.168.9.920
   Batschelet E., 1981, CIRCULAR STAT BIOL
   Bell KNI, 2008, ANAL CYCLES BIOL MED
   Bell ML, 2007, ENVIRON HEALTH PERSP, V115, P989, DOI 10.1289/ehp.9621
   Bell ML, 2009, EPIDEMIOLOGY, V20, P682, DOI 10.1097/EDE.0b013e3181aba749
   Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Brown HK, 2009, THROMB HAEMOSTASIS, V102, P676, DOI 10.1160/TH09-04-0214
   Carnevale C, 2010, SCI TOTAL ENVIRON, V409, P182, DOI 10.1016/j.scitotenv.2010.09.038
   Chuang KJ, 2007, AM J RESP CRIT CARE, V176, P370, DOI 10.1164/rccm.200611-1627OC
   Deitelzweig SB, 2011, AM J HEMATOL, V86, P217, DOI 10.1002/ajh.21917
   Dentali F, 2011, THROMB HAEMOSTASIS, V106, P439, DOI 10.1160/TH11-02-0116
   Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127
   Fisher NI, 1995, STAT ANAL CIRCULAR D
   Gallerani M, 2004, MED SCI MONITOR, V10, pCR191
   Gallerani M, 2007, CHRONOBIOL INT, V24, P143, DOI 10.1080/07420520601139755
   Gehrig R, 2003, ATMOS ENVIRON, V37, P2571, DOI 10.1016/S1352-2310(03)00221-8
   Hamper UM, 2007, RADIOL CLIN N AM, V45, P525, DOI 10.1016/j.rcl.2007.04.013
   Kunzli N, 1997, ENVIRON HEALTH PERSP, V105, P1078, DOI 10.2307/3433849
   Kwok RHF, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012809
   Martinelli N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034831
   Mojtabazadeh H, 2005, SUSTAINABLE DEV PLAN
   Mustafic H, 2012, JAMA-J AM MED ASSOC, V307, P713, DOI 10.1001/jama.2012.126
   Oanh NTK, 2006, ATMOS ENVIRON, V40, P3367, DOI 10.1016/j.atmosenv.2006.01.050
   Peng RD, 2005, AM J EPIDEMIOL, V161, P585, DOI 10.1093/aje/kwi075
   Peng RD, 2010, BIOSTATISTICS, V11, P720, DOI 10.1093/biostatistics/kxq017
   Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176
   Sacks JD, 2011, ENVIRON HEALTH PERSP, V119, P446, DOI 10.1289/ehp.1002255
   SCHWARTZ J, 1995, AM J EPIDEMIOL, V142, P23, DOI 10.1093/oxfordjournals.aje.a117541
   Shih RA, 2011, ENVIRON HEALTH PERSP, V119, P326, DOI 10.1289/ehp.1002256
   Stein PD, 2004, AM J CARDIOL, V93, P511, DOI 10.1016/j.amjcard.2003.10.061
   Turalioglu FS, 2005, ENVIRON MONIT ASSESS, V104, P119, DOI 10.1007/s10661-005-1607-7
   Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8
   WHITTAKER P, 1989, AM HEART J, V118, P341, DOI 10.1016/0002-8703(89)90195-6
   WHITTAKER P, 1991, MATRIX, V11, P56, DOI 10.1016/S0934-8832(11)80227-1
   Zhou JA, 2011, ENVIRON HEALTH PERSP, V119, P461, DOI 10.1289/ehp.1002613
   Zoller B, 2012, J THROMB THROMBOLYS, V34, P374, DOI 10.1007/s11239-012-0728-4
NR 39
TC 8
Z9 8
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 10
PY 2013
VL 8
IS 7
AR e68829
DI 10.1371/journal.pone.0068829
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 182SU
UT WOS:000321765300068
PM 23874781
OA DOAJ Gold, Green Published
DA 2019-05-24
ER

PT J
AU Wittkopp, S
   Staimer, N
   Tjoa, T
   Gillen, D
   Daher, N
   Shafer, M
   Schauer, JJ
   Sioutas, C
   Delfino, RJ
AF Wittkopp, Sharine
   Staimer, Norbert
   Tjoa, Thomas
   Gillen, Daniel
   Daher, Nancy
   Shafer, Martin
   Schauer, James J.
   Sioutas, Constantinos
   Delfino, Ralph J.
TI Mitochondrial Genetic Background Modifies the Relationship between
   Traffic-Related Air Pollution Exposure and Systemic Biomarkers of
   Inflammation
SO PLOS ONE
LA English
DT Article
ID AIRBORNE PARTICULATE MATTER; OXIDATIVE STRESS; ULTRAFINE PARTICLES;
   ANTIRETROVIRAL THERAPY; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION;
   SOURCE APPORTIONMENT; DNA HAPLOGROUPS; HEART-DISEASE; RISK
AB Background: Mitochondria are the main source of reactive oxygen species (ROS). Human mitochondrial haplogroups are linked to differences in ROS production and oxidative-stress induced inflammation that may influence disease pathogenesis, including coronary artery disease (CAD). We previously showed that traffic-related air pollutants were associated with biomarkers of systemic inflammation in a cohort panel of subjects with CAD in the Los Angeles air basin.
   Objective: We tested whether air pollutant exposure-associated inflammation was stronger in mitochondrial haplogroup H than U (high versus low ROS production) in this panel (38 subjects and 417 observations).
   Methods: Inflammation biomarkers were measured weekly in each subject (<= 12 weeks), including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), C-reactive protein, interleukin-6 soluble receptor and tumor necrosis factor-soluble receptor II. We determined haplogroup by restriction fragment length polymorphism analysis. Air pollutants included nitrogen oxides (NOx), carbon monoxide (CO), organic carbon, elemental and black carbon (EC, BC); and particulate matter mass, three size fractions (, 0.25 mu m, 0.25-2.5 mu m, and 2.5-10 mu m in aerodynamic diameter). Particulate matter extracts were analyzed for organic compounds, including polycyclic aromatic hydrocarbons (PAH), and in vitro oxidative potential of aqueous extracts. Associations between exposures and biomarkers, stratified by haplogroup, were analyzed by mixed-effects models.
   Results: IL-6 and TNF-alpha were associated with traffic-related air pollutants (BC, CO, NOx and PAH), and with mass and oxidative potential of quasi-ultrafine particles,0.25 mu m. These associations were stronger for haplogroup H than haplogroup U.
   Conclusions: Results suggest that mitochondrial haplogroup U is a novel protective factor for air pollution-related systemic inflammation in this small group of subjects.
C1 [Wittkopp, Sharine] Univ Calif Irvine, Sch Med, Dept Med, Occupat & Environm Med Div, Irvine, CA 92717 USA.
   [Staimer, Norbert; Tjoa, Thomas; Delfino, Ralph J.] Univ Calif Irvine, Sch Med, Dept Epidemiol, Irvine, CA 92717 USA.
   [Gillen, Daniel] Univ Calif Irvine, Sch Informat & Comp Sci, Dept Stat, Irvine, CA USA.
   [Daher, Nancy; Sioutas, Constantinos] Univ So Calif, Dept Civil & Environm Engn, Viterbi Sch Engn, Los Angeles, CA USA.
   [Shafer, Martin; Schauer, James J.] Univ Wisconsin, Environm Chem & Technol Program, Madison, WI USA.
RP Delfino, RJ (reprint author), Univ Calif Irvine, Sch Med, Dept Epidemiol, Irvine, CA 92717 USA.
EM rdelfino@uci.edu
FU U.S. National Institutes of Health from the National Institute of
   Environmental Health Sciences [R01 ES12243, R21 ES016420, F30
   ES021107-01A1]; National Center for Research Resources [MO1 RR00827];
   California Air Resources Board [03-329, 09-341]
FX The present project was supported by U.S. National Institutes of Health
   grant numbers R01 ES12243, R21 ES016420, and F30 ES021107-01A1 from the
   National Institute of Environmental Health Sciences, MO1 RR00827 from
   the National Center for Research Resources and California Air Resources
   Board contracts 03-329 and 09-341. Its contents are solely the
   responsibility of the authors and do not necessarily represent the
   official views of the funding agencies and no official endorsement
   should be inferred. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Alonso JR, 2003, PHARMACOL TOXICOL, V93, P142, DOI 10.1034/j.1600-0773.2003.930306.x
   Arhami M, 2010, INDOOR AIR, V20, P17, DOI 10.1111/j.1600-0668.2009.00620.x
   Ayres JG, 2008, INHAL TOXICOL, V20, P75, DOI 10.1080/08958370701665517 
   Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0
   Bhaskaran K, 2009, HEART, V95, P1746, DOI 10.1136/hrt.2009.175018
   Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Canter JA, 2010, J INFECT DIS, V201, P1703, DOI 10.1086/652419
   De Luca A, 2012, JAIDS-J ACQ IMM DEF, V59, P113, DOI [10.1097/QAI.0b013e31823daff3, 10.1097/QAI.0b013e31823daff3.]
   Delfino RJ, 2011, AIR QUAL ATMOS HLTH, V4, P37, DOI 10.1007/s11869-010-0095-2
   Delfino RJ, 2010, EPIDEMIOLOGY, V21, P892, DOI 10.1097/EDE.0b013e3181f20e6c
   Delfino RJ, 2010, ENVIRON HEALTH PERSP, V118, P756, DOI 10.1289/ehp.0901407
   Delfino RJ, 2010, EPIDEMIOLOGY, V21, P396, DOI 10.1097/EDE.0b013e3181d5e19b
   Delfino RJ, 2009, ENVIRON HEALTH PERSP, V117, P1232, DOI 10.1289/ehp.0800194
   Di Lorenzo C, 2009, NEUROLOGY, V72, P1588, DOI 10.1212/WNL.0b013e3181a41269
   Docherty KS, 2008, ENVIRON SCI TECHNOL, V42, P7655, DOI 10.1021/es8008166
   Fisman EZ, 2006, AM J CARDIOL, V98, P14, DOI 10.1016/j.amjcard.2006.01.045
   Gomez-Duran A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246
   Hiura TS, 2000, J IMMUNOL, V165, P2703, DOI 10.4049/jimmunol.165.5.2703
   Hou LF, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-48
   Khusnutdinova E, 2008, ANN NY ACAD SCI, V1147, P1, DOI 10.1196/annals.1427.001
   Landreman AP, 2008, AEROSOL SCI TECH, V42, P946, DOI 10.1080/02786820802363819
   Lee IT, 2012, BIOCHEM PHARMACOL, V84, P581, DOI 10.1016/j.bcp.2012.05.005
   Li N, 2003, ENVIRON HEALTH PERSP, V111, P455, DOI 10.1289/ehp.6000
   Li R, 2009, FREE RADICAL BIO MED, V46, P775, DOI 10.1016/j.freeradbiomed.2008.11.025
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Mo YQ, 2012, TOXICOL IN VITRO, V26, P295, DOI 10.1016/j.tiv.2011.12.001
   Morita M, 2012, J DIABETES COMPLICAT
   Morita M, 2011, THER APHER DIAL, V15, P147, DOI 10.1111/j.1744-9987.2010.00887.x
   Mutlu EA, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-19
   Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367
   NOHL H, 1994, ANN BIOL CLIN-PARIS, V52, P199
   Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967
   Peters A, 2004, NEW ENGL J MED, V351, P1721, DOI 10.1056/NEJMoa040203
   Pope CA, 2006, CIRCULATION, V114, P2443, DOI 10.1161/CIRCULATIONAHA.106.636977
   Raman K, 2013, CAN J CARDIOL, V29, P67, DOI 10.1016/j.cjca.2012.06.025
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Sannigrahi P, 2006, ENVIRON SCI TECHNOL, V40, P666, DOI 10.1021/es051150i
   Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002
   Sioutas C, 2005, ENVIRON HEALTH PERSP, V113, P947, DOI 10.1289/ehp.7939
   Soberanes S, 2009, J BIOL CHEM, V284, P2176, DOI 10.1074/jbc.M808844200
   Stone EA, 2008, ATMOS CHEM PHYS, V8, P1249, DOI 10.5194/acp-8-1249-2008
   Torroni A, 1996, GENETICS, V144, P1835
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Weber RJ, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008408
   Woods JA, 2009, IMMUNOL ALLERGY CLIN, V29, P381, DOI 10.1016/j.iac.2009.02.011
NR 48
TC 26
Z9 27
U1 0
U2 25
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 23
PY 2013
VL 8
IS 5
AR e64444
DI 10.1371/journal.pone.0064444
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 151BM
UT WOS:000319435600066
PM 23717615
OA DOAJ Gold, Green Published
DA 2019-05-24
ER

PT J
AU Wichmann, J
   Rosengren, A
   Sjoberg, K
   Barregard, L
   Sallsten, G
AF Wichmann, Janine
   Rosengren, Annika
   Sjoberg, Karin
   Barregard, Lars
   Sallsten, Gerd
TI Association between Ambient Temperature and Acute Myocardial Infarction
   Hospitalisations in Gothenburg, Sweden: 1985-2010
SO PLOS ONE
LA English
DT Article
ID ACUTE CORONARY SYNDROMES; CASE-CROSSOVER ANALYSES;
   ISCHEMIC-HEART-DISEASE; AIR-POLLUTION; CARDIOVASCULAR-DISEASE;
   SEASONAL-VARIATION; EUROPEAN CITIES; RISK-FACTORS; WEATHER; ADMISSIONS
AB Cardiovascular disease (CVD) is the number one cause of death globally and evidence is steadily increasing on the role of non-traditional risk factors such as meteorology and air pollution. Nevertheless, many research gaps remain, such as the association between these non-traditional risk factors and subtypes of CVD, such as acute myocardial infarction (AMI). The objective of this study was to investigate the association between daily ambient temperature and AMI hospitalisations using a case-crossover design in Gothenburg, Sweden (1985-2010). A secondary analysis was also performed for out-of-hospital ischemic heart disease (IHD) deaths. Susceptible groups by age and sex were explored. The entire year as well as the warm (April-September) and cold periods (October-March) were considered. In total 28 215 AMI hospitalisations (of 22 475 people) and 21 082 out-of-hospital IHD deaths occurred during the 26-year study period. A linear exposure-response corresponding to a 3% and 7% decrease in AMI hospitalisations was observed for an inter-quartile range (IQR) increase in the 2-day cumulative average of temperature during the entire year (11 degrees C) and the warm period (6 degrees C), respectively, with and without adjustment for PM10, NO2, NOx or O-3. No heat waves occurred during the warm period. No evidence of an association in the cold period nor any association between temperature and IHD deaths in the entire year, warm or cold periods - with and without adjusting for PM10, NO2, NOx or O-3 was found. No susceptible groups, based on age or sex, were identified either. The inverse association between temperature and AMI hospitalisations (entire year and warm period) in Gothenburg is in accordance with the majority of the few other studies that investigated this subtype of CVD.
C1 [Wichmann, Janine; Barregard, Lars; Sallsten, Gerd] Sahlgrens Univ Hosp, Dept Occupat & Environm Med, Gothenburg, Sweden.
   [Wichmann, Janine; Rosengren, Annika; Barregard, Lars; Sallsten, Gerd] Univ Gothenburg, Gothenburg, Sweden.
   [Rosengren, Annika] Sahlgrens Univ Hosp, Dept Mol & Clin Med, Gothenburg, Sweden.
   [Sjoberg, Karin] IVL Swedish Environm Res Inst, Gothenburg, Sweden.
RP Wichmann, J (reprint author), Sahlgrens Univ Hosp, Dept Occupat & Environm Med, Gothenburg, Sweden.
EM gerd.sallsten@amm.gu.se
OI Rosengren, Annika/0000-0002-5409-6605
FU Swedish Research Council Formas
FX The Swedish Research Council Formas funded the study. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Abrignani MG, 2009, INT J CARDIOL, V137, P123, DOI 10.1016/j.ijcard.2008.06.036
   Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266
   Anderson HR, 2004, METAANALYSIS TIME SE
   Anderson HR, 2007, QUANTITATIVE SYSTEMA
   Barnett AG, 2010, ENVIRON RES, V110, P604, DOI 10.1016/j.envres.2010.05.006
   Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40
   Bateson TF, 1999, EPIDEMIOLOGY, V10, P539, DOI 10.1097/00001648-199909000-00013
   Bateson TF, 2001, EPIDEMIOLOGY, V12, P654, DOI 10.1097/00001648-200111000-00013
   Bhaskaran K, 2009, HEART, V95, P1760, DOI 10.1136/hrt.2009.175000
   Bhaskaran K, 2009, HEART, V95, P1746, DOI 10.1136/hrt.2009.175018
   Bhaskaran K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3823
   Bokenes L., 2009, EUR J PUBLIC HEALTH, V21, P526, DOI DOI 10.1003/EURPUB/CKPL
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Danet S, 1999, CIRCULATION, V100, pE11, DOI 10.1161/01.CIR.100.1.e1
   Dudas K, 2011, CIRCULATION, V123, P46, DOI 10.1161/CIRCULATIONAHA.110.964999
   Ebi KL, 2004, INT J BIOMETEOROL, V49, P48, DOI 10.1007/s00484-004-0207-5
   ELWOOD PC, 1993, BRIT HEART J, V70, P520
   *EUR GROUP, 1997, LANCET, V349, P1341, DOI DOI 10.1016/S0140-6736(96)12338-2
   Green RS, 2010, INT J PUBLIC HEALTH, V55, P113, DOI 10.1007/s00038-009-0076-0
   Hanninen O, 2011, AIR QUAL ATMOS HLTH, V4, P221, DOI 10.1007/s11869-010-0076-5
   Kociol RD, 2012, JAMA-J AM MED ASSOC, V307, P66, DOI 10.1001/jama.2011.1926
   Kovats RS, 2008, ANNU REV PUBL HEALTH, V29, P41, DOI 10.1146/annurev.publhealth.29.020907.090843
   Lee JH, 2010, INT J CARDIOL, V144, P16, DOI 10.1016/j.ijcard.2009.03.122
   Levy D, 2001, EPIDEMIOLOGY, V12, P186, DOI 10.1097/00001648-200103000-00010
   Lloyd-Jones DM, 2006, CIRCULATION, V113, P791, DOI 10.1161/CIRCULATIONAHA.105.548206
   Lucas RM, 2005, B WORLD HEALTH ORGAN, V83, P792
   Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450
   MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853
   Matthews CE, 2001, AM J EPIDEMIOL, V153, P172, DOI 10.1093/aje/153.2.172
   Michelozzi P, 2009, AM J RESP CRIT CARE, V179, P383, DOI 10.1164/rccm.200802-217OC
   Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409
   Misailidou M, 2006, EUR J CARDIOV PREV R, V13, P846, DOI 10.1097/01.hjr.0000221857.04168.06
   Mustafic H, 2012, JAMA-J AM MED ASSOC, V307, P713, DOI 10.1001/jama.2012.126
   O'Neill MS, 2007, OCCUP ENVIRON MED, V64, P373, DOI 10.1136/oem.2006.030023
   Ostro B, 2010, AM J EPIDEMIOL, V172, P1053, DOI 10.1093/aje/kwq231
   Panagiotakos DB, 2004, INT J CARDIOL, V94, P229, DOI 10.1016/j.ijcard.2003.04.050
   Park SK, 2006, CIRCULATION, V114, P2798, DOI 10.1161/CIRCULATIONAHA.106.643197
   Parry ML, 2007, CONTRIBUTION WORKING
   Rayner M, 2009, EUR J CARDIOV PREV R, V16, pS43, DOI 10.1097/01.hjr.0000359235.59808.ba
   Schauble CL, 2012, OCCUP ENVIRON MED, V69, P670, DOI 10.1136/oemed-2011-100469
   Scheer FAJL, 2010, P NATL ACAD SCI USA, V107, P20541, DOI 10.1073/pnas.1006749107
   Sher L, 1999, J AM COLL CARDIOL, V33, P2088
   TENG HC, 1955, AM HEART J, V49, P9, DOI 10.1016/0002-8703(55)90049-1
   Turner LR, 2012, EPIDEMIOLOGY, V23, P594, DOI 10.1097/EDE.0b013e3182572795
   WHO, 2006, AIR QUAL GUID GLOB U
   Wichmann J, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-19
   Wolf K, 2009, CIRCULATION, V120, P735, DOI 10.1161/CIRCULATIONAHA.108.815860
   Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9
NR 48
TC 25
Z9 25
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 30
PY 2013
VL 8
IS 4
AR UNSP e62059
DI 10.1371/journal.pone.0062059
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 146GG
UT WOS:000319077300025
PM 23646115
OA DOAJ Gold, Green Published
DA 2019-05-24
ER

PT J
AU Kish, L
   Hotte, N
   Kaplan, GG
   Vincent, R
   Tso, R
   Ganzle, M
   Rioux, KP
   Thiesen, A
   Barkema, HW
   Wine, E
   Madsen, KL
AF Kish, Lisa
   Hotte, Naomi
   Kaplan, Gilaad G.
   Vincent, Renaud
   Tso, Robert
   Gaenzle, Michael
   Rioux, Kevin P.
   Thiesen, Aducio
   Barkema, Herman W.
   Wine, Eytan
   Madsen, Karen L.
TI Environmental Particulate Matter Induces Murine Intestinal Inflammatory
   Responses and Alters the Gut Microbiome
SO PLOS ONE
LA English
DT Article
ID FRAGMENT-LENGTH-POLYMORPHISMS; DIESEL EXHAUST PARTICLES; RAT ALVEOLAR
   MACROPHAGES; AMBIENT AIR-POLLUTION; GENE-DEFICIENT MICE;
   EPITHELIAL-CELLS; BOWEL DISEASES; CROHNS-DISEASE; RIBOSOMAL-RNA;
   CYTOKINE PRODUCTION
AB Background: Particulate matter (PM) is a key pollutant in ambient air that has been associated with negative health conditions in urban environments. The aim of this study was to examine the effects of orally administered PM on the gut microbiome and immune function under normal and inflammatory conditions.
   Methods: Wild-type 129/SvEv mice were gavaged with Ottawa urban PM10 (EHC-93) for 7-14 days and mucosal gene expression analyzed using Ingenuity Pathways software. Intestinal permeability was measured by lactulose/mannitol excretion in urine. At sacrifice, segments of small and large intestine were cultured and cytokine secretion measured. Splenocytes were isolated and incubated with PM10 for measurement of proliferation. Long-term effects of exposure (35 days) on intestinal cytokine expression were measured in wild-type and IL-10 deficient (IL-10(-/-)) mice. Microbial composition of stool samples was assessed using terminal restriction fragment length polymorphism. Short chain fatty acids were measured in caecum.
   Results: Short-term treatment of wild-type mice with PM10 altered immune gene expression, enhanced pro-inflammatory cytokine secretion in the small intestine, increased gut permeability, and induced hyporesponsiveness in splenocytes. Long-term treatment of wild-type and IL-10(-/-) mice increased pro-inflammatory cytokine expression in the colon and altered short chain fatty acid concentrations and microbial composition. IL-10(-/-) mice had increased disease as evidenced by enhanced histological damage.
   Conclusions: Ingestion of airborne particulate matter alters the gut microbiome and induces acute and chronic inflammatory responses in the intestine.
C1 [Kish, Lisa; Hotte, Naomi; Tso, Robert; Madsen, Karen L.] Univ Alberta, Dept Med, Edmonton, AB, Canada.
   [Kaplan, Gilaad G.; Rioux, Kevin P.] Univ Calgary, Dept Med, Calgary, AB, Canada.
   [Vincent, Renaud] Hlth Canada, Environm Hlth Directorate, Ottawa, ON K1A 0L2, Canada.
   [Gaenzle, Michael] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.
   [Thiesen, Aducio] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada.
   [Barkema, Herman W.] Univ Calgary, Dept Prod Anim Hlth, Calgary, AB, Canada.
   [Wine, Eytan] Univ Alberta, Dept Pediat, Edmonton, AB, Canada.
RP Madsen, KL (reprint author), Univ Alberta, Dept Med, Edmonton, AB, Canada.
EM karen.madsen@ualberta.ca
RI Ganzle, Michael/F-1432-2017; Barkema, Herman/B-9583-2008; Abbott,
   Derek/E-8352-2011
OI Ganzle, Michael/0000-0003-0972-928X; Barkema,
   Herman/0000-0002-9678-8378; Abbott, Derek/0000-0002-0945-2674; Kaplan,
   Gilaad/0000-0003-2719-0556
FU Alberta IBD Consortium; Alberta Innovates; Canadian Institutes for
   Health Research; Crohns and Colitis Foundation of Canada
FX This study was funded through the Alberta IBD Consortium, Alberta
   Innovates, Canadian Institutes for Health Research, and Crohns and
   Colitis Foundation of Canada. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adamson IYR, 1999, TOXICOL APPL PHARM, V157, P43, DOI 10.1006/taap.1999.8658
   Ananthakrishnan AN, 2011, INFLAMM BOWEL DIS, V17, P1138, DOI 10.1002/ibd.21455
   Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373
   Arrieta MC, 2009, GUT, V58, P41, DOI 10.1136/gut.2008.150888
   Beamish LA, 2011, J CROHNS COLITIS, V5, P279, DOI 10.1016/j.crohns.2011.02.017
   Becker S, 1996, TOXICOL APPL PHARM, V141, P637, DOI 10.1006/taap.1996.0330
   Brook RD, 2010, CURR ATHEROSCLER REP, V12, P291, DOI 10.1007/s11883-010-0122-7
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8
   Campeau JL, 2012, INFECT IMMUN, V80, P2632, DOI 10.1128/IAI.00288-12
   Carter JD, 1997, TOXICOL APPL PHARM, V146, P180, DOI 10.1006/taap.1997.8254
   Chen TM, 2007, AM J MED SCI, V333, P230, DOI 10.1097/MAJ.0b013e31803b8c91
   Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879
   De Brouwere K, 2012, SCI TOTAL ENVIRON, V419, P25, DOI 10.1016/j.scitotenv.2011.12.049
   Donaldson K, 2003, FREE RADICAL BIO MED, V34, P1369, DOI 10.1016/S0891-5849(03)00150-3
   Donaldson Ken, 2005, Part Fibre Toxicol, V2, P10
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008
   Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104
   Fujii T, 2001, AM J RESP CELL MOL, V25, P265, DOI 10.1165/ajrcmb.25.3.4445
   Ghio AJ, 1998, AM J PHYSIOL-LUNG C, V274, pL396
   GUBERAN E, 1992, BRIT J IND MED, V49, P337
   Hall J, 2008, IMMUNITY, V29, P1
   Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x
   Hetland Ragna B, 2005, Part Fibre Toxicol, V2, P4, DOI 10.1186/1743-8977-2-4
   Hirota JA, 2012, J ALLERGY CLIN IMMUN, V129, P1116, DOI 10.1016/j.jaci.2011.11.033
   Hotte NSC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037932
   Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009
   Kaplan GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047669
   Kaplan GG, 2010, AM J GASTROENTEROL, V105, P2412, DOI 10.1038/ajg.2010.252
   Kaplan GG, 2009, CAN MED ASSOC J, V181, P591, DOI 10.1503/cmaj.082068
   Kennedy T, 1998, AM J RESP CELL MOL, V19, P366, DOI 10.1165/ajrcmb.19.3.3042
   Kitts C L, 2001, Curr Issues Intest Microbiol, V2, P17
   Kooter IM, 2005, INHAL TOXICOL, V17, P53, DOI 10.1080/08958370590885717
   KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P
   Leblanc JC, 2005, FOOD ADDIT CONTAM, V22, P624, DOI 10.1080/02652030500135367
   LI XY, 1994, AM J RESP CRIT CARE, V149, P1518, DOI 10.1164/ajrccm.149.6.8004308
   Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516
   Lomer MCE, 2004, BRIT J NUTR, V92, P947, DOI 10.1079/BJN20041276
   Lomer MCE, 2002, P NUTR SOC, V61, P123, DOI 10.1079/PNS2001134
   Ma BW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047416
   Madara JL, 2000, ADV DRUG DELIVER REV, V41, P251, DOI 10.1016/S0169-409X(00)00044-2
   Madsen K, 2001, GASTROENTEROLOGY, V121, P580, DOI 10.1053/gast.2001.27224
   Madsen KL, 1999, GASTROENTEROLOGY, V116, P1107, DOI 10.1016/S0016-5085(99)70013-2
   Madsen KL, 2002, INFLAMM BOWEL DIS, V8, P390, DOI 10.1097/00054725-200211000-00003
   Madsen KL, 2000, GASTROENTEROLOGY, V118, P1094, DOI 10.1016/S0016-5085(00)70362-3
   Mage D, 1996, ATMOS ENVIRON, V30, P681, DOI 10.1016/1352-2310(95)00219-7
   Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817
   Meddings JB, 1998, GASTROENTEROLOGY, V114, P83, DOI 10.1016/S0016-5085(98)70636-5
   Mills NL, 2009, NAT CLIN PRACT CARD, V6, P36, DOI 10.1038/ncpcardio1399
   Moller W, 2004, J APPL PHYSIOL, V97, P2200, DOI 10.1152/japplphysiol.00970.2003
   Mukae H, 2000, AM J PHYSIOL-LUNG C, V279, pL924
   Mutlu EA, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-19
   Orazzo F, 2009, ENVIRON HEALTH PERSP, V117, P1780, DOI 10.1289/ehp.0900599
   Samet J M, 2000, Res Rep Health Eff Inst, V94, P5
   Samet JM, 2000, RES REP HLTH EFF I, V94, P71
   Sarkar S, 2012, ENV MONIT ASSESS
   Sarkar S, 2012, J IMMUNOL, V188, P2778, DOI 10.4049/jimmunol.1101380
   Semmler-Behnke M, 2007, ENVIRON HEALTH PERSP, V115, P728, DOI 10.1289/ehp.9685
   Sepehri S, 2007, INFLAMMATORY BOWEL D
   Shyu C, 2007, MICROB ECOL, V53, P562, DOI 10.1007/s00248-006-9106-0
   Solano AF, 2008, FREE RADICAL RES, V42, P707, DOI 10.1080/10715760802311179
   Soon IS, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-51
   Sunkara LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027225
   Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005
   Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294
   URBANSKI SJ, 1989, MODERN PATHOL, V2, P222
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Vincent R, 1997, AM J PATHOL, V151, P1563
   Vincent R, 1997, FUND APPL TOXICOL, V39, P18, DOI 10.1006/faat.1997.2336
   Willemsen LEM, 2003, GUT, V52, P1442, DOI 10.1136/gut.52.10.1442
   Yin XJJ, 2007, J TOXICOL ENV HEAL A, V70, P820, DOI 10.1080/15287390701209765
   Zhang R, 2008, FEMS MICROBIOL ECOL, V65, P169, DOI 10.1111/j.1574-6941.2008.00493.x
NR 73
TC 66
Z9 71
U1 5
U2 57
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 24
PY 2013
VL 8
IS 4
AR e62220
DI 10.1371/journal.pone.0062220
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 136DE
UT WOS:000318340400086
PM 23638009
OA Green Published, Other Gold
DA 2019-05-24
ER

PT J
AU Duan, JC
   Yu, YB
   Li, Y
   Yu, Y
   Li, YB
   Zhou, XQ
   Huang, PL
   Sun, ZW
AF Duan, Junchao
   Yu, Yongbo
   Li, Yang
   Yu, Yang
   Li, Yanbo
   Zhou, Xianqing
   Huang, Peili
   Sun, Zhiwei
TI Toxic Effect of Silica Nanoparticles on Endothelial Cells through DNA
   Damage Response via Chk1-Dependent G2/M Checkpoint
SO PLOS ONE
LA English
DT Article
ID SIZE-DEPENDENT CYTOTOXICITY; OXIDATIVE STRESS; AIR-POLLUTION; CHK1;
   PATHWAYS; MITOCHONDRIA; MAINTENANCE; MECHANISMS; GENERATION; PARTICLES
AB Silica nanoparticles have become promising carriers for drug delivery or gene therapy. Endothelial cells could be directly exposed to silica nanoparticles by intravenous administration. However, the underlying toxic effect mechanisms of silica nanoparticles on endothelial cells are still poorly understood. In order to clarify the cytotoxicity of endothelial cells induced by silica nanoparticles and its mechanisms, cellular morphology, cell viability and lactate dehydrogenase (LDH) release were observed in human umbilical vein endothelial cells (HUVECs) as assessing cytotoxicity, resulted in a dose- and time-dependent manner. Silica nanoparticles-induced reactive oxygen species (ROS) generation caused oxidative damage followed by the production of malondialdehyde (MDA) as well as the inhibition of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px). Both necrosis and apoptosis were increased significantly after 24 h exposure. The mitochondrial membrane potential (MMP) decreased obviously in a dose-dependent manner. The degree of DNA damage including the percentage of tail DNA, tail length and Olive tail moment (OTM) were markedly aggravated. Silica nanoparticles also induced G2/M arrest through the upregulation of Chk1 and the downregulation of Cdc25C, cyclin B1/Cdc2. In summary, our data indicated that the toxic effect mechanisms of silica nanoparticles on endothelial cells was through DNA damage response (DDR) via Chk1-dependent G2/M checkpoint signaling pathway, suggesting that exposure to silica nanoparticles could be a potential hazards for the development of cardiovascular diseases.
C1 [Duan, Junchao; Yu, Yongbo; Yu, Yang; Li, Yanbo; Zhou, Xianqing; Huang, Peili; Sun, Zhiwei] Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China.
   [Li, Yang; Sun, Zhiwei] Jilin Univ, Sch Publ Hlth, Changchun 130023, Jilin, Peoples R China.
RP Sun, ZW (reprint author), Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China.
EM zwsun@hotmail.com
FU National Natural Science Foundation of China [81230065, 81172704];
   Beijing Education Committee [PHR201006110, PHR201107116]
FX This work was supported by National Natural Science Foundation of China
   (number 81230065, number 81172704), Funding Project for Academic Human
   Resources Development of Beijing Education Committee (PHR201006110) and
   Innovative Team Project of Beijing Education Committee (PHR201107116).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Alom-Ruiz SP, 2008, ANTIOXID REDOX SIGN, V10, P1089, DOI 10.1089/ars.2007.2007
   Badr G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051661
   Barandeh F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029424
   Bauer AT, 2011, BIOMATERIALS, V32, P8385, DOI 10.1016/j.biomaterials.2011.07.078
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Chen Y, 2008, FRONT BIOSCI-LANDMRK, V13, P5016
   Choi SJ, 2009, J INORG BIOCHEM, V103, P463, DOI 10.1016/j.jinorgbio.2008.12.017
   Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019
   Corbalan JJ, 2011, INT J NANOMED, V6, P2821, DOI 10.2147/IJN.S25071
   Eom HJ, 2009, TOXICOL IN VITRO, V23, P1326, DOI 10.1016/j.tiv.2009.07.010
   Fotakis G, 2006, TOXICOL LETT, V160, P171, DOI 10.1016/j.toxlet.2005.07.001
   Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232
   Huang S, 2009, TOXICOL APPL PHARM, V241, P182, DOI 10.1016/j.taap.2009.08.013
   Inayat-Hussain SH, 2010, TOXICOL LETT, V193, P108, DOI 10.1016/j.toxlet.2009.12.010
   Jezek P, 2005, INT J BIOCHEM CELL B, V37, P2478, DOI 10.1016/j.biocel.2005.05.013
   Jiang JK, 2009, J NANOPART RES, V11, P77, DOI 10.1007/s11051-008-9446-4
   Kadam SS, 2009, IN VITRO CELL DEV-AN, V45, P23, DOI 10.1007/s11626-008-9155-4
   Kang JH, 2012, ANN EPIDEMIOL, V22, P257, DOI 10.1016/j.annepidem.2012.02.008
   Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004
   Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006
   Kumar R, 2010, ACS NANO, V4, P699, DOI 10.1021/nn901146y
   Lam MH, 2004, CELL CYCLE, V3, P1355, DOI 10.4161/cc.3.11.1225
   Lee JE, 2011, ACCOUNTS CHEM RES, V44, P893, DOI 10.1021/ar2000259
   Li Y, 2011, TOXICOL IN VITRO, V25, P1343, DOI 10.1016/j.tiv.2011.05.003
   Li ZX, 2012, CHEM SOC REV, V41, P2590, DOI 10.1039/c1cs15246g
   Liang YL, 2009, WORLD J SURG, V33, P661, DOI 10.1007/s00268-008-9840-1
   Liu X, 2010, BIOMATERIALS, V31, P8198, DOI 10.1016/j.biomaterials.2010.07.069
   Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248
   Loffler H, 2007, CELL CYCLE, V6, P2541
   Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005
   Mills NL, 2007, NEW ENGL J MED, V357, P1075, DOI 10.1056/NEJMoa066314
   Montero AJ, 2011, DRUGS, V71, P1385, DOI 10.2165/11592590-000000000-00000
   Nabeshi H, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-1
   Nabeshi H, 2011, BIOMATERIALS, V32, P2713, DOI 10.1016/j.biomaterials.2010.12.042
   Napierska D, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-39
   Napierska D, 2009, SMALL, V5, P846, DOI 10.1002/smll.200800461
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Park MVDZ, 2011, NANOTOXICOLOGY, V5, P168, DOI 10.3109/17435390.2010.506016
   Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F
   Rabolli V, 2010, NANOTOXICOLOGY, V4, P307, DOI 10.3109/17435390.2010.482749
   Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018
   Sandberg WJ, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-32
   Schneider A, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-29
   Schonn I, 2010, APOPTOSIS, V15, P162, DOI 10.1007/s10495-009-0440-9
   Shang Y, 2009, SCI CHINA SER B, V52, P1033, DOI 10.1007/s11426-009-0141-9
   Sharifi S, 2012, CHEM SOC REV, V41, P2323, DOI 10.1039/c1cs15188f
   Smith AM, 2008, ADV DRUG DELIVER REV, V60, P1226, DOI 10.1016/j.addr.2008.03.015
   Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4
   Smits VAJ, 2006, CURR BIOL, V16, P150, DOI 10.1016/j.cub.2005.11.066
   Sun L, 2011, TOXICOL IN VITRO, V25, P1619, DOI 10.1016/j.tiv.2011.06.012
   Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005
   Tedgui A, 2003, ARCH MAL COEUR VAISS, V96, P671
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Wan R, 2012, CHEM RES TOXICOL, V25, P1402, DOI 10.1021/tx200513t
   Wang JN, 2011, CELL CYCLE, V10, P500, DOI 10.4161/cc.10.3.14753
   Xu JQ, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-561
   Zhang YY, 2010, BIOMATERIALS, V31, P8465, DOI 10.1016/j.biomaterials.2010.07.060
   Zhao Y, 2011, ENVIRON SCI TECHNOL, V45, P3317, DOI 10.1021/es104107c
NR 58
TC 18
Z9 25
U1 7
U2 45
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 19
PY 2013
VL 8
IS 4
AR e62087
DI 10.1371/journal.pone.0062087
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 130JA
UT WOS:000317909500087
PM 23620807
OA DOAJ Gold, Green Published
DA 2019-05-24
ER

PT J
AU Strak, M
   Hoek, G
   Godri, KJ
   Gosens, I
   Mudway, IS
   van Oerle, R
   Spronk, HMH
   Cassee, FR
   Lebret, E
   Kelly, FJ
   Harrison, RM
   Brunekreef, B
   Steenhof, M
   Janssen, NAH
AF Strak, Maciej
   Hoek, Gerard
   Godri, Krystal J.
   Gosens, Ilse
   Mudway, Ian S.
   van Oerle, Rene
   Spronk, Henri M. H.
   Cassee, Flemming R.
   Lebret, Erik
   Kelly, Frank J.
   Harrison, Roy M.
   Brunekreef, Bert
   Steenhof, Maaike
   Janssen, Nicole A. H.
TI Composition of PM Affects Acute Vascular Inflammatory and Coagulative
   Markers - The RAPTES Project
SO PLOS ONE
LA English
DT Article
ID AIRBORNE PARTICULATE MATTER; AMERICAN-HEART-ASSOCIATION; AIR-POLLUTION;
   CARDIOVASCULAR-DISEASE; DIESEL EXHAUST; HEALTHY-VOLUNTEERS; TERM
   EXPOSURE; COMPONENTS; PARTICLES; MORTALITY
AB Background: Exposure to ambient particulate matter (PM) has been associated with adverse cardiovascular effects in epidemiological studies. Current knowledge of independent effects of individual PM characteristics remains limited.
   Methods: Using a semi-experimental design we investigated which PM characteristics were consistently associated with blood biomarkers believed to be predictive of the risk of cardiovascular events. We exposed healthy adult volunteers at 5 different locations chosen to provide PM exposure contrasts with reduced correlations among PM characteristics. Each of the 31 volunteers was exposed for 5 h, exercising intermittently, 3-7 times at different sites from March to October 2009. Extensive on-site exposure characterization included measurements of PM mass and number concentration, elemental-(EC) and organic carbon (OC), trace metals, sulfate, nitrate, and PM oxidative potential (OP). Before and 2 h and 18 h after exposure we measured acute vascular blood biomarkers - C-reactive protein, fibrinogen, platelet counts, von Willebrand Factor, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex. We used two-pollutant models to assess which PM characteristics were most consistently associated with the measured biomarkers.
   Results and Conclusion: We found OC, nitrate and sulfate to be most consistently associated with different biomarkers of acute cardiovascular risk. Associations with PM mass concentrations and OP were less consistent, whereas other measured components of the air pollution mixture, including PNC, EC, trace metals and NO2, were not associated with the biomarkers after adjusting for other pollutants.
C1 [Strak, Maciej; Gosens, Ilse; Cassee, Flemming R.; Lebret, Erik; Janssen, Nicole A. H.] Natl Inst Publ Hlth & Environm RIVM, Ctr Environm Hlth MGO, Bilthoven, Netherlands.
   [Strak, Maciej; Hoek, Gerard; Cassee, Flemming R.; Lebret, Erik; Brunekreef, Bert; Steenhof, Maaike] Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands.
   [Strak, Maciej; Hoek, Gerard; Cassee, Flemming R.; Lebret, Erik; Brunekreef, Bert; Steenhof, Maaike] Univ Utrecht, Inst Risk Assessment Sci, Div Toxicol, Utrecht, Netherlands.
   [Godri, Krystal J.; Mudway, Ian S.; Kelly, Frank J.] Kings Coll London, Environm Res Grp, MRC HPA Ctr Environm Hlth, London WC2R 2LS, England.
   [Godri, Krystal J.; Harrison, Roy M.] Univ Birmingham, Sch Geog Earth & Environm Sci, Div Environm Hlth & Risk Management, Birmingham, W Midlands, England.
   [van Oerle, Rene; Spronk, Henri M. H.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Lab Clin Thrombosis & Haemostasis,Dept Internal M, Maastricht, Netherlands.
   [Harrison, Roy M.] King Abdulaziz Univ, Dept Environm Sci, Ctr Excellence Environm Studies, Jeddah 21413, Saudi Arabia.
   [Brunekreef, Bert] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
RP Janssen, NAH (reprint author), Natl Inst Publ Hlth & Environm RIVM, Ctr Environm Hlth MGO, Bilthoven, Netherlands.
EM nicole.janssen@rivm.nl
RI Kelly, Frank J/C-6125-2009; Harrison, Roy/A-2256-2008
OI Kelly, Frank J/0000-0003-2558-8392; Harrison, Roy/0000-0002-2684-5226;
   Steenhof, Maaike/0000-0002-8812-8476; brunekreef,
   bert/0000-0001-9908-0060; Mudway, Ian/0000-0003-1239-5014; Godri
   Pollitt, Krystal/0000-0001-7332-2228; Strak, Maciej/0000-0002-9085-6026
FU RIVM Strategic Research Program [S630002]; Asthma UK
   [MRC-AsthmaUKCentre]; Medical Research Council [G1000758, G0801056,
   G0801056B]
FX The RAPTES project was funded by the RIVM Strategic Research Program
   (S630002). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Ayres JG, 2008, INHAL TOXICOL, V20, P75, DOI 10.1080/08958370701665517 
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8
   Brunekreef B, 2010, EPIDEMIOLOGY, V21, P903, DOI 10.1097/EDE.0b013e3181f4e1e6
   BURNETT RT, 1995, AM J EPIDEMIOL, V142, P15, DOI 10.1093/oxfordjournals.aje.a117540
   Carlsten C, 2007, THROMB RES, V120, P849, DOI 10.1016/j.thromres.2007.01.005
   Ghio AJ, 2003, INHAL TOXICOL, V15, P1465, DOI 10.1080/08958370390249111
   Godri KJ, 2010, ENVIRON HEALTH PERSP, V118, P493, DOI 10.1289/ehp.0901303
   Gong H, 2008, INHAL TOXICOL, V20, P533, DOI [10.1080/08958370801911340, 10.1080/08958370801911340 ]
   KANNEL WB, 1987, JAMA-J AM MED ASSOC, V258, P1183, DOI 10.1001/jama.258.9.1183
   Krewski D, 2000, REANALYSSI HARVARD 6
   Krintus M, 2010, CLIN BIOCHEM, V43, P626, DOI 10.1016/j.clinbiochem.2009.12.013
   Larsson BM, 2007, EUR RESPIR J, V29, P699, DOI 10.1183/09031936.00035706
   Lucking AJ, 2008, EUR HEART J, V29, P3043, DOI 10.1093/eurheartj/ehn464
   Nystrom AK, 2010, EUR RESPIR J, V36, P240, DOI 10.1183/09031936.00099909
   Ostro B, 2007, ENVIRON HEALTH PERSP, V115, P13, DOI 10.1289/ehp.9281
   Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45
   Peng RD, 2009, ENVIRON HEALTH PERSP, V117, P957, DOI 10.1289/ehp.0800185
   Pope CA, 2007, ENVIRON HEALTH PERSP, V115, P679, DOI 10.1289/ehp.9762
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132
   Riediker M, 2004, AM J RESP CRIT CARE, V169, P934, DOI 10.1164/rccm.200310-1463OC
   Riediker M, 2007, INHAL TOXICOL, V19, P99, DOI 10.1080/08958370701495238
   Salvi S, 1999, AM J RESP CRIT CARE, V159, P702, DOI 10.1164/ajrccm.159.3.9709083
   Samet JM, 2009, AM J RESP CRIT CARE, V179, P1034, DOI 10.1164/rccm.200807-1043OC
   Schlesinger RB, 2003, INHAL TOXICOL, V15, P197, DOI 10.1080/08958370390168247
   Solomon PA, 2008, J AIR WASTE MANAGE, V58, P164, DOI 10.3155/1047-3289.58.2.164
   Spiel AO, 2008, CIRCULATION, V117, P1449, DOI 10.1161/CIRCULATIONAHA.107.722827
   Strak M, 2012, ENVIRON HEALTH PERSP, V120, P1183, DOI 10.1289/ehp.1104389
   Strak M, 2011, ATMOS ENVIRON, V45, P4442, DOI 10.1016/j.atmosenv.2011.05.035
   teenhof M., 2011, PART FIBRE TOXICOL, V8
   Trigg DE, 2011, SEMIN THROMB HEMOST, V37, P77, DOI 10.1055/s-0030-1270074
   Valavanidis A, 2008, J ENVIRON SCI HEAL C, V26, P339, DOI 10.1080/10590500802494538
   Wagner DD, 2005, ARTERIOSCL THROM VAS, V25, P1321, DOI 10.1161/01.ATV.0000166521.90532.44
   WHO, 2007, HTLH REL PART MATT V
   Wiman B, 2000, ARTERIOSCL THROM VAS, V20, P2019, DOI 10.1161/01.ATV.20.8.2019
   Zuurbier M, 2011, ENVIRON HEALTH PERSP, V119, P1384, DOI 10.1289/ehp.1003151
NR 36
TC 22
Z9 23
U1 1
U2 20
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 13
PY 2013
VL 8
IS 3
AR e58944
DI 10.1371/journal.pone.0058944
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 115YY
UT WOS:000316849200124
PM 23516583
OA DOAJ Gold, Green Published
DA 2019-05-24
ER

PT J
AU Farina, F
   Sancini, G
   Battaglia, C
   Tinaglia, V
   Mantecca, P
   Camatini, M
   Palestini, P
AF Farina, Francesca
   Sancini, Giulio
   Battaglia, Cristina
   Tinaglia, Valentina
   Mantecca, Paride
   Camatini, Marina
   Palestini, Paola
TI Milano Summer Particulate Matter (PM10) Triggers Lung Inflammation and
   Extra Pulmonary Adverse Events in Mice
SO PLOS ONE
LA English
DT Article
ID AIR-POLLUTION; GENE-EXPRESSION; HEME OXYGENASE-1;
   CARDIOVASCULAR-DISEASE; ULTRAFINE PARTICLES; ENDOTHELIN SYSTEM; FINE
   PARTICLES; SHORT-TERM; IN-VIVO; TRANSLOCATION
AB Recent studies have suggested a link between particulate matter (PM) exposure and increased mortality and morbidity associated with pulmonary and cardiovascular diseases; accumulating evidences point to a new role for air pollution in CNS diseases. The purpose of our study is to investigate PM10sum effects on lungs and extra pulmonary tissues. Milano PM10sum has been intratracheally instilled into BALB/c mice. Broncho Alveolar Lavage fluid, lung parenchyma, heart and brain were screened for markers of inflammation (cell counts, cytokines, ET-1, HO-1, MPO, iNOS), cytotoxicity (LDH, ALP, Hsp70, Caspase8-p18, Caspase3-p17) for a putative pro-carcinogenic marker (Cyp1B1) and for TLR4 pathway activation. Brain was also investigated for CD68, TNF-alpha, GFAP. In blood, cell counts were performed while plasma was screened for endothelial activation (sP-selectin, ET-1) and for inflammation markers (TNF-alpha, MIP-2, IL-1 beta, MPO). Genes up-regulation (HMOX1, Cyp1B1, IL-1 beta, MIP-2, MPO) and miR-21 have been investigated in lungs and blood. Inflammation in the respiratory tract of PM10sum-treated mice has been confirmed in BALf and lung parenchyma by increased PMNs percentage, increased ET-1, MPO and cytokines levels. A systemic spreading of lung inflammation in PM10sum-treated mice has been related to the increased blood total cell count and neutrophils percentage, as well as to increased blood MPO. The blood-endothelium interface activation has been confirmed by significant increases of plasma ET-1 and sP-selectin. Furthermore PM10sum induced heart endothelial activation and PAHs metabolism, proved by increased ET-1 and Cyp1B1 levels. Moreover, PM10sum causes an increase in brain HO-1 and ET-1. These results state the translocation of inflammation mediators, ultrafine particles, LPS, metals associated to PM10sum, from lungs to bloodstream, thus triggering a systemic reaction, mainly involving heart and brain. Our results provided additional insight into the toxicity of PM10sum and could facilitate shedding light on mechanisms underlying the development of urban air pollution related diseases.
C1 [Farina, Francesca; Sancini, Giulio; Palestini, Paola] Univ Milano Bicocca, Dept Hlth Sci, POLARIS Res Ctr, Monza, Italy.
   [Battaglia, Cristina; Tinaglia, Valentina] Univ Milan, PhD Sch Mol Med, Dept Med Biotechnol & Translat Med BIOMETRA, Segrate, Italy.
   [Mantecca, Paride; Camatini, Marina] Univ Milano Bicocca, Dept Environm Sci, POLARIS Res Ctr, Milan, Italy.
RP Sancini, G (reprint author), Univ Milano Bicocca, Dept Hlth Sci, POLARIS Res Ctr, Monza, Italy.
EM giulio.sancini@unimib.it
RI Battaglia, Cristina/E-5166-2017; Sancini, Giulio/I-5136-2012
OI Battaglia, Cristina/0000-0003-3025-9657; Sancini,
   Giulio/0000-0003-2567-109X; Mantecca, Paride/0000-0002-6962-049X;
   Palestini, Paola/0000-0002-1045-8838
FU CARIPLO Foundation; Scuola di Dottorato di Medicina Molecolare,
   Universita degli Studi di Milano
FX This research has received a financial support by the CARIPLO Foundation
   to the project TOSCA "Toxicity of particulate matter and marker of
   risk''. Francesca Farina obtained a grant for this project. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.; Authors thank the
   researchers of the Atmospheric Chemistry group directed by Prof. E.
   Bolzacchini, operating in the POLARIS Research Center, Department of
   Environmental Science, University of Milano Bicocca, for their precious
   contribution in PM sampling and chemical characterization. Thanks to
   Prof. A. Pesci, Azienda Ospedaliera San Gerardo, Monza, for his precious
   contribution in microscope analyses. Valentina Tinaglia is recipient of
   PhD fellowship from Scuola di Dottorato di Medicina Molecolare,
   Universita degli Studi di Milano. We thank Maria Carla Proverbio
   (Universita degli Studi di Milano) for technical assistance with gene
   expression analysis.
CR Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104
   Araujo JA, 2008, CIRC RES, V102, P589, DOI 10.1161/CIRCRESAHA.107.164970
   Asea A, 2000, NAT MED, V6, P435
   Bessette EE, 2009, J BIOCHEM MOL TOXIC, V23, P222, DOI 10.1002/jbt.20283
   Bivas-Benita M, 2005, EUR J PHARM BIOPHARM, V61, P214, DOI 10.1016/j.ejpb.2005.04.009
   Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004
   Bourotte Christine Laure Marie, 2011, Rev. bras. meteorol., V26, P419, DOI 10.1590/S0102-77862011000300008
   Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Burger PC, 2003, BLOOD, V101, P2661, DOI 10.1182/blood-2002-07-2209
   Calderon-Garciduenas L, 2002, TOXICOL PATHOL, V30, P373, DOI 10.1080/01926230252929954
   Calderon-Garciduenas L, 2007, TOXICOL PATHOL, V35, P154, DOI 10.1080/01926230601059985
   Camatini M, 2012, ENVIRON TOXICOL, V27, P63, DOI 10.1002/tox.20611
   Campbell A, 2005, NEUROTOXICOLOGY, V26, P133, DOI 10.1016/j.neuro.2004.08.003
   Campen MJ, 2010, TOXICOL APPL PHARM, V242, P310, DOI 10.1016/j.taap.2009.10.021
   Cao Q, 2007, TOXICOL LETT, V171, P126, DOI 10.1016/j.toxlet.2007.05.007
   Case SR, 2011, EXP LUNG RES, V37, P500, DOI 10.3109/01902148.2011.596895
   Chauhan V, 2005, CELL BIOL TOXICOL, V21, P191, DOI 10.1007/s10565-005-0162-x
   Chen JM, 2006, TOXICOLOGY, V222, P195, DOI 10.1016/j.tox.2006.02.016
   Choi BM, 2003, FREE RADICAL BIO MED, V34, P1136, DOI 10.1016/S0891-5849(03)00064-9
   Chow JC, 2006, J AIR WASTE MANAGE, V56, P707, DOI 10.1080/10473289.2006.10464484
   DULARAY B, 1990, CLIN EXP IMMUNOL, V79, P195
   Emmerechts J, 2010, J THROMB HAEMOST, V8, P2651, DOI 10.1111/j.1538-7836.2010.04081.x
   Fagan KA, 2001, RESP RES, V2, P90, DOI 10.1186/rr44
   Farina F, 2011, TOXICOL LETT, V202, P209, DOI 10.1016/j.toxlet.2011.01.031
   Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36
   Franchini M, 2009, SEMIN THROMB HEMOST, V35, P665, DOI 10.1055/s-0029-1242720
   Franzetti A, 2011, APPL MICROBIOL BIOT, V90, P745, DOI 10.1007/s00253-010-3048-7
   Fredenburgh LE, 2007, AM J RESP CELL MOL, V36, P158, DOI 10.1165/rcmb.2006-0331TR
   Gilmour MI, 2007, INHAL TOXICOL, V19, P7, DOI 10.1080/08958370701490379
   Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600
   Graff DW, 2009, ENVIRON HEALTH PERSP, V117, P1089, DOI 10.1289/ehp0900558
   Graff DW, 2004, ENVIRON HEALTH PERSP, V112, P792, DOI 10.1289/txg.6865
   Gualtieri M, 2009, TOXICOL LETT, V188, P52, DOI 10.1016/j.toxlet.2009.03.003
   Gunnison A, 2005, INHAL TOXICOL, V17, P225, DOI 10.1080/08958370590912851
   Guo L, 2012, J HAZARD MATER, V213, P28, DOI 10.1016/j.jhazmat.2012.01.034
   Happo MS, 2010, INHAL TOXICOL, V22, P402, DOI 10.3109/08958370903527908
   Hasegawa G, 2011, INHAL TOXICOL, V23, P897, DOI 10.3109/08958378.2011.625058
   Henderson RF, 2005, EXP TOXICOL PATHOL, V57, P155, DOI 10.1016/j.etp.2005.05.004
   JACQUIERSARLIN MR, 1994, EXPERIENTIA, V50, P1031, DOI 10.1007/BF01923458
   Kang J, 2005, J HARD TISSUE BIOL, V14, P1
   Kang Y James, 2002, Cardiovasc Toxicol, V2, P253, DOI 10.1385/CT:2:4:253
   Khimji AK, 2010, CELL SIGNAL, V22, P1615, DOI 10.1016/j.cellsig.2010.05.002
   Kido T, 2011, AM J RESP CELL MOL, V44, P197, DOI 10.1165/rcmb.2009-0427OC
   Kreyling WG, 2010, NAT BIOTECHNOL, V28, P1275, DOI 10.1038/nbt.1735
   Langrish JP, 2009, HYPERTENSION, V54, P910, DOI 10.1161/HYPERTENSIONAHA.109.135947
   Lossinsky AS, 2004, HISTOL HISTOPATHOL, V19, P535, DOI 10.14670/HH-19.535
   Lund AK, 2009, ARTERIOSCL THROM VAS, V29, P511, DOI 10.1161/ATVBAHA.108.176107
   MacNee W, 2003, EUR RESPIR J, V21, p47S, DOI 10.1183/09031936.03.00403203
   Mantecca P, 2010, TOXICOL LETT, V198, P244, DOI 10.1016/j.toxlet.2010.07.002
   Mantecca P, 2009, TOXICOL LETT, V189, P206, DOI 10.1016/j.toxlet.2009.05.023
   Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044
   MohanKumar SMJ, 2008, NEUROTOXICOLOGY, V29, P479, DOI 10.1016/j.neuro.2007.12.004
   Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240
   Naota M, 2009, TOXICOL PATHOL, V37, P456, DOI 10.1177/0192623309335059
   Oberdorster G, 2002, ENVIRON HEALTH PERSP, V110, pA440, DOI 10.1289/ehp.110-a440
   Oberdorster G, 2004, INHAL TOXICOL, V16, P437, DOI 10.1080/08958370490439597
   Perrone MG, 2012, SCI TOTAL ENVIRON, V414, P343, DOI 10.1016/j.scitotenv.2011.11.026
   Reijerkerk A, 2012, J NEUROCHEM, V121, P730, DOI 10.1111/j.1471-4159.2011.07393.x
   Reiter TA, 2005, FREE RADICAL BIO MED, V39, P1075, DOI 10.1016/j.freeadbiomed.2005.05.023
   Samet JM, 2009, AM J RESP CRIT CARE, V179, P1034, DOI 10.1164/rccm.200807-1043OC
   Saunders V, 2010, ENVIRON HEALTH PERSP, V118, P640, DOI 10.1289/ehp.0901461
   Schicker B, 2009, EUR J APPL PHYSIOL, V105, P771, DOI 10.1007/s00421-008-0962-9
   Schipper HM, 2004, ANN NY ACAD SCI, V1012, P84, DOI 10.1196/annals.1306.007
   Schwarze PE, 2006, HUM EXP TOXICOL, V25, P559, DOI 10.1177/096032706072520
   Shah KB, 2009, CLIN CHEM, V55, P59, DOI 10.1373/clinchem.2008.108159
   Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828
   Stow LR, 2011, FASEB J, V25, P16, DOI 10.1096/fj.10-161612
   Svensson PA, 2006, ATHEROSCLEROSIS, V185, P32, DOI 10.1016/j.atheroscierosis.2005.05.007
   Thomson E, 2005, TOXICOL SCI, V88, P103, DOI 10.1093/toxsci/kfi272
   Utell MJ, 2000, J AEROSOL MED, V13, P355, DOI 10.1089/jam.2000.13.355
   van Eeden Stephan F, 2005, Proc Am Thorac Soc, V2, P61
   Watterson TL, 2009, TOXICOL SCI, V112, P111, DOI 10.1093/toxsci/kfp186
   WEINBERGER I, 1992, AM J CARDIOL, V70, P981, DOI 10.1016/0002-9149(92)90347-2
   XU WB, 1995, THORAX, V50, P1136, DOI 10.1136/thx.50.11.1136
NR 75
TC 42
Z9 42
U1 0
U2 35
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 25
PY 2013
VL 8
IS 2
AR e56636
DI 10.1371/journal.pone.0056636
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 115ZB
UT WOS:000316849500019
PM 23451061
OA DOAJ Gold, Green Published
DA 2019-05-24
ER

PT J
AU Wichmann, J
   Folke, F
   Torp-Pedersen, C
   Lippert, F
   Ketzel, M
   Ellermann, T
   Loft, S
AF Wichmann, Janine
   Folke, Fredrik
   Torp-Pedersen, Christian
   Lippert, Freddy
   Ketzel, Matthias
   Ellermann, Thomas
   Loft, Steffen
TI Out-of-Hospital Cardiac Arrests and Outdoor Air Pollution Exposure in
   Copenhagen, Denmark
SO PLOS ONE
LA English
DT Article
ID CASE-CROSSOVER ANALYSIS; AMERICAN-HEART-ASSOCIATION; FINE PARTICULATE
   MATTER; LONG-TERM EXPOSURE; MYOCARDIAL-INFARCTION; ULTRAFINE PARTICLES;
   AMBIENT AIR; CARDIOVASCULAR-DISEASE; VASCULAR FUNCTION; DISTRIBUTED LAG
AB Cardiovascular disease is the number one cause of death globally and air pollution can be a contributing cause. Acute myocardial infarction and cardiac arrest are frequent manifestations of coronary heart disease. The objectives of the study were to investigate the association between 4 657 out-of-hospital cardiac arrests (OHCA) and hourly and daily outdoor levels of PM10, PM2.5, coarse fraction of PM (PM10-2.5), ultrafine particle proxies, NOx, NO2, O-3 and CO in Copenhagen, Denmark, for the period 2000-2010. Susceptible groups by age and sex was also investigated. A case-crossover design was applied. None of the hourly lags of any of the pollutants were significantly associated with OHCA events. The strongest association with OHCA events was observed for the daily lag4 of PM2.5, lag3 of PM10, lag3 of PM10-2.5, lag3 of NOx and lag4 of CO. An IQR increase of PM2.5 and PM10 was associated with a significant increase of 4% (95% CI: 0%; 9%) and 5% (95% CI: 1%; 9%) in OHCA events with 3 days lag, respectively. None of the other daily lags or other pollutants was significantly associated with OHCA events. Adjustment for O-3 slightly increased the association between OHCA and PM2.5 and PM10. No susceptible groups were identified.
C1 [Wichmann, Janine; Loft, Steffen] Univ Copenhagen, Environm Hlth Sect, Dept Publ Hlth, Fac Hlth Sci, Copenhagen, Denmark.
   [Folke, Fredrik; Torp-Pedersen, Christian] Univ Copenhagen, Dept Cardiol, Gentofte Hosp, Copenhagen, Denmark.
   [Lippert, Freddy] Copenhagen Emergency Med Serv, Copenhagen, Denmark.
   [Ketzel, Matthias; Ellermann, Thomas] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark.
RP Wichmann, J (reprint author), Univ Copenhagen, Environm Hlth Sect, Dept Publ Hlth, Fac Hlth Sci, Copenhagen, Denmark.
EM stl@sund.ku.dk
RI Ketzel, Matthias/K-4246-2015; Torp-Pedersen, Christian/E-5931-2013
OI Ketzel, Matthias/0000-0001-9519-1935; Lippert,
   Freddy/0000-0002-2356-8809; Loft, Steffen/0000-0001-9552-8518; Folke,
   Fredrik/0000-0002-2284-7857
FU Danish Environmental Protection Agency
FX The Danish Environmental Protection Agency funded the air pollution and
   meteorological measurements as part of the Danish Air Quality Monitoring
   Programme. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Allen RW, 2011, AM J RESP CRIT CARE, V183, P1222, DOI 10.1164/rccm.201010-1572OC
   Andersen ZJ, 2007, J EXPO SCI ENV EPID, V17, P625, DOI 10.1038/sj.jes.7500546
   Andersen ZJ, 2010, EUR HEART J, V31, P2034, DOI 10.1093/eurheartj/ehq188
   Anderson HR, 2007, QUANTITATIVE SYSTEMA
   Bateson TF, 1999, EPIDEMIOLOGY, V10, P539, DOI 10.1097/00001648-199909000-00013
   Bateson TF, 2001, EPIDEMIOLOGY, V12, P654, DOI 10.1097/00001648-200111000-00013
   Bhaskaran K, 2009, HEART, V95, P1746, DOI 10.1136/hrt.2009.175018
   Bosson J, 2007, RESP MED, V101, P1140, DOI 10.1016/j.rmed.2006.11.010
   Brauner EV, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-13
   Brauner EV, 2008, AM J RESP CRIT CARE, V177, P419, DOI 10.1164/rccm.200704-632OC
   Brauner EV, 2007, ENVIRON HEALTH PERSP, V115, P1177, DOI 10.1289/ehp.9984
   Brauner EV, 2009, INHAL TOXICOL, V21, P38, DOI [10.1080/08958370802304735, 10.1080/08958370802304735 ]
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Chow JC, 2006, J AIR WASTE MANAGE, V56, P707, DOI 10.1080/10473289.2006.10464484
   Costa DL, 1997, ENVIRON HEALTH PERSP, V105, P1053, DOI 10.2307/3433509
   CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960
   Delfino RJ, 2009, ENVIRON HEALTH PERSP, V117, P1232, DOI 10.1289/ehp.0800194
   Dennekamp M, 2010, EPIDEMIOLOGY, V21, P494, DOI 10.1097/EDE.0b013e3181e093db
   Donaldson Ken, 2005, Part Fibre Toxicol, V2, P10
   Ellermann T, 2011, 836 AARH U NAT ENV R
   Folke F, 2009, CIRCULATION, V120, P510, DOI 10.1161/CIRCULATIONAHA.108.843755
   Forastiere F, 2005, AM J RESP CRIT CARE, V172, P1549, DOI 10.1164/rccm.200412-1726OC
   Ghio AJ, 2001, AM J RESP CRIT CARE, V164, P704, DOI 10.1164/ajrccm.164.4.2011089
   Gilliland FD, 2004, LANCET, V363, P119, DOI 10.1016/S0140-6736(03)15262-2
   Godleski J J, 2000, Res Rep Health Eff Inst, P5
   Goldberg M S, 2000, Res Rep Health Eff Inst, P7
   Guo YM, 2011, ENVIRON HEALTH PERSP, V119, P1719, DOI 10.1289/ehp.1103598
   Hoek G, 2002, LANCET, V360, P1203, DOI 10.1016/S0140-6736(02)11280-3
   Horsted TI, 2007, RESUSCITATION, V72, P214, DOI 10.1016/j.resuscitation.2006.06.029
   Ibald-Mulli A, 2001, AM J PUBLIC HEALTH, V91, P571, DOI 10.2105/AJPH.91.4.571
   Kodavanti UP, 2011, ENVIRON HEALTH PERSP, V119, P312, DOI 10.1289/ehp.1002386
   Lee JT, 2000, ENVIRON HEALTH PERSP, V108, P1107, DOI 10.2307/3434821
   Levy D, 2001, EPIDEMIOLOGY, V12, P193, DOI 10.1097/00001648-200103000-00011
   Levy D, 2001, EPIDEMIOLOGY, V12, P186, DOI 10.1097/00001648-200103000-00010
   Lipsett MJ, 2011, AM J RESP CRIT CARE, V184, P828, DOI 10.1164/rccm.201012-2082OC
   MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853
   Mauderly JL, 2009, ENVIRON HEALTH PERSP, V117, P1, DOI 10.1289/ehp.11654
   Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409
   MORENO PR, 1994, CIRCULATION, V90, P775, DOI 10.1161/01.CIR.90.2.775
   Mossman Brooke T, 2007, Part Fibre Toxicol, V4, P4, DOI 10.1186/1743-8977-4-4
   Mustafic H, 2012, JAMA-J AM MED ASSOC, V307, P713, DOI 10.1001/jama.2012.126
   Myerburg RJ, 2001, CARDIOVASC RES, V50, P177, DOI 10.1016/S0008-6363(01)00253-X
   Nemmar A, 2002, CIRCULATION, V105, P411, DOI 10.1161/hc0402.104118
   Nemmar A, 2003, AM J RESP CRIT CARE, V168, P1366, DOI 10.1164/rccm.200306-801OC
   Nemmar A, 2003, CIRCULATION, V107, P1202, DOI 10.1161/01.CIR.0000053568.13058.67
   O'Neill MS, 2007, OCCUP ENVIRON MED, V64, P373, DOI 10.1136/oem.2006.030023
   Park SK, 2006, CIRCULATION, V114, P2798, DOI 10.1161/CIRCULATIONAHA.106.643197
   Peters A, 2004, NEW ENGL J MED, V351, P1721, DOI 10.1056/NEJMoa040203
   Peters A, 2001, CIRCULATION, V103, P2810
   Priori SG, 2001, EUR HEART J, V22, P1374, DOI 10.1053/euhj.2001.2824
   Rayner M, 2009, EUR J CARDIOV PREV R, V16, pS43, DOI 10.1097/01.hjr.0000359235.59808.ba
   Rich DQ, 2006, ENVIRON HEALTH PERSP, V114, P120, DOI 10.1289/ehp.8371
   Rosenthal FS, 2008, ENVIRON HEALTH PERSP, V116, P631, DOI 10.1289/ehp.10757
   Schwartz J, 2000, EPIDEMIOLOGY, V11, P320, DOI 10.1097/00001648-200005000-00016
   SEATON A, 1995, LANCET, V345, P176, DOI 10.1016/S0140-6736(95)90173-6
   Silverman RA, 2010, AM J EPIDEMIOL, V172, P917, DOI 10.1093/aje/kwq217
   Sotoodehnia N, 2001, CARDIOVASC RES, V50, P197, DOI 10.1016/S0008-6363(01)00260-7
   Spooner PM, 2001, CIRCULATION, V103, P2361
   Sullivan J, 2003, AM J EPIDEMIOL, V157, P501, DOI 10.1093/aje/kwg015
   Vinzents PS, 2005, ENVIRON HEALTH PERSP, V113, P1485, DOI 10.1289/ehp.7562
   Wahlin P, 2001, ATMOS ENVIRON, V35, P3549, DOI 10.1016/S1352-2310(01)00066-8
   Wichmann J, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-19
   Wichmann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022904
   Willich SN, 1999, VASC MED, V4, P41, DOI 10.1177/1358836X9900400108
   Working group of the Danish Cardiac Arrest Registry, 2005, STAT REP
   Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334
NR 66
TC 27
Z9 28
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 14
PY 2013
VL 8
IS 1
AR e53684
DI 10.1371/journal.pone.0053684
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 087KE
UT WOS:000314759400066
PM 23341975
OA Other Gold, Green Published
DA 2019-05-24
ER

PT J
AU Barbosa, CMG
   Terra, M
   de Albuquerque, ALP
   Di Giorgi, D
   Grupi, C
   Negrao, CE
   Rondon, MUPB
   Martinez, DG
   Marcourakis, T
   dos Santos, FA
   Braga, ALF
   Zanetta, DMT
   Santos, UD
AF Galvao Barbosa, Cristiane Maria
   Terra-Filho, Mario
   Pereira de Albuquerque, Andre Luis
   Di Giorgi, Dante
   Grupi, Cesar
   Negrao, Carlos Eduardo
   Pinto Brandao Rondon, Maria Urbana
   Martinez, Daniel Godoy
   Marcourakis, Tania
   dos Santos, Fabiana Almeida
   Ferreira Braga, Alfesio Luis
   Trevisan Zanetta, Dirce Maria
   Santos, Ubiratan de Paula
TI Burnt Sugarcane Harvesting - Cardiovascular Effects on a Group of
   Healthy Workers, Brazil
SO PLOS ONE
LA English
DT Article
ID AIR-POLLUTION; OXIDATIVE STRESS; BLOOD-PRESSURE; EXERCISE; EXPOSURE;
   HYPONATREMIA; POLLUTANTS; FAILURE; IMPACT; ADULTS
AB Background: Brazil is the world's largest producer of sugarcane. Harvest is predominantly manual, exposing workers to health risks: intense physical exertion, heat, pollutants from sugarcane burning.
   Design: Panel study to evaluate the effects of burnt sugarcane harvesting on blood markers and on cardiovascular system.
   Methods: Twenty-eight healthy male workers, living in the countryside of Brazil were submitted to blood markers, blood pressure, heart rate variability, cardiopulmonary exercise testing, sympathetic nerve activity evaluation and forearm blood flow measures (venous occlusion plethysmography) during burnt sugarcane harvesting and four months later while they performed other activities in sugar cane culture.
   Results: Mean participant age was 31 +/- 6.3 years, and had worked for 9.8 +/- 8.4 years on sugarcane work. Work during the harvest period was associated with higher serum levels of Creatine Kinase - 136.5 U/L (IQR: 108.5-216.0) vs. 104.5 U/L (IQR: 77.5-170.5), (p = 0.001); plasma Malondialdehyde-7.5 +/- 1.4 mu M/dl vs. 6.9 +/- 1.0 mu M/dl, (p = 0.058); Glutathione Peroxidase - 55.1 +/- 11.8 Ug/Hb vs. 39.5 +/- 9.5 Ug/Hb, (p < 0.001); Glutathione Transferase- 3.4 +/- 1.3 Ug/Hb vs. 3.0 +/- 1.3 Ug/Hb, (p = 0.001); and 24-hour systolic blood pressure - 120.1 +/- 10.3 mmHg vs. 117.0 +/- 10.0 mmHg, (p = 0.034). In cardiopulmonary exercise testing, rest-to-peak diastolic blood pressure increased by 11.12 mmHg and 5.13 mmHg in the harvest and non-harvest period, respectively. A 10 miliseconds reduction in rMSSD and a 10 burst/min increase in sympathetic nerve activity were associated to 2.2 and 1.8 mmHg rises in systolic arterial pressure, respectively.
   Conclusion: Work in burnt sugarcane harvesting was associated with changes in blood markers and higher blood pressure, which may be related to autonomic imbalance.
C1 [Galvao Barbosa, Cristiane Maria; Terra-Filho, Mario; Pereira de Albuquerque, Andre Luis; Santos, Ubiratan de Paula] Univ Sao Paulo, Fac Med, Hosp Clin, Heart Inst InCor,Pulm Div, Sao Paulo, Brazil.
   [Galvao Barbosa, Cristiane Maria] FUNDACENTRO, Sao Paulo, Brazil.
   [Di Giorgi, Dante] Univ Sao Paulo, Fac Med, Hosp Clin, Heart Inst InCor,Hypertens Unit, Sao Paulo, Brazil.
   [Grupi, Cesar] Univ Sao Paulo, Fac Med, Hosp Clin, Heart Inst InCor,Electrocardiol Unit, Sao Paulo, Brazil.
   [Negrao, Carlos Eduardo; Pinto Brandao Rondon, Maria Urbana; Martinez, Daniel Godoy] Univ Sao Paulo, Fac Med, Hosp Clin, Heart Inst InCor,Unit Cardiovasc Rehabil & Exerci, Sao Paulo, Brazil.
   [Marcourakis, Tania; dos Santos, Fabiana Almeida] Univ Sao Paulo, Pharmacol Sci Sch, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
   [Ferreira Braga, Alfesio Luis] Univ Sao Paulo, Fac Med, Dept Pathol, Lab Expt Air Pollut,Environm Epidemiol Study Grp, Sao Paulo, Brazil.
   [Ferreira Braga, Alfesio Luis] Univ Catolica Santos, Environm Exposure & Risk Assessment Grp, Sao Paulo, Brazil.
   [Trevisan Zanetta, Dirce Maria] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil.
RP Santos, UD (reprint author), Univ Sao Paulo, Fac Med, Hosp Clin, Heart Inst InCor,Pulm Div, Sao Paulo, Brazil.
EM pneubiratan@incor.usp.br
RI Zanetta, Dirce/G-4950-2013; Martinez, Daniel/D-9135-2015; Terra-Filho,
   Mario/H-5806-2012; Negrao, Carlos/C-4281-2012; Santos,
   Ubiratan/H-7862-2012; Martinez, Daniel Godoy/O-6617-2019; Braga, Alfesio
   L. F./G-6920-2012; Rondon, Maria Urbana/G-5272-2012; Marcourakis,
   Tania/D-6667-2012
OI Martinez, Daniel/0000-0003-0034-7963; Terra-Filho,
   Mario/0000-0002-8642-5354; Santos, Ubiratan/0000-0003-4919-884X;
   Martinez, Daniel Godoy/0000-0003-0034-7963; Braga, Alfesio L.
   F./0000-0003-3254-3029; Rondon, Maria Urbana/0000-0002-4134-6126; 
CR ACGIH, 2010, TLVS BEIS THRESH LIM
   Alperovitch A, 2009, ARCH INTERN MED, V169, P75, DOI 10.1001/archinternmed.2008.512
   Alves Francisco, 2006, Saude soc., V15, P90, DOI 10.1590/S0104-12902006000300008
   Anastasakis A, 2005, HEART, V91, P1477, DOI 10.1136/hrt.2004.055053
   Anderson J, 2009, ATHEROSCLEROSIS, V10, P1
   Arbex MA, 2010, J EPIDEMIOL COMMUN H, V64, P573, DOI 10.1136/jech.2009.094342
   ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211
   Baccarelli A, 2007, J THROMB HAEMOST, V5, P252, DOI 10.1111/j.1538-7836.2007.02300.x
   Bankir L, 2007, CLIN J AM SOC NEPHRO, V2, P304, DOI 10.2215/CJN.03401006
   Baumgartner J, 2011, ENV HLTH PERSPECT
   Bosso RMV, 2006, SCI TOTAL ENVIRON, P382
   Brancaccio P, 2007, BRIT MED BULL, V81-82, P209, DOI 10.1093/bmb/ldm014
   Brazilian Society of Cardiology Brazilian Society of Hypertension and Brazilian society of Nephrology, 2005, ARQUIVOS BRASILEIROS, V85, P1
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Brook RD, 2009, HYPERTENSION, V54, P659, DOI 10.1161/HYPERTENSIONAHA.109.130237
   Brunekreef B, 2009, RES REP HLTH EFF I, V139, P73
   Brunekreef Bert, 2009, Res Rep Health Eff Inst, P5
   Cancado JE, 2006, ENVIRON HEALTH PERSP, V114, P725, DOI 10.1289/ehp.8485
   Canado Jos Eduardo Delfini, 2006, J. bras. pneumol., V32, pS5, DOI 10.1590/S1806-37132006000800003
   Delfino RJ, 2010, EPIDEMIOLOGY, V21, P396, DOI 10.1097/EDE.0b013e3181d5e19b
   Donde A, 2012, J OCCUP ENVIRON MED, V54, P466, DOI 10.1097/JOM.0b013e318246f1d4
   Feng J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033385
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   Forbes LJL, 2009, EPIDEMIOLOGY, V20, P245, DOI 10.1097/EDE.0b013e318190ea3f
   Fuks K., 2011, ENV HLTH PERSPECT
   Garigan TP, 1999, MIL MED, V164, P234
   GLINER JA, 1975, J APPL PHYSIOL, V39, P628
   Gold DR, 2000, CIRCULATION, V101, P1267, DOI 10.1161/01.CIR.101.11.1267
   Gomes EC, 2012, OXID MED CELL LONGEV, DOI 10.1155/2012/756132
   Goto DM, 2011, ENVIRON RES, V111, P664, DOI 10.1016/j.envres.2011.03.006
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   Haskell WL, 2007, CIRCULATION, V116, P1081, DOI 10.1161/CIRCULATIONAHA.107.185649
   Henderson SB, 2011, ENVIRON HEALTH PERSP, V119, P1266, DOI 10.1289/ehp.1002288
   Herdy AH, 2011, ARQ BRAS CARDIOL, V96, P54, DOI 10.1590/S0066-782X2010005000155
   Hew-Butler T, 2010, SPORTS MED, V40, P459, DOI 10.2165/11532070-000000000-00000
   Krewski D, 2009, RES REP HLTH EFF I, V2009, P115
   Krewski Daniel, 2009, Res Rep Health Eff Inst, P5
   LAAT E. F., 2008, IMPACTOS IND CANAVIE, P36
   Lakka TA, 2005, EUR HEART J, V26, P2018, DOI 10.1093/eurheartj/ehi394
   Li N, 2003, CLIN IMMUNOL, V109, P250, DOI 10.1016/j.clim.2003.08.006
   Liao DP, 2004, AM J EPIDEMIOL, V159, P768, DOI 10.1093/aje/kwh109
   Marzatico F, 1997, J SPORT MED PHYS FIT, V37, P235
   Mazzoli-Rocha F, 2008, ENVIRON RES, V108, P35, DOI 10.1016/j.envres.2008.05.004
   Naeher LP, 2007, INHAL TOXICOL, V19, P67, DOI 10.1080/08958370600985875
   Negrao CE, 2001, AM J PHYSIOL-HEART C, V280, pH1286
   Peters A, 2001, EUR HEART J, V22, P1198, DOI 10.1053/euhj.2000.2483
   Pope CA, 1999, AM HEART J, V138, P890, DOI 10.1016/S0002-8703(99)70014-1
   Qian ZM, 2008, ENVIRON HEALTH PERSP, V116, P1172, DOI 10.1289/ehp.10847
   Ribeiro H, 2008, REV SAUDE PUBL, V42, P1
   Romieu I, 2008, EUR RESPIR J, V31, P179, DOI 10.1183/09031936.00128106
   Sangani RG, 2010, INHAL TOXICOL, V22, P621, DOI 10.3109/08958371003599037
   Santos UD, 2005, EUR HEART J, V26, P193, DOI 10.1093/eurheartj/ehi035
   SHIEH SD, 1992, AM J NEPHROL, V12, P252, DOI 10.1159/000168454
   Sim AS, 2003, J CHROMATOGR B, V785, P337, DOI 10.1016/S1570-0232(02)00956-X
   SPURR GB, 1977, AM J CLIN NUTR, V30, P1740
   Tanskanen M, 2010, J SPORT SCI, V28, P309, DOI 10.1080/02640410903473844
   Task Force of Eur Soc Cardiology North Am Society Eletrophysiology, 1996, CIRCULATION, V93, P1043
   WHO (World Health Organization), 2006, WHO AIR QUAL GUID PA
   Yin Z, 2009, AM J PHYSIOL-HEART C, V296, pH1540
NR 59
TC 14
Z9 14
U1 1
U2 20
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 27
PY 2012
VL 7
IS 9
AR e46142
DI 10.1371/journal.pone.0046142
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 016KQ
UT WOS:000309517500065
PM 23029413
OA Other Gold, Green Published
DA 2019-05-24
ER

PT J
AU Nemmar, A
   Subramaniyan, D
   Ali, BH
AF Nemmar, Abderrahim
   Subramaniyan, Deepa
   Ali, Badreldin H.
TI Protective Effect of Curcumin on Pulmonary and Cardiovascular Effects
   Induced by Repeated Exposure to Diesel Exhaust Particles in Mice
SO PLOS ONE
LA English
DT Article
ID PLASMINOGEN-ACTIVATOR INHIBITOR-1; CORONARY-HEART-DISEASE;
   TUMOR-NECROSIS-FACTOR; ACUTE MYOCARDIAL-INFARCTION; AIR-POLLUTION
   EXPOSURE; PARTICULATE MATTER; INFLAMMATORY RESPONSES; THROMBOTIC EVENTS;
   HEALTHY HUMANS; BLOOD-PRESSURE
AB Particulate air pollution has been associated with increased risk of cardiopulmonary diseases. However, the underlying mechanisms are not fully understood. We have previously demonstrated that single dose exposure to diesel exhaust particle (DEP) causes lung inflammation and peripheral thrombotic events. Here, we exposed mice with repeated doses of DEP (15 mu g/animal) every 2nd day for 6 days (a total of 4 exposures), and measured several cardiopulmonary endpoints 48 h after the end of the treatments. Moreover, the potential protective effect of curcumin (the yellow pigment isolated from turmeric) on DEP-induced cardiopulmonary toxicity was assessed. DEP exposure increased macrophage and neutrophil numbers, tumor necrosis factor a (TNF alpha) in the bronchoalveolar lavage (BAL) fluid, and enhanced airway resistance to methacoline measured invasively using Flexivent. DEP also significantly increased plasma C-reactive protein (CRP) and TNF alpha concentrations, systolic blood pressure (SBP) as well as the pial arteriolar thrombosis. It also significantly enhanced the plasma D-dimer and plasminogen activator inhibitor-1 (PAI-1). Pretreatment with curcumin by oral gavage (45 mg/kg) 1h before exposure to DEP significantly prevented the influx of inflammatory cells and the increase of TNF alpha in BAL, and the increased airway resistance caused by DEP. Likewise, curcumin prevented the increase of SBP, CRP, TNF alpha, D-dimer and PAI-1. The thrombosis was partially but significantly mitigated. In conclusion, repeated exposure to DEP induced lung and systemic inflammation characterized by TNF alpha release, increased SBP, and accelerated coagulation. Our findings indicate that curcumin is a potent anti-inflammatory agent that prevents the release of TNF alpha and protects against the pulmonary and cardiovascular effects of DEP.
C1 [Nemmar, Abderrahim; Subramaniyan, Deepa] United Arab Emirates Univ, Dept Physiol, Fac Med & Hlth Sci, Al Ain, U Arab Emirates.
   [Ali, Badreldin H.] Sultan Qaboos Univ, Dept Pharmacol & Clin Pharm, Coll Med & Hlth Sci, Al Khoud, Oman.
RP Nemmar, A (reprint author), United Arab Emirates Univ, Dept Physiol, Fac Med & Hlth Sci, Al Ain, U Arab Emirates.
EM anemmar@uaeu.ac.ae
FU Emirates Foundation [2009-045]; United Arab Emirates University, Faculty
   of Medicine and Health Sciences
FX This work was supported by the Emirates Foundation grant Grant #:
   2009-045 and United Arab Emirates University, Faculty of Medicine and
   Health Sciences Grant. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ali BH, 2006, NAT PROD COMMUN, V1, P509
   BARRY CC, 1994, ENVIRONMENT, V36, P5
   Behndig AF, 2006, EUR RESPIR J, V27, P359, DOI 10.1183/09031936.06.00136904
   Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Brook RD, 2009, J AM SOC HYPERTENS, V3, P332, DOI 10.1016/j.jash.2009.08.005
   Brook RD, 2009, HYPERTENSION, V54, P659, DOI 10.1161/HYPERTENSIONAHA.109.130237
   Budinger GRS, 2011, PLOS ONE, P6
   Cesari M, 2010, CARDIOVASC THER, V28, pe72, DOI 10.1111/j.1755-5922.2010.00171.x
   Cheng AL, 2001, ANTICANCER RES, V21, P2895
   Delfino RJ, 2008, ENVIRON HEALTH PERSP, V116, P898, DOI 10.1289/ehp.11189
   Delfino RJ, 2009, ENVIRON HEALTH PERSP, V117, P1232, DOI 10.1289/ehp.0800194
   Driscoll KE, 2000, TOXICOL SCI, V55, P24, DOI 10.1093/toxsci/55.1.24
   Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941
   Epstein JA, 2008, J CLIN INVEST, V118, P850, DOI 10.1172/JCI34650
   Franchini M, 2011, BLOOD, V118, P2405, DOI 10.1182/blood-2011-04-343111
   Ghosh SS, 2009, AM J PHYSIOL-RENAL, V296, pF1146, DOI 10.1152/ajprenal.90732.2008
   Gruber F, 2003, BLOOD, V101, P3042, DOI 10.1182/blood-2002-07-2331
   Hou BD, 2004, J BIOL CHEM, V279, P18127, DOI 10.1074/jbc.M310438200
   Kido T, 2010, AM J RESP CELL MOL B
   Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146
   Lowe GDO, 1999, THROMB HAEMOSTASIS, V82, P667
   Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007
   Mills NL, 2007, NEW ENGL J MED, V357, P1075, DOI 10.1056/NEJMoa066314
   Mills NL, 2009, NAT CLIN PRACT CARD, V6, P36, DOI 10.1038/ncpcardio1399
   Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160
   Mutlu GM, 2007, J CLIN INVEST, V117, P2952, DOI 10.1172/JCI30639
   Nemmar A, 2004, CIRCULATION, V110, P1670, DOI 10.1161/01.CIR.0000142053.13921.21
   Nemmar A, 2003, CIRCULATION, V107, P1202, DOI 10.1161/01.CIR.0000053568.13058.67
   Nemmar A, 2008, EXP BIOL MED, V233, P610, DOI 10.3181/0706-RM-165
   Nemmar A, 2007, AM J PHYSIOL-LUNG C, V292, pL664, DOI 10.1152/ajplung.00240.2006
   Nemmar A, 2011, BRIT J PHARMACOL, V164, P1871, DOI 10.1111/j.1476-5381.2011.01442.x
   Nemmar A, 2010, TOXICOL LETT, V194, P58, DOI 10.1016/j.toxlet.2010.02.001
   Nemmar A, 2010, TOXICOL SCI, V113, P267, DOI 10.1093/toxsci/kfp222
   Nemmar A, 2009, TOXICOLOGY, V263, P84, DOI 10.1016/j.tox.2009.06.017
   Nordenhall C, 2001, EUR RESPIR J, V17, P909, DOI 10.1183/09031936.01.17509090
   Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360
   Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967
   Park NY, 2011, BRIT J NUTR, V106, P1514, DOI 10.1017/S0007114511001929
   Plomgaard P, 2005, J APPL PHYSIOL, V98, P2019, DOI 10.1152/japplphysiol.01220.2004
   Punithavathi D, 2000, BRIT J PHARMACOL, V131, P169, DOI 10.1038/sj.bjp.0703578
   RIDKER PM, 1994, CIRCULATION, V90, P2236, DOI 10.1161/01.CIR.90.5.2236
   Ruckerl R, 2006, AM J RESP CRIT CARE, V173, P432, DOI 10.1164/rccm.200507-1123OC
   Ruckerl Regina, 2007, Part Fibre Toxicol, V4, P1, DOI 10.1186/1743-8977-4-1
   Saber AT, 2005, ARCH TOXICOL, V79, P177, DOI 10.1007/s00204-004-0613-9
   Salam MT, 2008, CURR OPIN PULM MED, V14, P3, DOI 10.1097/MCP.0b013e3282f1987a
   Sallam N, 2010, MEDIAT INFLAMM, DOI 10.1155/2010/149678
   Salvi S, 1999, AM J RESP CRIT CARE, V159, P702, DOI 10.1164/ajrccm.159.3.9709083
   Shishodia S, 2003, CARCINOGENESIS, V24, P1269, DOI 10.1093/carcin/bgg078
   Su CC, 2010, PHYTOTHER RES, V24, P189, DOI 10.1002/ptr.2905
   Sun QH, 2010, CIRCULATION, V121, P2755, DOI 10.1161/CIRCULATIONAHA.109.893461
   Suresh MV, 2012, AM J RESP CELL MOL, V47, P280, DOI 10.1165/rcmb.2011-0175OC
   Suzuki M, 2009, AM J PHYSIOL-LUNG C, V296, pL614, DOI 10.1152/ajplung.90443.2008
   Thogersen AM, 1998, CIRCULATION, V98, P2241, DOI 10.1161/01.CIR.98.21.2241
   Vanoirbeek JAJ, 2004, TOXICOL SCI, V80, P310, DOI 10.1093/toxsci/kfh155
   Vermylen J, 2005, J THROMB HAEMOST, V3, P1955, DOI 10.1111/j.1538-7836.2005.01471.x
   Yamashita M, 1997, THROMB RES, V87, P165, DOI 10.1016/S0049-3848(97)00116-3
   Yeh ETH, 2004, CIRCULATION, V109, P11, DOI 10.1161/01.CIR.0000129507.12719.80
   Ying ZK, 2009, AM J PHYSIOL-HEART C, V296, pH1540, DOI 10.1152/ajpheart.01270.2008
NR 59
TC 42
Z9 44
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 22
PY 2012
VL 7
IS 6
AR e39554
DI 10.1371/journal.pone.0039554
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 964XV
UT WOS:000305730900076
PM 22745783
OA Green Published, Other Gold
DA 2019-05-24
ER

PT J
AU Sorensen, M
   Andersen, ZJ
   Nordsborg, RB
   Jensen, SS
   Lillelund, KG
   Beelen, R
   Schmidt, EB
   Tjonneland, A
   Overvad, K
   Raaschou-Nielsen, O
AF Sorensen, Mette
   Andersen, Zorana J.
   Nordsborg, Rikke B.
   Jensen, Steen S.
   Lillelund, Kenneth G.
   Beelen, Rob
   Schmidt, Erik B.
   Tjonneland, Anne
   Overvad, Kim
   Raaschou-Nielsen, Ole
TI Road Traffic Noise and Incident Myocardial Infarction: A Prospective
   Cohort Study
SO PLOS ONE
LA English
DT Article
ID AIR-POLLUTION; CARDIOVASCULAR-DISEASE; GLUCOSE-METABOLISM; HUMAN
   EXPOSURE; SLEEP; DANISH; RISK; REGISTER; INSOMNIA; OBESITY
AB Background: Both road traffic noise and ambient air pollution have been associated with risk for ischemic heart disease, but only few inconsistent studies include both exposures.
   Methods: In a population-based cohort of 57 053 people aged 50 to 64 years at enrolment in 1993-1997, we identified 1600 cases of first-ever MI between enrolment and 2006. The mean follow-up time was 9.8 years. Exposure to road traffic noise and air pollution from 1988 to 2006 was estimated for all cohort members from residential address history. Associations between exposure to road traffic noise and incident MI were analysed in a Cox regression model with adjustment for air pollution (NOx) and other potential confounders: age, sex, education, lifestyle confounders, railway and airport noise.
   Results: We found that residential exposure to road traffic noise (L-den) was significantly associated with MI, with an incidence rate ratio IRR of 1.12 per 10 dB for both of the two exposure windows: yearly exposure at the time of diagnosis (95% confidence interval (CI): 1.02-1.22) and 5-years time-weighted mean (95% CI: 1.02-1.23) preceding the diagnosis. Visualizing of the results using restricted cubic splines showed a linear dose-response relationship.
   Conclusions: Exposure to long-term residential road traffic noise was associated with a higher risk for MI, in a dose-dependent manner.
C1 [Sorensen, Mette; Andersen, Zorana J.; Nordsborg, Rikke B.; Tjonneland, Anne; Raaschou-Nielsen, Ole] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark.
   [Andersen, Zorana J.] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark.
   [Jensen, Steen S.] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark.
   [Lillelund, Kenneth G.] Ramboll Danmark AS, Aarhus, Denmark.
   [Beelen, Rob] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands.
   [Schmidt, Erik B.; Overvad, Kim] Aarhus Univ Hosp, Aalborg Hosp, Ctr Cardiovasc Res, Dept Cardiol, Aalborg, Denmark.
   [Overvad, Kim] Aarhus Univ, Sch Publ Hlth, Dept Epidemiol, Aarhus, Denmark.
RP Sorensen, M (reprint author), Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark.
EM mettes@cancer.dk
RI Andersen, Zorana Jovanovic/P-4983-2014
OI Andersen, Zorana Jovanovic/0000-0003-4138-9828; Sorensen,
   Mette/0000-0002-7302-4789; Baastrup Nordsborg,
   Rikke/0000-0003-4374-8230; Tjonneland, Anne/0000-0003-4385-2097
FU Danish Environmental Protection Agency; Research Centre for
   Environmental Health, Danish Ministry of the Interior and Health; Danish
   Cancer Society
FX This work was supported by funding from the Danish Environmental
   Protection Agency, the Research Centre for Environmental Health, Danish
   Ministry of the Interior and Health, and the Danish Cancer Society. The
   Danish Environmental Protection Agency participated in collecting
   information on railway and airport noise. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Babisch WF, 2005, EPIDEMIOLOGY, V16, P33, DOI 10.1097/01.ede.0000147104.84424.24
   Babisch Wolfgang, 2006, Noise Health, V8, P1
   Babisch W, 2008, NOISE HEALTH, V10, P27, DOI 10.4103/1463-1741.39005
   Beelen R, 2009, OCCUP ENVIRON MED, V66, P243, DOI 10.1136/oem.2008.042358
   Bendtsen H, 1999, SCI TOTAL ENVIRON, V235, P331, DOI 10.1016/S0048-9697(99)00216-8
   Berkowicz R, 2008, ENVIRON MODELL SOFTW, V23, P296, DOI 10.1016/j.envsoft.2007.04.007
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Buxton OM, 2010, DIABETES, V59, P2126, DOI 10.2337/db09-0699
   Portela PC, 2009, CEREBROVASC DIS, V27, P104, DOI 10.1159/000200447
   Council of the European Parliament, 2002, OFFICIAL J EUROPEA L, VL 189, P12
   Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958
   Hertel O, 2001, PURE APPL CHEM, V73, P137, DOI 10.1351/pac200173010137
   Hui L, 2007, BRAIN BEHAV IMMUN, V21, P308, DOI 10.1016/j.bbi.2006.09.005
   Huss A, 2010, EPIDEMIOLOGY, V21, P829, DOI 10.1097/EDE.0b013e3181f4e634
   Jarup L, 2008, ENVIRON HEALTH PERSP, V116, P329, DOI 10.1289/ehp.10775
   Jensen SS, 2001, TRANSPORT RES D-TR E, V6, P229, DOI 10.1016/S1361-9209(00)00026-2
   Joensen AM, 2009, J CLIN EPIDEMIOL, V62, P188, DOI 10.1016/j.jclinepi.2008.03.005
   Ketzel M, 2003, ATMOS ENVIRON, V37, P2735, DOI 10.1016/S1352-2310(03)00245-0
   Ketzel M, 2011, INT J ENVIRON POLLUT, V47, P226, DOI 10.1504/IJEP.2011.047337
   Leger D, 2000, J SLEEP RES, V9, P35, DOI 10.1046/j.1365-2869.2000.00178.x
   Lusk SL, 2004, ARCH ENVIRON HEALTH, V59, P392, DOI 10.3200/AEOH.59.8.392-399
   Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482
   Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050
   Miedema Henk M E, 2007, Behav Sleep Med, V5, P1, DOI 10.1207/s15402010bsm0501_1
   Miller MA, 2007, CURR VASC PHARMACOL, V5, P93, DOI 10.2174/157016107780368280
   Raaschou-Nielsen O, 2000, J EXPO ANAL ENV EPID, V10, P4, DOI 10.1038/sj.jea.7500070
   Raaschou-Nielsen O, 2011, ENVIRON HEALTH PERSP, V119, P860, DOI 10.1289/ehp.1002353
   Sateia MJ, 2000, SLEEP, V23, P243
   Selander J, 2009, EPIDEMIOLOGY, V20, P272, DOI 10.1097/EDE.0b013e31819463bd
   Sorensen M, 2011, EUR HEART J, V32, P737, DOI 10.1093/eurheartj/ehq466
   Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8
   Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23
   Stamatakis KA, 2010, CHEST, V137, P95, DOI 10.1378/chest.09-0791
   Thiebaut ACM, 2004, STAT MED, V23, P3803, DOI 10.1002/sim.2098
   Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986
   Wagner J, 2010, INT J HYG ENVIR HEAL, V213, P153, DOI 10.1016/j.ijheh.2009.08.004
   Wright CE, 2007, BRAIN BEHAV IMMUN, V21, P358, DOI 10.1016/j.bbi.2006.08.007
NR 37
TC 81
Z9 85
U1 0
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 20
PY 2012
VL 7
IS 6
AR e39283
DI 10.1371/journal.pone.0039283
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 964KK
UT WOS:000305693200057
PM 22745727
OA Other Gold, Green Published
DA 2019-05-24
ER

PT J
AU Martinelli, N
   Girelli, D
   Cigolini, D
   Sandri, M
   Ricci, G
   Rocca, G
   Olivieri, O
AF Martinelli, Nicola
   Girelli, Domenico
   Cigolini, Davide
   Sandri, Marco
   Ricci, Giorgio
   Rocca, Giampaolo
   Olivieri, Oliviero
TI Access Rate to the Emergency Department for Venous Thromboembolism in
   Relationship with Coarse and Fine Particulate Matter Air Pollution
SO PLOS ONE
LA English
DT Article
ID AMERICAN-HEART-ASSOCIATION; DEEP-VEIN THROMBOSIS;
   CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; NONLINEAR MODELS; EXPOSURE;
   PARTICLES; RISK; ATHEROSCLEROSIS; HEALTH
AB Particulate matter (PM) air pollution has been associated with cardiovascular and respiratory disease. Recent studies have proposed also a link with venous thromboembolism (VTE) risk. This study was aimed to evaluate the possible influence of air pollution-related changes on the daily flux of patients referring to the Emergency Department (ED) for VTE, dissecting the different effects of coarse and fine PM. From July 1(st), 2007, to June 30(th), 2009, data about ED accesses for VTE and about daily concentrations of PM air pollution in Verona district (Italy) were collected. Coarse PM (PM10-2.5) was calculated by subtracting the finest PM2.5 from the whole PM10. During the index period a total of 302 accesses for VTE were observed (135 males and 167 females; mean age 68.3 +/- 16.7 years). In multiple regression models adjusted for other atmospheric parameters PM10-2.5, but not PM2.5, concentrations were positively correlated with VTE (beta-coefficient = 0.237; P = 0.020). During the days with high levels of PM10-2.5 (>= 75(th) percentile) there was an increased risk of ED accesses for VTE (OR 1.69 with 95%CI 1.13-2.53). By analysing days of exposure using distributed lag non-linear models, the increase of VTE risk was limited to PM10-2.5 peaks in the short-term period. Consistently with these results, in another cohort of subjects without active thrombosis (n = 102) an inverse correlation between PM10-2.5 and prothrombin time was found (R = -0.247; P = 0.012). Our results suggest that short-time exposure to high concentrations of PM10-2.5 may favour an increased rate of ED accesses for VTE through the induction of a prothrombotic state.
C1 [Martinelli, Nicola; Girelli, Domenico; Cigolini, Davide; Sandri, Marco; Olivieri, Oliviero] Univ Verona, Dept Med, Sect Internal Med, I-37100 Verona, Italy.
   [Ricci, Giorgio; Rocca, Giampaolo] Hosp Verona, Emergency Dept, Verona, Italy.
RP Martinelli, N (reprint author), Univ Verona, Dept Med, Sect Internal Med, I-37100 Verona, Italy.
EM oliviero.olivieri@univr.it
RI Martinelli, Nicola/J-5622-2016; Olivieri, Oliviero/A-9126-2008; Sandri,
   Marco/L-2875-2013
OI Martinelli, Nicola/0000-0001-6465-5119; Olivieri,
   Oliviero/0000-0001-8209-9056; Sandri, Marco/0000-0002-1422-5695
CR Baccarelli A, 2007, J THROMB HAEMOST, V5, P252, DOI 10.1111/j.1538-7836.2007.02300.x
   Baccarelli A, 2008, ARCH INTERN MED, V168, P920, DOI 10.1001/archinte.168.9.920
   Baccarelli A, 2009, CIRCULATION, V119, P3118, DOI 10.1161/CIRCULATIONAHA.108.836163
   Becker S, 2002, TOXICOL IN VITRO, V16, P209, DOI 10.1016/S0887-2333(02)00015-2
   Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Brook RD, 2009, HYPERTENSION, V54, P659, DOI 10.1161/HYPERTENSIONAHA.109.130237
   Brunekreef B, 2005, EUR RESPIR J, V26, P309, DOI 10.1183/09031936.05.00001805
   Chahine T, 2007, ENVIRON HEALTH PERSP, V115, P1617, DOI 10.1289/ehp.10318
   Chuang KJ, 2007, AM J RESP CRIT CARE, V176, P370, DOI 10.1164/rccm.200611-1627OC
   Dales RE, 2010, J THROMB HAEMOST, V8, P669, DOI 10.1111/j.1538-7836.2010.03760.x
   Dales R, 2007, INT ARCH OCC ENV HEA, V81, P159, DOI 10.1007/s00420-007-0199-7
   Dentali F, 2011, THROMB HAEMOSTASIS, V106, P439, DOI 10.1160/TH11-02-0116
   DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401
   Franchini M, 2007, J THROMB HAEMOST, V5, P2169, DOI 10.1111/j.1538-7836.2007.02750.x
   Franchini M, 2011, BLOOD, V118, P2405, DOI 10.1182/blood-2011-04-343111
   Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940
   Gasparrini A, 2011, J STAT SOFTW, V43, P1
   Ghio AJ, 2003, INHAL TOXICOL, V15, P1465, DOI 10.1080/08958370390249111
   Ghio AJ, 2000, AM J RESP CRIT CARE, V162, P981, DOI 10.1164/ajrccm.162.3.9911115
   Gilmour PS, 2005, OCCUP ENVIRON MED, V62, P164, DOI 10.1136/oem.2004.014951
   Hoffmann B, 2007, CIRCULATION, V116, P489, DOI 10.1161/CIRCULATIONAHA.107.693622
   Hsiao WLW, 2000, MUTAT RES-GEN TOX EN, V471, P45
   Kan H, 2011, J THROMB HAEMOST, V9, P672, DOI 10.1111/j.1538-7836.2011.04210.x
   Kilinc E, 2011, J THROMB HAEMOST, V9, P1359, DOI 10.1111/j.1538-7836.2011.04280.x
   Lucking AJ, 2008, EUR HEART J, V29, P3043, DOI 10.1093/eurheartj/ehn464
   Mannucci PM, 2010, J THROMB HAEMOST, V8, P659, DOI 10.1111/j.1538-7836.2010.03804.x
   Mills NL, 2005, CIRCULATION, V112, P3930, DOI 10.1161/CIRCULATIONAHA.105.588962
   Nawrot TS, 2011, LANCET, V377, P732, DOI 10.1016/S0140-6736(10)62296-9
   Nemmar Abderrahim, 2006, Clin Occup Environ Med, V5, P865
   POPE CA, 1995, AM J RESP CRIT CARE, V151, P669
   R Development Core Team, 2011, R LANG ENV STAT COMP
   Roux AVD, 2008, AM J EPIDEMIOL, V167, P667, DOI 10.1093/aje/kwm359
   Shi T, 2003, OCCUP ENVIRON MED, V60, P315, DOI 10.1136/oem.60.5.315
   Shih RA, 2011, ENVIRON HEALTH PERSP, V119, P326, DOI 10.1289/ehp.1002256
   Sun QH, 2010, CIRCULATION, V121, P2755, DOI 10.1161/CIRCULATIONAHA.109.893461
   Venkataraman C, 1999, INHAL TOXICOL, V11, P151, DOI 10.1080/089583799197221
   Wilson WE, 1997, J AIR WASTE MANAGE, V47, P1238, DOI 10.1080/10473289.1997.10464074
   Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382
   Zeka A, 2006, INT J EPIDEMIOL, V35, P1347, DOI 10.1093/ije/dyl132
NR 40
TC 22
Z9 23
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 11
PY 2012
VL 7
IS 4
AR e34831
DI 10.1371/journal.pone.0034831
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959TP
UT WOS:000305336600061
PM 22509360
OA Other Gold, Green Published
DA 2019-05-24
ER

PT J
AU Clark, CR
   Coull, B
   Berkman, LF
   Buring, JE
   Ridker, PM
AF Clark, Cheryl R.
   Coull, Brent
   Berkman, Lisa F.
   Buring, Julie E.
   Ridker, Paul M.
TI Geographic Variation in Cardiovascular Inflammation among Healthy Women
   in the Women's Health Study
SO PLOS ONE
LA English
DT Article
ID C-REACTIVE PROTEIN; INDIVIDUAL PARTICIPANT METAANALYSIS;
   CORONARY-HEART-DISEASE; 4 US COMMUNITIES; OLDER POPULATIONS; STROKE
   INCIDENCE; UNITED-STATES; RISK; MORTALITY; LEVEL
AB Background: Geographic variation in traditional cardiovascular disease (CVD) risk factors has been observed among women in the US. It is not known whether state-level variation in cardiovascular inflammation exists or could be explained by traditional clinical risk factors and behavioral lifestyle factors.
   Methods and Results: We used multilevel linear regression to estimate state-level variation in inflammatory biomarker patterns adjusted for clinical and lifestyle characteristics among 26,029 women free of CVD. Participants derived from the Women's Health Study, a national cohort of healthy middle-aged and older women. Inflammatory biomarker patterns (plasma levels of high-sensitivity C-reactive protein (hsCRP), soluble intercellular adhesion molecule-1 (sICAM-1), and fibrinogen) were compared to state-level patterns of traditional CVD risk factors and global risk scores. We found that all three inflammatory biomarkers exhibited significant state-level variation including hsCRP (lowest vs. highest state median 1.3 mg/L vs. 2.7 mg/L, unadjusted random effect estimate 1(st) to 99(th) percentile range for log hsCRP 0.52, p<.001), sICAM-1 (325 ng/ml vs. 366ng/ml, unadjusted random effect estimate 1(st) to 99(th) percentile range 0.44, p<.001), and fibrinogen (322 mg/dL vs. 367 mg/dL, unadjusted random effect estimate 1(st) to 99(th) percentile range 0.41, p=.001). Neither demographic, clinical or lifestyle characteristics explained away state-level effects in biomarker patterns. Southern and Appalachian states (Arkansas, West Virginia) had the highest inflammatory biomarker values. Regional geographic patterns of traditional CVD risk factors and risk scores did not completely overlap with biomarkers of inflammation.
   Conclusions: There is state-level geographic variation in inflammatory biomarkers among otherwise healthy women that cannot be completely attributed to traditional clinical risk factors or lifestyle characteristics. Future research should aim to identify additional factors that may explain geographic variation in biomarkers of inflammation among healthy women.
C1 [Clark, Cheryl R.] Harvard Univ, Sch Med, Div Gen Med & Primary Care, Brigham & Womens Faulkner Hosp Program, Boston, MA 02215 USA.
   [Clark, Cheryl R.] Brigham & Womens Hosp, Ctr Community Hlth & Hlth Equ, Boston, MA 02115 USA.
   [Coull, Brent] Harvard Univ, Sch Med, Dept Biostat, Boston, MA USA.
   [Berkman, Lisa F.] Harvard Univ, Sch Publ Hlth, Harvard Ctr Populat & Dev Studies, Boston, MA 02115 USA.
   [Berkman, Lisa F.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA.
   [Buring, Julie E.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA.
   [Ridker, Paul M.] Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA.
   [Ridker, Paul M.] Harvard Univ, Brigham & Womens Hosp, Div Cardiovasc Dis, Sch Med, Boston, MA 02115 USA.
RP Clark, CR (reprint author), Harvard Univ, Sch Med, Div Gen Med & Primary Care, Brigham & Womens Faulkner Hosp Program, Boston, MA 02215 USA.
EM crclark@partners.org
OI Venkatasubramanian, Siddharth/0000-0002-5860-0768
FU National Institutes of Health; Robert Wood Johnson Foundation; National
   Institutes of Aging [K08 AG 032357]; Robert Wood Johnson Foundation
   Health Society [53572]; National Cancer Institute [CA047988]; National
   Heart, Lung, and Blood Institute [HL080467, HL043851, HL099355]
FX The authors gratefully acknowledge the funding support of the National
   Institutes of Health and the Robert Wood Johnson Foundation. This
   research was supported with funding from the National Institutes of
   Aging (K08 AG 032357), and the Robert Wood Johnson Foundation Health &
   Society Scholars program (53572). The Women's Health Study is supported
   with funding from the National Cancer Institute (CA047988) and the
   National Heart, Lung, and Blood Institute (HL080467, HL043851,
   HL099355). The funders had no role in the study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Barker LE, 2011, AM J PREV MED, V40, P434, DOI 10.1016/j.amepre.2010.12.019
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128
   Cushman M, 2009, CLIN CHEM, V55, P1627, DOI 10.1373/clinchem.2008.122093
   Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799
   El-Saed A, 2006, STROKE, V37, P1980, DOI 10.1161/01.STR.0000231454.77745.d9
   El-Saed A, 2006, STROKE, V37, P1975, DOI 10.1161/01.STR.0000231453.98473.67
   Expert Panel, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI DOI 10.1001/JAMA.285.19.2486
   Ezzati M, 2008, CIRCULATION, V117, P905, DOI 10.1161/CIRCULATIONAHA.107.732131
   Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9
   Glymour MM, 2007, STROKE, V38, P2415, DOI 10.1161/STROKEAHA.107.482059
   Greenland P, 2010, J AM COLL CARDIOL, V56, P2182, DOI 10.1016/j.jacc.2010.09.002
   Gregg EW, 2010, JAMA-J AM MED ASSOC, V303, P933
   Howard G, 2009, PREV MED, V49, P129, DOI 10.1016/j.ypmed.2009.03.004
   Hwang SJ, 1997, CIRCULATION, V96, P4219
   Jarvie JL, 2011, J WOMENS HEALTH, V20, P11, DOI 10.1089/jwh.2010.2036
   Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7
   Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646
   Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611
   Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6
   Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613
   Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202
   Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8
   Subramanian SV, 2003, NEIGHBORHOODS HLTH, P65
   Taylor HA, 2002, AM J PUBLIC HEALTH, V92, P548, DOI 10.2105/AJPH.92.4.548
NR 25
TC 4
Z9 4
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 10
PY 2011
VL 6
IS 11
AR e27468
DI 10.1371/journal.pone.0027468
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 852HQ
UT WOS:000297348800027
PM 22102899
OA DOAJ Gold, Green Published
DA 2019-05-24
ER

PT J
AU Budinger, GRS
   McKell, JL
   Urich, D
   Foiles, N
   Weiss, I
   Chiarella, SE
   Gonzalez, A
   Soberanes, S
   Ghio, AJ
   Nigdelioglu, R
   Mutlu, EA
   Radigan, KA
   Green, D
   Kwaan, HC
   Mutlu, GM
AF Budinger, G. R. Scott
   McKell, Joanne L.
   Urich, Daniela
   Foiles, Nancy
   Weiss, Ivy
   Chiarella, Sergio E.
   Gonzalez, Angel
   Soberanes, Saul
   Ghio, Andrew J.
   Nigdelioglu, Recep
   Mutlu, Ece A.
   Radigan, Kathryn A.
   Green, David
   Kwaan, Hau C.
   Mutlu, Goekhan M.
TI Particulate Matter-Induced Lung Inflammation Increases Systemic Levels
   of PAI-1 and Activates Coagulation Through Distinct Mechanisms
SO PLOS ONE
LA English
DT Article
ID NECROSIS-FACTOR-ALPHA; DIESEL-EXHAUST INHALATION; FACTOR PATHWAY
   INHIBITOR; AIR-POLLUTION PARTICLES; CORONARY-HEART-DISEASE;
   PLASMINOGEN-ACTIVATOR; MYOCARDIAL-INFARCTION; TISSUE FACTOR;
   ADIPOSE-TISSUE; EXPOSURE
AB Background: Exposure of human populations to ambient particulate matter (PM) air pollution significantly contributes to the mortality attributable to ischemic cardiovascular events. We reported that mice treated with intratracheally instilled PM develop a prothrombotic state that requires the release of IL-6 by alveolar macrophages. We sought to determine whether exposure of mice to PM increases the levels of PAI-1, a major regulator of thrombolysis, via a similar or distinct mechanism.
   Methods and Principal Findings: Adult, male C57BL/6 and IL-6 knock out (IL-6(-/-)) mice were exposed to either concentrated ambient PM less than 2.5 mu m (CAPs) or filtered air 8 hours daily for 3 days or were exposed to either urban particulate matter or PBS via intratracheal instillation and examined 24 hours later. Exposure to CAPs or urban PM resulted in the IL-6 dependent activation of coagulation in the lung and systemically. PAI-1 mRNA and protein levels were higher in the lung and adipose tissue of mice treated with CAPs or PM compared with filtered air or PBS controls. The increase in PAI-1 was similar in wild-type and IL-6(-/-) mice but was absent in mice treated with etanercept, a TNF-alpha inhibitor. Treatment with etanercept did not prevent the PM-induced tendency toward thrombus formation.
   Conclusions: Mice exposed to inhaled PM exhibited a TNF-alpha-dependent increase in PAI-1 and an IL-6-dependent activation of coagulation. These results suggest that multiple mechanisms link PM-induced lung inflammation with the development of a prothrombotic state.
C1 [Budinger, G. R. Scott; McKell, Joanne L.; Urich, Daniela; Chiarella, Sergio E.; Gonzalez, Angel; Soberanes, Saul; Nigdelioglu, Recep; Radigan, Kathryn A.; Mutlu, Goekhan M.] Northwestern Univ, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Foiles, Nancy; Weiss, Ivy; Green, David; Kwaan, Hau C.] Northwestern Univ, Div Hematol & Oncol, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Ghio, Andrew J.] US EPA, Res Triangle Pk, NC 27711 USA.
   [Mutlu, Ece A.] Rush Univ, Sect Gastroenterol & Nutr, Coll Med, Chicago, IL 60612 USA.
RP Budinger, GRS (reprint author), Northwestern Univ, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA.
EM g-mutlu@northwestern.edu
OI Chiarella, Sergio/0000-0002-0445-4929
FU NIH [ES015024, ES013995, P01HL071643]; Northwestern University Clinical
   and Translational Sciences Institute (NUCATS) [UL1 RR025741]; NMH
FX Sources of funding: NIH ES015024 (GMM), ES013995 (GRSB) and P01HL071643
   (GMM and GRSB) and the Northwestern University Clinical and
   Translational Sciences Institute (NUCATS) CTI Pilot Award (GMM) (UL1
   RR025741) and NMH Dixon Young Investigator Grant. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Baccarelli A, 2007, J THROMB HAEMOST, V5, P252, DOI 10.1111/j.1538-7836.2007.02300.x
   BASTARACHE J, 2007, THORAX
   Bastarache JA, 2008, AM J PHYSIOL-LUNG C, V294, pL874, DOI 10.1152/ajplung.00372.2007
   Bellmeyer A, 2007, AM J RESP CRIT CARE, V175, P587, DOI 10.1164/rccm.200603-312OC
   BONZINI M, 2009, J THROMB HAEMOST
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Cesari M, 2010, CARDIOVASC THER, V28, pe72, DOI 10.1111/j.1755-5922.2010.00171.x
   D'Ippoliti D, 2003, EPIDEMIOLOGY, V14, P528, DOI 10.1097/01.ede.0000082046.22919.72
   De Taeye BM, 2006, J BIOL CHEM, V281, P32796, DOI 10.1074/jbc.M606214200
   Diebold I, 2008, THROMB HAEMOSTASIS, V100, P984, DOI 10.1160/TH08-08-0524
   DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401
   Ghio AJ, 2003, INHAL TOXICOL, V15, P1465, DOI 10.1080/08958370390249111
   Ghio AJ, 2001, AM J RESP CRIT CARE, V164, P704, DOI 10.1164/ajrccm.164.4.2011089
   Ghio AJ, 2000, AM J RESP CRIT CARE, V162, P981, DOI 10.1164/ajrccm.162.3.9911115
   Graff DW, 2009, ENVIRON HEALTH PERSP, V117, P1089, DOI 10.1289/ehp0900558
   Hou BD, 2004, J BIOL CHEM, V279, P18127, DOI 10.1074/jbc.M310438200
   Huggins FE, 2000, J HAZARD MATER, V74, P1, DOI 10.1016/S0304-3894(99)00195-8
   Iochmann S, 1999, THROMB RES, V94, P165, DOI 10.1016/S0049-3848(98)00209-6
   Kerr R, 2001, BRIT J HAEMATOL, V115, P3, DOI 10.1046/j.1365-2141.2001.03061.x
   Ljungman P, 2009, ENVIRON HEALTH PERSP, V117, P1373, DOI 10.1289/ehp.0800370
   Maciejczyk P, 2005, INHAL TOXICOL, V17, P189, DOI 10.1080/08958370590912743
   Matute-Bello G, 2001, AM J RESP CRIT CARE, V163, P234, DOI 10.1164/ajrccm.163.1.9909034
   MEADE TW, 1993, LANCET, V342, P1076, DOI 10.1016/0140-6736(93)92062-X
   Mertens I, 2002, Obes Rev, V3, P85, DOI 10.1046/j.1467-789X.2002.00056.x
   Mills NL, 2007, NEW ENGL J MED, V357, P1075, DOI 10.1056/NEJMoa066314
   Mills NL, 2005, CIRCULATION, V112, P3930, DOI 10.1161/CIRCULATIONAHA.105.588962
   Mutlu GM, 2007, J CLIN INVEST, V117, P2952, DOI 10.1172/JCI30639
   Mutlu GM, 2006, AM J RESP CELL MOL, V34, P670, DOI 10.1165/rcmb.2005-0329OC
   Nemmar A, 2003, CIRCULATION, V107, P1202, DOI 10.1161/01.CIR.0000053568.13058.67
   Peters A, 2001, CIRCULATION, V103, P2810
   Plomgaard P, 2005, J APPL PHYSIOL, V98, P2019, DOI 10.1152/japplphysiol.01220.2004
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132
   Renckens R, 2005, J THROMB HAEMOST, V3, P1018, DOI 10.1111/j.1538-7836.2005.01311.x
   ROTHWARF DM, 1999, SCI STKE 1999
   Ruckerl R, 2006, AM J RESP CRIT CARE, V173, P432, DOI 10.1164/rccm.200507-1123OC
   Ruckerl R, 2007, ENVIRON HEALTH PERSP, V115, P1072, DOI 10.1289/ehp.10021
   Samad F, 1996, J CLIN INVEST, V97, P37, DOI 10.1172/JCI118404
   Shoenfelt J, 2009, J LEUKOCYTE BIOL, V86, P303, DOI 10.1189/jlb.1008587
   SIOUTAS C, 1995, ENVIRON HEALTH PERSP, V103, P172, DOI 10.2307/3432274
   Soberanes S, 2009, J BIOL CHEM, V284, P2176, DOI 10.1074/jbc.M808844200
   Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003
   Sun QH, 2008, INHAL TOXICOL, V20, P127, DOI 10.1080/08958370701821482 
   Thogersen AM, 1998, CIRCULATION, V98, P2241, DOI 10.1161/01.CIR.98.21.2241
   Urich D, 2009, FASEB J, V23, P2055, DOI 10.1096/fj.08-114546
   Venegas-Pont M, 2010, HYPERTENSION, V56, P643, DOI 10.1161/HYPERTENSIONAHA.110.157685
   Wagers SS, 2004, J CLIN INVEST, V114, P104, DOI 10.1172/JC1200419569
   Yan C, 2002, J BIOL CHEM, V277, P10967, DOI 10.1074/jbc.M109986200
NR 47
TC 55
Z9 55
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 11
PY 2011
VL 6
IS 4
AR e18525
DI 10.1371/journal.pone.0018525
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 747XH
UT WOS:000289354100016
PM 21494547
OA DOAJ Gold, Green Published
DA 2019-05-24
ER

EF